1	The	DT	O	the	det	3	SENT_1	[p1l31t81r79b103],
2	aryngoscope	NN	O	aryngoscope	nn	3	SENT_1	[p1l110t88r272b109],
3	©	NN	O	©	_	0	SENT_1	[p1l29t111r50b132],
4	2	CD	NUMBER	2	dep	3	SENT_1	[p1l60t111r74b132],
5	The	DT	O	the	det	14	SENT_1	[p1l134t110r185b132],
6	American	JJ	MISC	american	amod	7	SENT_1	[p1l195t110r326b132],
7	Laryngological	NNP	MISC	Laryngological	dep	14	SENT_1	[p1l337t110r542b138],
8	,	,	O	,	_	0	SENT_1	[p1l337t110r542b138],
9	Rhinological	NNP	PERSON	Rhinological	nn	12	SENT_1	[p1l30t139r197b167],
10	and	CC	O	and	_	0	SENT_1	[p1l208t139r257b162],
11	Otological	NNP	ORGANIZATION	Otological	nn	12	SENT_1	[p1l269t139r403b167],
12	Society	NNP	ORGANIZATION	Society	dep	7	SENT_1	[p1l414t139r513b167],
13	,	,	ORGANIZATION	,	_	0	SENT_1	[p1l414t139r513b167],
14	Inc.	NNP	ORGANIZATION	Inc.	dep	4	SENT_1	[p1l526t139r574b162],
15	.	.	O	.	_	0	SENT_1	[p1l526t139r574b162],

1	Gene	NNP	O	Gene	nn	4	SENT_2	[p1l34t304r266b380],
2	Single	JJ	O	single	amod	4	SENT_2	[p1l307t304r589b399],
3	Nucleotide	NN	O	nucleotide	nn	4	SENT_2	[p1l628t304r1118b380],
4	Polymorphism	NN	O	polymorphism	_	0	SENT_2	[p1l1157t304r1822b399],
5	Accumulation	NNP	O	Accumulation	nsubj	6	SENT_2	[p1l29t421r668b497],
6	Improves	VBZ	O	improve	rcmod	4	SENT_2	[p1l707t423r1130b516],
7	Survival	NNP	O	Survival	dobj	6	SENT_2	[p1l1172t421r1559b497],
8	in	IN	O	in	_	0	SENT_2	[p1l1597t423r1686b496],
9	Advanced	NNP	O	Advanced	nn	10	SENT_2	[p1l29t553r480b628],
10	Head	NNP	O	Head	prep_in	7	SENT_2	[p1l517t553r759b628],
11	and	CC	O	and	_	0	SENT_2	[p1l798t553r966b628],
12	Neck	NNP	O	Neck	nn	14	SENT_2	[p1l1002t553r1236b628],
13	Cancer	NNP	O	Cancer	nn	14	SENT_2	[p1l1273t553r1596b628],
14	Patients	NNPS	O	Patients	prep_in	7	SENT_2	[p1l1633t554r2014b628],

1	Treated	VBN	O	treat	_	0	SENT_3	[p1l31t703r385b779],
2	With	IN	O	with	_	0	SENT_3	[p1l420t703r644b779],
3	Weekly	NNP	SET	Weekly	nn	4	SENT_3	[p1l679t703r1015b798],
4	Paclitaxel	NN	O	paclitaxel	prep_with	1	SENT_3	[p1l1052t703r1505b779],

1	Juan	NNP	PERSON	Juan	nn	5	SENT_4	[p1l30t909r126b941],
2	J.	NNP	PERSON	J.	nn	5	SENT_4	[p1l141t909r172b941],
3	Grau	NNP	PERSON	Grau	nn	5	SENT_4	[p1l191t909r299b948],
4	,	,	O	,	_	0	SENT_4	[p1l191t909r299b948],
5	MD	NNP	O	MD	_	0	SENT_4	[p1l316t909r396b948],
6	,	,	O	,	_	0	SENT_4	[p1l316t909r396b948],
7	PhD	NN	O	phd	appos	5	SENT_4	[p1l414t909r508b948],
8	;	:	O	;	_	0	SENT_4	[p1l414t909r508b948],
9	Miguel	NNP	PERSON	Miguel	nn	10	SENT_4	[p1l525t909r658b949],
10	Caballero	NNP	PERSON	Caballero	dep	5	SENT_4	[p1l675t909r868b948],
11	,	,	O	,	_	0	SENT_4	[p1l675t909r868b948],
12	MD	NNP	O	MD	appos	10	SENT_4	[p1l885t909r965b948],
13	,	,	O	,	_	0	SENT_4	[p1l885t909r965b948],
14	PhD	NN	O	phd	appos	10	SENT_4	[p1l983t909r1077b948],
15	;	:	O	;	_	0	SENT_4	[p1l983t909r1077b948],
16	Marc	NNP	PERSON	Marc	nn	17	SENT_4	[p1l1094t909r1192b941],
17	Campayo	NNP	PERSON	Campayo	dep	10	SENT_4	[p1l1209t909r1397b949],
18	,	,	O	,	_	0	SENT_4	[p1l1209t909r1397b949],
19	MD	NN	O	md	appos	17	SENT_4	[p1l1414t909r1495b948],
20	;	:	O	;	_	0	SENT_4	[p1l1414t909r1495b948],
21	Sonia	NNP	PERSON	Sonia	nn	22	SENT_4	[p1l1513t909r1619b941],
22	Jansa	NNP	PERSON	Jansa	dep	10	SENT_4	[p1l1634t909r1757b948],
23	;	:	O	;	_	0	SENT_4	[p1l1634t909r1757b948],
24	Mauricio	NNP	PERSON	Mauricio	nn	25	SENT_4	[p1l30t954r201b985],
25	Vargas	NNP	PERSON	Vargas	dep	22	SENT_4	[p1l216t954r358b993],
26	,	,	O	,	_	0	SENT_4	[p1l216t954r358b993],
27	MD	NN	O	md	appos	25	SENT_4	[p1l375t954r456b992],
28	;	:	O	;	_	0	SENT_4	[p1l375t954r456b992],
29	Llucia	NNP	LOCATION	Llucia	nn	30	SENT_4	[p1l474t953r593b985],
30	Alés	NNP	LOCATION	Alés	dep	10	SENT_4	[p1l607t953r700b992],
31	,	,	O	,	_	0	SENT_4	[p1l607t953r700b992],
32	MD	NNP	O	MD	appos	30	SENT_4	[p1l717t954r797b992],
33	,	,	O	,	_	0	SENT_4	[p1l717t954r797b992],
34	PhD	NN	O	phd	appos	30	SENT_4	[p1l815t953r909b992],
35	;	:	O	;	_	0	SENT_4	[p1l815t953r909b992],
36	Mariano	NNP	PERSON	Mariano	nn	37	SENT_4	[p1l926t954r1088b985],
37	Monzo	NNP	PERSON	Monzo	dep	10	SENT_4	[p1l1104t954r1239b992],
38	,	,	O	,	_	0	SENT_4	[p1l1104t954r1239b992],
39	MD	NNP	O	MD	appos	37	SENT_4	[p1l1256t954r1337b992],
40	,	,	O	,	_	0	SENT_4	[p1l1256t954r1337b992],
41	PhD	NN	O	phd	appos	37	SENT_4	[p1l1354t953r1437b985],

1	Objectives/Hypothesis	NNP	O	Objectives/Hypothesis	_	0	SENT_5	[p1l242t1153r1184b1229],
2	:	:	O	:	_	0	SENT_5	[p1l242t1153r1184b1229],
3	Single	JJ	O	single	amod	5	SENT_5	[p1l1227t1153r1453b1229],
4	nucleotide	NN	O	nucleotide	nn	5	SENT_5	[p1l1494t1153r1870b1213],
5	polymorphisms	NNS	O	polymorphism	nsubj	6	SENT_5	[p1l1911t1153r2087b1229, p1l62t1241r469b1317],
6	(	VBP	O	(	dep	1	SENT_5	[p1l512t1241r766b1310],
7	SNPs	NNS	O	snp	nsubj	16	SENT_5	[p1l512t1241r766b1310],
8	)	CD	NUMBER	)	num	7	SENT_5	[p1l512t1241r766b1310],
9	of	IN	O	of	_	0	SENT_5	[p1l808t1241r880b1301],
10	certain	JJ	O	certain	amod	11	SENT_5	[p1l912t1242r1169b1301],
11	genes	NNS	O	gene	prep_of	7	SENT_5	[p1l1210t1260r1415b1317],
12	involved	VBN	O	involve	partmod	11	SENT_5	[p1l1456t1241r1766b1301],
13	in	IN	O	in	_	0	SENT_5	[p1l1806t1242r1878b1300],
14	drug	NN	O	drug	nn	15	SENT_5	[p1l1919t1241r2090b1317],
15	metabolism	NN	O	metabolism	prep_in	12	SENT_5	[p1l62t1329r488b1389],
16	correlate	VBP	O	correlate	ccomp	6	SENT_5	[p1l517t1329r840b1389],
17	with	IN	O	with	_	0	SENT_5	[p1l871t1329r1036b1389],
18	survival	NN	O	survival	prep_with	16	SENT_5	[p1l1068t1329r1383b1389],
19	.	.	O	.	_	0	SENT_5	[p1l1068t1329r1383b1389],

1	Methods	NNS	O	method	_	0	SENT_6	[p1l240t1417r615b1477],
2	:	:	O	:	_	0	SENT_6	[p1l240t1417r615b1477],
3	We	PRP	O	we	nsubj	4	SENT_6	[p1l653t1418r764b1477],
4	evaluated	VBD	O	evaluate	dep	1	SENT_6	[p1l797t1416r1157b1477],
5	the	DT	O	the	det	6	SENT_6	[p1l1188t1417r1304b1477],
6	presence	NN	O	presence	nsubj	12	SENT_6	[p1l1337t1437r1656b1493],
7	of	IN	O	of	_	0	SENT_6	[p1l1690t1417r1762b1477],
8	SNPs	NNS	O	snp	prep_of	6	SENT_6	[p1l1787t1417r1985b1477],
9	in	IN	O	in	_	0	SENT_6	[p1l2017t1418r2089b1476],
10	six	CD	NUMBER	six	num	11	SENT_6	[p1l65t1506r165b1565],
11	genes	NNS	O	gene	prep_in	8	SENT_6	[p1l188t1523r393b1580],
12	(	VBP	O	(	ccomp	4	SENT_6	[p1l419t1504r772b1578],
13	CYP2C8	NN	O	cyp2c8	dobj	12	SENT_6	[p1l419t1504r772b1578],
14	,	,	O	,	_	0	SENT_6	[p1l419t1504r772b1578],
15	GSTT1	NN	O	gstt1	dobj	12	SENT_6	[p1l801t1504r1085b1578],
16	,	,	O	,	_	0	SENT_6	[p1l801t1504r1085b1578],
17	GSTP1	NN	O	gstp1	dobj	12	SENT_6	[p1l1113t1504r1397b1578],
18	,	,	O	,	_	0	SENT_6	[p1l1113t1504r1397b1578],
19	MDR1-57	NN	O	mdr1-57	dobj	12	SENT_6	[p1l1420t1505r1796b1578],
20	,	,	O	,	_	0	SENT_6	[p1l1420t1505r1796b1578],
21	MDR162	NN	O	mdr162	dobj	12	SENT_6	[p1l1820t1505r2084b1565, p1l63t1595r167b1666],
22	,	,	O	,	_	0	SENT_6	[p1l1820t1505r2084b1565, p1l63t1595r167b1666],
23	and	CC	O	and	_	0	SENT_6	[p1l210t1592r345b1653],
24	ERCC1	NN	O	ercc1	conj_and	13	SENT_6	[p1l378t1592r681b1662],
25	)	NN	O	)	dep	13	SENT_6	[p1l378t1592r681b1662],
26	and	CC	O	and	_	0	SENT_6	[p1l721t1592r856b1653],
27	the	DT	O	the	det	32	SENT_6	[p1l893t1592r1009b1653],
28	response	NN	O	response	nn	32	SENT_6	[p1l1048t1613r1369b1668],
29	rate	NN	O	rate	nn	32	SENT_6	[p1l1408t1598r1555b1653],
30	(	CD	NUMBER	(	num	32	SENT_6	[p1l1595t1593r1778b1666],
31	RR	NN	O	rr	nn	32	SENT_6	[p1l1595t1593r1778b1666],
32	)	NN	O	)	dep	13	SENT_6	[p1l1595t1593r1778b1666],
33	,	,	O	,	_	0	SENT_6	[p1l1595t1593r1778b1666],
34	time	NN	O	time	conj_and	13	SENT_6	[p1l1819t1594r1982b1653],
35	to	TO	O	to	_	0	SENT_6	[p1l2021t1598r2088b1653],
36	progression	NN	O	progression	nn	39	SENT_6	[p1l63t1682r488b1757],
37	(	CD	NUMBER	(	num	39	SENT_6	[p1l565t1681r793b1754],
38	TTP	NN	O	ttp	nn	39	SENT_6	[p1l565t1681r793b1754],
39	)	NN	O	)	prep_to	34	SENT_6	[p1l565t1681r793b1754],
40	,	,	O	,	_	0	SENT_6	[p1l565t1681r793b1754],
41	and	CC	O	and	_	0	SENT_6	[p1l874t1681r1009b1741],
42	overall	JJ	O	overall	amod	43	SENT_6	[p1l1086t1681r1335b1741],
43	survival	NN	O	survival	conj_and	13	SENT_6	[p1l1413t1681r1710b1741],
44	(	CD	NUMBER	(	num	46	SENT_6	[p1l1787t1681r1948b1750],
45	OS	NN	O	os	nn	46	SENT_6	[p1l1787t1681r1948b1750],
46	)	NN	O	)	nsubj	54	SENT_6	[p1l1787t1681r1948b1750],
47	of	IN	O	of	_	0	SENT_6	[p1l2026t1681r2099b1741],
48	advanced	JJ	O	advanced	amod	49	SENT_6	[p1l64t1768r408b1829],
49	head	NN	O	head	prep_of	46	SENT_6	[p1l440t1768r617b1829],
50	and	CC	O	and	_	0	SENT_6	[p1l652t1768r787b1829],
51	neck	NN	O	neck	nn	53	SENT_6	[p1l820t1768r991b1829],
52	cancer	NN	O	cancer	nn	53	SENT_6	[p1l1024t1789r1261b1829],
53	patients	NNS	O	patient	prep_of	46	SENT_6	[p1l1294t1770r1592b1844],
54	treated	VBN	O	treat	rcmod	43	SENT_6	[p1l1626t1768r1891b1829],
55	with	IN	O	with	_	0	SENT_6	[p1l1923t1768r2089b1829],
56	weekly	JJ	SET	weekly	amod	57	SENT_6	[p1l62t1856r319b1932],
57	paclitaxel	NN	O	paclitaxel	prep_with	54	SENT_6	[p1l341t1856r715b1932],
58	.	.	O	.	_	0	SENT_6	[p1l341t1856r715b1932],

1	Results	NNS	O	result	_	0	SENT_7	[p1l240t1944r567b2005],
2	:	:	O	:	_	0	SENT_7	[p1l240t1944r567b2005],
3	SNPs	NNS	O	snp	nsubj	14	SENT_7	[p1l656t1944r855b2005],
4	in	IN	O	in	_	0	SENT_7	[p1l935t1946r1007b2004],
5	CYP2C8	NN	O	cyp2c8	nn	7	SENT_7	[p1l1088t1944r1414b2018],
6	,	,	O	,	_	0	SENT_7	[p1l1088t1944r1414b2018],
7	MDR1-57	NN	O	mdr1-57	prep_in	3	SENT_7	[p1l1494t1945r1870b2018],
8	,	,	O	,	_	0	SENT_7	[p1l1494t1945r1870b2018],
9	and	CC	O	and	_	0	SENT_7	[p1l1954t1944r2089b2005],
10	MDR1-62	NN	O	mdr1-62	nn	11	SENT_7	[p1l59t2033r414b2093],
11	genes	NNS	O	gene	prep_in	3	SENT_7	[p1l463t2052r668b2108],
12	were	VBD	O	be	cop	14	SENT_7	[p1l716t2053r891b2093],
13	more	RBR	O	more	advmod	14	SENT_7	[p1l938t2053r1121b2093],
14	frequent	JJ	O	frequent	dep	1	SENT_7	[p1l1169t2032r1484b2108],
15	than	IN	O	than	_	0	SENT_7	[p1l1529t2032r1700b2093],
16	wild-type	JJ	O	wild-type	amod	17	SENT_7	[p1l1746t2032r2087b2108],
17	genes	NNS	O	gene	prep_than	14	SENT_7	[p1l62t2140r268b2196],
18	in	IN	O	in	_	0	SENT_7	[p1l293t2122r364b2180],
19	our	PRP$	O	we	poss	20	SENT_7	[p1l390t2141r512b2181],
20	patients	NNS	O	patient	prep_in	17	SENT_7	[p1l536t2122r852b2196],
21	.	.	O	.	_	0	SENT_7	[p1l536t2122r852b2196],

1	RR	NN	O	rr	nsubj	16	SENT_8	[p1l882t2121r995b2181],
2	was	VBD	O	be	cop	4	SENT_8	[p1l1017t2141r1158b2181],
3	45	CD	PERCENT	45	num	4	SENT_8	[p1l1184t2123r1334b2181],
4	%	NN	PERCENT	%	rcmod	1	SENT_8	[p1l1184t2123r1334b2181],
5	(	CD	NUMBER	(	number	6	SENT_8	[p1l1360t2120r1629b2194],
6	21/47	CD	NUMBER	21/47	num	7	SENT_8	[p1l1360t2120r1629b2194],
7	)	NN	O	)	attr	4	SENT_8	[p1l1360t2120r1629b2194],
8	,	,	O	,	_	0	SENT_8	[p1l1360t2120r1629b2194],
9	and	CC	O	and	_	0	SENT_8	[p1l1658t2120r1793b2181],
10	median	JJ	O	median	amod	11	SENT_8	[p1l1816t2120r2089b2181],
11	TTP	NN	O	ttp	attr	4	SENT_8	[p1l62t2209r220b2268],
12	in	IN	O	in	_	0	SENT_8	[p1l247t2210r318b2268],
13	responders	NNS	O	responder	prep_in	11	SENT_8	[p1l346t2208r748b2284],
14	was	VBD	O	be	cop	16	SENT_8	[p1l776t2228r916b2269],
15	5.1	CD	DURATION	5.1	num	16	SENT_8	[p1l947t2210r1051b2269],
16	months	NNS	NUMBER	month	_	0	SENT_8	[p1l1081t2208r1373b2269],
17	.	.	O	.	_	0	SENT_8	[p1l1081t2208r1373b2269],

1	OS	NNP	O	OS	nsubj	7	SENT_9	[p1l1407t2208r1514b2269],
2	for	IN	O	for	_	0	SENT_9	[p1l1542t2208r1643b2269],
3	all	DT	O	all	det	4	SENT_9	[p1l1672t2208r1761b2269],
4	patients	NNS	O	patient	prep_for	1	SENT_9	[p1l1790t2210r2088b2284],
5	was	VBD	O	be	cop	7	SENT_9	[p1l62t2316r202b2357],
6	5.6	CD	DURATION	5.6	num	7	SENT_9	[p1l258t2298r363b2357],
7	months	NNS	NUMBER	month	_	0	SENT_9	[p1l416t2296r708b2357],
8	.	.	O	.	_	0	SENT_9	[p1l416t2296r708b2357],

1	Response	NN	O	response	nsubj	3	SENT_10	[p1l765t2297r1107b2372],
2	was	VBD	O	be	cop	3	SENT_10	[p1l1160t2316r1301b2357],
3	higher	JJR	O	higher	_	0	SENT_10	[p1l1353t2296r1594b2372],
4	in	IN	O	in	_	0	SENT_10	[p1l1646t2298r1718b2356],
5	SNPs	NNS	O	snp	prep_in	3	SENT_10	[p1l1773t2296r1971b2357],
6	of	IN	O	of	_	0	SENT_10	[p1l2026t2296r2099b2357],
7	MDR1-62	NN	O	mdr1-62	prep_of	5	SENT_10	[p1l59t2385r435b2458],
8	,	,	O	,	_	0	SENT_10	[p1l59t2385r435b2458],
9	MDR1-57	NN	O	mdr1-57	appos	7	SENT_10	[p1l474t2385r851b2458],
10	,	,	O	,	_	0	SENT_10	[p1l474t2385r851b2458],
11	or	CC	O	or	_	0	SENT_10	[p1l894t2405r967b2445],
12	in	IN	O	in	_	0	SENT_10	[p1l1005t2386r1077b2444],
13	two	CD	NUMBER	two	num	17	SENT_10	[p1l1116t2390r1245b2445],
14	or	CC	O	or	_	0	SENT_10	[p1l1287t2405r1359b2445],
15	more	JJR	O	more	num	17	SENT_10	[p1l1398t2405r1580b2445],
16	accumulated	VBN	O	accumulate	amod	17	SENT_10	[p1l1622t2384r2089b2445],
17	genes	NNS	O	gene	conj_or	5	SENT_10	[p1l62t2492r268b2549],
18	than	IN	O	than	dep	3	SENT_10	[p1l298t2473r469b2533],
19	in	IN	O	in	_	0	SENT_10	[p1l499t2474r571b2532],
20	those	DT	O	those	prep_in	3	SENT_10	[p1l600t2473r793b2533],
21	with	IN	O	with	_	0	SENT_10	[p1l824t2473r989b2533],
22	wild-type	JJ	O	wild-type	amod	23	SENT_10	[p1l1018t2473r1360b2549],
23	genes	NNS	O	gene	prep_with	20	SENT_10	[p1l1391t2492r1615b2549],
24	.	.	O	.	_	0	SENT_10	[p1l1391t2492r1615b2549],

1	OS	NN	O	os	nsubjpass	11	SENT_11	[p1l1652t2473r1759b2533],
2	was	VBD	O	be	auxpass	11	SENT_11	[p1l1789t2493r1929b2533],
3	signiﬁcantly	RB	O	signiﬁcantly	advmod	11	SENT_11	[p1l1962t2474r2087b2549, p1l62t2560r414b2636],
4	longer	RBR	O	longer	advmod	11	SENT_11	[p1l440t2560r672b2636],
5	in	IN	O	in	_	0	SENT_11	[p1l697t2562r769b2620],
6	patients	NNS	O	patient	prep_in	4	SENT_11	[p1l796t2562r1094b2636],
7	with	IN	O	with	_	0	SENT_11	[p1l1121t2560r1287b2621],
8	two	CD	NUMBER	two	prep_with	6	SENT_11	[p1l1312t2565r1443b2621],
9	or	CC	O	or	_	0	SENT_11	[p1l1471t2580r1543b2621],
10	more	JJR	O	more	prep_with	6	SENT_11	[p1l1570t2580r1753b2621],
11	accumulated	VBN	O	accumulate	_	0	SENT_11	[p1l1782t2580r2088b2621, p1l62t2649r246b2709],
12	SNPS	NNP	O	SNPS	nn	17	SENT_11	[p1l271t2649r469b2709],
13	(	CD	NUMBER	(	num	14	SENT_11	[p1l494t2649r572b2717],
14	P	NN	O	p	dep	12	SENT_11	[p1l494t2649r572b2717],
15	=	JJ	O	=	amod	17	SENT_11	[p1l596t2678r650b2697],
16	.039	CD	NUMBER	.039	tmod	15	SENT_11	[p1l670t2649r862b2717],
17	)	NN	O	)	dobj	11	SENT_11	[p1l670t2649r862b2717],
18	.	.	O	.	_	0	SENT_11	[p1l670t2649r862b2717],

1	Conclusions	NNS	O	conclusion	_	0	SENT_12	[p1l242t2736r768b2796],
2	:	:	O	:	_	0	SENT_12	[p1l242t2736r768b2796],
3	Response	NN	O	response	nsubj	9	SENT_12	[p1l798t2737r1140b2812],
4	rate	NN	O	rate	amod	3	SENT_12	[p1l1171t2741r1318b2796],
5	and	CC	O	and	_	0	SENT_12	[p1l1351t2736r1486b2796],
6	OS	NN	O	os	amod	3	SENT_12	[p1l1516t2736r1623b2796],
7	were	VBD	O	be	cop	9	SENT_12	[p1l1653t2756r1828b2796],
8	significantly	RB	O	significantly	advmod	9	SENT_12	[p1l1861t2736r2087b2812, p1l62t2823r314b2899],
9	higher	JJR	O	higher	dep	1	SENT_12	[p1l350t2823r591b2899],
10	in	IN	O	in	_	0	SENT_12	[p1l628t2825r700b2883],
11	patients	NNS	O	patient	prep_in	9	SENT_12	[p1l739t2825r1037b2899],
12	with	IN	O	with	_	0	SENT_12	[p1l1075t2823r1241b2884],
13	two	CD	NUMBER	two	num	17	SENT_12	[p1l1278t2828r1408b2884],
14	or	CC	O	or	_	0	SENT_12	[p1l1448t2843r1521b2884],
15	more	JJR	O	more	num	17	SENT_12	[p1l1558t2843r1741b2884],
16	accumulated	VBN	O	accumulate	amod	17	SENT_12	[p1l1782t2843r2088b2884, p1l62t2912r246b2972],
17	SNPs	NNS	O	snp	prep_with	11	SENT_12	[p1l277t2912r495b2972],
18	.	.	O	.	_	0	SENT_12	[p1l277t2912r495b2972],

1	Key	NN	O	key	nn	2	SENT_13	[p1l240t3001r398b3076],
2	Words	NNS	O	word	_	0	SENT_13	[p1l418t3000r694b3060],
3	:	:	O	:	_	0	SENT_13	[p1l418t3000r694b3060],
4	Head	NNP	O	Head	dep	2	SENT_13	[p1l718t3000r911b3060],
5	and	CC	O	and	_	0	SENT_13	[p1l935t3000r1069b3060],
6	neck	NN	O	neck	nn	7	SENT_13	[p1l1092t3000r1261b3060],
7	cancer	NN	O	cancer	dep	2	SENT_13	[p1l1283t3020r1532b3074],
8	,	,	O	,	_	0	SENT_13	[p1l1283t3020r1532b3074],
9	chemotherapy	NN	O	chemotherapy	appos	7	SENT_13	[p1l1559t3000r2086b3076],
10	,	,	O	,	_	0	SENT_13	[p1l1559t3000r2086b3076],

1	paclitaxel	NN	O	paclitaxel	_	0	SENT_14	[p1l63t3087r434b3163],
2	,	,	O	,	_	0	SENT_14	[p1l63t3087r434b3163],
3	genotypes	NNS	O	genotype	appos	1	SENT_14	[p1l460t3093r841b3163],
4	,	,	O	,	_	0	SENT_14	[p1l460t3093r841b3163],
5	polymorphisms	NNS	O	polymorphism	appos	3	SENT_14	[p1l867t3087r1442b3163],
6	.	.	O	.	_	0	SENT_14	[p1l867t3087r1442b3163],

1	Laryngoscope	NN	O	laryngoscope	_	0	SENT_15	[p1l677t3177r1259b3252],
2	,	,	O	,	_	0	SENT_15	[p1l677t3177r1259b3252],
3	119:1484	CD	NUMBER	119:1484	number	4	SENT_15	[p1l1301t3178r1877b3250],
4	—	CD	NUMBER	—	appos	1	SENT_15	[p1l1301t3178r1877b3250],
5	1490	CD	DATE	1490	dep	1	SENT_15	[p1l1301t3178r1877b3250],
6	,	,	DATE	,	_	0	SENT_15	[p1l1301t3178r1877b3250],
7	2009	CD	DATE	2009	appos	5	SENT_15	[p1l1908t3178r2088b3236],

1	INTRODUCTION	NN	O	introduction	_	0	SENT_16	[p1l9t3412r764b3475],

1	It	PRP	O	it	nsubjpass	4	SENT_17	[p1l188t3513r248b3572],
2	is	VBZ	O	be	auxpass	4	SENT_17	[p1l294t3513r352b3572],
3	well	RB	O	well	advmod	4	SENT_17	[p1l400t3512r550b3572],
4	known	VBN	O	know	_	0	SENT_17	[p1l597t3512r844b3572],
5	that	IN	O	that	complm	13	SENT_17	[p1l890t3512r1043b3572],
6	the	DT	O	the	det	7	SENT_17	[p1l1090t3512r1206b3572],
7	efﬁcacy	NN	O	efﬁcacy	nsubj	13	SENT_17	[p1l1256t3512r1530b3588],
8	and	CC	O	and	_	0	SENT_17	[p1l1578t3512r1713b3572],
9	toxicity	NN	O	toxicity	nsubj	13	SENT_17	[p1l1760t3513r2032b3588],
10	of	IN	O	of	_	0	SENT_17	[p1l2079t3512r2152b3572],
11	most	JJS	O	most	amod	12	SENT_17	[p1l9t3614r185b3669],
12	drugs	NNS	O	drug	prep_of	7	SENT_17	[p1l217t3608r423b3684],
13	exhibit	VBP	O	exhibit	ccomp	4	SENT_17	[p1l457t3608r711b3669],
14	wide	JJ	O	wide	amod	16	SENT_17	[p1l741t3608r911b3669],
15	interpatient	JJ	O	interpatient	amod	16	SENT_17	[p1l943t3610r1388b3684],
16	variability	NN	O	variability	dobj	13	SENT_17	[p1l1418t3608r1811b3684],
17	.	.	O	.	_	0	SENT_17	[p1l1418t3608r1811b3684],

1	In	IN	O	in	_	0	SENT_18	[p1l1849t3610r1926b3668],
2	addition	NN	O	addition	pobj	1	SENT_18	[p1l1960t3608r2141b3669, p1l9t3708r151b3767],
3	to	TO	O	to	_	0	SENT_18	[p1l228t3712r295b3767],
4	environmental	JJ	O	environmental	amod	5	SENT_18	[p1l375t3706r913b3767],
5	inﬂuences	NNS	O	inﬂuences	prep_to	2	SENT_18	[p1l991t3706r1384b3780],
6	,	,	O	,	_	0	SENT_18	[p1l991t3706r1384b3780],
7	variation	NN	O	variation	appos	5	SENT_18	[p1l1463t3708r1799b3767],
8	in	IN	O	in	_	0	SENT_18	[p1l1876t3708r1948b3766],
9	the	DT	O	the	prep_in	7	SENT_18	[p1l2025t3706r2141b3767],

1	From	IN	O	from	_	0	SENT_19	[p2l187t97r345b144],
2	the	DT	O	the	det	4	SENT_19	[p2l391t97r485b144],
3	Oncology	NNP	ORGANIZATION	Oncology	nn	4	SENT_19	[p2l534t96r805b156],
4	Department	NNP	ORGANIZATION	Department	prep_from	52	SENT_19	[p2l851t97r1228b156],
5	,	,	O	,	_	0	SENT_19	[p2l851t97r1228b156],
6	ICMHO	NNP	O	ICMHO	nn	9	SENT_19	[p2l1279t97r1510b144],
7	(	CD	NUMBER	(	num	9	SENT_19	[p2l1559t97r1811b150],
8	Institut	NNP	ORGANIZATION	Institut	nn	9	SENT_19	[p2l1559t97r1811b150],
9	Clinic	NNP	ORGANIZATION	Clinic	nsubj	52	SENT_19	[p2l1858t97r2030b144],
10	de	IN	O	de	_	0	SENT_19	[p2l2079t97r2142b144],
11	Malalties	NNP	O	Malalties	nn	12	SENT_19	[p2l9t167r317b214],
12	Hemato-Oncologiques	NNP	O	Hemato-Oncologiques	prep_de	9	SENT_19	[p2l373t167r1120b226],
13	)	NN	O	)	dep	20	SENT_19	[p2l373t167r1120b226],
14	and	CC	O	and	_	0	SENT_19	[p2l1178t167r1293b214],
15	IDIBAPS	NN	O	idibap	dep	20	SENT_19	[p2l1348t167r1645b214],
16	(	CD	NUMBER	(	dep	20	SENT_19	[p2l1700t168r2018b221],
17	Instituto	NNP	O	Instituto	nn	20	SENT_19	[p2l1700t168r2018b221],
18	de	IN	O	de	amod	20	SENT_19	[p2l2074t167r2142b214],
19	Investigaciones	NNP	O	Investigaciones	nn	20	SENT_19	[p2l9t240r451b298],
20	Biomédicas	NNP	O	Biomédicas	dep	26	SENT_19	[p2l486t239r811b286],
21	Augusto	NNP	O	Augusto	nn	23	SENT_19	[p2l844t239r1082b298],
22	Pi	NNP	O	Pi	nn	23	SENT_19	[p2l1117t240r1175b285],
23	Sunyer	NNP	O	Sunyer	dep	20	SENT_19	[p2l1211t239r1435b298],
24	)	CD	NUMBER	)	number	25	SENT_19	[p2l1211t239r1435b298],
25	(	CD	NUMBER	(	dep	23	SENT_19	[p2l1470t239r1638b296],
26	J.J.G.	NNP	O	J.J.G.	dep	9	SENT_19	[p2l1470t239r1638b296],
27	,	,	O	,	_	0	SENT_19	[p2l1470t239r1638b296],
28	M.	NNP	PERSON	M.	nn	29	SENT_19	[p2l1674t253r1970b296],
29	CAMPAYO	NNP	PERSON	CAMPAYO	appos	26	SENT_19	[p2l1674t253r1970b296],
30	,	,	O	,	_	0	SENT_19	[p2l1674t253r1970b296],
31	M.V.	NNP	O	M.V.	nn	32	SENT_19	[p2l2006t239r2140b296],
32	)	NNP	O	)	appos	26	SENT_19	[p2l2006t239r2140b296],
33	,	,	O	,	_	0	SENT_19	[p2l2006t239r2140b296],
34	Otorhinolaryngology	NNP	ORGANIZATION	Otorhinolaryngology	nn	39	SENT_19	[p2l10t309r634b369],
35	Department	NNP	ORGANIZATION	Department	nn	39	SENT_19	[p2l681t310r1046b369],
36	(	NNP	O	(	nn	39	SENT_19	[p2l1093t310r1169b363],
37	M.	NNP	PERSON	M.	nn	39	SENT_19	[p2l1093t310r1169b363],
38	CABALLERO	NNP	PERSON	CABALLERO	nn	39	SENT_19	[p2l1221t310r1553b367],
39	)	NN	O	)	appos	26	SENT_19	[p2l1221t310r1553b367],
40	,	,	O	,	_	0	SENT_19	[p2l1221t310r1553b367],
41	Human	JJ	O	human	amod	45	SENT_19	[p2l1603t310r1825b357],
42	Anatomy	NNP	O	Anatomy	nn	45	SENT_19	[p2l1871t309r2143b369],
43	Department	NNP	O	Department	nn	45	SENT_19	[p2l9t382r358b440],
44	(	NN	O	(	nn	45	SENT_19	[p2l400t382r520b439],
45	s.J.	NN	O	s.j.	appos	26	SENT_19	[p2l400t382r520b439],
46	,	,	O	,	_	0	SENT_19	[p2l400t382r520b439],
47	M.M.	NNP	O	M.M.	nn	48	SENT_19	[p2l563t381r715b439],
48	)	NNP	O	)	appos	26	SENT_19	[p2l563t381r715b439],
49	,	,	O	,	_	0	SENT_19	[p2l563t381r715b439],
50	Pathology	NNP	O	Pathology	nn	51	SENT_19	[p2l760t381r1047b440],
51	Department	NNP	O	Department	appos	26	SENT_19	[p2l1088t382r1437b440],
52	(	VBD	O	(	_	0	SENT_19	[p2l1480t381r1629b439],
53	L.A.	NNP	LOCATION	L.A.	nn	54	SENT_19	[p2l1480t381r1629b439],
54	)	NNP	O	)	nsubj	65	SENT_19	[p2l1480t381r1629b439],
55	,	,	O	,	_	0	SENT_19	[p2l1480t381r1629b439],
56	Hospital	NNP	ORGANIZATION	Hospital	nn	57	SENT_19	[p2l1673t381r1916b440],
57	Clinic	NNP	ORGANIZATION	Clinic	appos	54	SENT_19	[p2l1959t381r2140b439],
58	,	,	O	,	_	0	SENT_19	[p2l1959t381r2140b439],
59	University	NNP	ORGANIZATION	University	appos	54	SENT_19	[p2l8t453r315b511],
60	of	IN	ORGANIZATION	of	_	0	SENT_19	[p2l338t452r394b499],
61	Barcelona	NNP	ORGANIZATION	Barcelona	prep_of	59	SENT_19	[p2l410t452r711b510],
62	,	,	O	,	_	0	SENT_19	[p2l410t452r711b510],
63	Barcelona	NNP	ORGANIZATION	Barcelona	appos	54	SENT_19	[p2l738t452r1040b510],
64	,	,	O	,	_	0	SENT_19	[p2l738t452r1040b510],
65	Spain	NNP	LOCATION	Spain	xcomp	52	SENT_19	[p2l1068t452r1244b511],
66	.	.	O	.	_	0	SENT_19	[p2l1068t452r1244b511],

1	Editor	NNP	O	Editor	poss	3	SENT_20	[p2l187t532r410b579],
2	’s	POS	O	’s	_	0	SENT_20	[p2l187t532r410b579],
3	Note	NN	O	note	_	0	SENT_20	[p2l441t533r590b579],
4	:	:	O	:	_	0	SENT_20	[p2l441t533r590b579],
5	This	DT	O	this	det	6	SENT_20	[p2l623t532r748b579],
6	Manuscript	NN	O	manuscript	dep	3	SENT_20	[p2l779t533r1112b591],
7	was	VBD	O	be	auxpass	8	SENT_20	[p2l1141t548r1250b579],
8	accepted	VBN	O	accept	rcmod	6	SENT_20	[p2l1282t532r1528b591],
9	for	IN	O	for	_	0	SENT_20	[p2l1558t532r1636b579],
10	publication	NN	O	publication	prep_for	8	SENT_20	[p2l1666t532r1986b591],
11	February	NNP	DATE	February	tmod	8	SENT_20	[p2l2017t532r2141b579, p2l8t620r169b663],
12	12	CD	DATE	12	num	11	SENT_20	[p2l197t606r273b661],
13	,	,	DATE	,	_	0	SENT_20	[p2l197t606r273b661],
14	2009	CD	DATE	2009	num	11	SENT_20	[p2l300t606r448b651],
15	.	.	O	.	_	0	SENT_20	[p2l300t606r448b651],

1	Send	VB	O	send	_	0	SENT_21	[p2l188t685r329b732],
2	correspondence	NN	O	correspondence	dobj	1	SENT_21	[p2l376t685r816b744],
3	to	TO	O	to	_	0	SENT_21	[p2l864t689r916b732],
4	Miguel	NNP	PERSON	Miguel	nn	5	SENT_21	[p2l963t685r1162b744],
5	Caballero	NNP	PERSON	Caballero	prep_to	1	SENT_21	[p2l1210t685r1499b743],
6	,	,	O	,	_	0	SENT_21	[p2l1210t685r1499b743],
7	Otorhinolaryngology	NNP	ORGANIZATION	Otorhinolaryngology	nn	8	SENT_21	[p2l1550t685r2143b744],
8	Department	NNP	ORGANIZATION	Department	appos	5	SENT_21	[p2l9t757r372b815],
9	,	,	O	,	_	0	SENT_21	[p2l9t757r372b815],
10	Hospital	NNP	ORGANIZATION	Hospital	nn	11	SENT_21	[p2l425t756r667b815],
11	Clinic	NNP	ORGANIZATION	Clinic	appos	5	SENT_21	[p2l718t756r899b814],
12	,	,	O	,	_	0	SENT_21	[p2l718t756r899b814],
13	University	NNP	ORGANIZATION	University	appos	5	SENT_21	[p2l951t757r1258b815],
14	of	IN	ORGANIZATION	of	_	0	SENT_21	[p2l1308t756r1364b803],
15	Barcelona	NNP	ORGANIZATION	Barcelona	nn	18	SENT_21	[p2l1407t756r1708b814],
16	,	,	O	,	_	0	SENT_21	[p2l1407t756r1708b814],
17	Villarroel	NNP	PERSON	Villarroel	appos	18	SENT_21	[p2l1759t756r2032b803],
18	St	NNP	O	St	prep_of	13	SENT_21	[p2l2083t756r2143b803],
19	170-08036	CD	NUMBER	170-08036	num	18	SENT_21	[p2l13t829r332b884],
20	,	,	O	,	_	0	SENT_21	[p2l13t829r332b884],
21	Barcelona	NNP	ORGANIZATION	Barcelona	nn	23	SENT_21	[p2l358t827r659b884],
22	,	,	O	,	_	0	SENT_21	[p2l358t827r659b884],
23	Spain	NNP	LOCATION	Spain	appos	18	SENT_21	[p2l687t827r863b886],
24	.	.	O	.	_	0	SENT_21	[p2l687t827r863b886],

1	E-mail	NN	O	e-mail	_	0	SENT_22	[p2l891t827r1097b874],
2	:	:	O	:	_	0	SENT_22	[p2l891t827r1097b874],
3	mcaba@clinic.ub.es	NNS	O	mcaba@clinic.ub.es	dep	1	SENT_22	[p2l1123t827r1674b874],

1	DOI	NNP	O	DOI	_	0	SENT_23	[p2l186t969r333b1016],
2	:	:	O	:	_	0	SENT_23	[p2l186t969r333b1016],
3	10.1002	CD	NUMBER	10.1002	dep	1	SENT_23	[p2l360t969r925b1028],
4	/	:	O	/	punct	6	SENT_23	[p2l360t969r925b1028],
5	lary	JJ	O	lary	amod	6	SENT_23	[p2l360t969r925b1028],
6	.20254	NN	NUMBER	.20254	dep	3	SENT_23	[p2l360t969r925b1028],

1	Laryngoscope	NN	O	laryngoscope	_	0	SENT_24	[p2l13t1188r516b1262],
2	119	CD	NUMBER	119	num	1	SENT_24	[p2l551t1188r693b1246],
3	:	:	O	:	_	0	SENT_24	[p2l551t1188r693b1246],
4	August	NNP	DATE	August	dep	1	SENT_24	[p2l726t1188r975b1262],
5	2009	CD	DATE	2009	num	4	SENT_24	[p2l1006t1188r1177b1246],

1	1484	CD	DATE	1484	num	3	SENT_25	[p2l15t1323r201b1388],
2	genetic	JJ	O	genetic	amod	3	SENT_25	[p2l7t1422r268b1496],
3	constitution	NN	O	constitution	nsubj	7	SENT_25	[p2l327t1422r766b1481],
4	of	IN	O	of	_	0	SENT_25	[p2l823t1421r896b1481],
5	individuals	NNS	O	individual	prep_of	3	SENT_25	[p2l943t1421r1354b1481],
6	will	MD	O	will	aux	7	SENT_25	[p2l1411t1421r1546b1481],
7	have	VB	O	have	_	0	SENT_25	[p2l1603t1421r1776b1481],
8	a	DT	O	a	det	10	SENT_25	[p2l1835t1441r1876b1481],
9	major	JJ	O	major	amod	10	SENT_25	[p2l1931t1422r2144b1496],
10	impact	NN	O	impact	dobj	7	SENT_25	[p2l7t1519r258b1593],
11	on	IN	O	on	_	0	SENT_25	[p2l315t1538r400b1578],
12	drug	NN	O	drug	nn	13	SENT_25	[p2l458t1517r630b1593],
13	metabolism	NN	O	metabolism	prep_on	10	SENT_25	[p2l685t1517r1128b1578],
14	.	.	O	.	_	0	SENT_25	[p2l685t1517r1128b1578],

1	Pharmacogenetic	JJ	MISC	pharmacogenetic	amod	2	SENT_26	[p2l1190t1517r1825b1593],
2	studies	NNS	O	study	nsubj	4	SENT_26	[p2l1884t1517r2142b1578],
3	may	MD	O	may	aux	4	SENT_26	[p2l7t1635r163b1690],
4	detect	VB	O	detect	_	0	SENT_26	[p2l195t1614r415b1675],
5	the	DT	O	the	det	7	SENT_26	[p2l444t1614r560b1675],
6	hereditary	JJ	O	hereditary	amod	7	SENT_26	[p2l591t1614r981b1690],
7	basis	NN	O	basis	dobj	4	SENT_26	[p2l1009t1614r1193b1675],
8	for	IN	O	for	_	0	SENT_26	[p2l1224t1614r1325b1675],
9	interpatient	JJ	O	interpatient	amod	10	SENT_26	[p2l1355t1616r1800b1690],
10	differences	NNS	O	difference	prep_for	4	SENT_26	[p2l1832t1614r2142b1675, p2l8t1732r115b1772],
11	in	IN	O	in	_	0	SENT_26	[p2l155t1713r227b1771],
12	drug	NN	O	drug	nn	13	SENT_26	[p2l267t1712r438b1788],
13	response	NN	O	response	prep_in	10	SENT_26	[p2l475t1732r815b1788],
14	.	.	O	.	_	0	SENT_26	[p2l475t1732r815b1788],

1	These	DT	O	these	det	2	SENT_27	[p2l858t1712r1074b1772],
2	differences	NNS	O	difference	nsubj	4	SENT_27	[p2l1116t1712r1512b1772],
3	are	VBP	O	be	cop	4	SENT_27	[p2l1554t1732r1669b1772],
4	due	JJ	O	due	_	0	SENT_27	[p2l1710t1712r1839b1772],
5	in	IN	O	in	_	0	SENT_27	[p2l1879t1713r1951b1771],
6	part	NN	O	part	prep_in	4	SENT_27	[p2l1989t1717r2144b1788],
7	to	TO	O	to	_	0	SENT_27	[p2l7t1814r74b1869],
8	polymorphisms	NNS	O	polymorphism	prep_to	4	SENT_27	[p2l121t1808r682b1884],
9	in	IN	O	in	_	0	SENT_27	[p2l728t1810r800b1868],
10	genes	NNS	O	gene	prep_in	8	SENT_27	[p2l845t1828r1050b1884],
11	encoding	VBG	O	encode	partmod	10	SENT_27	[p2l1098t1808r1425b1884],
12	drug-metabolizing	JJ	O	drug-metabolizing	amod	13	SENT_27	[p2l1470t1808r2145b1884],
13	enzymes	NNS	O	enzyme	dobj	11	SENT_27	[p2l8t1925r342b1981],
14	,	,	O	,	_	0	SENT_27	[p2l8t1925r342b1981],
15	drug	NN	O	drug	nn	16	SENT_27	[p2l398t1905r569b1981],
16	transporters	NNS	O	transporter	conj_and	13	SENT_27	[p2l618t1910r1096b1981],
17	,	,	O	,	_	0	SENT_27	[p2l618t1910r1096b1981],
18	and	CC	O	and	_	0	SENT_27	[p2l1153t1905r1288b1966],
19	genes	NNS	O	gene	conj_and	13	SENT_27	[p2l1339t1924r1543b1981],
20	that	WDT	O	that	nsubj	23	SENT_27	[p2l1595t1905r1748b1966],
21	recognize	VBP	O	recognize	rcmod	19	SENT_27	[p2l1798t1907r2142b1981],
22	and	CC	O	and	_	0	SENT_27	[p2l9t2004r144b2064],
23	repair	VBP	O	repair	conj_and	21	SENT_27	[p2l176t2005r401b2079],
24	DNA	NN	O	dna	nn	25	SENT_27	[p2l433t2004r618b2064],
25	lesions	NNS	O	lesion	dobj	21	SENT_27	[p2l647t2004r915b2064],
26	.	.	O	.	_	0	SENT_27	[p2l647t2004r915b2064],

1	The	DT	O	the	det	4	SENT_28	[p2l953t2004r1091b2064],
2	most	RBS	O	most	advmod	3	SENT_28	[p2l1125t2009r1302b2064],
3	frequent	JJ	O	frequent	amod	4	SENT_28	[p2l1333t2004r1647b2079],
4	type	NN	O	type	nsubj	13	SENT_28	[p2l1679t2009r1835b2079],
5	of	IN	O	of	_	0	SENT_28	[p2l1870t2004r1942b2064],
6	polymorphism	NN	O	polymorphism	prep_of	4	SENT_28	[p2l1966t2004r2142b2079, p2l7t2101r379b2177],
7	is	VBZ	O	be	cop	13	SENT_28	[p2l418t2102r476b2161],
8	the	DT	O	the	det	13	SENT_28	[p2l515t2101r632b2161],
9	single-nucleotide	JJ	O	single-nucleotide	amod	13	SENT_28	[p2l674t2101r1295b2177],
10	polymorphism	NN	O	polymorphism	nn	13	SENT_28	[p2l1337t2101r1863b2177],
11	(	NN	O	(	nn	13	SENT_28	[p2l1903t2101r2140b2175],
12	SNP	NN	ORGANIZATION	snp	nn	13	SENT_28	[p2l1903t2101r2140b2175],
13	)	NN	O	)	ccomp	35	SENT_28	[p2l1903t2101r2140b2175],
14	,	,	O	,	_	0	SENT_28	[p2l1903t2101r2140b2175],
15	which	WDT	O	which	nsubj	16	SENT_28	[p2l6t2197r226b2258],
16	accounts	VBZ	O	account	rcmod	13	SENT_28	[p2l266t2203r582b2258],
17	for	IN	O	for	dep	16	SENT_28	[p2l621t2197r722b2258],
18	over	IN	O	over	_	0	SENT_28	[p2l759t2218r916b2258],
19	90	CD	PERCENT	90	num	20	SENT_28	[p2l954t2200r1104b2258],
20	%	NN	PERCENT	%	prep_over	16	SENT_28	[p2l954t2200r1104b2258],
21	of	IN	O	of	_	0	SENT_28	[p2l1144t2197r1216b2258],
22	genetic	JJ	O	genetic	amod	23	SENT_28	[p2l1245t2199r1506b2273],
23	variation	NN	O	variation	prep_of	20	SENT_28	[p2l1543t2199r1879b2258],
24	in	IN	O	in	_	0	SENT_28	[p2l1917t2199r1988b2257],
25	the	DT	O	the	det	27	SENT_28	[p2l2026t2197r2142b2258],
26	human	JJ	O	human	amod	27	SENT_28	[p2l6t2295r267b2356],
27	genome	NN	O	genome	prep_in	16	SENT_28	[p2l305t2281r640b2371],
28	.1	CD	NUMBER	.1	num	27	SENT_28	[p2l305t2281r640b2371],
29	To	TO	O	to	_	0	SENT_28	[p2l680t2296r763b2356],
30	date	NN	O	date	prep_to	27	SENT_28	[p2l804t2295r980b2369],
31	,	,	O	,	_	0	SENT_28	[p2l804t2295r980b2369],
32	most	JJS	O	most	amod	33	SENT_28	[p2l1021t2300r1198b2356],
33	studies	NNS	O	study	nsubj	35	SENT_28	[p2l1237t2295r1495b2356],
34	have	VBP	O	have	aux	35	SENT_28	[p2l1534t2295r1708b2356],
35	focused	VBN	O	focus	_	0	SENT_28	[p2l1747t2295r2019b2356],
36	on	IN	O	on	_	0	SENT_28	[p2l2058t2315r2143b2356],
37	the	DT	O	the	det	38	SENT_28	[p2l7t2394r123b2454],
38	analysis	NN	O	analysis	prep_on	35	SENT_28	[p2l179t2394r478b2469],
39	of	IN	O	of	_	0	SENT_28	[p2l534t2394r607b2454],
40	single-phased	JJ	O	single-phased	amod	41	SENT_28	[p2l654t2394r1157b2469],
41	SNPS	NNS	O	snp	prep_of	38	SENT_28	[p2l1213t2394r1412b2454],
42	in	IN	O	in	_	0	SENT_28	[p2l1467t2395r1538b2453],
43	specific	JJ	O	specific	amod	44	SENT_28	[p2l1594t2394r1860b2469],
44	genes	NNS	O	gene	prep_in	41	SENT_28	[p2l1914t2413r2139b2469],
45	.	.	O	.	_	0	SENT_28	[p2l1914t2413r2139b2469],

1	However	RB	O	however	advmod	7	SENT_29	[p2l7t2491r346b2564],
2	,	,	O	,	_	0	SENT_29	[p2l7t2491r346b2564],
3	considerable	JJ	O	considerable	amod	4	SENT_29	[p2l395t2490r853b2551],
4	efforts	NNS	O	effort	nsubjpass	7	SENT_29	[p2l900t2490r1133b2551],
5	are	VBP	O	be	aux	7	SENT_29	[p2l1180t2511r1294b2551],
6	being	VBG	O	be	auxpass	7	SENT_29	[p2l1340t2490r1542b2566],
7	made	VBN	O	make	_	0	SENT_29	[p2l1586t2490r1782b2551],
8	today	NN	DATE	today	tmod	7	SENT_29	[p2l1828t2490r2031b2566],
9	to	TO	O	to	aux	10	SENT_29	[p2l2075t2496r2143b2551],
10	broaden	VB	O	broaden	xcomp	7	SENT_29	[p2l6t2587r304b2648],
11	our	PRP$	O	we	poss	12	SENT_29	[p2l350t2608r473b2648],
12	understanding	NN	O	understanding	dobj	10	SENT_29	[p2l517t2587r1061b2663],
13	of	IN	O	of	_	0	SENT_29	[p2l1107t2587r1179b2648],
14	genetic	JJ	O	genetic	amod	15	SENT_29	[p2l1216t2589r1477b2663],
15	variation	NN	O	variation	nn	22	SENT_29	[p2l1522t2589r1859b2648],
16	within	IN	O	within	_	0	SENT_29	[p2l1904t2587r2144b2648],
17	entire	JJ	O	entire	amod	18	SENT_29	[p2l8t2687r224b2746],
18	biological	JJ	O	biological	prep_within	15	SENT_29	[p2l253t2685r600b2761],
19	and	CC	O	and	_	0	SENT_29	[p2l631t2685r766b2746],
20	pharmacological	JJ	O	pharmacological	amod	21	SENT_29	[p2l796t2685r1398b2761],
21	pathways	NNS	O	pathway	conj_and	18	SENT_29	[p2l1428t2671r1836b2761],
22	.2	NN	NUMBER	.2	prep_of	12	SENT_29	[p2l1428t2671r1836b2761],

1	SNP	NN	O	snp	nn	2	SENT_30	[p2l188t2782r352b2843],
2	analysis	NN	O	analysis	nsubjpass	5	SENT_30	[p2l396t2782r695b2858],
3	can	MD	O	can	aux	5	SENT_30	[p2l742t2802r867b2843],
4	be	VB	O	be	auxpass	5	SENT_30	[p2l910t2782r991b2843],
5	performed	VBN	O	perform	_	0	SENT_30	[p2l1037t2782r1415b2858],
6	at	IN	O	at	_	0	SENT_30	[p2l1461t2787r1532b2843],
7	the	DT	O	the	det	8	SENT_30	[p2l1575t2782r1691b2843],
8	moment	NN	O	moment	prep_at	5	SENT_30	[p2l1737t2787r2037b2843],
9	of	IN	O	of	_	0	SENT_30	[p2l2081t2782r2153b2843],
10	diagnosis	NN	O	diagnosis	prep_of	8	SENT_30	[p2l9t2880r349b2956],
11	to	TO	O	to	aux	12	SENT_30	[p2l388t2885r455b2940],
12	select	VB	O	select	ccomp	5	SENT_30	[p2l497t2880r702b2940],
13	the	DT	O	the	det	15	SENT_30	[p2l739t2880r855b2940],
14	optimal	JJ	O	optimal	amod	15	SENT_30	[p2l896t2880r1173b2956],
15	therapy	NN	O	therapy	dobj	12	SENT_30	[p2l1212t2880r1500b2956],
16	for	IN	O	for	_	0	SENT_30	[p2l1537t2880r1638b2940],
17	each	DT	O	each	det	18	SENT_30	[p2l1677t2880r1842b2940],
18	patient	NN	O	patient	prep_for	15	SENT_30	[p2l1880t2881r2145b2956],
19	and	CC	O	and	_	0	SENT_30	[p2l9t2976r144b3037],
20	to	TO	O	to	aux	21	SENT_30	[p2l173t2982r240b3037],
21	reduce	VB	O	reduce	conj_and	12	SENT_30	[p2l270t2976r513b3037],
22	the	DT	O	the	det	23	SENT_30	[p2l543t2976r660b3037],
23	incidence	NN	O	incidence	dobj	21	SENT_30	[p2l690t2976r1033b3037],
24	of	IN	O	of	_	0	SENT_30	[p2l1065t2976r1137b3037],
25	drug	NN	O	drug	nn	26	SENT_30	[p2l1159t2976r1330b3052],
26	toxicity	NN	O	toxicity	prep_of	23	SENT_30	[p2l1358t2978r1639b3052],
27	.	.	O	.	_	0	SENT_30	[p2l1358t2978r1639b3052],

1	Weekly	NNP	SET	Weekly	nn	2	SENT_31	[p2l184t3073r454b3149],
2	paclitaxel	NN	O	paclitaxel	nsubjpass	5	SENT_31	[p2l495t3073r851b3149],
3	has	VBZ	O	have	aux	5	SENT_31	[p2l893t3073r1019b3134],
4	been	VBN	O	be	auxpass	5	SENT_31	[p2l1061t3073r1233b3134],
5	used	VBN	O	use	_	0	SENT_31	[p2l1275t3073r1444b3134],
6	as	IN	O	as	_	0	SENT_31	[p2l1487t3093r1562b3134],
7	an	DT	O	a	det	9	SENT_31	[p2l1607t3093r1696b3134],
8	alternative	JJ	O	alternative	amod	9	SENT_31	[p2l1739t3073r2142b3134],
9	approach	NN	O	approach	prep_as	5	SENT_31	[p2l9t3172r345b3247],
10	in	IN	O	in	_	0	SENT_31	[p2l370t3173r442b3231],
11	advanced	JJ	O	advanced	amod	12	SENT_31	[p2l467t3172r812b3232],
12	head	NN	O	head	prep_in	9	SENT_31	[p2l835t3172r1013b3232],
13	and	CC	O	and	_	0	SENT_31	[p2l1038t3172r1173b3232],
14	neck	NN	O	neck	nn	16	SENT_31	[p2l1198t3172r1368b3232],
15	cancer	NN	O	cancer	nn	16	SENT_31	[p2l1392t3192r1630b3232],
16	patients	NNS	O	patient	prep_in	9	SENT_31	[p2l1654t3173r1953b3247],
17	with	IN	O	with	_	0	SENT_31	[p2l1978t3172r2144b3232],
18	resistance	NN	O	resistance	prep_with	5	SENT_31	[p2l7t3270r377b3329],
19	to	TO	O	to	_	0	SENT_31	[p2l441t3274r508b3329],
20	platinum-based	JJ	O	platinum-based	amod	21	SENT_31	[p2l572t3268r1147b3344],
21	chemotherapy	NN	O	chemotherapy	prep_to	5	SENT_31	[p2l1210t3268r1741b3344],
22	.	.	O	.	_	0	SENT_31	[p2l1210t3268r1741b3344],

1	In	IN	O	in	_	0	SENT_32	[p2l1809t3270r1887b3328],
2	these	DT	O	these	det	3	SENT_32	[p2l1949t3268r2142b3329],
3	patients	NNS	O	patient	prep_in	9	SENT_32	[p2l7t3367r326b3441],
4	,	,	O	,	_	0	SENT_32	[p2l7t3367r326b3441],
5	low-dose	JJ	O	low-dose	amod	7	SENT_32	[p2l354t3365r667b3426],
6	weekly	JJ	SET	weekly	amod	7	SENT_32	[p2l693t3365r950b3441],
7	paclitaxel	NN	O	paclitaxel	nsubjpass	9	SENT_32	[p2l975t3365r1331b3441],
8	was	VBD	O	be	auxpass	9	SENT_32	[p2l1355t3385r1495b3426],
9	tested	VBN	O	test	_	0	SENT_32	[p2l1521t3365r1743b3426],
10	in	IN	O	in	_	0	SENT_32	[p2l1768t3367r1839b3425],
11	a	DT	O	a	det	14	SENT_32	[p2l1866t3385r1906b3426],
12	phase	NN	O	phase	nn	14	SENT_32	[p2l1930t3365r2142b3441],
13	II	CD	NUMBER	ii	num	14	SENT_32	[p2l8t3465r68b3523],
14	study	NN	O	study	prep_in	9	SENT_32	[p2l96t3464r298b3539],
15	of	IN	O	of	_	0	SENT_32	[p2l323t3464r396b3524],
16	48	CD	NUMBER	48	num	17	SENT_32	[p2l411t3466r495b3524],
17	patients	NNS	O	patient	prep_of	14	SENT_32	[p2l521t3449r876b3539],
18	?	.	O	?	_	0	SENT_32	[p2l521t3449r876b3539],

1	’	NN	O	’	npadvmod	8	SENT_33	[p2l521t3449r876b3539],
2	In	IN	O	in	_	0	SENT_33	[p2l903t3465r981b3523],
3	the	DT	O	the	det	5	SENT_33	[p2l1005t3464r1122b3524],
4	present	JJ	DATE	present	amod	5	SENT_33	[p2l1148t3469r1425b3539],
5	study	NN	O	study	prep_in	8	SENT_33	[p2l1451t3464r1663b3539],
6	,	,	O	,	_	0	SENT_33	[p2l1451t3464r1663b3539],
7	we	PRP	O	we	nsubj	8	SENT_33	[p2l1691t3484r1789b3524],
8	analyzed	VBD	O	analyze	_	0	SENT_33	[p2l1818t3464r2144b3539],
9	a	DT	O	a	det	10	SENT_33	[p2l9t3581r49b3621],
10	group	NN	O	group	dobj	8	SENT_33	[p2l79t3580r289b3636],
11	of	IN	O	of	_	0	SENT_33	[p2l322t3560r394b3621],
12	SNPS	NN	O	snp	prep_of	10	SENT_33	[p2l418t3560r617b3621],
13	of	IN	O	of	_	0	SENT_33	[p2l649t3560r722b3621],
14	the	DT	O	the	det	15	SENT_33	[p2l743t3560r859b3621],
15	genes	NNS	O	gene	prep_of	12	SENT_33	[p2l891t3580r1096b3636],
16	involved	VBN	O	involve	partmod	15	SENT_33	[p2l1128t3560r1438b3621],
17	in	IN	O	in	_	0	SENT_33	[p2l1468t3562r1539b3620],
18	the	DT	O	the	det	19	SENT_33	[p2l1570t3560r1686b3621],
19	metabolism	NN	O	metabolism	prep_in	16	SENT_33	[p2l1718t3560r2144b3621],
20	of	IN	O	of	_	0	SENT_33	[p3l8t17r80b77],
21	this	DT	O	this	det	22	SENT_33	[p3l108t17r246b78],
22	drug	NN	O	drug	prep_of	19	SENT_33	[p3l287t17r475b93],
23	.	.	O	.	_	0	SENT_33	[p3l287t17r475b93],

1	CYP2C8	NN	O	cyp2c8	dep	118	SENT_34	[p3l519t17r827b78],
2	is	VBZ	O	be	dep	118	SENT_34	[p3l865t19r923b78],
3	a	DT	O	a	dep	118	SENT_34	[p3l963t38r1004b78],
4	member	NN	O	member	dep	118	SENT_34	[p3l1041t17r1341b78],
5	of	IN	O	of	dep	118	SENT_34	[p3l1379t17r1452b78],
6	P450	NN	O	p450	dep	118	SENT_34	[p3l1481t18r1662b78],
7	cytochrome	NN	O	cytochrome	dep	118	SENT_34	[p3l1702t17r2139b93],
8	,	,	O	,	_	0	SENT_34	[p3l1702t17r2139b93],
9	which	WDT	O	which	dep	118	SENT_34	[p3l6t116r226b176],
10	is	VBZ	O	be	dep	118	SENT_34	[p3l264t117r321b176],
11	involved	VBN	O	involve	dep	118	SENT_34	[p3l360t116r670b176],
12	in	IN	O	in	dep	118	SENT_34	[p3l708t117r780b175],
13	phase	NN	O	phase	dep	118	SENT_34	[p3l818t116r1029b191],
14	1	CD	NUMBER	1	dep	118	SENT_34	[p3l1074t118r1107b175],
15	drug	NN	O	drug	dep	118	SENT_34	[p3l1149t116r1320b191],
16	metabolism	NN	O	metabolism	dep	118	SENT_34	[p3l1357t101r1838b176],
17	.4	CD	NUMBER	.4	dep	118	SENT_34	[p3l1357t101r1838b176],
18	GSTT1	NN	O	gstt1	dep	118	SENT_34	[p3l1877t116r2138b176],
19	and	CC	O	and	dep	118	SENT_34	[p3l9t212r144b273],
20	GSTP1	NN	O	gstp1	dep	118	SENT_34	[p3l170t212r429b273],
21	genes	NNS	O	gene	dep	118	SENT_34	[p3l460t232r665b288],
22	are	VBP	O	be	dep	118	SENT_34	[p3l694t233r808b273],
23	encoding	VBG	O	encode	dep	118	SENT_34	[p3l835t212r1162b288],
24	members	NNS	O	member	dep	118	SENT_34	[p3l1186t212r1521b273],
25	of	IN	O	of	dep	118	SENT_34	[p3l1548t212r1620b273],
26	a	DT	O	a	dep	118	SENT_34	[p3l1638t233r1678b273],
27	superfamily	NN	O	superfamily	dep	118	SENT_34	[p3l1706t212r2145b288],
28	of	IN	O	of	dep	118	SENT_34	[p3l8t310r80b370],
29	proteins	NNS	O	protein	dep	118	SENT_34	[p3l100t311r399b386],
30	involved	VBN	O	involve	dep	118	SENT_34	[p3l429t310r739b370],
31	in	IN	O	in	dep	118	SENT_34	[p3l767t311r839b369],
32	phase	NN	O	phase	dep	118	SENT_34	[p3l868t310r1080b386],
33	2	CD	NUMBER	2	dep	118	SENT_34	[p3l1111t312r1150b370],
34	drug	NN	O	drug	dep	118	SENT_34	[p3l1182t310r1353b386],
35	metabolism	NN	O	metabolism	dep	118	SENT_34	[p3l1381t310r1825b384],
36	,	,	O	,	_	0	SENT_34	[p3l1381t310r1825b384],
37	catalyzing	VBG	O	catalyze	dep	118	SENT_34	[p3l1859t310r2141b386, p3l7t409r124b483],
38	the	DT	O	the	dep	118	SENT_34	[p3l151t408r267b468],
39	conjugation	NN	O	conjugation	dep	118	SENT_34	[p3l299t409r725b483],
40	of	IN	O	of	dep	118	SENT_34	[p3l756t408r829b468],
41	reduced	VBN	O	reduce	dep	118	SENT_34	[p3l849t408r1139b468],
42	glutathione	NN	O	glutathione	dep	118	SENT_34	[p3l1168t408r1591b483],
43	to	TO	O	to	dep	118	SENT_34	[p3l1621t413r1689b468],
44	a	DT	O	a	dep	118	SENT_34	[p3l1721t428r1762b468],
45	variety	NN	O	variety	dep	118	SENT_34	[p3l1789t409r2051b483],
46	of	IN	O	of	dep	118	SENT_34	[p3l2081t408r2153b468],
47	electrophilic	JJ	O	electrophilic	dep	118	SENT_34	[p3l8t504r458b580],
48	and	CC	O	and	dep	118	SENT_34	[p3l489t504r624b565],
49	hydrophobic	JJ	O	hydrophobic	dep	118	SENT_34	[p3l651t504r1104b580],
50	compounds	NNS	O	compound	dep	118	SENT_34	[p3l1134t504r1563b580],
51	,	,	O	,	_	0	SENT_34	[p3l1134t504r1563b580],
52	including	VBG	O	include	dep	118	SENT_34	[p3l1595t504r1942b580],
53	cytotoxic	JJ	O	cytotoxic	dep	118	SENT_34	[p3l1970t510r2142b580, p3l7t604r179b663],
54	agents	NNS	O	agent	dep	118	SENT_34	[p3l231t589r576b679],
55	.5	CD	NUMBER	.5	dep	118	SENT_34	[p3l231t589r576b679],
56	’	CD	NUMBER	’	dep	118	SENT_34	[p3l231t589r576b679],
57	6	CD	NUMBER	6	dep	118	SENT_34	[p3l231t589r576b679],
58	MDR1-57	NN	O	mdr1-57	dep	118	SENT_34	[p3l624t604r985b663],
59	and	CC	O	and	dep	118	SENT_34	[p3l1034t603r1169b663],
60	MDR	NN	O	mdr	dep	118	SENT_34	[p3l1215t604r1598b663],
61	—	CD	NUMBER	—	dep	118	SENT_34	[p3l1215t604r1598b663],
62	1-62	CD	NUMBER	1-62	dep	118	SENT_34	[p3l1215t604r1598b663],
63	are	VBP	O	be	dep	118	SENT_34	[p3l1652t623r1766b663],
64	encoding	VBG	O	encode	dep	118	SENT_34	[p3l1818t603r2145b679],
65	proteins	NNS	O	protein	dep	118	SENT_34	[p3l7t702r307b776],
66	of	IN	O	of	dep	118	SENT_34	[p3l332t701r404b761],
67	the	DT	O	the	dep	118	SENT_34	[p3l418t701r534b761],
68	MDR/TAP	NN	O	mdr/tap	dep	118	SENT_34	[p3l558t701r935b761],
69	subfamily	NN	O	subfamily	dep	118	SENT_34	[p3l959t701r1331b776],
70	,	,	O	,	_	0	SENT_34	[p3l959t701r1331b776],
71	which	WDT	O	which	dep	118	SENT_34	[p3l1357t701r1577b761],
72	are	VBP	O	be	dep	118	SENT_34	[p3l1601t721r1716b761],
73	involved	VBN	O	involve	dep	118	SENT_34	[p3l1739t701r2049b761],
74	in	IN	O	in	dep	118	SENT_34	[p3l2072t702r2144b760],
75	drug	NN	O	drug	dep	118	SENT_34	[p3l9t797r180b873],
76	membrane	NN	O	membrane	dep	118	SENT_34	[p3l223t797r615b858],
77	transport	NN	O	transport	dep	118	SENT_34	[p3l661t803r1028b873],
78	,	,	O	,	_	0	SENT_34	[p3l661t803r1028b873],
79	and	CC	O	and	dep	118	SENT_34	[p3l1078t797r1213b858],
80	are	VBP	O	be	dep	118	SENT_34	[p3l1259t818r1373b858],
81	responsible	JJ	O	responsible	dep	118	SENT_34	[p3l1420t797r1835b873],
82	for	IN	O	for	dep	118	SENT_34	[p3l1881t797r1981b858],
83	the	DT	O	the	dep	118	SENT_34	[p3l2026t797r2142b858],
84	decreased	VBN	O	decrease	dep	118	SENT_34	[p3l9t895r369b955],
85	drug	NN	O	drug	dep	118	SENT_34	[p3l447t895r618b971],
86	accumulation	NN	O	accumulation	dep	118	SENT_34	[p3l695t895r1190b955],
87	in	IN	O	in	dep	118	SENT_34	[p3l1266t896r1338b954],
88	multidrug-resistant	JJ	O	multidrug-resistant	dep	118	SENT_34	[p3l1414t895r2144b971],
89	cells	NNS	O	cell	dep	118	SENT_34	[p3l8t978r272b1053],
90	.7	CD	NUMBER	.7	dep	118	SENT_34	[p3l8t978r272b1053],
91	’	CD	NUMBER	’	dep	118	SENT_34	[p3l8t978r272b1053],
92	8	CD	NUMBER	8	dep	118	SENT_34	[p3l8t978r272b1053],
93	ERCC1	NN	O	ercc1	dep	118	SENT_34	[p3l341t992r613b1053],
94	is	VBZ	O	be	dep	118	SENT_34	[p3l691t994r749b1053],
95	a	DT	O	a	dep	118	SENT_34	[p3l825t1013r866b1053],
96	structure-speciﬁc	JJ	O	structure-speciﬁc	dep	118	SENT_34	[p3l940t992r1577b1068],
97	endonuclease	NN	O	endonuclease	dep	118	SENT_34	[p3l1652t992r2142b1053],
98	involved	VBN	O	involve	dep	118	SENT_34	[p3l7t1089r316b1150],
99	in	IN	O	in	dep	118	SENT_34	[p3l339t1091r411b1149],
100	DNA	NN	MISC	dna	dep	118	SENT_34	[p3l434t1089r619b1150],
101	repair	NN	O	repair	dep	118	SENT_34	[p3l639t1091r877b1165],
102	,	,	O	,	_	0	SENT_34	[p3l639t1091r877b1165],
103	catalyzing	VBG	O	catalyze	dep	118	SENT_34	[p3l904t1089r1282b1165],
104	the	DT	O	the	dep	118	SENT_34	[p3l1303t1089r1419b1150],
105	5	CD	NUMBER	5	dep	118	SENT_34	[p3l1446t1089r1501b1150],
106	’	NN	O	’	dep	118	SENT_34	[p3l1446t1089r1501b1150],
107	and	CC	O	and	dep	118	SENT_34	[p3l1526t1089r1661b1150],
108	3	CD	NUMBER	3	dep	118	SENT_34	[p3l1686t1089r1741b1150],
109	’	NN	O	’	dep	118	SENT_34	[p3l1686t1089r1741b1150],
110	incision	NN	O	incision	dep	118	SENT_34	[p3l1765t1091r2049b1150],
111	in	IN	O	in	dep	118	SENT_34	[p3l2072t1091r2144b1149],
112	the	DT	O	the	dep	118	SENT_34	[p3l7t1188r123b1248],
113	oligonucleotide	NN	O	oligonucleotide	dep	118	SENT_34	[p3l148t1188r698b1264],
114	that	WDT	O	that	dep	118	SENT_34	[p3l723t1188r876b1248],
115	contains	VBZ	O	contain	dep	118	SENT_34	[p3l899t1189r1205b1248],
116	the	DT	O	the	dep	118	SENT_34	[p3l1229t1188r1346b1248],
117	lesion	NN	O	lesion	dep	118	SENT_34	[p3l1369t1174r1638b1248],
118	.9	NN	NUMBER	.9	_	0	SENT_34	[p3l1369t1174r1638b1248],

1	CYPZC8	NN	O	cypzc8	nn	4	SENT_35	[p3l187t1284r494b1345],
2	and	CC	O	and	_	0	SENT_35	[p3l558t1284r693b1345],
3	MDR1	NN	O	mdr1	conj_and	1	SENT_35	[p3l751t1286r988b1345],
4	SNPs	NNS	O	snp	nsubj	19	SENT_35	[p3l1058t1284r1257b1345],
5	have	VBP	O	have	aux	7	SENT_35	[p3l1319t1284r1493b1345],
6	been	VBN	O	be	auxpass	7	SENT_35	[p3l1555t1284r1727b1345],
7	tested	VBN	O	test	_	0	SENT_35	[p3l1788t1284r2011b1345],
8	in	IN	O	in	_	0	SENT_35	[p3l2072t1286r2144b1344],
9	patients	NNS	O	patient	prep_in	7	SENT_35	[p3l7t1383r306b1457],
10	treated	VBN	O	treat	partmod	9	SENT_35	[p3l339t1381r604b1442],
11	with	IN	O	with	_	0	SENT_35	[p3l635t1381r801b1442],
12	standard	JJ	O	standard	amod	13	SENT_35	[p3l835t1381r1163b1442],
13	doses	NNS	O	dose	prep_with	10	SENT_35	[p3l1196t1381r1389b1442],
14	of	IN	O	of	_	0	SENT_35	[p3l1423t1381r1496b1441],
15	paclitaxel	NN	O	paclitaxel	prep_of	13	SENT_35	[p3l1519t1381r1875b1457],
16	but	CC	O	but	_	0	SENT_35	[p3l1906t1381r2030b1442],
17	do	VBP	O	do	aux	19	SENT_35	[p3l2062t1381r2142b1442],
18	not	RB	O	not	neg	19	SENT_35	[p3l7t1484r125b1539],
19	explain	VB	O	explain	conj_but	7	SENT_35	[p3l154t1479r423b1555],
20	the	DT	O	the	det	23	SENT_35	[p3l451t1479r568b1539],
21	substantial	JJ	O	substantial	amod	23	SENT_35	[p3l600t1479r1012b1539],
22	interpatient	JJ	O	interpatient	amod	23	SENT_35	[p3l1040t1480r1486b1555],
23	variability	NN	O	variability	dobj	19	SENT_35	[p3l1512t1479r1898b1555],
24	in	IN	O	in	_	0	SENT_35	[p3l1926t1480r1997b1538],
25	the	DT	O	the	prep_in	19	SENT_35	[p3l2026t1479r2142b1539],

1	Grau	NNP	PERSON	Grau	dep	161	SENT_36	[p3l477t1711r645b1772],
2	et	NNP	O	et	dep	161	SENT_36	[p3l679t1716r743b1771],
3	aI.	NNP	O	aI.	dep	161	SENT_36	[p3l774t1713r870b1771],
4	:	:	O	:	_	0	SENT_36	[p3l774t1713r870b1771],
5	Advanced	NNP	O	Advanced	dep	161	SENT_36	[p3l904t1713r1261b1771],
6	Head	NNP	O	Head	dep	161	SENT_36	[p3l1298t1713r1479b1771],
7	and	CC	O	and	dep	161	SENT_36	[p3l1514t1713r1641b1771],
8	Neck	NNP	O	Neck	dep	161	SENT_36	[p3l1679t1713r1859b1771],
9	Cancer	NNP	O	Cancer	dep	161	SENT_36	[p3l1890t1711r2145b1772],
10	drug	NN	O	drug	dep	161	SENT_36	[p3l16t1817r235b1892],
11	’s	POS	O	’s	dep	161	SENT_36	[p3l16t1817r235b1892],
12	pharmacokinetics	NNS	O	pharmacokinetic	dep	161	SENT_36	[p3l264t1802r1004b1892],
13	.10	CD	NUMBER	.10	dep	161	SENT_36	[p3l264t1802r1004b1892],
14	However	RB	O	however	dep	161	SENT_36	[p3l1033t1818r1370b1890],
15	,	,	O	,	_	0	SENT_36	[p3l1033t1818r1370b1890],
16	it	PRP	O	it	dep	161	SENT_36	[p3l1401t1818r1455b1877],
17	has	VBZ	O	have	dep	161	SENT_36	[p3l1481t1817r1607b1877],
18	been	VBN	O	be	dep	161	SENT_36	[p3l1635t1817r1806b1877],
19	reported	VBN	O	report	dep	161	SENT_36	[p3l1833t1817r2145b1893],
20	that	IN	O	that	dep	161	SENT_36	[p3l14t1913r167b1974],
21	SNP	NN	ORGANIZATION	snp	dep	161	SENT_36	[p3l192t1913r355b1974],
22	in	IN	O	in	dep	161	SENT_36	[p3l378t1915r449b1973],
23	the	DT	O	the	dep	161	SENT_36	[p3l472t1913r588b1974],
24	CYPZC8	NN	O	cypzc8	dep	161	SENT_36	[p3l614t1913r920b1974],
25	gene	NN	O	gene	dep	161	SENT_36	[p3l944t1933r1112b1989],
26	decreases	VBZ	O	decrease	dep	161	SENT_36	[p3l1139t1913r1488b1974],
27	paclitaxel	NN	O	paclitaxel	dep	161	SENT_36	[p3l1512t1913r1867b1989],
28	metabolism	NN	O	metabolism	dep	161	SENT_36	[p3l1891t1913r2143b1974, p3l15t1998r293b2072],
29	.11	CD	NUMBER	.11	dep	161	SENT_36	[p3l1891t1913r2143b1974, p3l15t1998r293b2072],
30	SNPs	NNS	O	snp	dep	161	SENT_36	[p3l326t2012r524b2072],
31	in	IN	O	in	dep	161	SENT_36	[p3l553t2013r625b2071],
32	glutathione	NN	O	glutathione	dep	161	SENT_36	[p3l653t2012r1075b2088],
33	S-transferase	NN	MISC	s-transferase	dep	161	SENT_36	[p3l1108t2012r1597b2072],
34	correlate	VBP	O	correlate	dep	161	SENT_36	[p3l1628t2012r1950b2072],
35	with	IN	O	with	dep	161	SENT_36	[p3l1979t2012r2145b2072],
36	the	DT	O	the	dep	161	SENT_36	[p3l14t2108r130b2169],
37	mean	NN	O	mean	dep	161	SENT_36	[p3l161t2129r362b2169],
38	survival	NN	O	survival	dep	161	SENT_36	[p3l395t2108r692b2169],
39	time	NN	O	time	dep	161	SENT_36	[p3l722t2110r885b2169],
40	and	CC	O	and	dep	161	SENT_36	[p3l918t2108r1052b2169],
41	the	DT	O	the	dep	161	SENT_36	[p3l1083t2108r1199b2169],
42	progression-free	JJ	O	progression-free	dep	161	SENT_36	[p3l1231t2108r1823b2184],
43	interval	NN	O	interval	dep	161	SENT_36	[p3l1854t2108r2144b2169],
44	in	IN	O	in	dep	161	SENT_36	[p3l14t2207r85b2265],
45	platinum/paclitaxel-based	JJ	O	platinum/paclitaxel-based	dep	161	SENT_36	[p3l144t2205r1099b2281],
46	chemotherapy	NN	O	chemotherapy	dep	161	SENT_36	[p3l1158t2205r1680b2281],
47	in	IN	O	in	dep	161	SENT_36	[p3l1736t2207r1808b2265],
48	ovarian	JJ	O	ovarian	dep	161	SENT_36	[p3l1867t2207r2145b2266],
49	carcinoma	NN	O	carcinoma	dep	161	SENT_36	[p3l15t2290r446b2364],
50	.5	CD	NUMBER	.5	dep	161	SENT_36	[p3l15t2290r446b2364],
51	SNPs	NNS	O	snp	dep	161	SENT_36	[p3l501t2304r699b2364],
52	in	IN	O	in	dep	161	SENT_36	[p3l750t2305r822b2363],
53	the	DT	O	the	dep	161	SENT_36	[p3l873t2304r989b2364],
54	MDR1	NN	O	mdr1	dep	161	SENT_36	[p3l1037t2305r1273b2365],
55	gene	NN	O	gene	dep	161	SENT_36	[p3l1330t2323r1498b2380],
56	(	NN	O	(	dep	161	SENT_36	[p3l1552t2304r1719b2373],
57	also	RB	O	also	dep	161	SENT_36	[p3l1552t2304r1719b2373],
58	known	VBN	O	know	dep	161	SENT_36	[p3l1770t2304r2016b2364],
59	as	IN	O	as	dep	161	SENT_36	[p3l2069t2324r2143b2364],
60	ABCB1	NN	O	abcb1	dep	161	SENT_36	[p3l6t2400r310b2469],
61	)	CD	NUMBER	)	dep	161	SENT_36	[p3l6t2400r310b2469],
62	have	VBP	O	have	dep	161	SENT_36	[p3l346t2400r519b2461],
63	been	VBN	O	be	dep	161	SENT_36	[p3l555t2400r726b2461],
64	implicated	VBN	O	implicate	dep	161	SENT_36	[p3l761t2400r1147b2476],
65	in	IN	O	in	dep	161	SENT_36	[p3l1182t2402r1253b2460],
66	paclitaxel	NN	O	paclitaxel	dep	161	SENT_36	[p3l1290t2400r1645b2476],
67	chemoresistance	NN	O	chemoresistance	dep	161	SENT_36	[p3l1682t2400r2143b2461, p3l16t2484r285b2559],
68	.7	CD	NUMBER	.7	dep	161	SENT_36	[p3l1682t2400r2143b2461, p3l16t2484r285b2559],
69	’	NN	O	’	dep	161	SENT_36	[p3l1682t2400r2143b2461, p3l16t2484r285b2559],
70	8	CD	NUMBER	8	dep	161	SENT_36	[p3l1682t2400r2143b2461, p3l16t2484r285b2559],
71	The	DT	O	the	dep	161	SENT_36	[p3l318t2498r456b2559],
72	potential	JJ	O	potential	dep	161	SENT_36	[p3l490t2498r817b2574],
73	value	NN	O	value	dep	161	SENT_36	[p3l849t2498r1047b2559],
74	of	IN	O	of	dep	161	SENT_36	[p3l1082t2498r1154b2559],
75	the	DT	O	the	dep	161	SENT_36	[p3l1176t2498r1292b2559],
76	ABCB1	NN	O	abcb1	dep	161	SENT_36	[p3l1318t2498r1590b2559],
77	267	CD	NUMBER	267	dep	161	SENT_36	[p3l1624t2501r1760b2559],
78	7G	NN	O	7g	dep	161	SENT_36	[p3l1765t2498r1864b2559],
79	>	JJR	O	>	dep	161	SENT_36	[p3l1902t2514r1951b2561],
80	T/A	NN	O	t/a	dep	161	SENT_36	[p3l1989t2498r2143b2566],
81	genotype	NN	O	genotype	dep	161	SENT_36	[p3l14t2601r342b2672],
82	as	IN	O	as	dep	161	SENT_36	[p3l381t2616r456b2656],
83	a	DT	O	a	dep	161	SENT_36	[p3l494t2616r535b2656],
84	marker	NN	O	marker	dep	161	SENT_36	[p3l570t2596r841b2656],
85	for	IN	O	for	dep	161	SENT_36	[p3l876t2596r976b2656],
86	paclitaxel	NN	O	paclitaxel	dep	161	SENT_36	[p3l1012t2596r1367b2672],
87	response	NN	O	response	dep	161	SENT_36	[p3l1402t2616r1722b2672],
88	in	IN	O	in	dep	161	SENT_36	[p3l1759t2597r1830b2655],
89	ovarian	JJ	O	ovarian	dep	161	SENT_36	[p3l1867t2597r2145b2656],
90	cancer	NN	O	cancer	dep	161	SENT_36	[p3l15t2714r253b2754],
91	has	VBZ	O	have	dep	161	SENT_36	[p3l296t2693r423b2754],
92	been	VBN	O	be	dep	161	SENT_36	[p3l468t2693r639b2754],
93	reported	VBN	O	report	dep	161	SENT_36	[p3l683t2679r1165b2769],
94	.12	CD	NUMBER	.12	dep	161	SENT_36	[p3l683t2679r1165b2769],
95	’13	CD	NUMBER	’13	dep	161	SENT_36	[p3l683t2679r1165b2769],
96	SNPs	NNS	O	snp	dep	161	SENT_36	[p3l1214t2693r1412b2754],
97	in	IN	O	in	dep	161	SENT_36	[p3l1457t2695r1529b2753],
98	the	DT	O	the	dep	161	SENT_36	[p3l1574t2693r1690b2754],
99	MDR	NN	ORGANIZATION	mdr	dep	161	SENT_36	[p3l1732t2694r1928b2754],
100	gene	NN	O	gene	dep	161	SENT_36	[p3l1975t2713r2143b2769],
101	have	VBP	O	have	dep	161	SENT_36	[p3l14t2790r186b2851],
102	also	RB	O	also	dep	161	SENT_36	[p3l217t2790r357b2851],
103	been	VBN	O	be	dep	161	SENT_36	[p3l384t2790r555b2851],
104	associated	VBN	O	associate	dep	161	SENT_36	[p3l584t2790r959b2851],
105	with	IN	O	with	dep	161	SENT_36	[p3l985t2790r1150b2851],
106	greater	JJR	O	greater	dep	161	SENT_36	[p3l1177t2795r1445b2866],
107	paclitaxel-induced	JJ	O	paclitaxel-induced	dep	161	SENT_36	[p3l1472t2790r2145b2866],
108	peripheral	JJ	O	peripheral	dep	161	SENT_36	[p3l15t2888r397b2964],
109	neuropathy	NN	O	neuropathy	dep	161	SENT_36	[p3l460t2888r885b2964],
110	and	CC	O	and	dep	161	SENT_36	[p3l947t2888r1082b2948],
111	neutropenia	NN	O	neutropenia	dep	161	SENT_36	[p3l1144t2889r1590b2964],
112	and	CC	O	and	dep	161	SENT_36	[p3l1653t2888r1787b2948],
113	are	VBP	O	be	dep	161	SENT_36	[p3l1851t2908r1964b2948],
114	not	RB	O	not	dep	161	SENT_36	[p3l2028t2893r2145b2948],
115	involved	VBN	O	involve	dep	161	SENT_36	[p3l14t2985r323b3046],
116	in	IN	O	in	dep	161	SENT_36	[p3l361t2987r433b3045],
117	the	DT	O	the	dep	161	SENT_36	[p3l471t2985r587b3046],
118	drug	NN	O	drug	dep	161	SENT_36	[p3l629t2985r848b3061],
119	’s	POS	O	’s	dep	161	SENT_36	[p3l629t2985r848b3061],
120	pharmacokinetics	NNS	O	pharmacokinetic	dep	161	SENT_36	[p3l889t2971r1629b3061],
121	.14	CD	NUMBER	.14	dep	161	SENT_36	[p3l889t2971r1629b3061],
122	ERCC1	NN	O	ercc1	dep	161	SENT_36	[p3l1663t2985r1935b3046],
123	SNP	NN	O	snp	dep	161	SENT_36	[p3l1982t2985r2145b3046],
124	may	MD	O	may	dep	161	SENT_36	[p3l14t3102r170b3158],
125	predict	VB	O	predict	dep	161	SENT_36	[p3l209t3082r466b3158],
126	survival	NN	O	survival	dep	161	SENT_36	[p3l506t3082r803b3143],
127	in	IN	O	in	dep	161	SENT_36	[p3l842t3084r914b3142],
128	patients	NNS	O	patient	dep	161	SENT_36	[p3l954t3084r1252b3158],
129	treated	VBN	O	treat	dep	161	SENT_36	[p3l1292t3082r1557b3143],
130	with	IN	O	with	dep	161	SENT_36	[p3l1595t3082r1760b3143],
131	palliative	JJ	O	palliative	dep	161	SENT_36	[p3l1800t3082r2143b3158],
132	platinum-based	JJ	O	platinum-based	dep	161	SENT_36	[p3l15t3180r589b3255],
133	chemotherapy	NN	O	chemotherapy	dep	161	SENT_36	[p3l665t3180r1187b3255],
134	also	RB	O	also	dep	161	SENT_36	[p3l1264t3180r1403b3240],
135	containing	VBG	O	contain	dep	161	SENT_36	[p3l1482t3181r1871b3255],
136	paclitaxel	NN	O	paclitaxel	dep	161	SENT_36	[p3l1946t3180r2143b3256, p3l14t3262r282b3337],
137	.15	CD	NUMBER	.15	dep	161	SENT_36	[p3l1946t3180r2143b3256, p3l14t3262r282b3337],
138	Furthermore	RB	O	furthermore	dep	161	SENT_36	[p3l317t3277r814b3351],
139	,	,	O	,	_	0	SENT_36	[p3l317t3277r814b3351],
140	SNPS	NN	O	snp	dep	161	SENT_36	[p3l853t3277r1051b3337],
141	in	IN	O	in	dep	161	SENT_36	[p3l1086t3278r1157b3336],
142	DNA	NN	MISC	dna	dep	161	SENT_36	[p3l1192t3277r1376b3337],
143	repair	NN	O	repair	dep	161	SENT_36	[p3l1406t3278r1631b3353],
144	genes	NNS	O	gene	dep	161	SENT_36	[p3l1664t3296r1869b3353],
145	and	CC	O	and	dep	161	SENT_36	[p3l1905t3277r2040b3337],
146	in	IN	O	in	dep	161	SENT_36	[p3l2073t3278r2145b3336],
147	genes	NNS	O	gene	dep	161	SENT_36	[p3l14t3393r219b3449],
148	encoding	VBG	O	encode	dep	161	SENT_36	[p3l257t3373r583b3449],
149	drug	NN	O	drug	dep	161	SENT_36	[p3l618t3373r789b3449],
150	protein	NN	O	protein	dep	161	SENT_36	[p3l823t3375r1087b3449],
151	transporters	NNS	O	transporter	dep	161	SENT_36	[p3l1122t3379r1579b3449],
152	are	VBP	O	be	dep	161	SENT_36	[p3l1618t3394r1732b3434],
153	associated	VBN	O	associate	dep	161	SENT_36	[p3l1771t3373r2145b3434],
154	with	IN	O	with	dep	161	SENT_36	[p3l14t3472r179b3533],
155	clinical	JJ	O	clinical	dep	161	SENT_36	[p3l203t3472r463b3533],
156	outcome	NN	O	outcome	dep	161	SENT_36	[p3l487t3478r789b3533],
157	in	IN	O	in	dep	161	SENT_36	[p3l812t3474r884b3532],
158	other	JJ	O	other	dep	161	SENT_36	[p3l907t3472r1100b3533],
159	cancers	NNS	O	cancer	dep	161	SENT_36	[p3l1123t3458r1568b3533],
160	.16	CD	NUMBER	.16	dep	161	SENT_36	[p3l1123t3458r1568b3533],
161	’17	CD	NUMBER	’17	_	0	SENT_36	[p3l1123t3458r1568b3533],

1	Because	IN	O	because	prep	30	SENT_37	[p3l193t3572r491b3631],
2	of	IN	O	of	_	0	SENT_37	[p3l542t3571r615b3631],
3	the	DT	O	the	det	4	SENT_37	[p3l653t3571r769b3631],
4	correlations	NNS	O	correlation	prep_of	5	SENT_37	[p3l821t3571r1254b3631],
5	between	IN	O	between	pobj	1	SENT_37	[p3l1303t3571r1607b3631],
6	SNPs	NNS	O	snp	pobj	5	SENT_37	[p3l1659t3571r1857b3631],
7	in	IN	O	in	_	0	SENT_37	[p3l1907t3572r1979b3630],
8	the	DT	O	the	det	9	SENT_37	[p3l2027t3571r2143b3631],
9	genes	NNS	O	gene	prep_in	6	SENT_37	[p3l14t3687r219b3743],
10	described	VBN	O	describe	partmod	9	SENT_37	[p3l279t3667r624b3728],
11	above	IN	O	above	prep	10	SENT_37	[p3l682t3667r888b3728],
12	and	CC	O	and	_	0	SENT_37	[p3l947t3667r1082b3728],
13	drug	NN	O	drug	nn	14	SENT_37	[p3l1141t3667r1312b3743],
14	toxicity	NN	O	toxicity	pobj	1	SENT_37	[p3l1367t3669r1649b3743],
15	,	,	O	,	_	0	SENT_37	[p3l1367t3669r1649b3743],
16	the	DT	O	the	det	18	SENT_37	[p3l1708t3667r1825b3728],
17	clinical	JJ	O	clinical	amod	18	SENT_37	[p3l1884t3667r2144b3728],
18	outcome	NN	O	outcome	appos	14	SENT_37	[p4l15t22r316b78],
19	of	IN	O	of	_	0	SENT_37	[p4l370t17r442b78],
20	cancer	NN	O	cancer	nn	21	SENT_37	[p4l484t37r721b78],
21	patients	NNS	O	patient	prep_of	18	SENT_37	[p4l772t19r1070b93],
22	and	CC	O	and	_	0	SENT_37	[p4l1124t17r1258b78],
23	their	PRP$	O	they	poss	24	SENT_37	[p4l1308t17r1487b78],
24	response	NN	O	response	appos	14	SENT_37	[p4l1537t37r1857b93],
25	to	TO	O	to	_	0	SENT_37	[p4l1909t22r1976b78],
26	the	DT	O	the	det	27	SENT_37	[p4l2027t17r2144b78],
27	chemotherapy	NN	O	chemotherapy	prep_to	24	SENT_37	[p4l15t115r547b191],
28	,	,	O	,	_	0	SENT_37	[p4l15t115r547b191],
29	we	PRP	O	we	nsubj	30	SENT_37	[p4l593t135r692b175],
30	hypothesized	VBD	O	hypothesize	_	0	SENT_37	[p4l735t115r1217b191],
31	that	IN	O	that	complm	48	SENT_37	[p4l1259t115r1412b175],
32	SNPs	NNS	O	snp	nsubjpass	48	SENT_37	[p4l1457t115r1655b175],
33	in	IN	O	in	_	0	SENT_37	[p4l1699t116r1770b174],
34	CYPZC8	NN	O	cypzc8	prep_in	32	SENT_37	[p4l1815t115r2141b189],
35	,	,	O	,	_	0	SENT_37	[p4l1815t115r2141b189],
36	GSTT1	NN	O	gstt1	appos	34	SENT_37	[p4l16t211r300b285],
37	,	,	O	,	_	0	SENT_37	[p4l16t211r300b285],
38	GSTP1	NN	O	gstp1	appos	34	SENT_37	[p4l336t211r613b284],
39	,	,	O	,	_	0	SENT_37	[p4l336t211r613b284],
40	MDR-1-57	NN	O	mdr-1-57	conj_and	36	SENT_37	[p4l649t212r1047b284],
41	,	,	O	,	_	0	SENT_37	[p4l649t212r1047b284],
42	MDR-1-62	NN	O	mdr-1-62	conj_and	36	SENT_37	[p4l1082t212r1480b284],
43	,	,	O	,	_	0	SENT_37	[p4l1082t212r1480b284],
44	and	CC	O	and	_	0	SENT_37	[p4l1521t211r1655b272],
45	ERCC1	NN	O	ercc1	conj_and	36	SENT_37	[p4l1681t211r1952b272],
46	may	MD	O	may	aux	48	SENT_37	[p4l1989t232r2145b287],
47	be	VB	O	be	auxpass	48	SENT_37	[p4l13t308r94b369],
48	associated	VBN	O	associate	ccomp	30	SENT_37	[p4l139t308r514b369],
49	with	IN	O	with	_	0	SENT_37	[p4l555t308r720b369],
50	survival	NN	O	survival	prep_with	48	SENT_37	[p4l764t308r1060b369],
51	in	IN	O	in	_	0	SENT_37	[p4l1103t310r1174b368],
52	stage	NN	O	stage	nn	54	SENT_37	[p4l1218t313r1407b384],
53	IV	CD	NUMBER	iv	num	54	SENT_37	[p4l1451t309r1540b369],
54	head	NN	O	head	prep_in	50	SENT_37	[p4l1578t308r1755b369],
55	and	CC	O	and	_	0	SENT_37	[p4l1799t308r1933b369],
56	neck	NN	O	neck	nn	58	SENT_37	[p4l1975t308r2146b369],
57	cancer	NN	O	cancer	nn	58	SENT_37	[p4l15t426r253b466],
58	patients	NNS	O	patient	prep_with	48	SENT_37	[p4l278t407r576b481],
59	treated	VBN	O	treat	partmod	58	SENT_37	[p4l602t406r867b466],
60	With	IN	O	with	_	0	SENT_37	[p4l891t406r1057b466],
61	paclitaxel	NN	O	paclitaxel	prep_with	59	SENT_37	[p4l1082t406r1455b481],
62	.	.	O	.	_	0	SENT_37	[p4l1082t406r1455b481],

1	We	PRP	O	we	nsubj	3	SENT_38	[p4l1485t407r1596b466],
2	therefore	RB	O	therefore	advmod	3	SENT_38	[p4l1622t406r1957b466],
3	analyzed	VBD	O	analyze	_	0	SENT_38	[p4l1985t426r2143b466, p4l14t502r204b578],
4	SNPs	NNS	O	snp	dobj	3	SENT_38	[p4l274t502r472b563],
5	in	IN	O	in	_	0	SENT_38	[p4l540t504r612b562],
6	the	DT	O	the	det	8	SENT_38	[p4l680t502r795b563],
7	six	CD	NUMBER	six	num	8	SENT_38	[p4l867t504r967b563],
8	genes	NNS	O	gene	prep_in	4	SENT_38	[p4l1034t522r1239b578],
9	mentioned	VBN	O	mention	partmod	8	SENT_38	[p4l1308t502r1696b563],
10	and	CC	O	and	_	0	SENT_38	[p4l1765t502r1899b563],
11	their	PRP$	O	they	poss	12	SENT_38	[p4l1966t502r2145b563],
12	association	NN	O	association	conj_and	4	SENT_38	[p4l16t601r419b660],
13	with	IN	O	with	_	0	SENT_38	[p4l455t599r620b660],
14	response	NN	O	response	nn	15	SENT_38	[p4l656t619r976b675],
15	rate	NN	O	rate	prep_with	12	SENT_38	[p4l1014t604r1180b673],
16	,	,	O	,	_	0	SENT_38	[p4l1014t604r1180b673],
17	time	NN	O	time	conj_and	4	SENT_38	[p4l1220t601r1382b660],
18	to	TO	O	to	_	0	SENT_38	[p4l1420t604r1487b660],
19	progression	NN	O	progression	prep_to	17	SENT_38	[p4l1525t601r1969b675],
20	,	,	O	,	_	0	SENT_38	[p4l1525t601r1969b675],
21	and	CC	O	and	_	0	SENT_38	[p4l2010t599r2145b660],
22	overall	JJ	O	overall	amod	23	SENT_38	[p4l15t697r264b757],
23	survival	NN	O	survival	conj_and	4	SENT_38	[p4l355t697r651b757],
24	in	IN	O	in	_	0	SENT_38	[p4l739t698r810b756],
25	patients	NNS	O	patient	prep_in	23	SENT_38	[p4l899t698r1196b772],
26	treated	VBN	O	treat	partmod	25	SENT_38	[p4l1285t697r1550b757],
27	with	IN	O	with	_	0	SENT_38	[p4l1637t697r1802b757],
28	weekly	JJ	SET	weekly	amod	29	SENT_38	[p4l1889t697r2146b772],
29	paclitaxel	NN	O	paclitaxel	prep_with	26	SENT_38	[p4l15t793r388b869],
30	.	.	O	.	_	0	SENT_38	[p4l15t793r388b869],

1	MATERIALS	NNS	O	material	_	0	SENT_39	[p4l13t1021r566b1085],
2	AND	CC	O	and	_	0	SENT_39	[p4l595t1021r799b1084],
3	METHODS	NNS	O	method	conj_and	1	SENT_39	[p4l830t1021r1306b1085],

1	Patient	NN	O	patient	_	0	SENT_40	[p4l9t1170r335b1233],
2	Population	NNP	O	Population	dep	1	SENT_40	[p4l360t1170r846b1249],

1	Patients	NNS	O	patient	nsubjpass	21	SENT_41	[p4l192t1267r464b1320],
2	with	IN	O	with	_	0	SENT_41	[p4l491t1266r638b1320],
3	locally	RB	O	locally	advmod	4	SENT_41	[p4l665t1266r875b1333],
4	advanced	JJ	O	advanced	amod	5	SENT_41	[p4l903t1266r1208b1320],
5	and/or	NN	O	and/or	prep_with	1	SENT_41	[p4l1237t1266r1444b1320],
6	metastatic	JJ	O	metastatic	amod	7	SENT_41	[p4l1470t1268r1812b1320],
7	head	NN	O	head	dep	5	SENT_41	[p4l1839t1266r1997b1320],
8	and	CC	O	and	_	0	SENT_41	[p4l2026t1266r2146b1320],
9	neck	NN	O	neck	nn	10	SENT_41	[p4l14t1353r166b1407],
10	cancer	NN	O	cancer	conj_and	5	SENT_41	[p4l187t1372r398b1407],
11	with	IN	O	with	_	0	SENT_41	[p4l418t1353r564b1407],
12	conﬁrmed	JJ	O	conﬁrmed	amod	13	SENT_41	[p4l586t1353r911b1407],
13	diagnosis	NN	O	diagnosis	prep_with	10	SENT_41	[p4l933t1353r1234b1420],
14	of	IN	O	of	_	0	SENT_41	[p4l1258t1353r1322b1407],
15	disease	NN	O	disease	nn	16	SENT_41	[p4l1336t1353r1570b1407],
16	progression	NN	O	progression	prep_of	13	SENT_41	[p4l1592t1355r1969b1420],
17	after	IN	O	after	_	0	SENT_41	[p4l1992t1353r2146b1407],
18	platinum-based	JJ	O	platinum-based	amod	19	SENT_41	[p4l14t1441r524b1508],
19	chemotherapy	NN	O	chemotherapy	prep_after	16	SENT_41	[p4l585t1441r1048b1508],
20	were	VBD	O	be	auxpass	21	SENT_41	[p4l1108t1459r1263b1494],
21	included	VBN	O	include	_	0	SENT_41	[p4l1324t1441r1603b1494],
22	in	IN	O	in	_	0	SENT_41	[p4l1663t1442r1727b1493],
23	the	DT	O	the	det	24	SENT_41	[p4l1787t1441r1890b1494],
24	study	NN	O	study	prep_in	21	SENT_41	[p4l1954t1441r2140b1508],
25	.	.	O	.	_	0	SENT_41	[p4l1954t1441r2140b1508],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_42	[p4l14t1528r286b1581],
2	were	VBD	O	be	auxpass	3	SENT_42	[p4l309t1545r464b1581],
3	treated	VBN	O	treat	_	0	SENT_42	[p4l486t1527r722b1581],
4	With	IN	O	with	_	0	SENT_42	[p4l743t1527r890b1581],
5	palliative	JJ	O	palliative	amod	6	SENT_42	[p4l912t1527r1218b1594],
6	intention	NN	O	intention	prep_with	3	SENT_42	[p4l1240t1529r1539b1581],
7	and	CC	O	and	_	0	SENT_42	[p4l1563t1527r1682b1581],
8	no	DT	O	no	det	11	SENT_42	[p4l1705t1545r1780b1581],
9	other	JJ	O	other	amod	11	SENT_42	[p4l1804t1527r1975b1581],
10	local	JJ	O	local	amod	11	SENT_42	[p4l1996t1527r2145b1581],
11	therapies	NNS	O	therapy	nsubj	13	SENT_42	[p4l14t1614r319b1681],
12	were	VBD	O	be	cop	13	SENT_42	[p4l365t1633r520b1668],
13	possible	JJ	O	possible	conj_and	3	SENT_42	[p4l568t1614r841b1681],
14	.	.	O	.	_	0	SENT_42	[p4l568t1614r841b1681],

1	Inclusion	NN	MISC	inclusion	nn	2	SENT_43	[p4l892t1614r1193b1668],
2	criteria	NNS	O	criterion	nsubj	3	SENT_43	[p4l1240t1616r1479b1668],
3	consisted	VBD	O	consist	_	0	SENT_43	[p4l1525t1614r1824b1668],
4	of	IN	O	of	_	0	SENT_43	[p4l1870t1614r1935b1668],
5	documented	VBN	O	document	amod	7	SENT_43	[p4l1974t1614r2144b1668, p4l14t1702r258b1755],
6	tumor	NN	O	tumor	nn	7	SENT_43	[p4l325t1707r524b1755],
7	progression	NN	O	progression	prep_of	3	SENT_43	[p4l592t1703r969b1769],
8	after	IN	O	after	_	0	SENT_43	[p4l1039t1702r1193b1755],
9	prior	JJ	O	prior	amod	12	SENT_43	[p4l1261t1703r1421b1769],
10	systemic	JJ	O	systemic	amod	12	SENT_43	[p4l1491t1703r1769b1769],
11	induction	NN	O	induction	nn	12	SENT_43	[p4l1837t1702r2146b1755],
12	chemotherapy	NN	O	chemotherapy	prep_after	3	SENT_43	[p4l15t1789r478b1856],
13	plus	CC	O	plus	prep	12	SENT_43	[p4l498t1789r633b1856],
14	chemoradiotherapy	NN	O	chemoradiotherapy	dep	13	SENT_43	[p4l656t1789r1287b1856],
15	during	IN	O	during	_	0	SENT_43	[p4l1309t1789r1527b1856],
16	the	DT	O	the	det	18	SENT_43	[p4l1546t1789r1649b1842],
17	ﬁrst	NN	O	ﬁrst	nn	18	SENT_43	[p4l1671t1789r1807b1842],
18	year	NN	DURATION	year	prep_during	3	SENT_43	[p4l1825t1807r1970b1856],
19	after	IN	O	after	_	0	SENT_43	[p4l1992t1789r2146b1842],
20	the	DT	O	the	det	21	SENT_43	[p4l14t1876r117b1929],
21	end	NN	O	end	prep_after	3	SENT_43	[p4l140t1876r257b1929],
22	of	IN	O	of	_	0	SENT_43	[p4l279t1876r343b1929],
23	treatment	NN	O	treatment	prep_of	21	SENT_43	[p4l356t1880r701b1941],
24	,	,	O	,	_	0	SENT_43	[p4l356t1880r701b1941],
25	and	CC	O	and	_	0	SENT_43	[p4l727t1876r846b1929],
26	no	DT	O	no	det	33	SENT_43	[p4l868t1894r943b1929],
27	more	JJR	O	more	mwe	28	SENT_43	[p4l966t1894r1127b1929],
28	than	IN	O	than	quantmod	29	SENT_43	[p4l1149t1876r1301b1929],
29	one	CD	NUMBER	one	num	33	SENT_43	[p4l1323t1894r1433b1929],
30	prior	JJ	O	prior	amod	33	SENT_43	[p4l1456t1877r1616b1943],
31	systemic	JJ	O	systemic	amod	33	SENT_43	[p4l1639t1877r1917b1943],
32	palliative	JJ	O	palliative	amod	33	SENT_43	[p4l1938t1876r2143b1943, p4l14t1964r134b2016],
33	chemotherapy	NN	O	chemotherapy	prep_after	3	SENT_43	[p4l184t1963r653b2030],
34	.	.	O	.	_	0	SENT_43	[p4l184t1963r653b2030],

1	Additional	JJ	O	additional	amod	3	SENT_44	[p4l704t1963r1048b2016],
2	eligibility	NN	O	eligibility	nn	3	SENT_44	[p4l1096t1963r1406b2030],
3	criteria	NNS	O	criterion	nsubj	4	SENT_44	[p4l1453t1964r1693b2016],
4	included	VBD	O	include	_	0	SENT_44	[p4l1739t1963r2018b2016],
5	an	DT	O	a	det	14	SENT_44	[p4l2066t1981r2145b2016],
6	Eastern	JJ	ORGANIZATION	eastern	amod	14	SENT_44	[p4l14t2051r273b2103],
7	Cooperative	NNP	ORGANIZATION	Cooperative	nn	14	SENT_44	[p4l307t2050r693b2117],
8	Oncology	NNP	ORGANIZATION	Oncology	nn	14	SENT_44	[p4l728t2050r1026b2117],
9	Group	NNP	ORGANIZATION	Group	nn	14	SENT_44	[p4l1059t2050r1260b2117],
10	(	CD	NUMBER	(	num	14	SENT_44	[p4l1295t2050r1550b2111],
11	ECOG	NNP	O	ECOG	nn	14	SENT_44	[p4l1295t2050r1550b2111],
12	)	CD	NUMBER	)	num	14	SENT_44	[p4l1295t2050r1550b2111],
13	performance	NN	O	performance	nn	14	SENT_44	[p4l1584t2050r1991b2117],
14	status	NN	O	status	dobj	4	SENT_44	[p4l2027t2055r2144b2103, p4l14t2141r114b2190],
15	of	IN	O	of	_	0	SENT_44	[p4l157t2137r222b2190],
16	2	CD	NUMBER	2	prep_of	4	SENT_44	[p4l256t2139r290b2189],
17	or	CC	O	or	_	0	SENT_44	[p4l334t2155r399b2190],
18	less	JJR	O	less	prep_of	4	SENT_44	[p4l439t2137r577b2202],
19	,	,	O	,	_	0	SENT_44	[p4l439t2137r577b2202],
20	a	DT	O	a	det	22	SENT_44	[p4l622t2155r658b2190],
21	life	NN	O	life	nn	22	SENT_44	[p4l699t2136r799b2190],
22	expectancy	NN	O	expectancy	appos	16	SENT_44	[p4l842t2141r1202b2204],
23	of	IN	O	of	_	0	SENT_44	[p4l1243t2137r1307b2190],
24	at	IN	DURATION	at	quantmod	26	SENT_44	[p4l1342t2141r1405b2190],
25	least	JJS	DURATION	least	mwe	24	SENT_44	[p4l1446t2137r1601b2190],
26	2	CD	DURATION	2	num	27	SENT_44	[p4l1643t2139r1676b2189],
27	months	NNS	NUMBER	month	prep_of	22	SENT_44	[p4l1720t2137r1980b2202],
28	,	,	O	,	_	0	SENT_44	[p4l1720t2137r1980b2202],
29	and	CC	O	and	_	0	SENT_44	[p4l2026t2136r2146b2190],
30	adequate	JJ	O	adequate	amod	32	SENT_44	[p4l16t2224r311b2291],
31	bone	NN	O	bone	nn	32	SENT_44	[p4l354t2224r505b2277],
32	marrow	NN	O	marrow	prep_of	22	SENT_44	[p4l550t2242r815b2289],
33	,	,	O	,	_	0	SENT_44	[p4l550t2242r815b2289],
34	hepatic	JJ	O	hepatic	conj_and	32	SENT_44	[p4l861t2224r1116b2291],
35	,	,	O	,	_	0	SENT_44	[p4l861t2224r1116b2291],
36	and	CC	O	and	_	0	SENT_44	[p4l1164t2224r1284b2277],
37	renal	JJ	O	renal	amod	38	SENT_44	[p4l1327t2224r1497b2277],
38	function	NN	O	function	conj_and	32	SENT_44	[p4l1540t2224r1825b2277],
39	.	.	O	.	_	0	SENT_44	[p4l1540t2224r1825b2277],

1	Patients	NNS	O	patient	nsubj	12	SENT_45	[p4l1873t2225r2144b2277],
2	with	IN	O	with	_	0	SENT_45	[p4l13t2311r160b2364],
3	documented	VBN	O	document	amod	5	SENT_45	[p4l197t2311r590b2364],
4	brain	NN	O	brain	nn	5	SENT_45	[p4l624t2311r799b2364],
5	metastases	NNS	O	metastase	prep_with	1	SENT_45	[p4l834t2316r1212b2376],
6	,	,	O	,	_	0	SENT_45	[p4l834t2316r1212b2376],
7	clinically	RB	O	clinically	advmod	8	SENT_45	[p4l1252t2311r1545b2378],
8	signiﬁcant	JJ	O	signiﬁcant	amod	11	SENT_45	[p4l1581t2311r1924b2378],
9	thirdspace	NN	O	thirdspace	nn	11	SENT_45	[p4l1958t2311r2144b2364, p4l16t2416r190b2465],
10	ﬂuid	NN	O	ﬂuid	nn	11	SENT_45	[p4l211t2398r361b2451],
11	collections	NNS	O	collection	appos	1	SENT_45	[p4l382t2398r718b2451],
12	(	VBP	O	(	_	0	SENT_45	[p4l740t2398r891b2465],
13	e.g.	FW	O	e.g.	dobj	12	SENT_45	[p4l740t2398r891b2465],
14	,	,	O	,	_	0	SENT_45	[p4l740t2398r891b2465],
15	ascites	NNS	O	ascite	dobj	12	SENT_45	[p4l915t2399r1131b2451],
16	or	CC	O	or	_	0	SENT_45	[p4l1153t2416r1217b2451],
17	pleural	JJ	O	pleural	amod	18	SENT_45	[p4l1238t2398r1470b2465],
18	effusions	NNS	O	effusion	dobj	12	SENT_45	[p4l1490t2398r1820b2463],
19	)	RB	O	)	advmod	12	SENT_45	[p4l1490t2398r1820b2463],
20	,	,	O	,	_	0	SENT_45	[p4l1490t2398r1820b2463],
21	or	CC	O	or	_	0	SENT_45	[p4l1844t2416r1909b2451],
22	second	JJ	ORDINAL	second	amod	24	SENT_45	[p4l1930t2397r2146b2451],
23	primary	JJ	O	primary	amod	24	SENT_45	[p4l14t2486r279b2552],
24	malignancies	NNS	O	malignancy	nsubjpass	32	SENT_45	[p4l305t2485r734b2552],
25	treated	VBN	O	treat	partmod	24	SENT_45	[p4l762t2485r998b2538],
26	in	IN	O	in	_	0	SENT_45	[p4l1024t2486r1088b2537],
27	the	DT	DURATION	the	det	30	SENT_45	[p4l1114t2485r1218b2538],
28	last	JJ	DURATION	last	amod	30	SENT_45	[p4l1245t2485r1365b2538],
29	5	CD	DURATION	5	num	30	SENT_45	[p4l1393t2487r1426b2538],
30	years	NNS	NUMBER	year	prep_in	25	SENT_45	[p4l1453t2503r1628b2552],
31	were	VBD	O	be	auxpass	32	SENT_45	[p4l1656t2503r1812b2538],
32	excluded	VBN	O	exclude	conj_or	12	SENT_45	[p4l1840t2485r2141b2538],
33	.	.	O	.	_	0	SENT_45	[p4l1840t2485r2141b2538],

1	Pregnant	JJ	O	pregnant	amod	4	SENT_46	[p4l14t2572r319b2638],
2	or	CC	O	or	_	0	SENT_46	[p4l345t2590r409b2625],
3	breastfeeding	JJ	O	breastfeeding	amod	4	SENT_46	[p4l434t2571r878b2638],
4	women	NNS	O	woman	nsubjpass	25	SENT_46	[p4l902t2590r1133b2625],
5	and	CC	O	and	_	0	SENT_46	[p4l1161t2571r1280b2625],
6	patients	NNS	O	patient	nsubjpass	25	SENT_46	[p4l1306t2573r1571b2638],
7	unable	JJ	O	unable	amod	6	SENT_46	[p4l1596t2571r1817b2625],
8	to	TO	O	to	aux	9	SENT_46	[p4l1843t2576r1903b2625],
9	use	VB	O	use	xcomp	7	SENT_46	[p4l1929t2590r2038b2625],
10	an	DT	O	a	det	13	SENT_46	[p4l2066t2590r2145b2625],
11	approved	VBN	O	approve	amod	13	SENT_46	[p4l16t2658r314b2725],
12	contraceptive	NN	O	contraceptive	nn	13	SENT_46	[p4l341t2660r776b2725],
13	method	NN	O	method	dobj	9	SENT_46	[p4l803t2658r1047b2712],
14	during	IN	O	during	_	0	SENT_46	[p4l1073t2658r1291b2725],
15	the	DT	O	the	det	16	SENT_46	[p4l1315t2658r1418b2712],
16	study	NN	O	study	prep_during	9	SENT_46	[p4l1447t2658r1626b2725],
17	and	CC	O	and	_	0	SENT_46	[p4l1653t2658r1772b2712],
18	for	IN	O	for	_	0	SENT_46	[p4l1798t2658r1887b2712],
19	the	DT	DURATION	the	det	22	SENT_46	[p4l1912t2658r2015b2712],
20	following	VBG	DURATION	follow	amod	22	SENT_46	[p4l2042t2658r2143b2712, p4l14t2745r230b2813],
21	3	CD	DURATION	3	num	22	SENT_46	[p4l255t2748r288b2799],
22	months	NNS	NUMBER	month	prep_for	9	SENT_46	[p4l314t2746r556b2799],
23	were	VBD	O	be	auxpass	25	SENT_46	[p4l582t2764r737b2799],
24	also	RB	O	also	advmod	25	SENT_46	[p4l763t2746r888b2799],
25	excluded	VBN	O	exclude	_	0	SENT_46	[p4l915t2746r1214b2799],
26	.	.	O	.	_	0	SENT_46	[p4l915t2746r1214b2799],

1	The	DT	O	the	det	2	SENT_47	[p4l1243t2746r1366b2799],
2	study	NN	O	study	nsubjpass	4	SENT_47	[p4l1394t2746r1573b2813],
3	was	VBD	O	be	auxpass	4	SENT_47	[p4l1596t2764r1720b2799],
4	approved	VBN	O	approve	_	0	SENT_47	[p4l1747t2746r2046b2813],
5	by	IN	O	by	_	0	SENT_47	[p4l2068t2746r2146b2812],
6	the	DT	O	the	det	8	SENT_47	[p4l14t2832r117b2886],
7	ethics	NNS	O	ethic	nn	8	SENT_47	[p4l143t2832r331b2886],
8	committee	NN	O	committee	agent	4	SENT_47	[p4l358t2834r693b2886],
9	of	IN	O	of	_	0	SENT_47	[p4l719t2832r784b2886],
10	the	DT	O	the	det	12	SENT_47	[p4l799t2832r902b2886],
11	Hospital	NNP	ORGANIZATION	Hospital	nn	12	SENT_47	[p4l928t2832r1203b2899],
12	Clinic	NNP	ORGANIZATION	Clinic	prep_of	8	SENT_47	[p4l1229t2832r1417b2886],
13	of	IN	ORGANIZATION	of	_	0	SENT_47	[p4l1443t2832r1507b2886],
14	Barcelona	NNP	ORGANIZATION	Barcelona	prep_of	12	SENT_47	[p4l1523t2832r1866b2886],
15	.	.	O	.	_	0	SENT_47	[p4l1523t2832r1866b2886],

1	Written	VBN	O	write	csubjpass	5	SENT_48	[p4l1893t2833r2145b2886],
2	informed	JJ	O	informed	amod	3	SENT_48	[p4l14t2919r308b2973],
3	consent	NN	O	consent	dobj	1	SENT_48	[p4l334t2924r582b2973],
4	was	VBD	O	be	auxpass	5	SENT_48	[p4l607t2938r731b2973],
5	obtained	VBN	O	obtain	_	0	SENT_48	[p4l760t2919r1039b2973],
6	from	IN	O	from	_	0	SENT_48	[p4l1065t2919r1218b2973],
7	all	DT	O	all	det	8	SENT_48	[p4l1245t2919r1324b2973],
8	patients	NNS	O	patient	prep_from	5	SENT_48	[p4l1351t2921r1633b2986],
9	.	.	O	.	_	0	SENT_48	[p4l1351t2921r1633b2986],

1	The	DT	O	the	det	2	SENT_49	[p4l1663t2919r1786b2973],
2	study	NN	O	study	nsubjpass	4	SENT_49	[p4l1816t2919r1994b2986],
3	was	VBD	O	be	auxpass	4	SENT_49	[p4l2020t2938r2144b2973],
4	conducted	VBN	O	conduct	_	0	SENT_49	[p4l15t3007r342b3060],
5	in	IN	O	in	_	0	SENT_49	[p4l367t3008r431b3059],
6	accordance	NN	O	accordance	prep_in	4	SENT_49	[p4l458t3007r815b3060],
7	with	IN	O	with	_	0	SENT_49	[p4l840t3007r987b3060],
8	the	DT	O	the	det	10	SENT_49	[p4l1013t3007r1116b3060],
9	Helsinki	NNP	LOCATION	Helsinki	nn	10	SENT_49	[p4l1143t3007r1420b3060],
10	Declaration	NNP	O	Declaration	prep_with	4	SENT_49	[p4l1446t3007r1826b3060],
11	and	CC	O	and	_	0	SENT_49	[p4l1853t3007r1973b3060],
12	with	IN	O	with	_	0	SENT_49	[p4l1998t3007r2145b3060],
13	the	DT	O	the	det	14	SENT_49	[p4l14t3093r117b3147],
14	guidelines	NNS	O	guideline	prep_with	4	SENT_49	[p4l138t3093r471b3160],
15	of	IN	O	of	_	0	SENT_49	[p4l492t3093r557b3147],
16	good	JJ	O	good	amod	18	SENT_49	[p4l569t3093r717b3160],
17	clinical	JJ	O	clinical	amod	18	SENT_49	[p4l738t3093r969b3147],
18	practice	NN	O	practice	prep_of	14	SENT_49	[p4l989t3095r1263b3160],
19	.	.	O	.	_	0	SENT_49	[p4l989t3095r1263b3160],

1	Treatment	NN	O	treatment	nn	2	SENT_50	[p4l16t3321r462b3384],
2	Plan	NN	O	plan	_	0	SENT_50	[p4l487t3320r696b3384],
3	and	CC	O	and	_	0	SENT_50	[p4l729t3320r899b3384],
4	Dose	NN	O	dose	nn	5	SENT_50	[p4l923t3321r1127b3384],
5	Modiﬁcations	NNS	O	modiﬁcations	conj_and	2	SENT_50	[p4l1157t3320r1754b3400],

1	Patients	NNS	O	patient	nsubj	2	SENT_51	[p4l192t3419r464b3472],
2	enrolled	VBD	O	enrol	_	0	SENT_51	[p4l496t3418r760b3472],
3	in	IN	O	in	mark	6	SENT_51	[p4l790t3420r854b3471],
4	the	DT	O	the	det	5	SENT_51	[p4l885t3418r988b3472],
5	study	NN	O	study	nsubj	6	SENT_51	[p4l1022t3418r1201b3485],
6	received	VBD	O	receive	advcl	2	SENT_51	[p4l1231t3418r1500b3472],
7	80	CD	NUMBER	80	num	8	SENT_51	[p4l1532t3420r1606b3472],
8	mg/m2	NN	O	mg/m2	dobj	6	SENT_51	[p4l1638t3405r1848b3485],
9	of	IN	O	of	_	0	SENT_51	[p4l1881t3418r1945b3472],
10	paclitaxel	NN	O	paclitaxel	prep_of	8	SENT_51	[p4l1968t3418r2144b3485, p4l14t3505r174b3559],
11	with	IN	O	with	_	0	SENT_51	[p4l225t3505r371b3559],
12	a	DT	O	a	det	15	SENT_51	[p4l424t3524r460b3559],
13	1-hour	JJ	DURATION	1-hour	amod	15	SENT_51	[p4l516t3505r725b3559],
14	infusion	NN	O	infusion	nn	15	SENT_51	[p4l775t3505r1040b3559],
15	schedule	NN	O	schedule	prep_with	6	SENT_51	[p4l1092t3505r1372b3559],
16	administered	VBN	O	administer	partmod	15	SENT_51	[p4l1425t3505r1855b3559],
17	weekly	RB	SET	weekly	advmod	16	SENT_51	[p4l1905t3505r2140b3572],
18	.	.	O	.	_	0	SENT_51	[p4l1905t3505r2140b3572],

1	Associated	NNP	O	Associated	nn	2	SENT_52	[p5l12t17r360b70],
2	medication	NN	O	medication	nsubj	3	SENT_52	[p5l383t17r741b70],
3	consisted	VBD	O	consist	_	0	SENT_52	[p5l765t17r1064b70],
4	of	IN	O	of	_	0	SENT_52	[p5l1088t17r1152b70],
5	8	CD	NUMBER	8	num	6	SENT_52	[p5l1168t19r1203b70],
6	mg	NN	O	mg	prep_of	3	SENT_52	[p5l1227t34r1328b84],
7	of	IN	O	of	_	0	SENT_52	[p5l1350t17r1415b70],
8	dexamethasone	NN	O	dexamethasone	prep_of	6	SENT_52	[p5l1432t17r1936b70],
9	intravenously	RB	O	intravenously	advmod	12	SENT_52	[p5l1959t18r2144b70, p5l13t103r302b170],
10	(	RB	O	(	amod	12	SENT_52	[p5l347t103r487b168],
11	IV	CD	NUMBER	iv	tmod	10	SENT_52	[p5l347t103r487b168],
12	)	NN	O	)	rcmod	8	SENT_52	[p5l347t103r487b168],
13	,	,	O	,	_	0	SENT_52	[p5l347t103r487b168],
14	50	CD	NUMBER	50	num	15	SENT_52	[p5l537t105r610b157],
15	mg	NN	O	mg	prep_of	6	SENT_52	[p5l655t120r756b170],
16	of	IN	O	of	_	0	SENT_52	[p5l799t103r864b157],
17	diphenhydramine	NN	O	diphenhydramine	prep_of	15	SENT_52	[p5l902t103r1480b170],
18	IV	CD	NUMBER	iv	num	17	SENT_52	[p5l1527t104r1611b168],
19	,	,	O	,	_	0	SENT_52	[p5l1527t104r1611b168],
20	and	CC	O	and	_	0	SENT_52	[p5l1660t103r1780b157],
21	50	CD	NUMBER	50	num	22	SENT_52	[p5l1826t105r1899b157],
22	mg	NN	O	mg	conj_and	8	SENT_52	[p5l1945t120r2045b170],
23	of	IN	O	of	_	0	SENT_52	[p5l2089t103r2153b157],
24	ranitidine	NN	O	ranitidine	prep_of	22	SENT_52	[p5l14t190r338b243],
25	IV	CD	NUMBER	iv	num	24	SENT_52	[p5l386t191r469b244],
26	.	.	O	.	_	0	SENT_52	[p5l386t191r469b244],

1	Treatment	NN	O	treatment	nsubjpass	3	SENT_53	[p5l518t191r863b243],
2	was	VBD	O	be	auxpass	3	SENT_53	[p5l907t208r1032b243],
3	administered	VBN	O	administer	_	0	SENT_53	[p5l1079t190r1509b243],
4	for	IN	O	for	_	0	SENT_53	[p5l1554t190r1643b243],
5	6	CD	NUMBER	6	num	7	SENT_53	[p5l1689t192r1723b243],
6	consecutive	JJ	O	consecutive	amod	7	SENT_53	[p5l1771t192r2144b244],
7	weeks	NNS	DURATION	week	prep_for	3	SENT_53	[p5l13t278r212b331],
8	on	IN	O	on	_	0	SENT_53	[p5l266t296r342b331],
9	an	DT	O	a	det	11	SENT_53	[p5l395t296r474b331],
10	outpatient	JJ	O	outpatient	amod	11	SENT_53	[p5l527t279r866b345],
11	basis	NN	O	basis	prep_on	7	SENT_53	[p5l917t278r1097b331],
12	.	.	O	.	_	0	SENT_53	[p5l917t278r1097b331],

1	Before	IN	O	before	_	0	SENT_54	[p5l1153t278r1363b331],
2	each	DT	O	each	det	4	SENT_54	[p5l1416t278r1563b331],
3	paclitaxel	NN	O	paclitaxel	nn	4	SENT_54	[p5l1616t278r1930b345],
4	dose	NN	O	dose	pobj	1	SENT_54	[p5l1985t278r2142b343],
5	,	,	O	,	_	0	SENT_54	[p5l1985t278r2142b343],

1	Laryngoscope	NN	O	laryngoscope	dep	8	SENT_55	[p5l19t503r520b577],
2	119	CD	NUMBER	119	num	1	SENT_55	[p5l555t503r697b561],
3	:	:	O	:	_	0	SENT_55	[p5l555t503r697b561],
4	August	NNP	DATE	August	nn	6	SENT_55	[p5l730t503r979b577],
5	2009	CD	DATE	2009	num	6	SENT_55	[p5l1009t503r1181b561],
6	patients	NNS	O	patient	nsubjpass	8	SENT_55	[p5l15t597r281b663],
7	were	VBD	O	be	auxpass	8	SENT_55	[p5l305t614r460b649],
8	asked	VBN	O	ask	_	0	SENT_55	[p5l487t595r674b649],
9	about	IN	O	about	_	0	SENT_55	[p5l698t596r880b649],
10	their	PRP$	O	they	poss	11	SENT_55	[p5l903t596r1062b649],
11	symptoms	NNS	O	symptom	prep_about	8	SENT_55	[p5l1087t600r1433b663],
12	,	,	O	,	_	0	SENT_55	[p5l1087t600r1433b663],
13	and	CC	O	and	_	0	SENT_55	[p5l1461t595r1581b649],
14	a	DT	O	a	det	17	SENT_55	[p5l1606t614r1643b649],
15	complete	JJ	O	complete	amod	17	SENT_55	[p5l1667t596r1954b663],
16	blood	NN	O	blood	nn	17	SENT_55	[p5l1978t596r2150b649],
17	exam	NN	O	exam	nsubjpass	24	SENT_55	[p5l16t700r190b736],
18	and	CC	O	and	_	0	SENT_55	[p5l218t682r338b736],
19	physical	JJ	O	physical	amod	20	SENT_55	[p5l366t682r633b749],
20	exam	NN	O	exam	conj_and	17	SENT_55	[p5l662t700r835b736],
21	for	IN	O	for	_	0	SENT_55	[p5l862t682r952b736],
22	toxicity	NN	O	toxicity	prep_for	17	SENT_55	[p5l978t684r1221b749],
23	was	VBD	O	be	auxpass	24	SENT_55	[p5l1247t700r1371b736],
24	performed	VBN	O	perform	conj_and	8	SENT_55	[p5l1400t682r1751b749],
25	.	.	O	.	_	0	SENT_55	[p5l1400t682r1751b749],

1	In	IN	O	in	_	0	SENT_56	[p5l1784t683r1853b735],
2	the	DT	O	the	det	3	SENT_56	[p5l1880t682r1983b736],
3	case	NN	O	case	prep_in	11	SENT_56	[p5l2013t700r2148b736],
4	of	IN	O	of	_	0	SENT_56	[p5l16t769r81b823],
5	clinical	JJ	O	clinical	amod	6	SENT_56	[p5l95t769r327b823],
6	response	NN	O	response	prep_of	3	SENT_56	[p5l349t788r634b836],
7	or	CC	O	or	_	0	SENT_56	[p5l658t788r723b823],
8	stabilization	NN	O	stabilization	prep_of	3	SENT_56	[p5l746t769r1166b835],
9	,	,	O	,	_	0	SENT_56	[p5l746t769r1166b835],
10	patients	NNS	O	patient	nsubj	11	SENT_56	[p5l1191t771r1457b836],
11	continued	VBD	O	continue	conj_or	11	SENT_56	[p5l1480t769r1802b823],
12	on	IN	O	on	_	0	SENT_56	[p5l1824t788r1900b823],
13	weekly	JJ	SET	weekly	amod	14	SENT_56	[p5l1922t769r2151b836],
14	paclitaxel	NN	O	paclitaxel	prep_on	11	SENT_56	[p5l15t857r331b924],
15	for	IN	O	for	_	0	SENT_56	[p5l359t857r448b910],
16	6	CD	DURATION	6	num	17	SENT_56	[p5l478t859r512b910],
17	months	NNS	NUMBER	month	prep_for	11	SENT_56	[p5l542t857r784b910],
18	or	CC	O	or	_	0	SENT_56	[p5l813t875r878b910],
19	until	IN	O	until	_	0	SENT_56	[p5l906t856r1063b910],
20	objective	JJ	O	objective	amod	21	SENT_56	[p5l1091t857r1374b924],
21	progression	NN	O	progression	prep_until	11	SENT_56	[p5l1403t858r1780b924],
22	of	IN	O	of	_	0	SENT_56	[p5l1809t857r1873b910],
23	disease	NN	O	disease	prep_of	21	SENT_56	[p5l1895t857r2146b922],
24	,	,	O	,	_	0	SENT_56	[p5l1895t857r2146b922],
25	intolerance	NN	O	intolerance	prep_of	21	SENT_56	[p5l15t943r398b1008],
26	,	,	O	,	_	0	SENT_56	[p5l15t943r398b1008],
27	toxicity	NN	O	toxicity	prep_of	21	SENT_56	[p5l421t945r672b1010],
28	,	,	O	,	_	0	SENT_56	[p5l421t945r672b1010],
29	or	CC	O	or	_	0	SENT_56	[p5l696t961r760b997],
30	voluntary	JJ	O	voluntary	amod	32	SENT_56	[p5l779t943r1098b1010],
31	patient	NN	O	patient	nn	32	SENT_56	[p5l1118t945r1352b1010],
32	withdrawal	NN	O	withdrawal	prep_of	21	SENT_56	[p5l1371t943r1762b997],
33	.	.	O	.	_	0	SENT_56	[p5l1371t943r1762b997],

1	When	WRB	O	when	advmod	9	SENT_57	[p5l192t1030r384b1084],
2	acute	JJ	O	acute	amod	3	SENT_57	[p5l432t1035r605b1084],
3	toxicity	NN	O	toxicity	nsubj	9	SENT_57	[p5l652t1032r895b1097],
4	such	JJ	O	such	_	0	SENT_57	[p5l943t1030r1090b1084],
5	as	IN	O	as	_	0	SENT_57	[p5l1139t1049r1206b1084],
6	paresthesia	NN	O	paresthesium	prep_such_as	3	SENT_57	[p5l1255t1030r1632b1097],
7	or	CC	O	or	_	0	SENT_57	[p5l1680t1049r1744b1084],
8	leukopenia	NN	O	leukopenia	prep_such_as	3	SENT_57	[p5l1791t1030r2150b1097],
9	appeared	VBD	O	appear	advcl	14	SENT_57	[p5l17t1118r334b1185],
10	,	,	O	,	_	0	SENT_57	[p5l17t1118r334b1185],
11	the	DT	O	the	det	12	SENT_57	[p5l375t1118r478b1171],
12	treatment	NN	O	treatment	nsubjpass	14	SENT_57	[p5l518t1123r848b1171],
13	was	VBD	O	be	auxpass	14	SENT_57	[p5l885t1136r1010b1171],
14	delayed	VBN	O	delay	_	0	SENT_57	[p5l1051t1118r1300b1185],
15	1	CD	DURATION	1	num	16	SENT_57	[p5l1344t1120r1373b1170],
16	week	NN	NUMBER	week	tmod	14	SENT_57	[p5l1415t1118r1598b1171],
17	.	.	O	.	_	0	SENT_57	[p5l1415t1118r1598b1171],

1	Treatment	NN	O	treatment	nsubjpass	3	SENT_58	[p5l1640t1119r1986b1171],
2	was	VBD	O	be	auxpass	3	SENT_58	[p5l2024t1136r2148b1171],
3	discontinued	VBN	O	discontinue	_	0	SENT_58	[p5l17t1205r432b1258],
4	if	IN	O	if	mark	6	SENT_58	[p5l458t1205r510b1258],
5	toxicity	NN	O	toxicity	nsubj	6	SENT_58	[p5l527t1206r769b1272],
6	persisted	VBD	O	persist	advcl	3	SENT_58	[p5l794t1205r1091b1272],
7	continuously	RB	O	continuously	advmod	6	SENT_58	[p5l1117t1205r1535b1272],
8	for	IN	O	for	_	0	SENT_58	[p5l1560t1205r1649b1258],
9	3	CD	DURATION	3	num	10	SENT_58	[p5l1675t1207r1709b1258],
10	weeks	NNS	NUMBER	week	prep_for	6	SENT_58	[p5l1736t1205r1952b1258],
11	.	.	O	.	_	0	SENT_58	[p5l1736t1205r1952b1258],

1	Response	NN	O	response	_	0	SENT_59	[p5l10t1433r408b1512],
2	Assessment	NNP	O	Assessment	dep	1	SENT_59	[p5l433t1432r926b1496],

1	Response	NN	O	response	nn	3	SENT_60	[p5l194t1531r496b1597],
2	evaluation	NN	O	evaluation	nn	3	SENT_60	[p5l534t1530r878b1583],
3	criteria	NNS	O	criterion	nsubj	5	SENT_60	[p5l913t1531r1152b1583],
4	were	VBD	O	be	cop	5	SENT_60	[p5l1186t1548r1341b1583],
5	those	DT	O	those	dep	16	SENT_60	[p5l1377t1530r1549b1583],
6	recommended	VBN	O	recommend	partmod	5	SENT_60	[p5l1585t1530r2039b1583],
7	by	IN	O	by	_	0	SENT_60	[p5l2073t1530r2150b1597],
8	the	DT	O	the	det	10	SENT_60	[p5l15t1617r118b1671],
9	standard	JJ	O	standard	amod	10	SENT_60	[p5l141t1617r432b1671],
10	Response	NN	O	response	agent	6	SENT_60	[p5l451t1618r755b1684],
11	to	TO	O	to	_	0	SENT_60	[p5l775t1622r835b1671],
12	Treatment	NN	O	treatment	prep_to	6	SENT_60	[p5l856t1618r1201b1671],
13	in	IN	O	in	_	0	SENT_60	[p5l1219t1618r1284b1670],
14	Solid	JJ	O	solid	amod	15	SENT_60	[p5l1305t1617r1466b1671],
15	Tumors	NNS	O	tumor	prep_in	12	SENT_60	[p5l1485t1618r1731b1671],
16	(	VBP	O	(	_	0	SENT_60	[p5l1753t1604r2149b1678],
17	RECIST	NN	O	recist	dobj	16	SENT_60	[p5l1753t1604r2149b1678],
18	)	CD	NUMBER	)	number	19	SENT_60	[p5l1753t1604r2149b1678],
19	.18	CD	NUMBER	.18	nsubj	16	SENT_60	[p5l1753t1604r2149b1678],
20	Computed	VBN	O	compute	rcmod	19	SENT_60	[p5l17t1705r350b1772],
21	tomography	NN	O	tomography	nsubj	22	SENT_60	[p5l377t1705r770b1772],
22	scan	VB	O	scan	ccomp	20	SENT_60	[p5l798t1723r942b1758],
23	or	CC	O	or	dep	25	SENT_60	[p5l970t1723r1035b1758],
24	magnetic	JJ	O	magnetic	amod	25	SENT_60	[p5l1061t1706r1360b1772],
25	resonance	NN	O	resonance	dep	22	SENT_60	[p5l1388t1723r1731b1770],
26	,	,	O	,	_	0	SENT_60	[p5l1388t1723r1731b1770],
27	chest	NN	O	chest	nn	28	SENT_60	[p5l1763t1705r1932b1758],
28	radiographs	NNS	O	radiograph	conj_and	25	SENT_60	[p5l1958t1705r2148b1758, p5l15t1792r256b1859],
29	,	,	O	,	_	0	SENT_60	[p5l1958t1705r2148b1758, p5l15t1792r256b1859],
30	and	CC	O	and	_	0	SENT_60	[p5l288t1792r408b1845],
31	upper	JJ	O	upper	amod	34	SENT_60	[p5l434t1810r625b1859],
32	respiratory	JJ	O	respiratory	amod	34	SENT_60	[p5l651t1793r1016b1859],
33	tract	NN	O	tract	nn	34	SENT_60	[p5l1042t1797r1198b1845],
34	exam	NN	O	exam	dep	22	SENT_60	[p5l1225t1810r1399b1845],
35	were	VBD	O	be	auxpass	36	SENT_60	[p5l1425t1810r1581b1845],
36	used	VBN	O	use	dep	22	SENT_60	[p5l1608t1792r1758b1845],
37	as	IN	O	as	_	0	SENT_60	[p5l1787t1810r1853b1845],
38	baseline	NN	O	baseline	prep_as	36	SENT_60	[p5l1881t1792r2149b1845],
39	and	CC	O	and	_	0	SENT_60	[p5l17t1879r137b1932],
40	every	DT	O	every	det	42	SENT_60	[p5l166t1897r343b1946],
41	six	CD	NUMBER	six	num	42	SENT_60	[p5l372t1880r461b1932],
42	doses	NNS	O	dose	prep_as	36	SENT_60	[p5l491t1879r663b1932],
43	or	CC	O	or	_	0	SENT_60	[p5l693t1897r757b1932],
44	when	WRB	O	when	advmod	48	SENT_60	[p5l784t1879r961b1932],
45	disease	NN	O	disease	nn	46	SENT_60	[p5l990t1879r1224b1932],
46	progression	NN	O	progression	nsubjpass	48	SENT_60	[p5l1253t1880r1630b1946],
47	was	VBD	O	be	auxpass	48	SENT_60	[p5l1658t1897r1782b1932],
48	suspected	VBN	O	suspect	conj_or	36	SENT_60	[p5l1813t1879r2146b1946],
49	.	.	O	.	_	0	SENT_60	[p5l1813t1879r2146b1946],

1	Response	NN	O	response	nsubj	3	SENT_61	[p5l15t1967r319b2033],
2	was	VBD	O	be	cop	3	SENT_61	[p5l355t1984r479b2019],
3	ﬁrst	JJ	O	ﬁrst	_	0	SENT_61	[p5l516t1966r652b2019],
4	evaluated	VBN	O	evaluate	ccomp	3	SENT_61	[p5l688t1966r1007b2019],
5	after	IN	O	after	_	0	SENT_61	[p5l1044t1966r1199b2019],
6	six	CD	NUMBER	six	num	7	SENT_61	[p5l1235t1967r1325b2019],
7	doses	NNS	O	dose	prep_after	4	SENT_61	[p5l1362t1966r1534b2019],
8	and	CC	O	and	_	0	SENT_61	[p5l1572t1966r1692b2019],
9	conﬁrmatory	JJ	O	conﬁrmatory	amod	10	SENT_61	[p5l1729t1966r2150b2033],
10	scans	NNS	O	scan	nsubjpass	12	SENT_61	[p5l17t2071r192b2106],
11	were	VBD	O	be	auxpass	12	SENT_61	[p5l224t2071r380b2106],
12	obtained	VBN	O	obtain	conj_and	3	SENT_61	[p5l414t2053r694b2106],
13	4	CD	DURATION	4	num	14	SENT_61	[p5l726t2055r762b2105],
14	weeks	NNS	NUMBER	week	tmod	12	SENT_61	[p5l794t2053r993b2106],
15	to	TO	O	to	_	0	SENT_61	[p5l1026t2057r1086b2106],
16	6	CD	DURATION	6	num	17	SENT_61	[p5l1120t2055r1154b2106],
17	weeks	NNS	NUMBER	week	prep_to	12	SENT_61	[p5l1187t2053r1385b2106],
18	following	VBG	O	follow	_	0	SENT_61	[p5l1418t2053r1717b2120],
19	initial	JJ	O	initial	amod	20	SENT_61	[p5l1747t2053r1944b2106],
20	documentation	NN	O	documentation	prep_following	17	SENT_61	[p5l1978t2053r2148b2106, p5l15t2141r351b2193],
21	of	IN	O	of	_	0	SENT_61	[p5l389t2139r454b2193],
22	an	DT	O	a	det	24	SENT_61	[p5l485t2158r564b2193],
23	objective	JJ	O	objective	amod	24	SENT_61	[p5l603t2139r885b2206],
24	response	NN	O	response	prep_of	20	SENT_61	[p5l924t2158r1226b2206],
25	.	.	O	.	_	0	SENT_61	[p5l924t2158r1226b2206],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_62	[p5l1268t2140r1540b2193],
2	were	VBD	O	be	auxpass	3	SENT_62	[p5l1578t2158r1734b2193],
3	visited	VBN	O	visit	_	0	SENT_62	[p5l1772t2139r1990b2193],
4	and	CC	O	and	_	0	SENT_62	[p5l2029t2139r2149b2193],
5	examined	VBN	O	examine	conj_and	3	SENT_62	[p5l16t2227r331b2280],
6	by	IN	O	by	_	0	SENT_62	[p5l350t2227r427b2294],
7	a	DT	O	a	det	8	SENT_62	[p5l448t2245r484b2280],
8	physician	NN	O	physician	agent	3	SENT_62	[p5l504t2227r816b2294],
9	every	DT	SET	every	det	10	SENT_62	[p5l836t2245r1014b2294],
10	week	NN	SET	week	dobj	3	SENT_62	[p5l1032t2227r1201b2280],
11	before	IN	SET	before	_	0	SENT_62	[p5l1218t2227r1417b2280],
12	treatment	NN	O	treatment	prep_before	10	SENT_62	[p5l1438t2231r1782b2280],
13	.	.	O	.	_	0	SENT_62	[p5l1438t2231r1782b2280],

1	Evaluations	NNS	O	evaluation	nsubjpass	3	SENT_63	[p5l194t2314r585b2367],
2	were	VBD	O	be	auxpass	3	SENT_63	[p5l643t2332r799b2367],
3	performed	VBN	O	perform	_	0	SENT_63	[p5l858t2314r1194b2381],
4	according	VBG	O	accord	_	0	SENT_63	[p5l1253t2314r1566b2381],
5	to	TO	O	to	prepc_according_to	3	SENT_63	[p5l1621t2318r1681b2367],
6	intentiontotreat	NN	O	intentiontotreat	pobj	3	SENT_63	[p5l1740t2315r2148b2367, p5l15t2405r190b2454],
7	.	.	O	.	_	0	SENT_63	[p5l1740t2315r2148b2367, p5l15t2405r190b2454],

1	All	DT	O	all	det	2	SENT_64	[p5l222t2400r317b2453],
2	patients	NNS	O	patient	nsubjpass	13	SENT_64	[p5l348t2402r613b2467],
3	who	WP	O	who	nsubj	5	SENT_64	[p5l642t2400r774b2454],
4	had	VBD	O	have	aux	5	SENT_64	[p5l805t2400r927b2454],
5	received	VBN	O	receive	rcmod	2	SENT_64	[p5l957t2400r1226b2454],
6	at	IN	O	at	quantmod	8	SENT_64	[p5l1258t2405r1321b2454],
7	least	JJS	O	least	mwe	6	SENT_64	[p5l1350t2400r1506b2454],
8	two	CD	NUMBER	two	num	9	SENT_64	[p5l1534t2405r1649b2454],
9	doses	NNS	O	dose	dobj	5	SENT_64	[p5l1682t2400r1854b2454],
10	of	IN	O	of	_	0	SENT_64	[p5l1886t2400r1950b2454],
11	paclitaxel	NN	O	paclitaxel	prep_of	9	SENT_64	[p5l1972t2400r2148b2467, p5l15t2488r176b2541],
12	were	VBD	O	be	auxpass	13	SENT_64	[p5l222t2506r377b2541],
13	included	VBN	O	include	_	0	SENT_64	[p5l424t2487r703b2541],
14	for	IN	O	for	_	0	SENT_64	[p5l749t2488r838b2541],
15	the	DT	O	the	det	16	SENT_64	[p5l884t2488r987b2541],
16	analysis	NN	O	analysis	prep_for	13	SENT_64	[p5l1036t2488r1302b2555],
17	of	IN	O	of	_	0	SENT_64	[p5l1350t2488r1414b2541],
18	time	NN	O	time	prep_of	16	SENT_64	[p5l1452t2489r1597b2541],
19	to	TO	O	to	_	0	SENT_64	[p5l1644t2492r1704b2541],
20	progression	NN	O	progression	prep_to	13	SENT_64	[p5l1751t2489r2147b2555],
21	,	,	O	,	_	0	SENT_64	[p5l1751t2489r2147b2555],
22	overall	JJ	O	overall	amod	23	SENT_64	[p5l16t2575r238b2628],
23	survival	NN	O	survival	conj_and	20	SENT_64	[p5l265t2575r547b2640],
24	,	,	O	,	_	0	SENT_64	[p5l265t2575r547b2640],
25	and	CC	O	and	_	0	SENT_64	[p5l577t2575r697b2628],
26	toxicity	NN	O	toxicity	conj_and	20	SENT_64	[p5l722t2576r972b2642],
27	.	.	O	.	_	0	SENT_64	[p5l722t2576r972b2642],

1	DNA	NN	O	dna	nn	2	SENT_65	[p5l10t2802r217b2866],
2	Isolation	NN	O	isolation	_	0	SENT_65	[p5l244t2802r633b2866],

1	In	IN	O	in	_	0	SENT_66	[p5l195t2903r264b2955],
2	all	DT	O	all	det	3	SENT_66	[p5l304t2903r383b2956],
3	patients	NNS	O	patient	prep_in	14	SENT_66	[p5l423t2904r689b2970],
4	a	DT	O	a	det	8	SENT_66	[p5l730t2921r766b2956],
5	biopsy	NN	O	biopsy	nn	8	SENT_66	[p5l803t2903r1011b2970],
6	or	CC	O	or	_	0	SENT_66	[p5l1050t2921r1115b2956],
7	surgical	JJ	O	surgical	nn	8	SENT_66	[p5l1156t2903r1413b2970],
8	specimen	NN	O	specimen	nsubjpass	14	SENT_66	[p5l1454t2904r1755b2970],
9	of	IN	O	of	_	0	SENT_66	[p5l1795t2903r1859b2956],
10	the	DT	O	the	det	12	SENT_66	[p5l1889t2903r1993b2956],
11	primary	JJ	O	primary	amod	12	SENT_66	[p5l2033t2904r2147b2970, p5l15t3007r186b3056],
12	tumor	NN	O	tumor	prep_of	8	SENT_66	[p5l238t2994r438b3043],
13	was	VBD	O	be	auxpass	14	SENT_66	[p5l490t3007r614b3043],
14	used	VBN	O	use	_	0	SENT_66	[p5l668t2989r819b3043],
15	for	IN	O	for	_	0	SENT_66	[p5l871t2989r961b3043],
16	laboratory	NN	O	laboratory	nn	17	SENT_66	[p5l1013t2989r1352b3056],
17	analysis	NN	O	analysis	prep_for	14	SENT_66	[p5l1406t2989r1688b3056],
18	.	.	O	.	_	0	SENT_66	[p5l1406t2989r1688b3056],

1	Slides	NNS	O	slide	nsubjpass	3	SENT_67	[p5l1747t2989r1939b3043],
2	were	VBD	O	be	auxpass	3	SENT_67	[p5l1993t3007r2148b3043],
3	reviewed	VBN	O	review	_	0	SENT_67	[p5l15t3076r309b3130],
4	by	IN	O	by	_	0	SENT_67	[p5l338t3076r415b3143],
5	a	DT	O	a	det	6	SENT_67	[p5l446t3095r482b3130],
6	pathologist	NN	O	pathologist	agent	3	SENT_67	[p5l512t3076r876b3143],
7	to	TO	O	to	aux	8	SENT_67	[p5l905t3081r964b3130],
8	conﬁrm	VB	O	conﬁrm	xcomp	3	SENT_67	[p5l997t3076r1246b3130],
9	the	DT	O	the	det	10	SENT_67	[p5l1276t3076r1379b3130],
10	histology	NN	O	histology	dobj	8	SENT_67	[p5l1410t3076r1705b3143],
11	of	IN	O	of	_	0	SENT_67	[p5l1735t3076r1800b3130],
12	squamous	JJ	O	squamous	amod	13	SENT_67	[p5l1825t3095r2148b3143],
13	carcinoma	NN	O	carcinoma	prep_of	10	SENT_67	[p5l16t3165r352b3217],
14	to	TO	O	to	aux	15	SENT_67	[p5l388t3168r448b3217],
15	obtain	VB	O	obtain	xcomp	8	SENT_67	[p5l488t3164r692b3217],
16	an	DT	O	a	det	18	SENT_67	[p5l731t3182r810b3217],
17	adequate	JJ	O	adequate	amod	18	SENT_67	[p5l850t3164r1144b3231],
18	selection	NN	O	selection	dobj	15	SENT_67	[p5l1185t3164r1468b3217],
19	of	IN	O	of	_	0	SENT_67	[p5l1506t3164r1570b3217],
20	a	DT	O	a	det	23	SENT_67	[p5l1602t3182r1637b3217],
21	representative	JJ	O	representative	amod	23	SENT_67	[p5l1674t3165r2148b3231],
22	tumor	NN	O	tumor	nn	23	SENT_67	[p5l15t3255r215b3303],
23	section	NN	O	section	prep_of	18	SENT_67	[p5l242t3252r482b3303],
24	.	.	O	.	_	0	SENT_67	[p5l242t3252r482b3303],

1	If	IN	O	if	mark	5	SENT_68	[p5l195t3337r252b3390],
2	a	DT	O	a	det	3	SENT_68	[p5l279t3356r315b3391],
3	patient	NN	O	patient	nsubjpass	5	SENT_68	[p5l349t3339r583b3404],
4	was	VBD	O	be	auxpass	5	SENT_68	[p5l615t3356r740b3391],
5	treated	VBN	O	treat	advcl	17	SENT_68	[p5l775t3337r1010b3391],
6	with	IN	O	with	_	0	SENT_68	[p5l1043t3337r1190b3391],
7	chemotherapy	NN	O	chemotherapy	prep_with	5	SENT_68	[p5l1225t3337r1689b3404],
8	or	CC	O	or	_	0	SENT_68	[p5l1723t3356r1788b3391],
9	radiotherapy	NN	O	radiotherapy	prep_with	5	SENT_68	[p5l1821t3337r2148b3391, p5l17t3443r132b3492],
10	before	IN	O	before	_	0	SENT_68	[p5l171t3425r370b3478],
11	surgery	NN	O	surgery	prep_before	5	SENT_68	[p5l414t3442r671b3492],
12	,	,	O	,	_	0	SENT_68	[p5l414t3442r671b3492],
13	the	DT	O	the	det	15	SENT_68	[p5l715t3425r818b3478],
14	sample	NN	O	sample	nn	15	SENT_68	[p5l863t3425r1090b3492],
15	tissue	NN	O	tissue	nsubjpass	17	SENT_68	[p5l1132t3426r1322b3478],
16	was	VBD	O	be	auxpass	17	SENT_68	[p5l1364t3443r1489b3478],
17	obtained	VBN	O	obtain	_	0	SENT_68	[p5l1531t3425r1811b3478],
18	from	IN	O	from	_	0	SENT_68	[p5l1853t3425r2005b3478],
19	the	DT	O	the	det	21	SENT_68	[p5l2045t3425r2148b3478],
20	initial	JJ	O	initial	amod	21	SENT_68	[p5l15t3511r212b3565],
21	biopsy	NN	O	biopsy	prep_from	17	SENT_68	[p5l237t3511r445b3578],
22	to	TO	O	to	aux	23	SENT_68	[p5l469t3516r529b3565],
23	avoid	VB	O	avoid	xcomp	17	SENT_68	[p5l557t3511r730b3565],
24	DNA	NN	O	dna	nn	25	SENT_68	[p5l756t3511r920b3565],
25	damage	NN	O	damage	dobj	23	SENT_68	[p5l945t3511r1195b3578],
26	in	IN	O	in	_	0	SENT_68	[p5l1222t3513r1286b3564],
27	the	DT	O	the	det	28	SENT_68	[p5l1311t3511r1415b3565],
28	tumor	NN	O	tumor	prep_in	23	SENT_68	[p5l1441t3516r1651b3565],
29	.	.	O	.	_	0	SENT_68	[p5l1441t3516r1651b3565],

1	Tissue	NN	O	tissue	nn	2	SENT_69	[p5l193t3599r402b3652],
2	samples	NNS	O	sample	nsubjpass	4	SENT_69	[p5l436t3598r697b3665],
3	were	VBD	O	be	auxpass	4	SENT_69	[p5l729t3616r884b3652],
4	sectioned	VBN	O	section	_	0	SENT_69	[p5l918t3598r1220b3652],
5	in	IN	O	in	_	0	SENT_69	[p5l1250t3600r1314b3651],
6	a	DT	O	a	det	8	SENT_69	[p5l1347t3616r1383b3652],
7	single	JJ	O	single	amod	8	SENT_69	[p5l1416t3598r1605b3665],
8	5	CD	NUMBER	5	prep_in	4	SENT_69	[p5l1639t3600r1801b3665],
9	-	:	O	-	_	0	SENT_69	[p5l1639t3600r1801b3665],
10	,	,	O	,	_	0	SENT_69	[p5l1639t3600r1801b3665],
11	um	NN	O	um	nn	13	SENT_69	[p5l1639t3600r1801b3665],
12	thick	JJ	O	thick	amod	13	SENT_69	[p5l1831t3598r1997b3652],
13	section	NN	O	section	xcomp	4	SENT_69	[p5l2030t3616r2148b3652, p6l15t18r142b70],

1	and	CC	O	and	cc	3	SENT_70	[p6l175t17r295b70],
2	were	VBD	O	be	auxpass	3	SENT_70	[p6l326t35r481b70],
3	dewaxed	VBN	O	dewax	_	0	SENT_70	[p6l515t17r797b70],
4	with	IN	O	with	_	0	SENT_70	[p6l828t17r975b70],
5	two	CD	NUMBER	two	num	6	SENT_70	[p6l1006t22r1121b70],
6	washes	NNS	O	wash	prep_with	3	SENT_70	[p6l1154t17r1389b70],
7	of	IN	O	of	_	0	SENT_70	[p6l1423t17r1488b70],
8	xylene	NN	O	xylene	prep_of	6	SENT_70	[p6l1510t17r1739b84],
9	,	,	O	,	_	0	SENT_70	[p6l1510t17r1739b84],
10	followed	VBN	O	follow	partmod	6	SENT_70	[p6l1774t17r2042b70],
11	by	IN	O	by	_	0	SENT_70	[p6l2073t17r2150b84],
12	the	DT	O	the	det	13	SENT_70	[p6l15t104r118b157],
13	addition	NN	O	addition	agent	10	SENT_70	[p6l147t104r415b157],
14	of	IN	O	of	_	0	SENT_70	[p6l442t104r506b157],
15	1	CD	NUMBER	1	num	16	SENT_70	[p6l529t106r558b156],
16	mL	NN	O	ml	prep_of	13	SENT_70	[p6l587t105r695b156],
17	of	IN	O	of	_	0	SENT_70	[p6l722t104r787b157],
18	100	CD	PERCENT	100	number	19	SENT_70	[p6l810t106r977b158],
19	%	NN	PERCENT	%	amod	20	SENT_70	[p6l810t106r977b158],
20	ethanol	NN	O	ethanol	prep_of	16	SENT_70	[p6l1006t104r1250b157],
21	to	TO	O	to	aux	22	SENT_70	[p6l1276t109r1336b157],
22	remove	VB	O	remove	xcomp	10	SENT_70	[p6l1363t122r1599b157],
23	residual	JJ	O	residual	amod	24	SENT_70	[p6l1626t104r1891b157],
24	xylene	NN	O	xylene	dobj	22	SENT_70	[p6l1917t104r2145b171],
25	.	.	O	.	_	0	SENT_70	[p6l1917t104r2145b171],

1	After	IN	O	after	_	0	SENT_71	[p6l13t190r183b244],
2	dewaxing	VBG	O	dewax	prepc_after	6	SENT_71	[p6l215t191r542b258],
3	,	,	O	,	_	0	SENT_71	[p6l215t191r542b258],
4	samples	NNS	O	sample	nsubjpass	6	SENT_71	[p6l578t191r839b258],
5	were	VBD	O	be	auxpass	6	SENT_71	[p6l871t209r1026b244],
6	incubated	VBN	O	incubate	_	0	SENT_71	[p6l1059t190r1381b244],
7	at	IN	O	at	_	0	SENT_71	[p6l1413t195r1476b244],
8	55	CD	NUMBER	55	number	9	SENT_71	[p6l1509t191r1662b244],
9	°	CD	NUMBER	°	num	10	SENT_71	[p6l1509t191r1662b244],
10	C	NN	O	c	prep_at	6	SENT_71	[p6l1509t191r1662b244],
11	for	IN	O	for	_	0	SENT_71	[p6l1695t191r1785b244],
12	5	CD	DURATION	5	num	13	SENT_71	[p6l1817t193r1850b244],
13	minutes	NNS	NUMBER	minute	prep_for	10	SENT_71	[p6l1884t192r2149b244],
14	to	TO	O	to	_	0	SENT_71	[p6l15t283r75b331],
15	10	CD	DURATION	10	num	16	SENT_71	[p6l107t280r177b331],
16	minutes	NNS	NUMBER	minute	prep_to	6	SENT_71	[p6l204t279r469b331],
17	and	CC	O	and	_	0	SENT_71	[p6l498t278r618b331],
18	180	CD	NUMBER	180	num	19	SENT_71	[p6l650t280r758b331],
19	ML	NN	O	ml	conj_and	16	SENT_71	[p6l787t279r870b345],
20	of	IN	O	of	_	0	SENT_71	[p6l897t278r962b331],
21	ATL	NN	O	atl	nn	22	SENT_71	[p6l978t278r1119b330],
22	buffer	NN	O	buffer	prep_of	19	SENT_71	[p6l1145t278r1341b331],
23	and	CC	O	and	_	0	SENT_71	[p6l1369t278r1489b331],
24	20	CD	NUMBER	20	num	27	SENT_71	[p6l1516t280r1590b331],
25	ML	NN	O	ml	nn	27	SENT_71	[p6l1618t279r1701b345],
26	proteinase	NN	O	proteinase	nn	27	SENT_71	[p6l1729t279r2068b345],
27	K	NN	O	k	nsubjpass	29	SENT_71	[p6l2096t279r2152b330],
28	were	VBD	O	be	auxpass	29	SENT_71	[p6l15t383r170b418],
29	added	VBN	O	add	conj_and	6	SENT_71	[p6l210t365r418b418],
30	.	.	O	.	_	0	SENT_71	[p6l210t365r418b418],

1	Samples	NNS	O	sample	nsubjpass	3	SENT_72	[p6l461t365r734b432],
2	were	VBD	O	be	auxpass	3	SENT_72	[p6l771t383r926b418],
3	incubated	VBN	O	incubate	_	0	SENT_72	[p6l964t365r1286b418],
4	at	IN	O	at	_	0	SENT_72	[p6l1323t370r1386b418],
5	55	CD	NUMBER	55	number	6	SENT_72	[p6l1424t365r1577b418],
6	°	CD	NUMBER	°	prep_at	3	SENT_72	[p6l1424t365r1577b418],
7	C	NN	O	c	dep	6	SENT_72	[p6l1424t365r1577b418],
8	overnight	JJ	TIME	overnight	amod	7	SENT_72	[p6l1617t365r1946b432],
9	.	.	O	.	_	0	SENT_72	[p6l1617t365r1946b432],

1	DNA	NN	O	dna	nsubjpass	3	SENT_73	[p6l1988t365r2152b419],
2	was	VBD	O	be	auxpass	3	SENT_73	[p6l14t470r139b505],
3	obtained	VBN	O	obtain	_	0	SENT_73	[p6l174t451r454b505],
4	using	VBG	O	use	xcomp	3	SENT_73	[p6l485t453r665b519],
5	the	DT	O	the	det	9	SENT_73	[p6l696t452r800b505],
6	commercial	JJ	O	commercial	amod	9	SENT_73	[p6l834t452r1207b505],
7	DNeasy	NN	O	dneasy	nn	9	SENT_73	[p6l1240t452r1496b519],
8	tissue	NN	O	tissue	nn	9	SENT_73	[p6l1527t453r1718b505],
9	kit	NN	O	kit	dobj	4	SENT_73	[p6l1751t452r1842b505],
10	(	CD	NUMBER	(	num	13	SENT_73	[p6l1874t452r2147b519],
11	Qiagen	NNP	ORGANIZATION	Qiagen	nn	13	SENT_73	[p6l1874t452r2147b519],
12	,	,	O	,	_	0	SENT_73	[p6l1874t452r2147b519],
13	Valencia	NNP	LOCATION	Valencia	dep	9	SENT_73	[p6l13t539r309b604],
14	,	,	O	,	_	0	SENT_73	[p6l13t539r309b604],
15	CA	NNP	O	CA	nn	16	SENT_73	[p6l363t539r484b600],
16	)	NNP	O	)	appos	9	SENT_73	[p6l363t539r484b600],
17	following	VBG	O	follow	_	0	SENT_73	[p6l535t539r834b606],
18	the	DT	O	the	det	19	SENT_73	[p6l881t539r985b592],
19	manufacturer	NN	O	manufacturer	poss	21	SENT_73	[p6l1036t539r1535b592],
20	’s	POS	O	’s	_	0	SENT_73	[p6l1036t539r1535b592],
21	protocol	NN	O	protocol	prep_following	16	SENT_73	[p6l1587t539r1860b606],
22	.	.	O	.	_	0	SENT_73	[p6l1587t539r1860b606],

1	Brieﬂy	NNP	O	Brieﬂy	nsubjpass	5	SENT_74	[p6l1915t539r2146b606],
2	,	,	O	,	_	0	SENT_74	[p6l1915t539r2146b606],
3	samples	NNS	O	sample	nsubjpass	5	SENT_74	[p6l17t626r277b693],
4	were	VBD	O	be	auxpass	5	SENT_74	[p6l304t644r460b679],
5	vortexed	VBN	O	vortex	_	0	SENT_74	[p6l487t626r769b679],
6	for	IN	O	for	_	0	SENT_74	[p6l795t626r884b679],
7	15	CD	DURATION	15	num	8	SENT_74	[p6l917t628r985b679],
8	seconds	NNS	NUMBER	seconds	prep_for	5	SENT_74	[p6l1016t626r1281b691],
9	,	,	O	,	_	0	SENT_74	[p6l1016t626r1281b691],
10	200	CD	NUMBER	200	num	11	SENT_74	[p6l1311t628r1425b679],
11	ML	NN	O	ml	appos	8	SENT_74	[p6l1454t627r1537b693],
12	of	IN	O	of	_	0	SENT_74	[p6l1565t626r1630b679],
13	AL.	NNP	O	AL.	prep_of	11	SENT_74	[p6l1645t626r1759b679],
14	.	.	O	.	_	0	SENT_74	[p6l1645t626r1759b679],

1	Buffer	NN	O	buffer	nsubjpass	3	SENT_75	[p6l1791t626r1998b679],
2	was	VBD	O	be	auxpass	3	SENT_75	[p6l2024t644r2148b679],
3	added	VBN	O	add	_	0	SENT_75	[p6l17t713r210b766],
4	and	CC	O	and	_	0	SENT_75	[p6l243t713r363b766],
5	mixed	VBN	O	mix	conj_and	3	SENT_75	[p6l395t712r607b766],
6	.	.	O	.	_	0	SENT_75	[p6l395t712r607b766],

1	Then	RB	O	then	advmod	12	SENT_76	[p6l643t713r812b766],
2	200	CD	NUMBER	200	num	4	SENT_76	[p6l844t715r958b766],
3	ML	NN	O	ml	nn	4	SENT_76	[p6l991t714r1075b780],
4	ethanol	NN	O	ethanol	nsubjpass	12	SENT_76	[p6l1107t712r1351b766],
5	(	CD	PERCENT	(	num	7	SENT_76	[p6l1384t713r1765b774],
6	96	CD	PERCENT	96	num	7	SENT_76	[p6l1384t713r1765b774],
7	%	NN	PERCENT	%	dep	4	SENT_76	[p6l1384t713r1765b774],
8	-100	CD	PERCENT	-100	num	9	SENT_76	[p6l1384t713r1765b774],
9	%	NN	PERCENT	%	dep	4	SENT_76	[p6l1384t713r1765b774],
10	)	CD	NUMBER	)	dep	9	SENT_76	[p6l1384t713r1765b774],
11	Was	VBD	O	be	auxpass	12	SENT_76	[p6l1797t731r1921b766],
12	added	VBN	O	add	_	0	SENT_76	[p6l1956t713r2150b766],
13	and	CC	O	and	_	0	SENT_76	[p6l17t800r137b853],
14	samples	NNS	O	sample	nsubj	16	SENT_76	[p6l167t800r427b867],
15	were	VBD	O	be	cop	16	SENT_76	[p6l456t818r611b853],
16	mixed	JJ	O	mixed	conj_and	12	SENT_76	[p6l641t800r839b853],
17	again	RB	O	again	advmod	16	SENT_76	[p6l868t801r1047b867],
18	by	IN	O	by	_	0	SENT_76	[p6l1075t799r1152b867],
19	Vortexing	NN	PERSON	vortexing	prep_by	16	SENT_76	[p6l1179t801r1505b867],
20	.	.	O	.	_	0	SENT_76	[p6l1179t801r1505b867],

1	Then	RB	O	then	advmod	6	SENT_77	[p6l1537t800r1722b865],
2	,	,	O	,	_	0	SENT_77	[p6l1537t800r1722b865],
3	the	DT	O	the	det	4	SENT_77	[p6l1753t799r1856b853],
4	samples	NNS	O	sample	nsubjpass	15	SENT_77	[p6l1888t799r2148b867],
5	were	VBD	O	be	auxpass	6	SENT_77	[p6l15t904r170b940],
6	pipetted	VBN	O	pipet	_	0	SENT_77	[p6l200t886r468b953],
7	into	IN	O	into	_	0	SENT_77	[p6l496t888r622b940],
8	the	DT	O	the	det	10	SENT_77	[p6l651t886r754b940],
9	DNeasy	NNP	O	DNeasy	nn	10	SENT_77	[p6l784t887r1041b953],
10	Mini	NNP	O	Mini	prep_into	6	SENT_77	[p6l1070t887r1223b939],
11	spin	VB	O	spin	ccomp	6	SENT_77	[p6l1253t888r1388b953],
12	column	NN	O	column	dobj	11	SENT_77	[p6l1417t886r1654b940],
13	and	CC	O	and	_	0	SENT_77	[p6l1684t886r1804b940],
14	were	VBD	O	be	auxpass	15	SENT_77	[p6l1831t904r1987b940],
15	centrifugated	VBN	O	centrifugate	conj_and	6	SENT_77	[p6l2017t904r2148b940, p6l15t973r343b1040],
16	at	IN	O	at	_	0	SENT_77	[p6l378t978r441b1027],
17	600	CD	NUMBER	600	prep_at	15	SENT_77	[p6l476t976r588b1027],
18	x	CC	O	x	_	0	SENT_77	[p6l632t991r666b1025],
19	g	NN	O	g	conj_x	17	SENT_77	[p6l702t990r745b1040],
20	for	IN	O	for	_	0	SENT_77	[p6l779t973r868b1027],
21	a	DT	DURATION	a	det	22	SENT_77	[p6l902t992r939b1027],
22	minute	NN	DURATION	minute	prep_for	15	SENT_77	[p6l972t975r1220b1027],
23	.	.	O	.	_	0	SENT_77	[p6l972t975r1220b1027],

1	Then	RB	O	then	advmod	13	SENT_78	[p6l1258t973r1443b1039],
2	,	,	O	,	_	0	SENT_78	[p6l1258t973r1443b1039],
3	a	DT	DURATION	a	det	5	SENT_78	[p6l1481t992r1517b1027],
4	second	JJ	DURATION	second	amod	5	SENT_78	[p6l1552t973r1768b1027],
5	Wash	NNP	O	Wash	nsubjpass	13	SENT_78	[p6l1800t973r1970b1027],
6	with	IN	O	with	_	0	SENT_78	[p6l2002t973r2149b1027],
7	500	CD	NUMBER	500	num	8	SENT_78	[p6l17t1063r130b1114],
8	ML	NN	O	ml	prep_with	5	SENT_78	[p6l159t1062r242b1128],
9	of	IN	O	of	_	0	SENT_78	[p6l270t1061r334b1114],
10	AW2	NN	O	aw2	nn	11	SENT_78	[p6l351t1061r502b1114],
11	buffer	NN	O	buffer	prep_of	8	SENT_78	[p6l530t1061r727b1114],
12	was	VBD	O	be	auxpass	13	SENT_78	[p6l753t1079r878b1114],
13	performed	VBN	O	perform	_	0	SENT_78	[p6l906t1061r1242b1128],
14	at	IN	O	at	_	0	SENT_78	[p6l1270t1065r1333b1114],
15	6,000	CD	NUMBER	6,000	num	17	SENT_78	[p6l1361t1063r1533b1126],
16	X	NN	O	x	nn	17	SENT_78	[p6l1571t1078r1605b1112],
17	g	NN	O	g	prep_at	13	SENT_78	[p6l1634t1077r1677b1128],
18	for	IN	O	for	_	0	SENT_78	[p6l1704t1061r1793b1114],
19	3	CD	DURATION	3	num	20	SENT_78	[p6l1822t1063r1854b1114],
20	minutes	NNS	NUMBER	minute	prep_for	17	SENT_78	[p6l1884t1062r2149b1114],
21	to	TO	O	to	aux	22	SENT_78	[p6l15t1152r75b1201],
22	dry	VB	O	dry	xcomp	13	SENT_78	[p6l106t1147r214b1214],
23	the	DT	O	the	det	25	SENT_78	[p6l242t1147r345b1201],
24	DNeasy	JJ	O	dneasy	amod	25	SENT_78	[p6l375t1148r632b1214],
25	membrane	NN	O	membrane	dobj	22	SENT_78	[p6l660t1147r1023b1201],
26	.	.	O	.	_	0	SENT_78	[p6l660t1147r1023b1201],

1	To	TO	O	to	aux	2	SENT_79	[p6l1056t1148r1130b1201],
2	elude	VB	O	elude	purpcl	12	SENT_79	[p6l1161t1147r1334b1201],
3	the	DT	O	the	det	4	SENT_79	[p6l1363t1147r1467b1201],
4	DNA	NN	MISC	dna	dobj	2	SENT_79	[p6l1497t1147r1676b1212],
5	,	,	O	,	_	0	SENT_79	[p6l1497t1147r1676b1212],
6	200	CD	NUMBER	200	num	7	SENT_79	[p6l1708t1149r1821b1201],
7	ML	NN	O	ml	nsubjpass	12	SENT_79	[p6l1852t1148r1935b1214],
8	of	IN	O	of	_	0	SENT_79	[p6l1965t1147r2029b1201],
9	AE	NN	O	ae	nn	10	SENT_79	[p6l2047t1147r2147b1200],
10	buffer	NN	O	buffer	prep_of	7	SENT_79	[p6l14t1234r211b1288],
11	Was	VBD	O	be	auxpass	12	SENT_79	[p6l236t1253r360b1288],
12	added	VBN	O	add	_	0	SENT_79	[p6l388t1234r582b1288],
13	to	TO	O	to	_	0	SENT_79	[p6l607t1239r667b1288],
14	each	DT	O	each	det	15	SENT_79	[p6l695t1234r841b1288],
15	sample	NN	O	sample	prep_to	12	SENT_79	[p6l869t1234r1113b1301],
16	.	.	O	.	_	0	SENT_79	[p6l869t1234r1113b1301],

1	To	TO	O	to	aux	2	SENT_80	[p6l193t1323r267b1375],
2	measure	VB	O	measure	purpcl	23	SENT_80	[p6l304t1340r582b1375],
3	DNA	NN	MISC	dna	nn	4	SENT_80	[p6l619t1322r784b1375],
4	quantity	NN	O	quantity	dobj	2	SENT_80	[p6l818t1323r1096b1389],
5	and	CC	O	and	_	0	SENT_80	[p6l1134t1322r1254b1375],
6	quality	NN	O	quality	conj_and	4	SENT_80	[p6l1291t1322r1528b1389],
7	,	,	O	,	_	0	SENT_80	[p6l1291t1322r1528b1389],
8	a	DT	O	a	det	11	SENT_80	[p6l1570t1340r1605b1375],
9	NanoDrop	NNP	O	NanoDrop	nn	11	SENT_80	[p6l1641t1323r1978b1389],
10	ND1000	NN	O	nd1000	nn	11	SENT_80	[p6l2014t1323r2148b1375, p6l21t1410r169b1462],
11	spectrophotometer	NN	O	spectrophotometer	appos	4	SENT_80	[p6l220t1408r828b1475],
12	(	CD	NUMBER	(	dep	11	SENT_80	[p6l876t1408r1152b1469],
13	Thermo	NNP	ORGANIZATION	Thermo	nn	16	SENT_80	[p6l876t1408r1152b1469],
14	Fisher	NNP	ORGANIZATION	Fisher	nn	16	SENT_80	[p6l1202t1408r1413b1462],
15	Scientiﬁc	NNP	ORGANIZATION	Scientiﬁc	nn	16	SENT_80	[p6l1463t1408r1763b1462],
16	Inc.	NNP	ORGANIZATION	Inc.	dep	11	SENT_80	[p6l1813t1409r1951b1473],
17	,	,	O	,	_	0	SENT_80	[p6l1813t1409r1951b1473],
18	Waltham	NNP	LOCATION	Waltham	appos	4	SENT_80	[p6l2001t1408r2148b1462, p6l15t1495r203b1561],
19	,	,	O	,	_	0	SENT_80	[p6l2001t1408r2148b1462, p6l15t1495r203b1561],
20	MA	NNP	LOCATION	MA	nn	21	SENT_80	[p6l232t1495r370b1556],
21	)	NNP	O	)	nsubjpass	23	SENT_80	[p6l232t1495r370b1556],
22	was	VBD	O	be	auxpass	23	SENT_80	[p6l397t1514r521b1549],
23	used	VBN	O	use	_	0	SENT_80	[p6l548t1495r713b1549],
24	.	.	O	.	_	0	SENT_80	[p6l548t1495r713b1549],

1	Genes	NNS	O	gene	_	0	SENT_81	[p6l16t1722r285b1800],
2	,	,	O	,	_	0	SENT_81	[p6l16t1722r285b1800],
3	Primers	NNS	O	primer	conj_and	1	SENT_81	[p6l320t1722r686b1800],
4	,	,	O	,	_	0	SENT_81	[p6l320t1722r686b1800],
5	and	CC	O	and	_	0	SENT_81	[p6l725t1722r895b1785],
6	Probes	NNS	O	probe	conj_and	1	SENT_81	[p6l920t1721r1211b1785],

1	Primers	NNS	O	primer	nsubjpass	5	SENT_82	[p6l194t1820r454b1873],
2	and	CC	O	and	_	0	SENT_82	[p6l498t1819r618b1873],
3	probes	NNS	O	probe	nsubjpass	5	SENT_82	[p6l659t1819r870b1886],
4	were	VBD	O	be	auxpass	5	SENT_82	[p6l912t1837r1067b1873],
5	obtained	VBN	O	obtain	_	0	SENT_82	[p6l1110t1819r1390b1873],
6	from	IN	O	from	_	0	SENT_82	[p6l1431t1819r1583b1873],
7	Applied	NNP	O	Applied	nn	8	SENT_82	[p6l1622t1819r1875b1886],
8	Biosystems	NNP	O	Biosystems	prep_from	5	SENT_82	[p6l1916t1820r2148b1886, p6l15t1908r185b1961],
9	’	CD	NUMBER	’	number	10	SENT_82	[p6l1916t1820r2148b1886, p6l15t1908r185b1961],
10	(	CD	NUMBER	(	xcomp	5	SENT_82	[p6l237t1908r510b1975],
11	Applied	NNP	ORGANIZATION	Applied	nn	13	SENT_82	[p6l237t1908r510b1975],
12	Biosystems	NNP	ORGANIZATION	Biosystems	nn	13	SENT_82	[p6l560t1909r927b1975],
13	Inc.	NNP	ORGANIZATION	Inc.	dep	10	SENT_82	[p6l979t1909r1117b1973],
14	,	,	O	,	_	0	SENT_82	[p6l979t1909r1117b1973],
15	Foster	NNP	LOCATION	Foster	nn	16	SENT_82	[p6l1170t1909r1378b1961],
16	City	NNP	LOCATION	City	appos	10	SENT_82	[p6l1429t1908r1572b1975],
17	,	,	O	,	_	0	SENT_82	[p6l1429t1908r1572b1975],
18	CA	NNP	LOCATION	CA	nn	21	SENT_82	[p6l1627t1908r1748b1969],
19	)	NNP	O	)	nn	21	SENT_82	[p6l1627t1908r1748b1969],
20	AssaysonDemand	NNP	O	AssaysonDemand	nn	21	SENT_82	[p6l1797t1908r2148b1975, p6l16t1996r291b2049],
21	SNP	NN	O	snp	appos	10	SENT_82	[p6l325t1996r471b2049],
22	genotyping	VBG	O	genotype	partmod	21	SENT_82	[p6l504t1997r866b2063],
23	product	NN	O	product	dobj	22	SENT_82	[p6l898t1996r1163b2063],
24	.	.	O	.	_	0	SENT_82	[p6l898t1996r1163b2063],

1	In	IN	O	in	_	0	SENT_83	[p6l1201t1997r1270b2048],
2	accordance	NN	O	accordance	_	0	SENT_83	[p6l1305t1996r1660b2049],
3	with	IN	O	with	_	0	SENT_83	[p6l1694t1996r1841b2049],
4	the	DT	O	the	det	5	SENT_83	[p6l1874t1996r1977b2049],
5	supplier	NN	O	supplier	poss	7	SENT_83	[p6l2013t2014r2148b2063, p6l16t2083r212b2150],
6	’s	POS	O	’s	_	0	SENT_83	[p6l2013t2014r2148b2063, p6l16t2083r212b2150],
7	instructions	NNS	O	instruction	prep_in_accordance_with	14	SENT_83	[p6l254t2085r663b2148],
8	,	,	O	,	_	0	SENT_83	[p6l254t2085r663b2148],
9	the	DT	O	the	det	10	SENT_83	[p6l707t2083r810b2137],
10	primers	NNS	O	primer	nsubjpass	14	SENT_83	[p6l852t2085r1105b2150],
11	and	CC	O	and	_	0	SENT_83	[p6l1149t2083r1268b2137],
12	probes	NNS	O	probe	nsubjpass	14	SENT_83	[p6l1309t2083r1521b2150],
13	were	VBD	O	be	auxpass	14	SENT_83	[p6l1562t2101r1717b2137],
14	designed	VBN	O	design	_	0	SENT_83	[p6l1760t2083r2046b2150],
15	in	IN	O	in	_	0	SENT_83	[p6l2086t2085r2150b2136],
16	the	DT	O	the	det	17	SENT_83	[p6l15t2172r118b2225],
17	regions	NNS	O	region	prep_in	14	SENT_83	[p6l145t2173r381b2239],
18	of	IN	O	of	_	0	SENT_83	[p6l409t2172r474b2225],
19	DNA	NN	O	dna	nn	21	SENT_83	[p6l491t2172r655b2225],
20	(	NN	O	(	nn	21	SENT_83	[p6l679t2172r879b2233],
21	Table	NNP	O	Table	prep_of	17	SENT_83	[p6l679t2172r879b2233],
22	I	PRP	O	I	nsubj	23	SENT_83	[p6l906t2172r971b2233],
23	)	VBP	O	)	rcmod	21	SENT_83	[p6l906t2172r971b2233],
24	.	.	O	.	_	0	SENT_83	[p6l906t2172r971b2233],

1	Analysis	NN	O	analysis	_	0	SENT_84	[p6l7t2399r378b2479],
2	of	IN	O	of	_	0	SENT_84	[p6l411t2399r505b2479],
3	SNPs	NNS	O	snp	prep_of	1	SENT_84	[p6l519t2399r749b2463],

1	SNP	NN	O	snp	nn	2	SENT_85	[p6l195t2498r341b2552],
2	analysis	NN	O	analysis	nsubjpass	9	SENT_85	[p6l383t2498r648b2565],
3	of	IN	O	of	_	0	SENT_85	[p6l691t2498r755b2552],
4	the	DT	O	the	det	7	SENT_85	[p6l787t2498r891b2552],
5	six	CD	NUMBER	six	num	7	SENT_85	[p6l935t2500r1024b2552],
6	candidate	NN	O	candidate	nn	7	SENT_85	[p6l1065t2498r1382b2552],
7	genes	NNS	O	gene	prep_of	2	SENT_85	[p6l1423t2515r1605b2565],
8	was	VBD	O	be	auxpass	9	SENT_85	[p6l1647t2516r1772b2552],
9	performed	VBN	O	perform	_	0	SENT_85	[p6l1814t2498r2150b2565],
10	using	VBG	O	use	xcomp	9	SENT_85	[p6l15t2587r195b2653],
11	a	DT	O	a	det	18	SENT_85	[p6l255t2604r290b2639],
12	real-time	JJ	O	real-time	amod	18	SENT_85	[p6l350t2586r647b2639],
13	polymerase	NN	O	polymerase	nn	18	SENT_85	[p6l708t2586r1078b2653],
14	chain	NN	O	chain	nn	18	SENT_85	[p6l1140t2586r1318b2639],
15	reaction	NN	O	reaction	nn	18	SENT_85	[p6l1377t2587r1643b2639],
16	(	CD	NUMBER	(	num	18	SENT_85	[p6l1703t2586r1896b2647],
17	PCR	NN	O	pcr	nn	18	SENT_85	[p6l1703t2586r1896b2647],
18	)	NN	O	)	nsubj	19	SENT_85	[p6l1703t2586r1896b2647],
19	allelic	JJ	O	allelic	xcomp	10	SENT_85	[p6l1958t2586r2149b2639],

1	Grau	NNP	PERSON	Grau	nn	3	SENT_86	[p6l485t2810r652b2871],
2	et	NNP	O	et	nn	3	SENT_86	[p6l686t2815r750b2870],
3	aI.	NNP	O	aI.	_	0	SENT_86	[p6l781t2812r878b2870],
4	:	:	O	:	_	0	SENT_86	[p6l781t2812r878b2870],
5	Advanced	NNP	O	Advanced	nn	6	SENT_86	[p6l911t2812r1267b2870],
6	Head	NNP	O	Head	dep	3	SENT_86	[p6l1305t2812r1486b2870],
7	and	CC	O	and	_	0	SENT_86	[p6l1520t2812r1648b2870],
8	Neck	NNP	O	Neck	nn	9	SENT_86	[p6l1685t2812r1865b2870],
9	Cancer	NNP	O	Cancer	dep	3	SENT_86	[p6l1895t2810r2151b2871],

1	TABLE	NN	O	table	nn	2	SENT_87	[p6l942t3206r1153b3257],
2	I.	NN	O	i.	_	0	SENT_87	[p6l1184t3206r1212b3257],

1	Genes	NNS	O	gene	_	0	SENT_88	[p6l639t3293r841b3347],
2	and	CC	O	and	_	0	SENT_88	[p6l869t3294r983b3347],
3	Polymorphisms	NNS	O	polymorphism	conj_and	1	SENT_88	[p6l1016t3294r1518b3361],
4	.	.	O	.	_	0	SENT_88	[p6l1016t3294r1518b3361],

1	Gene	NNP	O	Gene	nn	3	SENT_89	[p6l11t3427r156b3474],
2	Context	NNP	O	Context	nn	3	SENT_89	[p6l836t3427r1054b3474],
3	Sequence	NN	O	sequence	nsubj	4	SENT_89	[p6l1077t3427r1356b3486],
4	rs	VBZ	O	r	_	0	SENT_89	[p6l1906t3440r1953b3474],
5	NCBI	NN	O	ncbus	dobj	4	SENT_89	[p6l1980t3427r2120b3474],

1	CYP2C8	NN	O	cyp2c8	nn	2	SENT_90	[p6l11t3552r279b3605],
2	CTGCAACACT	NN	O	ctgcaacact	dep	9	SENT_90	[p6l527t3552r1648b3618],
3	[	CD	NUMBER	[	num	4	SENT_90	[p6l527t3552r1648b3618],
4	C/T	NN	O	c/t	dep	2	SENT_90	[p6l527t3552r1648b3618],
5	]	CD	NUMBER	]	num	6	SENT_90	[p6l527t3552r1648b3618],
6	GGCAGCCATG	NN	O	ggcagccatg	dep	9	SENT_90	[p6l527t3552r1648b3618],
7	2275622	CD	NUMBER	2275622	num	9	SENT_90	[p6l1878t3553r2148b3605],
8	GSTT1	NN	O	gstt1	nn	9	SENT_90	[p6l11t3649r216b3702],
9	AATGGCTTGC	NN	O	aatggcttgc	_	0	SENT_90	[p6l524t3649r1613b3715],
10	[	CD	NUMBER	[	num	11	SENT_90	[p6l524t3649r1613b3715],
11	C/TJTAAGACTTGC	NNP	O	C/TJTAAGACTTGC	dep	9	SENT_90	[p6l524t3649r1613b3715],
12	4630	CD	NUMBER	4630	num	11	SENT_90	[p6l1996t3651r2150b3702],

1	GSTP1	NN	O	gstp1	nn	3	SENT_91	[p7l11t22r221b76],
2	CTG	NN	O	ctg	nn	3	SENT_91	[p7l527t22r666b76],
3	CAAATAC	NN	O	caaatac	dep	10	SENT_91	[p7l673t22r1606b90],
4	[	CD	NUMBER	[	num	5	SENT_91	[p7l673t22r1606b90],
5	A/G	NN	O	a/g	dep	3	SENT_91	[p7l673t22r1606b90],
6	]	CD	NUMBER	]	num	7	SENT_91	[p7l673t22r1606b90],
7	TCTCCCTCAT	NN	O	tctccctcat	dep	10	SENT_91	[p7l673t22r1606b90],
8	1	CD	NUMBER	1	num	10	SENT_91	[p7l2000t24r2020b75],
9	695	CD	NUMBER	695	num	10	SENT_91	[p7l2036t24r2149b76],
10	MDR1-62	NN	O	mdr1-62	dep	20	SENT_91	[p7l14t121r312b173],
11	TC	NN	O	tc	dep	10	SENT_91	[p7l524t120r1642b186],
12	'	''	O	'	_	0	SENT_91	[p7l524t120r1642b186],
13	|	JJ	O	|	amod	17	SENT_91	[p7l524t120r1642b186],
14	TGAAGGG	NN	O	tgaaggg	nn	17	SENT_91	[p7l524t120r1642b186],
15	[	CD	NUMBER	[	num	17	SENT_91	[p7l524t120r1642b186],
16	Cf	NN	O	cf	nn	17	SENT_91	[p7l524t120r1642b186],
17	|	NN	O	|	rcmod	11	SENT_91	[p7l524t120r1642b186],
18	'	''	O	'	_	0	SENT_91	[p7l524t120r1642b186],
19	]	JJ	O	]	amod	20	SENT_91	[p7l524t120r1642b186],
20	CTGAACCTGA	NN	O	ctgaacctga	dep	29	SENT_91	[p7l524t120r1642b186],
21	1128503	CD	NUMBER	1128503	num	24	SENT_91	[p7l1882t121r2149b173],
22	MDR	NN	O	mdr	nn	24	SENT_91	[p7l14t218r314b270],
23	‘	NN	O	‘	nn	24	SENT_91	[p7l14t218r314b270],
24	l	NN	O	l	dep	20	SENT_91	[p7l14t218r314b270],
25	—	CD	NUMBER	—	number	26	SENT_91	[p7l14t218r314b270],
26	57	CD	NUMBER	57	num	27	SENT_91	[p7l14t218r314b270],
27	AGGAAGAGAT	NN	O	aggaagagat	dep	24	SENT_91	[p7l524t217r1664b283],
28	[	CD	NUMBER	[	num	29	SENT_91	[p7l524t217r1664b283],
29	C/T	NN	O	c/t	dep	31	SENT_91	[p7l524t217r1664b283],
30	]	CD	NUMBER	]	num	31	SENT_91	[p7l524t217r1664b283],
31	GTGAGGGCAG	NN	O	gtgagggcag	dep	33	SENT_91	[p7l524t217r1664b283],
32	1045642	CD	NUMBER	1045642	num	33	SENT_91	[p7l1882t219r2148b270],
33	ERCC1	NN	O	ercc1	dep	34	SENT_91	[p7l14t314r230b368],
34	CCCAAAGGGA	NN	O	cccaaaggga	dep	36	SENT_91	[p7l527t314r1654b382],
35	[	CD	NUMBER	[	num	34	SENT_91	[p7l527t314r1654b382],
36	A/C	NN	O	a/c	dep	38	SENT_91	[p7l527t314r1654b382],
37	]	CD	NUMBER	]	num	36	SENT_91	[p7l527t314r1654b382],
38	AGAAACC	NN	O	agaaacc	_	0	SENT_91	[p7l527t314r1654b382],
39	'	''	O	'	_	0	SENT_91	[p7l527t314r1654b382],
40	|	NN	O	|	nn	42	SENT_91	[p7l527t314r1654b382],
41	'	''	O	'	_	0	SENT_91	[p7l527t314r1654b382],
42	|	NN	O	|	dep	38	SENT_91	[p7l527t314r1654b382],
43	'	''	O	'	_	0	SENT_91	[p7l527t314r1654b382],
44	C	NN	O	c	prep	42	SENT_91	[p7l527t314r1654b382],
45	735482	CD	NUMBER	735482	dep	44	SENT_91	[p7l1918t316r2148b368],

1	rs	NNS	O	r	nn	2	SENT_92	[p7l191t472r238b506],
2	NCBI	NN	O	ncbus	nsubj	4	SENT_92	[p7l275t459r415b506],
3	=	JJ	O	=	amod	4	SENT_92	[p7l455t482r497b497],
4	reference	NN	O	reference	_	0	SENT_92	[p7l534t460r792b506],
5	single	JJ	O	single	amod	8	SENT_92	[p7l827t460r986b518],
6	nucleotide	NN	O	nucleotide	nn	8	SENT_92	[p7l1023t460r1308b506],
7	polymorphism	NN	O	polymorphism	nn	8	SENT_92	[p7l1345t460r1735b518],
8	record	NN	O	record	dobj	4	SENT_92	[p7l1775t460r1949b506],
9	in	IN	O	in	_	0	SENT_92	[p7l1988t460r2028b505],
10	the	DT	O	the	det	11	SENT_92	[p7l2063t460r2149b506],
11	format	NN	O	format	prep_in	8	SENT_92	[p7l9t541r188b587],
12	of	IN	O	of	_	0	SENT_92	[p7l214t541r266b587],
13	the	DT	O	the	det	15	SENT_92	[p7l287t542r373b587],
14	National	NNP	ORGANIZATION	National	nn	15	SENT_92	[p7l399t542r621b587],
15	Center	NNP	ORGANIZATION	Center	prep_of	11	SENT_92	[p7l649t541r834b588],
16	for	IN	ORGANIZATION	for	_	0	SENT_92	[p7l855t541r930b587],
17	Biotechnology	NNP	ORGANIZATION	Biotechnology	nn	18	SENT_92	[p7l955t542r1351b600],
18	Information	NNP	ORGANIZATION	Information	prep_for	4	SENT_92	[p7l1378t541r1702b587],
19	.	.	O	.	_	0	SENT_92	[p7l1378t541r1702b587],

1	discrimination	NN	O	discrimination	nn	7	SENT_93	[p7l11t746r487b800],
2	TaqMan	NN	O	taqman	nn	7	SENT_93	[p7l520t747r792b814],
3	assay	NN	O	assay	nn	7	SENT_93	[p7l827t764r1007b814],
4	(	CD	NUMBER	(	num	7	SENT_93	[p7l1040t746r1315b814],
5	Applied	NNP	O	Applied	nn	7	SENT_93	[p7l1040t746r1315b814],
6	Biosystems	NNP	O	Biosystems	nn	7	SENT_93	[p7l1348t746r1741b814],
7	)	NN	O	)	_	0	SENT_93	[p7l1348t746r1741b814],
8	with	IN	O	with	_	0	SENT_93	[p7l1775t746r1922b800],
9	minor	JJ	O	minor	amod	10	SENT_93	[p7l1956t747r2151b800],
10	modiﬁcations	NNS	O	modiﬁcations	prep_with	7	SENT_93	[p7l10t835r464b889],
11	.	.	O	.	_	0	SENT_93	[p7l10t835r464b889],

1	All	DT	O	all	det	3	SENT_94	[p7l493t835r589b888],
2	PCR	NN	O	pcr	nn	3	SENT_94	[p7l618t835r766b889],
3	reactions	NNS	O	reaction	nsubjpass	9	SENT_94	[p7l792t836r1090b889],
4	were	VBD	O	be	auxpass	5	SENT_94	[p7l1118t853r1274b889],
5	run	VBN	O	run	_	0	SENT_94	[p7l1302t853r1419b889],
6	in	IN	O	in	_	0	SENT_94	[p7l1447t836r1511b888],
7	duplicate	VB	O	duplicate	prepc_in	5	SENT_94	[p7l1540t835r1839b903],
8	and	CC	O	and	_	0	SENT_94	[p7l1870t835r1990b889],
9	contained	VBD	O	contain	conj_and	5	SENT_94	[p7l2019t853r2149b889, p7l9t923r217b977],
10	50	CD	NUMBER	50	num	11	SENT_94	[p7l262t925r335b977],
11	ng	NN	O	ng	dobj	9	SENT_94	[p7l380t940r461b991],
12	of	IN	O	of	_	0	SENT_94	[p7l504t923r569b977],
13	patient	NN	O	patient	nn	14	SENT_94	[p7l604t924r839b991],
14	DNA	NN	MISC	dna	prep_of	11	SENT_94	[p7l882t922r1061b989],
15	,	,	O	,	_	0	SENT_94	[p7l882t922r1061b989],
16	6.25	CD	NUMBER	6.25	num	17	SENT_94	[p7l1108t925r1241b977],
17	ML	NN	O	ml	dobj	9	SENT_94	[p7l1287t923r1370b991],
18	of	IN	O	of	_	0	SENT_94	[p7l1415t923r1479b977],
19	TaqMan	NNP	O	TaqMan	nn	25	SENT_94	[p7l1514t923r1786b991],
20	Universal	NNP	O	Universal	nn	25	SENT_94	[p7l1828t923r2150b977],
21	Master	NNP	O	Master	nn	25	SENT_94	[p7l10t1013r243b1066],
22	Mix	NNP	O	Mix	nn	25	SENT_94	[p7l277t1013r404b1065],
23	(	NNP	O	(	nn	25	SENT_94	[p7l440t1012r714b1080],
24	Applied	NNP	ORGANIZATION	Applied	nn	25	SENT_94	[p7l440t1012r714b1080],
25	Biosystems	NNPS	ORGANIZATION	Biosystems	prep_of	17	SENT_94	[p7l749t1013r1117b1080],
26	Inc.	NNP	ORGANIZATION	Inc.	dep	25	SENT_94	[p7l1154t1012r1316b1078],
27	)	CD	NUMBER	)	num	26	SENT_94	[p7l1154t1012r1316b1078],
28	,	,	O	,	_	0	SENT_94	[p7l1154t1012r1316b1078],
29	0.25	CD	NUMBER	0.25	num	26	SENT_94	[p7l1356t1014r1489b1066],
30	,	,	O	,	_	0	SENT_94	[p7l1526t1013r1610b1080],
31	uL	NN	O	ul	dobj	9	SENT_94	[p7l1526t1013r1610b1080],
32	of	IN	O	of	_	0	SENT_94	[p7l1646t1012r1711b1066],
33	primers	NNS	O	primer	prep_of	31	SENT_94	[p7l1738t1013r1993b1080],
34	and	CC	O	and	_	0	SENT_94	[p7l2031t1012r2151b1066],
35	probes	NNS	O	probe	prep_of	31	SENT_94	[p7l10t1099r241b1167],
36	,	,	O	,	_	0	SENT_94	[p7l10t1099r241b1167],
37	and	CC	O	and	_	0	SENT_94	[p7l284t1099r405b1154],
38	water	NN	O	water	conj_and	11	SENT_94	[p7l443t1104r632b1154],
39	for	IN	O	for	_	0	SENT_94	[p7l671t1099r760b1154],
40	a	DT	O	a	det	42	SENT_94	[p7l801t1118r836b1154],
41	ﬁnal	JJ	O	ﬁnal	amod	42	SENT_94	[p7l875t1099r1024b1154],
42	volume	NN	O	volume	prep_for	38	SENT_94	[p7l1062t1099r1299b1154],
43	of	IN	O	of	_	0	SENT_94	[p7l1340t1099r1405b1154],
44	12.5	CD	NUMBER	12.5	prep_of	42	SENT_94	[p7l1442t1101r1570b1154],
45	,	,	O	,	_	0	SENT_94	[p7l1612t1100r1711b1168],
46	uL	NN	O	ul	appos	44	SENT_94	[p7l1612t1100r1711b1168],
47	.	.	O	.	_	0	SENT_94	[p7l1612t1100r1711b1168],

1	Appropriate	JJ	O	appropriate	amod	3	SENT_95	[p7l1753t1099r2149b1167],
2	negative	JJ	O	negative	amod	3	SENT_95	[p7l10t1189r288b1256],
3	controls	NNS	O	control	nsubjpass	6	SENT_95	[p7l322t1188r578b1242],
4	were	VBD	O	be	auxpass	6	SENT_95	[p7l610t1206r767b1242],
5	also	RB	O	also	advmod	6	SENT_95	[p7l801t1188r926b1242],
6	run	VBN	O	run	_	0	SENT_95	[p7l958t1206r1091b1242],
7	.	.	O	.	_	0	SENT_95	[p7l958t1206r1091b1242],

1	Real-time	JJ	O	real-time	amod	2	SENT_96	[p7l1128t1187r1445b1242],
2	PCR	NN	O	pcr	nsubjpass	4	SENT_96	[p7l1478t1188r1626b1242],
3	was	VBD	O	be	auxpass	4	SENT_96	[p7l1656t1206r1780b1242],
4	performed	VBN	O	perform	_	0	SENT_96	[p7l1814t1188r2150b1256],
5	on	IN	O	on	_	0	SENT_96	[p7l11t1295r87b1331],
6	an	DT	O	a	det	12	SENT_96	[p7l115t1295r194b1331],
7	ABI	NNP	MISC	ABI	nn	12	SENT_96	[p7l218t1277r348b1330],
8	Prism	NNP	O	Prism	nn	12	SENT_96	[p7l377t1278r572b1331],
9	7500	CD	NUMBER	7500	num	12	SENT_96	[p7l600t1279r751b1331],
10	Sequence	NN	O	sequence	nn	12	SENT_96	[p7l781t1277r1086b1345],
11	Detection	NN	O	detection	nn	12	SENT_96	[p7l1114t1278r1426b1331],
12	System	NN	O	system	prep_on	4	SENT_96	[p7l1454t1277r1693b1345],
13	(	CD	NUMBER	(	num	15	SENT_96	[p7l1719t1277r1994b1345],
14	Applied	NNP	ORGANIZATION	Applied	nn	15	SENT_96	[p7l1719t1277r1994b1345],
15	Biosystems	NNPS	ORGANIZATION	Biosystems	dep	12	SENT_96	[p7l2020t1278r2149b1331, p7l12t1370r269b1433],
16	Inc.	NNP	ORGANIZATION	Inc.	dobj	4	SENT_96	[p7l336t1366r480b1427],
17	)	CD	NUMBER	)	num	16	SENT_96	[p7l336t1366r480b1427],
18	using	VBG	O	use	partmod	16	SENT_96	[p7l545t1367r726b1433],
19	the	DT	O	the	det	21	SENT_96	[p7l788t1365r892b1420],
20	following	JJ	O	following	amod	21	SENT_96	[p7l957t1365r1257b1433],
21	conditions	NNS	O	condition	dobj	18	SENT_96	[p7l1321t1365r1670b1420],
22	:	:	O	:	_	0	SENT_96	[p7l1321t1365r1670b1420],
23	50	CD	NUMBER	50	number	24	SENT_96	[p7l1740t1365r1893b1420],
24	°	CD	NUMBER	°	num	25	SENT_96	[p7l1740t1365r1893b1420],
25	C	NN	O	c	conj_and	16	SENT_96	[p7l1740t1365r1893b1420],
26	for	IN	O	for	_	0	SENT_96	[p7l1959t1365r2049b1420],
27	2	CD	DURATION	2	num	28	SENT_96	[p7l2114t1368r2148b1419],
28	minutes	NNS	NUMBER	minute	prep_for	25	SENT_96	[p7l10t1455r293b1520],
29	,	,	O	,	_	0	SENT_96	[p7l10t1455r293b1520],
30	95	CD	NUMBER	95	num	32	SENT_96	[p7l338t1454r491b1508],
31	°	NN	O	°	nn	32	SENT_96	[p7l338t1454r491b1508],
32	C	NN	O	c	conj_and	16	SENT_96	[p7l338t1454r491b1508],
33	for	IN	O	for	_	0	SENT_96	[p7l534t1454r624b1508],
34	10	CD	DURATION	10	num	35	SENT_96	[p7l670t1456r740b1508],
35	minutes	NNS	NUMBER	minute	prep_for	32	SENT_96	[p7l782t1455r1065b1520],
36	,	,	O	,	_	0	SENT_96	[p7l782t1455r1065b1520],
37	and	CC	O	and	_	0	SENT_96	[p7l1111t1454r1231b1508],
38	40	CD	NUMBER	40	num	39	SENT_96	[p7l1272t1456r1347b1508],
39	cycles	NNS	O	cycle	conj_and	16	SENT_96	[p7l1390t1454r1579b1522],
40	of	IN	O	of	_	0	SENT_96	[p7l1622t1454r1686b1508],
41	ampliﬁcation	NN	O	ampliﬁcation	prep_of	39	SENT_96	[p7l1720t1454r2150b1522],
42	(	CD	NUMBER	(	number	43	SENT_96	[p7l11t1542r188b1604],
43	95	CD	NUMBER	95	num	45	SENT_96	[p7l11t1542r188b1604],
44	°	NN	O	°	nn	45	SENT_96	[p7l11t1542r188b1604],
45	C	NN	O	c	dep	41	SENT_96	[p7l11t1542r188b1604],
46	for	IN	O	for	_	0	SENT_96	[p7l217t1542r306b1596],
47	15	CD	DURATION	15	num	48	SENT_96	[p7l338t1544r407b1596],
48	seconds	NNS	NUMBER	seconds	prep_for	45	SENT_96	[p7l437t1542r685b1596],
49	and	CC	O	and	_	0	SENT_96	[p7l714t1542r834b1596],
50	60	CD	NUMBER	60	num	52	SENT_96	[p7l862t1542r1015b1596],
51	°	NN	O	°	nn	52	SENT_96	[p7l862t1542r1015b1596],
52	C	NN	O	c	prep_of	39	SENT_96	[p7l862t1542r1015b1596],
53	for	IN	O	for	_	0	SENT_96	[p7l1044t1542r1134b1596],
54	1	CD	DURATION	1	num	56	SENT_96	[p7l1165t1544r1194b1596],
55	minute	NN	NUMBER	minute	nn	56	SENT_96	[p7l1223t1542r1496b1604],
56	)	NN	O	)	prep_for	52	SENT_96	[p7l1223t1542r1496b1604],
57	.	.	O	.	_	0	SENT_96	[p7l1223t1542r1496b1604],

1	For	IN	O	for	_	0	SENT_97	[p7l1528t1543r1640b1596],
2	each	DT	O	each	det	3	SENT_97	[p7l1668t1542r1815b1596],
3	cycle	NN	O	cycle	prep_for	7	SENT_97	[p7l1842t1542r2016b1610],
4	,	,	O	,	_	0	SENT_97	[p7l1842t1542r2016b1610],
5	the	DT	O	the	det	6	SENT_97	[p7l2045t1542r2149b1596],
6	software	NN	O	software	nsubj	7	SENT_97	[p7l12t1631r289b1686],
7	determined	VBD	O	determine	_	0	SENT_97	[p7l337t1631r711b1686],
8	the	DT	O	the	det	10	SENT_97	[p7l757t1631r860b1686],
9	ﬂuorescent	JJ	O	ﬂuorescent	amod	10	SENT_97	[p7l908t1631r1270b1686],
10	signal	NN	O	signal	dobj	7	SENT_97	[p7l1319t1631r1513b1699],
11	from	IN	O	from	_	0	SENT_97	[p7l1559t1631r1712b1686],
12	the	DT	O	the	det	13	SENT_97	[p7l1758t1631r1862b1686],
13	VIC	NNP	O	VIC	prep_from	7	SENT_97	[p7l1907t1631r2036b1686],
14	or	CC	O	or	_	0	SENT_97	[p7l2086t1650r2151b1686],
15	FAM-labeled	JJ	O	fam-labeled	amod	16	SENT_97	[p7l10t1720r427b1775],
16	probe	NN	O	probe	prep_from	7	SENT_97	[p7l454t1720r650b1788],
17	.	.	O	.	_	0	SENT_97	[p7l454t1720r650b1788],

1	Statistical	JJ	O	statistical	amod	2	SENT_98	[p7l8t1949r467b2013],
2	Methods	NNS	O	method	_	0	SENT_98	[p7l495t1949r857b2013],

1	Clinical	JJ	O	clinical	amod	2	SENT_99	[p7l190t2048r441b2102],
2	data	NNS	O	datum	nsubjpass	4	SENT_99	[p7l504t2048r648b2102],
3	were	VBD	O	be	auxpass	4	SENT_99	[p7l707t2066r863b2102],
4	recorded	VBN	O	record	dep	28	SENT_99	[p7l925t2048r1207b2102],
5	in	IN	O	in	_	0	SENT_99	[p7l1267t2049r1331b2101],
6	a	DT	O	a	det	11	SENT_99	[p7l1394t2066r1430b2102],
7	computer	NN	O	computer	nn	11	SENT_99	[p7l1491t2053r1798b2116],
8	database	NN	O	database	nn	11	SENT_99	[p7l1860t2048r2150b2102],
9	(	CD	NUMBER	(	num	11	SENT_99	[p7l11t2136r340b2197],
10	Microsoft	NNP	ORGANIZATION	Microsoft	nn	11	SENT_99	[p7l11t2136r340b2197],
11	Access	NN	O	access	prep_in	4	SENT_99	[p7l377t2135r592b2190],
12	2.00	CD	NUMBER	2.00	dep	11	SENT_99	[p7l633t2138r785b2202],
13	,	,	O	,	_	0	SENT_99	[p7l633t2138r785b2202],
14	Microsoft	NNP	ORGANIZATION	Microsoft	nn	15	SENT_99	[p7l828t2136r1134b2190],
15	Corporation	NNP	ORGANIZATION	Corporation	dep	11	SENT_99	[p7l1175t2136r1583b2204],
16	,	,	O	,	_	0	SENT_99	[p7l1175t2136r1583b2204],
17	Redmond	NNP	PERSON	Redmond	dep	11	SENT_99	[p7l1626t2135r1951b2202],
18	,	,	O	,	_	0	SENT_99	[p7l1626t2135r1951b2202],
19	WA	NNP	LOCATION	WA	nn	20	SENT_99	[p7l1993t2135r2148b2202],
20	)	NNP	O	)	dep	11	SENT_99	[p7l1993t2135r2148b2202],
21	,	,	O	,	_	0	SENT_99	[p7l1993t2135r2148b2202],
22	and	CC	O	and	_	0	SENT_99	[p7l11t2225r131b2279],
23	all	PDT	O	all	predet	26	SENT_99	[p7l165t2225r244b2279],
24	the	DT	O	the	det	26	SENT_99	[p7l277t2225r380b2279],
25	statistical	JJ	O	statistical	amod	26	SENT_99	[p7l415t2225r736b2279],
26	analysis	NN	O	analysis	conj_and	12	SENT_99	[p7l770t2225r1036b2293],
27	were	VBD	O	be	auxpass	28	SENT_99	[p7l1068t2243r1223b2279],
28	performed	VBN	O	perform	_	0	SENT_99	[p7l1257t2225r1594b2293],
29	with	IN	O	with	_	0	SENT_99	[p7l1625t2225r1772b2279],
30	SPSS	NN	ORGANIZATION	spss	nn	32	SENT_99	[p7l1806t2225r1982b2279],
31	12.0	CD	NUMBER	12.0	num	32	SENT_99	[p7l2020t2227r2149b2279],
32	program	NN	O	program	prep_with	28	SENT_99	[p7l10t2331r289b2382],
33	for	IN	O	for	_	0	SENT_99	[p7l315t2314r405b2368],
34	Windows	NNP	MISC	Windows	prep_for	32	SENT_99	[p7l430t2314r726b2368],
35	(	CD	NUMBER	(	num	34	SENT_99	[p7l755t2314r955b2376],
36	SPSS	NNP	ORGANIZATION	SPSS	nn	37	SENT_99	[p7l755t2314r955b2376],
37	Inc.	NNP	ORGANIZATION	Inc.	nsubjpass	28	SENT_99	[p7l984t2315r1122b2380],
38	,	,	O	,	_	0	SENT_99	[p7l984t2315r1122b2380],
39	Chicago	NNP	LOCATION	Chicago	appos	37	SENT_99	[p7l1154t2314r1429b2382],
40	,	,	O	,	_	0	SENT_99	[p7l1154t2314r1429b2382],
41	IL	NN	LOCATION	il	nn	42	SENT_99	[p7l1460t2314r1572b2376],
42	)	NN	O	)	appos	39	SENT_99	[p7l1460t2314r1572b2376],
43	.	.	O	.	_	0	SENT_99	[p7l1460t2314r1572b2376],

1	For	IN	O	for	_	0	SENT_100	[p7l1604t2315r1717b2368],
2	comparisons	NNS	O	comparison	prep_for	8	SENT_100	[p7l1744t2315r2149b2382],
3	of	IN	O	of	_	0	SENT_100	[p7l11t2402r75b2456],
4	ordinal	JJ	O	ordinal	amod	5	SENT_100	[p7l109t2401r341b2456],
5	variables	NNS	O	variable	prep_of	2	SENT_100	[p7l381t2402r697b2468],
6	,	,	O	,	_	0	SENT_100	[p7l381t2402r697b2468],
7	we	PRP	O	we	nsubj	8	SENT_100	[p7l741t2420r829b2456],
8	performed	VBD	O	perform	_	0	SENT_100	[p7l871t2402r1208b2470],
9	contingency	NN	O	contingency	nn	11	SENT_100	[p7l1249t2403r1640b2470],
10	table	NN	O	table	nn	11	SENT_100	[p7l1679t2402r1840b2456],
11	analysis	NN	O	analysis	dobj	8	SENT_100	[p7l1884t2401r2150b2470],
12	with	IN	O	with	_	0	SENT_100	[p7l9t2491r157b2545],
13	the	DT	O	the	dep	15	SENT_100	[p7l184t2491r288b2545],
14	Fisher	NNP	O	Fisher	amod	15	SENT_100	[p7l318t2491r529b2545],
15	exact	JJ	O	exact	prep_with	11	SENT_100	[p7l558t2496r728b2545],
16	or	CC	O	or	_	0	SENT_100	[p7l756t2509r820b2545],
17	chi-square	JJ	O	chi-square	amod	18	SENT_100	[p7l849t2491r1189b2559],
18	tests	NNS	O	test	prep_with	11	SENT_100	[p7l1218t2496r1370b2545],
19	for	IN	O	for	_	0	SENT_100	[p7l1400t2491r1489b2545],
20	determining	VBG	O	determine	prepc_for	15	SENT_100	[p7l1518t2491r1921b2559],
21	statistical	JJ	O	statistical	amod	22	SENT_100	[p7l1949t2492r2149b2545, p7l9t2579r150b2634],
22	signiﬁcance	NN	O	signiﬁcance	dobj	20	SENT_100	[p7l182t2579r581b2647],
23	.	.	O	.	_	0	SENT_100	[p7l182t2579r581b2647],

1	For	IN	O	for	_	0	SENT_101	[p7l615t2580r728b2634],
2	comparisons	NNS	O	comparison	prep_for	8	SENT_101	[p7l758t2581r1162b2647],
3	of	IN	O	of	_	0	SENT_101	[p7l1194t2579r1259b2634],
4	quantitative	JJ	O	quantitative	amod	5	SENT_101	[p7l1281t2581r1683b2647],
5	variables	NNS	O	variable	prep_of	2	SENT_101	[p7l1712t2579r2029b2646],
6	,	,	O	,	_	0	SENT_101	[p7l1712t2579r2029b2646],
7	we	PRP	O	we	nsubj	8	SENT_101	[p7l2061t2598r2149b2634],
8	used	VBD	O	use	_	0	SENT_101	[p7l10t2668r160b2722],
9	Student	NN	O	student	nn	11	SENT_101	[p7l188t2668r448b2722],
10	t	NN	O	t	nn	11	SENT_101	[p7l473t2676r495b2722],
11	test	NN	O	test	dobj	8	SENT_101	[p7l522t2672r644b2722],
12	to	TO	O	to	aux	13	SENT_101	[p7l668t2672r728b2722],
13	determine	VB	O	determine	xcomp	8	SENT_101	[p7l757t2668r1087b2722],
14	statistical	JJ	O	statistical	amod	15	SENT_101	[p7l1117t2668r1438b2722],
15	signiﬁcance	NN	O	signiﬁcance	dobj	13	SENT_101	[p7l1465t2668r1864b2736],
16	.	.	O	.	_	0	SENT_101	[p7l1465t2668r1864b2736],

1	Survival	NN	O	survival	nsubjpass	3	SENT_102	[p7l191t2756r467b2810],
2	was	VBD	O	be	auxpass	3	SENT_102	[p7l508t2774r633b2810],
3	calculated	VBN	O	calculate	_	0	SENT_102	[p7l676t2756r1008b2810],
4	from	IN	O	from	_	0	SENT_102	[p7l1048t2756r1201b2810],
5	the	DT	DATE	the	det	7	SENT_102	[p7l1241t2755r1345b2810],
6	ﬁrst	JJ	DATE	ﬁrst	amod	7	SENT_102	[p7l1388t2756r1524b2810],
7	day	NN	DATE	day	prep_from	3	SENT_102	[p7l1566t2755r1682b2824],
8	of	IN	O	of	_	0	SENT_102	[p7l1723t2756r1788b2810],
9	treatment	NN	O	treatment	prep_of	7	SENT_102	[p7l1821t2760r2151b2810],
10	with	IN	O	with	_	0	SENT_102	[p7l9t2844r157b2898],
11	chemotherapy	NN	O	chemotherapy	prep_with	3	SENT_102	[p7l185t2844r650b2912],
12	until	IN	O	until	_	0	SENT_102	[p7l677t2844r834b2898],
13	death	NN	O	death	prep_until	3	SENT_102	[p7l864t2844r1048b2898],
14	or	CC	O	or	_	0	SENT_102	[p7l1076t2862r1141b2898],
15	until	IN	O	until	_	0	SENT_102	[p7l1168t2844r1325b2898],
16	the	DT	O	the	det	19	SENT_102	[p7l1353t2844r1457b2898],
17	last	JJ	O	last	amod	19	SENT_102	[p7l1485t2844r1606b2898],
18	patient	NN	O	patient	nn	19	SENT_102	[p7l1633t2846r1868b2912],
19	contact	NN	O	contact	conj_or	13	SENT_102	[p7l1896t2849r2146b2898],
20	.	.	O	.	_	0	SENT_102	[p7l1896t2849r2146b2898],

1	Kaplan-Meier	JJR	O	kaplan-meier	amod	2	SENT_103	[p7l10t2933r466b3001],
2	estimates	NNS	O	estimate	nsubjpass	11	SENT_103	[p7l510t2935r822b2988],
3	of	IN	O	of	_	0	SENT_103	[p7l869t2933r933b2988],
4	the	DT	O	the	det	6	SENT_103	[p7l969t2933r1072b2988],
5	survival	NN	O	survival	nn	6	SENT_103	[p7l1120t2933r1385b2988],
6	function	NN	O	function	prep_of	2	SENT_103	[p7l1429t2933r1699b2988],
7	were	VBD	O	be	auxpass	8	SENT_103	[p7l1743t2952r1899b2988],
8	generated	VBN	O	generate	_	0	SENT_103	[p7l1944t2951r2149b3001, p7l11t3023r168b3089],
9	,	,	O	,	_	0	SENT_103	[p7l1944t2951r2149b3001, p7l11t3023r168b3089],
10	and	CC	O	and	_	0	SENT_103	[p7l216t3023r335b3077],
11	compared	VBN	O	compare	conj_and	8	SENT_103	[p7l379t3023r695b3091],
12	using	VBG	O	use	xcomp	11	SENT_103	[p7l738t3024r918b3091],
13	the	DT	O	the	det	15	SENT_103	[p7l959t3023r1063b3077],
14	log-rank	JJ	O	log-rank	amod	15	SENT_103	[p7l1107t3023r1384b3091],
15	method	NN	O	method	dobj	12	SENT_103	[p7l1425t3023r1670b3077],
16	to	TO	O	to	aux	17	SENT_103	[p7l1712t3028r1772b3077],
17	determine	VB	O	determine	xcomp	12	SENT_103	[p7l1818t3023r2149b3077],
18	statistical	JJ	O	statistical	amod	19	SENT_103	[p7l12t3111r333b3165],
19	signiﬁcance	NN	O	signiﬁcance	dobj	17	SENT_103	[p7l368t3111r767b3179],
20	.	.	O	.	_	0	SENT_103	[p7l368t3111r767b3179],

1	The	DT	O	the	det	3	SENT_104	[p7l804t3111r927b3165],
2	test	NN	O	test	nn	3	SENT_104	[p7l961t3116r1083b3165],
3	level	NN	O	level	nsubjpass	8	SENT_104	[p7l1115t3111r1267b3166],
4	of	IN	O	of	_	0	SENT_104	[p7l1301t3111r1366b3165],
5	alpha	NN	O	alpha	nn	6	SENT_104	[p7l1391t3111r1574b3179],
6	signiﬁcance	NN	O	signiﬁcance	prep_of	3	SENT_104	[p7l1608t3111r1990b3179],
7	was	VBD	O	be	auxpass	8	SENT_104	[p7l2024t3129r2149b3166],
8	deﬁned	VBN	O	deﬁned	_	0	SENT_104	[p7l11t3199r250b3254],
9	as	IN	O	as	_	0	SENT_104	[p7l278t3218r344b3254],
10	P	NN	O	p	prep_as	8	SENT_104	[p7l368t3200r418b3253],
11	<	VBG	O	<	xcomp	8	SENT_104	[p7l447t3214r491b3255],
12	.05	CD	NUMBER	.05	dobj	11	SENT_104	[p7l516t3202r624b3254],
13	.	.	O	.	_	0	SENT_104	[p7l516t3202r624b3254],

1	The	DT	O	the	det	2	SENT_105	[p7l188t3289r312b3343],
2	status	NN	O	status	nsubj	6	SENT_105	[p7l345t3294r543b3343],
3	of	IN	O	of	_	0	SENT_105	[p7l576t3289r640b3343],
4	the	DT	O	the	det	5	SENT_105	[p7l661t3289r765b3343],
5	alleles	NNS	O	allele	prep_of	2	SENT_105	[p7l799t3289r1382b3357],
6	—	VBP	O	—	_	0	SENT_105	[p7l799t3289r1382b3357],
7	wild-type	JJ	O	wild-type	nsubjpass	15	SENT_105	[p7l799t3289r1382b3357],
8	or	CC	O	or	_	0	SENT_105	[p7l1414t3307r1478b3343],
9	at	IN	O	at	quantmod	11	SENT_105	[p7l1510t3294r1574b3343],
10	least	JJS	O	least	mwe	9	SENT_105	[p7l1603t3289r1759b3343],
11	one	CD	NUMBER	one	num	13	SENT_105	[p7l1789t3307r1900b3343],
12	SNP	NN	O	snp	nn	13	SENT_105	[p7l1934t3289r2152b3343],
13	—	NN	O	—	conj_or	7	SENT_105	[p7l1934t3289r2152b3343],
14	was	VBD	O	be	auxpass	15	SENT_105	[p7l9t3395r134b3431],
15	compared	VBN	O	compare	ccomp	6	SENT_105	[p7l184t3377r500b3445],
16	with	IN	O	with	_	0	SENT_105	[p7l548t3377r695b3432],
17	response	NN	O	response	nn	18	SENT_105	[p7l743t3395r1029b3445],
18	rate	NN	O	rate	prep_with	15	SENT_105	[p7l1078t3382r1227b3443],
19	,	,	O	,	_	0	SENT_105	[p7l1078t3382r1227b3443],
20	time	NN	O	time	nn	22	SENT_105	[p7l1278t3379r1423b3431],
21	to	TO	O	to	dep	22	SENT_105	[p7l1472t3382r1532b3431],
22	progression	NN	O	progression	conj_and	18	SENT_105	[p7l1582t3379r1977b3445],
23	,	,	O	,	_	0	SENT_105	[p7l1582t3379r1977b3445],
24	and	CC	O	and	_	0	SENT_105	[p7l2031t3377r2151b3431],
25	overall	JJ	O	overall	amod	26	SENT_105	[p7l11t3485r233b3539],
26	survival	NN	O	survival	conj_and	18	SENT_105	[p7l269t3485r550b3539],
27	.	.	O	.	_	0	SENT_105	[p7l269t3485r550b3539],

1	SNPs	NNS	O	snp	nsubjpass	18	SENT_106	[p7l591t3485r768b3539],
2	in	IN	O	in	_	0	SENT_106	[p7l803t3487r867b3538],
3	CYPZC8	NN	O	cypzc8	prep_in	1	SENT_106	[p7l903t3485r1194b3550],
4	,	,	O	,	_	0	SENT_106	[p7l903t3485r1194b3550],
5	GSTT1	NN	O	gstt1	prep_in	1	SENT_106	[p7l1233t3485r1486b3551],
6	,	,	O	,	_	0	SENT_106	[p7l1233t3485r1486b3551],
7	GSTP1	NN	O	gstp1	prep_in	1	SENT_106	[p7l1525t3485r1772b3549],
8	,	,	O	,	_	0	SENT_106	[p7l1525t3485r1772b3549],
9	MDR1	NN	O	mdr1	conj_and	3	SENT_106	[p7l1812t3486r2147b3551],
10	—	CD	NUMBER	—	number	11	SENT_106	[p7l1812t3486r2147b3551],
11	57	CD	NUMBER	57	dep	9	SENT_106	[p7l1812t3486r2147b3551],
12	,	,	O	,	_	0	SENT_106	[p7l1812t3486r2147b3551],
13	MDR1-62	NN	O	mdr1-62	conj_and	3	SENT_106	[p7l7t3575r337b3639],
14	,	,	O	,	_	0	SENT_106	[p7l7t3575r337b3639],
15	and	CC	O	and	_	0	SENT_106	[p7l388t3574r509b3628],
16	ERCC1	NN	O	ercc1	conj_and	3	SENT_106	[p7l547t3574r788b3628],
17	were	VBD	O	be	auxpass	18	SENT_106	[p7l835t3592r991b3628],
18	considered	VBN	O	consider	_	0	SENT_106	[p7l1034t3574r1383b3628],
19	individually	RB	O	individually	advmod	18	SENT_106	[p7l1424t3574r1820b3642],
20	for	IN	O	for	_	0	SENT_106	[p7l1860t3574r1950b3628],
21	their	PRP$	O	they	poss	22	SENT_106	[p7l1991t3574r2151b3628],
22	relationship	NN	O	relationship	prep_for	18	SENT_106	[p8l10t17r404b85],
23	to	TO	O	to	_	0	SENT_106	[p8l440t22r500b71],
24	overall	JJ	O	overall	amod	25	SENT_106	[p8l537t17r760b71],
25	survival	NN	O	survival	prep_to	18	SENT_106	[p8l798t17r1062b71],
26	and	CC	O	and	_	0	SENT_106	[p8l1099t17r1219b71],
27	time	NN	O	time	conj_and	25	SENT_106	[p8l1254t18r1400b71],
28	to	TO	O	to	_	0	SENT_106	[p8l1436t22r1496b71],
29	progression	NN	O	progression	prep_to	18	SENT_106	[p8l1533t18r1911b85],
30	in	IN	O	in	_	0	SENT_106	[p8l1946t18r2010b70],
31	the	DT	O	the	det	33	SENT_106	[p8l2046t17r2149b71],
32	univariate	JJ	O	univariate	amod	33	SENT_106	[p8l10t106r350b159],
33	analysis	NN	O	analysis	prep_in	29	SENT_106	[p8l387t105r670b173],
34	.	.	O	.	_	0	SENT_106	[p8l387t105r670b173],

1	We	PRP	O	we	nsubj	3	SENT_107	[p8l708t106r806b159],
2	also	RB	O	also	advmod	3	SENT_107	[p8l844t104r969b159],
3	analyzed	VBD	O	analyze	_	0	SENT_107	[p8l1005t105r1296b172],
4	SNPs	NNS	O	snp	dobj	3	SENT_107	[p8l1332t105r1509b159],
5	in	IN	O	in	_	0	SENT_107	[p8l1544t106r1608b158],
6	genes	NNS	O	gene	prep_in	3	SENT_107	[p8l1642t122r1825b173],
7	encoding	VBG	O	encode	partmod	6	SENT_107	[p8l1861t105r2152b173],
8	drug-metabolizing	JJ	O	drug-metabolizing	amod	9	SENT_107	[p8l11t194r611b262],
9	enzymes	NNS	O	enzyme	dobj	7	SENT_107	[p8l644t212r923b262],
10	as	IN	O	as	_	0	SENT_107	[p8l959t212r1026b248],
11	a	DT	O	a	det	12	SENT_107	[p8l1062t212r1098b248],
12	group	NN	O	group	prep_as	7	SENT_107	[p8l1132t211r1319b262],
13	and	CC	O	and	_	0	SENT_107	[p8l1355t194r1475b248],
14	SNPs	NNS	O	snp	prep_as	7	SENT_107	[p8l1510t194r1687b248],
15	in	IN	O	in	_	0	SENT_107	[p8l1721t195r1786b247],
16	multidrug	JJ	O	multidrug	amod	18	SENT_107	[p8l1819t194r2151b262],
17	resistance	NN	O	resistance	nn	18	SENT_107	[p8l10t284r340b337],
18	genes	NNS	O	gene	prep_in	7	SENT_107	[p8l381t300r563b351],
19	as	IN	O	as	_	0	SENT_107	[p8l606t301r672b337],
20	another	DT	O	another	det	21	SENT_107	[p8l715t283r969b337],
21	combination	NN	O	combination	prep_as	7	SENT_107	[p8l1009t283r1427b349],
22	,	,	O	,	_	0	SENT_107	[p8l1009t283r1427b349],
23	and	CC	O	and	_	0	SENT_107	[p8l1472t283r1592b337],
24	evaluated	VBD	O	evaluate	conj_and	3	SENT_107	[p8l1632t283r1952b337],
25	their	PRP$	O	they	poss	26	SENT_107	[p8l1991t283r2151b337],
26	impact	NN	O	impact	dobj	24	SENT_107	[p8l9t372r233b439],
27	on	IN	O	on	_	0	SENT_107	[p8l265t389r341b425],
28	overall	JJ	O	overall	amod	29	SENT_107	[p8l374t371r596b425],
29	survival	NN	O	survival	prep_on	24	SENT_107	[p8l631t371r896b425],
30	and	CC	O	and	_	0	SENT_107	[p8l929t370r1049b425],
31	time	NN	O	time	prep_on	24	SENT_107	[p8l1081t372r1226b425],
32	to	TO	O	to	_	0	SENT_107	[p8l1259t375r1319b425],
33	progression	NN	O	progression	prep_to	24	SENT_107	[p8l1353t372r1747b439],
34	.	.	O	.	_	0	SENT_107	[p8l1353t372r1747b439],

1	Finally	RB	O	finally	advmod	4	SENT_108	[p8l1783t371r2026b439],
2	,	,	O	,	_	0	SENT_108	[p8l1783t371r2026b439],
3	we	PRP	O	we	nsubj	4	SENT_108	[p8l2061t389r2149b425],
4	selected	VBD	O	select	_	0	SENT_108	[p8l12t460r270b514],
5	patients	NNS	O	patient	dobj	4	SENT_108	[p8l307t461r573b528],
6	with	IN	O	with	_	0	SENT_108	[p8l609t460r757b514],
7	two	CD	NUMBER	two	num	11	SENT_108	[p8l793t465r909b514],
8	or	CC	O	or	_	0	SENT_108	[p8l948t478r1012b514],
9	more	JJR	O	more	num	11	SENT_108	[p8l1049t478r1212b514],
10	accumulated	VBN	O	accumulate	amod	11	SENT_108	[p8l1251t460r1667b514],
11	SNPs	NNS	O	snp	prep_with	4	SENT_108	[p8l1705t460r1882b514],
12	for	IN	O	for	_	0	SENT_108	[p8l1920t460r2010b514],
13	the	DT	O	the	det	15	SENT_108	[p8l2045t460r2149b514],
14	same	JJ	O	same	amod	15	SENT_108	[p8l12t567r177b603],
15	evaluation	NN	O	evaluation	prep_for	11	SENT_108	[p8l205t548r565b603],
16	.	.	O	.	_	0	SENT_108	[p8l205t548r565b603],

1	Both	DT	O	both	det	6	SENT_109	[p8l189t637r344b691],
2	univariate	JJ	O	univariate	amod	6	SENT_109	[p8l372t638r712b691],
3	and	CC	O	and	_	0	SENT_109	[p8l743t637r863b691],
4	multivariate	JJ	O	multivariate	amod	6	SENT_109	[p8l891t637r1301b691],
5	Cox	NN	O	cox	nn	6	SENT_109	[p8l1331t637r1454b691],
6	regression	NN	O	regression	nsubjpass	8	SENT_109	[p8l1480t638r1819b705],
7	was	VBD	O	be	auxpass	8	SENT_109	[p8l1846t655r1971b691],
8	used	VBN	O	use	_	0	SENT_109	[p8l2000t637r2151b691],
9	to	TO	O	to	aux	10	SENT_109	[p8l9t729r69b779],
10	analyze	VB	O	analyze	xcomp	8	SENT_109	[p8l99t724r347b793],
11	factors	NNS	O	factor	dobj	10	SENT_109	[p8l374t725r594b779],
12	potentially	RB	O	potentially	advmod	13	SENT_109	[p8l622t725r976b793],
13	affecting	VBG	O	affect	partmod	11	SENT_109	[p8l1003t725r1287b793],
14	overall	JJ	O	overall	amod	15	SENT_109	[p8l1313t725r1535b779],
15	survival	NN	O	survival	dobj	13	SENT_109	[p8l1564t724r1845b779],
16	.	.	O	.	_	0	SENT_109	[p8l1564t724r1845b779],

1	The	DT	O	the	dep	118	SENT_110	[p8l1876t725r2000b779],
2	Cox	NN	O	cox	dep	118	SENT_110	[p8l2029t725r2151b779],
3	multivariate	JJ	O	multivariate	dep	118	SENT_110	[p8l10t813r419b867],
4	analysis	NN	O	analysis	dep	118	SENT_110	[p8l472t813r738b881],
5	(	CD	NUMBER	(	dep	118	SENT_110	[p8l788t813r1068b875],
6	forward	RB	O	forward	dep	118	SENT_110	[p8l788t813r1068b875],
7	likelihood	NN	O	likelihood	dep	118	SENT_110	[p8l1117t813r1437b867],
8	ratio	NN	O	ratio	dep	118	SENT_110	[p8l1486t815r1640b867],
9	(	CD	NUMBER	(	dep	118	SENT_110	[p8l1691t814r1833b875],
10	LR	NN	O	lr	dep	118	SENT_110	[p8l1691t814r1833b875],
11	)	NN	O	)	dep	118	SENT_110	[p8l1691t814r1833b875],
12	method	NN	O	method	dep	118	SENT_110	[p8l1883t813r2149b875],
13	)	NN	O	)	dep	118	SENT_110	[p8l1883t813r2149b875],
14	included	VBD	O	include	dep	118	SENT_110	[p8l9t902r289b957],
15	prognostic	JJ	O	prognostic	dep	118	SENT_110	[p8l317t904r655b970],
16	variables	NNS	O	variable	dep	118	SENT_110	[p8l682t902r980b957],
17	as	IN	O	as	dep	118	SENT_110	[p8l1012t921r1078b957],
18	age	NN	O	age	dep	118	SENT_110	[p8l1109t920r1218b970],
19	(	CD	NUMBER	(	dep	118	SENT_110	[p8l1248t903r1346b964],
20	60	CD	DURATION	60	dep	118	SENT_110	[p8l1248t903r1346b964],
21	years	NNS	NUMBER	year	dep	118	SENT_110	[p8l1374t921r1550b970],
22	or	CC	O	or	dep	118	SENT_110	[p8l1579t921r1644b957],
23	more	JJR	O	more	dep	118	SENT_110	[p8l1672t921r1835b957],
24	vs.	CC	O	vs.	dep	118	SENT_110	[p8l1863t921r1948b957],
25	59	CD	NUMBER	59	dep	118	SENT_110	[p8l1983t904r2056b957],
26	or	CC	O	or	dep	118	SENT_110	[p8l2086t921r2151b957],
27	less	JJR	O	less	dep	118	SENT_110	[p8l9t992r171b1058],
28	)	NN	O	)	dep	118	SENT_110	[p8l9t992r171b1058],
29	,	,	O	,	_	0	SENT_110	[p8l9t992r171b1058],
30	performance	NN	O	performance	dep	118	SENT_110	[p8l217t992r626b1060],
31	status	NN	O	status	dep	118	SENT_110	[p8l671t997r870b1046],
32	(	NN	O	(	dep	118	SENT_110	[p8l913t992r970b1054],
33	1	CD	NUMBER	1	dep	118	SENT_110	[p8l913t992r970b1054],
34	vs.	CC	O	vs.	dep	118	SENT_110	[p8l1014t1010r1099b1046],
35	2	CD	NUMBER	2	dep	118	SENT_110	[p8l1147t992r1224b1058],
36	)	NN	O	)	dep	118	SENT_110	[p8l1147t992r1224b1058],
37	,	,	O	,	_	0	SENT_110	[p8l1147t992r1224b1058],
38	gender	NN	O	gender	dep	118	SENT_110	[p8l1269t992r1493b1060],
39	(	NN	O	(	dep	118	SENT_110	[p8l1536t992r1716b1054],
40	male	JJ	O	male	dep	118	SENT_110	[p8l1536t992r1716b1054],
41	vs.	CC	O	vs.	dep	118	SENT_110	[p8l1758t1010r1843b1046],
42	female	JJ	O	female	dep	118	SENT_110	[p8l1889t992r2148b1058],
43	)	NN	O	)	dep	118	SENT_110	[p8l1889t992r2148b1058],
44	,	,	O	,	_	0	SENT_110	[p8l1889t992r2148b1058],
45	stage	NN	O	stage	dep	118	SENT_110	[p8l12t1085r180b1148],
46	(	CD	NUMBER	(	dep	118	SENT_110	[p8l208t1081r312b1142],
47	IV	CD	NUMBER	iv	dep	118	SENT_110	[p8l208t1081r312b1142],
48	B	NN	O	b	dep	118	SENT_110	[p8l336t1081r401b1146],
49	,	,	O	,	_	0	SENT_110	[p8l336t1081r401b1146],
50	inoperable	JJ	O	inoperable	dep	118	SENT_110	[p8l431t1080r792b1148],
51	,	,	O	,	_	0	SENT_110	[p8l431t1080r792b1148],
52	T4b	NN	O	t4b	dep	118	SENT_110	[p8l821t1080r945b1135],
53	vs.	CC	O	vs.	dep	118	SENT_110	[p8l971t1098r1057b1135],
54	stage	NN	O	stage	dep	118	SENT_110	[p8l1090t1085r1258b1148],
55	IV	CD	NUMBER	iv	dep	118	SENT_110	[p8l1287t1081r1366b1135],
56	C	NN	O	c	dep	118	SENT_110	[p8l1392t1080r1456b1147],
57	,	,	O	,	_	0	SENT_110	[p8l1392t1080r1456b1147],
58	metastatic	JJ	O	metastatic	dep	118	SENT_110	[p8l1485t1080r1870b1146],
59	)	NN	O	)	dep	118	SENT_110	[p8l1485t1080r1870b1146],
60	,	,	O	,	_	0	SENT_110	[p8l1485t1080r1870b1146],
61	or	CC	O	or	dep	118	SENT_110	[p8l1901t1098r1966b1134],
62	polymorphism	NN	O	polymorphism	dep	118	SENT_110	[p8l1992t1080r2149b1148, p8l10t1169r340b1237],
63	status	NN	O	status	dep	118	SENT_110	[p8l370t1174r568b1224],
64	of	IN	O	of	dep	118	SENT_110	[p8l596t1169r661b1224],
65	each	DT	O	each	dep	118	SENT_110	[p8l680t1169r827b1224],
66	studied	VBN	O	study	dep	118	SENT_110	[p8l856t1169r1096b1224],
67	gene	NN	O	gene	dep	118	SENT_110	[p8l1122t1187r1272b1237],
68	(	CD	NUMBER	(	dep	118	SENT_110	[p8l1301t1169r1627b1237],
69	wild-type	JJ	O	wild-type	dep	118	SENT_110	[p8l1301t1169r1627b1237],
70	vs.	IN	O	vs.	dep	118	SENT_110	[p8l1654t1188r1740b1224],
71	one	CD	NUMBER	one	dep	118	SENT_110	[p8l1772t1188r1883b1224],
72	SNP	NN	O	snp	dep	118	SENT_110	[p8l1913t1169r2059b1224],
73	or	CC	O	or	dep	118	SENT_110	[p8l2086t1188r2151b1224],
74	vs.	FW	O	vs.	dep	118	SENT_110	[p8l9t1277r94b1313],
75	two	CD	NUMBER	two	dep	118	SENT_110	[p8l125t1264r240b1313],
76	or	CC	O	or	dep	118	SENT_110	[p8l268t1277r333b1313],
77	more	JJR	O	more	dep	118	SENT_110	[p8l358t1277r521b1313],
78	accumulated	VBN	O	accumulate	dep	118	SENT_110	[p8l550t1259r966b1313],
79	SNPs	NNS	O	snp	dep	118	SENT_110	[p8l993t1259r1194b1320],
80	)	CD	NUMBER	)	dep	118	SENT_110	[p8l993t1259r1194b1320],
81	and	CC	O	and	dep	118	SENT_110	[p8l1223t1259r1343b1313],
82	number	NN	O	number	dep	118	SENT_110	[p8l1370t1259r1625b1313],
83	of	IN	O	of	dep	118	SENT_110	[p8l1651t1259r1716b1313],
84	accumulated	VBN	O	accumulate	dep	118	SENT_110	[p8l1735t1259r2150b1313],
85	SNPs	NNS	O	snp	dep	118	SENT_110	[p8l12t1346r189b1401],
86	(	CD	NUMBER	(	dep	118	SENT_110	[p8l242t1346r568b1414],
87	wild-type	JJ	O	wild-type	dep	118	SENT_110	[p8l242t1346r568b1414],
88	or	CC	O	or	dep	118	SENT_110	[p8l621t1364r685b1400],
89	one	CD	NUMBER	one	dep	118	SENT_110	[p8l736t1364r847b1400],
90	SNP	NN	O	snp	dep	118	SENT_110	[p8l901t1346r1046b1400],
91	vs.	IN	O	vs.	dep	118	SENT_110	[p8l1096t1364r1181b1401],
92	two	CD	NUMBER	two	dep	118	SENT_110	[p8l1236t1351r1352b1401],
93	or	CC	O	or	dep	118	SENT_110	[p8l1404t1364r1469b1400],
94	more	JJR	O	more	dep	118	SENT_110	[p8l1519t1364r1682b1400],
95	accumulated	VBN	O	accumulate	dep	118	SENT_110	[p8l1735t1346r2150b1400],
96	SNPs	NNS	O	snp	dep	118	SENT_110	[p8l12t1435r231b1501],
97	)	CD	NUMBER	)	dep	118	SENT_110	[p8l12t1435r231b1501],
98	,	,	O	,	_	0	SENT_110	[p8l12t1435r231b1501],
99	using	VBG	O	use	dep	118	SENT_110	[p8l259t1437r440b1503],
100	an	DT	O	a	dep	118	SENT_110	[p8l465t1453r545b1489],
101	input	NN	O	input	dep	118	SENT_110	[p8l570t1437r747b1503],
102	variable	JJ	O	variable	dep	118	SENT_110	[p8l771t1435r1037b1490],
103	criterion	NN	O	criterion	dep	118	SENT_110	[p8l1065t1437r1345b1489],
104	(	CD	NUMBER	(	dep	118	SENT_110	[p8l1371t1436r1440b1497],
105	P	NN	O	p	dep	118	SENT_110	[p8l1371t1436r1440b1497],
106	<	JJR	O	<	dep	118	SENT_110	[p8l1469t1449r1513b1491],
107	.05	CD	NUMBER	.05	dep	118	SENT_110	[p8l1538t1436r1653b1497],
108	)	NN	O	)	dep	118	SENT_110	[p8l1538t1436r1653b1497],
109	and	CC	O	and	dep	118	SENT_110	[p8l1682t1435r1802b1489],
110	an	DT	O	a	dep	118	SENT_110	[p8l1829t1453r1908b1489],
111	output	NN	O	output	dep	118	SENT_110	[p8l1935t1440r2152b1503],
112	variable	JJ	O	variable	dep	118	SENT_110	[p8l9t1525r275b1579],
113	criterion	NN	O	criterion	dep	118	SENT_110	[p8l303t1526r582b1579],
114	(	CD	NUMBER	(	dep	118	SENT_110	[p8l609t1525r678b1586],
115	P	NN	O	p	dep	118	SENT_110	[p8l609t1525r678b1586],
116	>	JJR	O	>	dep	118	SENT_110	[p8l707t1539r751b1580],
117	.10	CD	NUMBER	.10	dep	118	SENT_110	[p8l776t1525r908b1586],
118	)	NN	O	)	_	0	SENT_110	[p8l776t1525r908b1586],
119	.	.	O	.	_	0	SENT_110	[p8l776t1525r908b1586],

1	Laryngoscope	NN	O	laryngoscope	_	0	SENT_111	[p8l14t1747r518b1821],
2	119	CD	NUMBER	119	num	1	SENT_111	[p8l553t1747r696b1805],
3	:	:	O	:	_	0	SENT_111	[p8l553t1747r696b1805],
4	August	NNP	DATE	August	dep	1	SENT_111	[p8l729t1747r979b1821],
5	2009	CD	DATE	2009	num	4	SENT_111	[p8l1010t1747r1182b1805],

1	RESULTS	NNS	O	result	_	0	SENT_112	[p8l11t1998r442b2062],

1	Patient	NN	O	patient	nn	2	SENT_113	[p8l6t2149r333b2212],
2	Characteristics	NNS	O	characteristic	_	0	SENT_113	[p8l364t2148r1036b2212],
3	and	CC	O	and	_	0	SENT_113	[p8l1069t2148r1239b2212],
4	Response	NN	O	response	conj_and	2	SENT_113	[p8l1264t2150r1663b2228],

1	Forty-seven	CD	NUMBER	forty-seven	num	3	SENT_114	[p8l190t2250r628b2325],
2	consecutive	JJ	O	consecutive	amod	3	SENT_114	[p8l684t2250r1106b2309],
3	patients	NNS	O	patient	nsubjpass	26	SENT_114	[p8l1163t2250r1462b2325],
4	(	IN	O	(	_	0	SENT_114	[p8l1519t2249r1628b2318],
5	43	CD	NUMBER	43	num	6	SENT_114	[p8l1519t2249r1628b2318],
6	male	NN	O	male	prep_(	3	SENT_114	[p8l1686t2249r1862b2309],
7	and	CC	O	and	_	0	SENT_114	[p8l1920t2249r2056b2309],
8	4	CD	NUMBER	4	num	9	SENT_114	[p8l2111t2251r2152b2308],
9	female	NN	O	female	prep_(	3	SENT_114	[p8l11t2345r276b2420],
10	;	:	O	;	_	0	SENT_114	[p8l11t2345r276b2420],
11	median	NN	O	median	nn	12	SENT_114	[p8l304t2345r576b2406],
12	age	NN	O	age	dep	6	SENT_114	[p8l604t2365r746b2421],
13	,	,	O	,	_	0	SENT_114	[p8l604t2365r746b2421],
14	57	CD	DURATION	57	num	15	SENT_114	[p8l777t2348r859b2406],
15	years	NNS	NUMBER	year	appos	12	SENT_114	[p8l884t2366r1103b2421],
16	,	,	O	,	_	0	SENT_114	[p8l884t2366r1103b2421],
17	range	NN	O	range	appos	12	SENT_114	[p8l1131t2365r1361b2421],
18	,	,	O	,	_	0	SENT_114	[p8l1131t2365r1361b2421],
19	46	CD	DURATION	46	number	20	SENT_114	[p8l1390t2348r1474b2406],
20	years	NNS	NUMBER	year	num	23	SENT_114	[p8l1499t2366r1697b2421],
21	to	TO	O	to	dep	20	SENT_114	[p8l1723t2351r1790b2406],
22	80	CD	DURATION	80	number	20	SENT_114	[p8l1818t2348r1901b2406],
23	years	NNS	NUMBER	year	appos	12	SENT_114	[p8l1926t2346r2151b2421],
24	)	CD	NUMBER	)	dep	23	SENT_114	[p8l1926t2346r2151b2421],
25	were	VBD	O	be	auxpass	26	SENT_114	[p8l10t2462r186b2503],
26	included	VBN	O	include	_	0	SENT_114	[p8l214t2442r528b2503],
27	in	IN	O	in	_	0	SENT_114	[p8l554t2444r626b2502],
28	the	DT	O	the	det	29	SENT_114	[p8l652t2442r769b2503],
29	study	NN	O	study	prep_in	26	SENT_114	[p8l799t2442r1010b2518],
30	.	.	O	.	_	0	SENT_114	[p8l799t2442r1010b2518],

1	All	DT	O	all	nsubj	3	SENT_115	[p8l1039t2442r1146b2502],
2	were	VBD	O	be	cop	3	SENT_115	[p8l1172t2462r1348b2503],
3	Caucasian	JJ	MISC	caucasian	_	0	SENT_115	[p8l1377t2442r1778b2503],
4	.	.	O	.	_	0	SENT_115	[p8l1377t2442r1778b2503],

1	The	DT	O	the	det	5	SENT_116	[p8l1809t2442r1948b2503],
2	most	RBS	O	most	advmod	3	SENT_116	[p8l1976t2447r2153b2503],
3	frequent	JJ	O	frequent	amod	5	SENT_116	[p8l11t2540r326b2615],
4	tumor	NN	O	tumor	nn	5	SENT_116	[p8l349t2545r574b2600],
5	locations	NNS	O	location	nsubj	11	SENT_116	[p8l597t2540r921b2600],
6	were	VBD	O	be	cop	11	SENT_116	[p8l946t2560r1122b2600],
7	the	DT	O	the	det	11	SENT_116	[p8l1146t2540r1263b2600],
8	oral	JJ	O	oral	amod	11	SENT_116	[p8l1289t2540r1430b2600],
9	cavity	NN	O	cavity	nn	11	SENT_116	[p8l1455t2541r1676b2615],
10	(	NN	O	(	nn	11	SENT_116	[p8l1700t2540r1772b2609],
11	n	NN	O	n	_	0	SENT_116	[p8l1700t2540r1772b2609],
12	:	:	O	:	_	0	SENT_116	[p8l1799t2569r1853b2588],
13	12	CD	NUMBER	12	num	14	SENT_116	[p8l1885t2540r1990b2609],
14	)	NN	O	)	conj_and	11	SENT_116	[p8l1885t2540r1990b2609],
15	and	CC	O	and	_	0	SENT_116	[p8l2017t2540r2152b2600],
16	the	DT	O	the	det	19	SENT_116	[p8l11t2636r127b2697],
17	oropharynx	NN	O	oropharynx	nn	19	SENT_116	[p8l174t2636r599b2712],
18	(	NN	O	(	nn	19	SENT_116	[p8l644t2637r716b2706],
19	n	NN	O	n	conj_and	14	SENT_116	[p8l644t2637r716b2706],
20	:	:	O	:	_	0	SENT_116	[p8l762t2666r816b2685],
21	12	CD	NUMBER	12	num	22	SENT_116	[p8l868t2637r994b2711],
22	)	NN	O	)	dep	14	SENT_116	[p8l868t2637r994b2711],
23	;	:	O	;	_	0	SENT_116	[p8l868t2637r994b2711],
24	other	JJ	O	other	amod	25	SENT_116	[p8l1042t2636r1236b2697],
25	sites	NNS	O	site	nsubj	29	SENT_116	[p8l1281t2638r1444b2697],
26	were	VBD	O	be	cop	29	SENT_116	[p8l1489t2657r1664b2697],
27	supraglottis	JJ	O	supraglottis	amod	29	SENT_116	[p8l1712t2636r2151b2712],
28	(	NN	O	(	nn	29	SENT_116	[p8l12t2733r84b2802],
29	n	NN	O	n	dep	22	SENT_116	[p8l12t2733r84b2802],
30	:	:	O	:	_	0	SENT_116	[p8l117t2763r171b2782],
31	10	CD	NUMBER	10	num	32	SENT_116	[p8l209t2733r334b2807],
32	)	NN	O	)	conj_and	11	SENT_116	[p8l209t2733r334b2807],
33	,	,	O	,	_	0	SENT_116	[p8l209t2733r334b2807],
34	hypopharynx	NN	O	hypopharynx	nn	36	SENT_116	[p8l367t2733r856b2809],
35	(	NN	O	(	nn	36	SENT_116	[p8l887t2733r959b2802],
36	n	NN	O	n	appos	32	SENT_116	[p8l887t2733r959b2802],
37	:	:	O	:	_	0	SENT_116	[p8l991t2763r1045b2782],
38	7	CD	NUMBER	7	num	39	SENT_116	[p8l1080t2733r1165b2807],
39	)	NN	O	)	dep	11	SENT_116	[p8l1080t2733r1165b2807],
40	,	,	O	,	_	0	SENT_116	[p8l1080t2733r1165b2807],
41	and	CC	O	and	_	0	SENT_116	[p8l1200t2733r1335b2794],
42	glottis	NN	O	glottis	nn	44	SENT_116	[p8l1364t2733r1593b2809],
43	(	NN	O	(	nn	44	SENT_116	[p8l1625t2733r1697b2802],
44	n	NN	O	n	conj_and	11	SENT_116	[p8l1625t2733r1697b2802],
45	=	JJ	O	=	amod	47	SENT_116	[p8l1729t2763r1783b2782],
46	6	CD	NUMBER	6	tmod	45	SENT_116	[p8l1817t2733r1901b2802],
47	)	NN	O	)	dep	44	SENT_116	[p8l1817t2733r1901b2802],
48	.	.	O	.	_	0	SENT_116	[p8l1817t2733r1901b2802],

1	Other	JJ	O	other	amod	3	SENT_117	[p8l1937t2733r2153b2794],
2	patient	NN	O	patient	nn	3	SENT_117	[p8l11t2832r276b2906],
3	characteristics	NNS	O	characteristic	nsubjpass	5	SENT_117	[p8l310t2831r849b2891],
4	are	VBP	O	be	auxpass	5	SENT_117	[p8l886t2851r1001b2891],
5	included	VBN	O	include	_	0	SENT_117	[p8l1036t2831r1350b2891],
6	in	IN	O	in	_	0	SENT_117	[p8l1384t2832r1456b2890],
7	Table	NNP	O	Table	nn	8	SENT_117	[p8l1490t2831r1689b2891],
8	II	NNP	O	II	prep_in	5	SENT_117	[p8l1726t2832r1805b2891],
9	.	.	O	.	_	0	SENT_117	[p8l1726t2832r1805b2891],

1	No	DT	O	no	det	3	SENT_118	[p8l1844t2832r1945b2891],
2	complete	JJ	O	complete	amod	3	SENT_118	[p8l1981t2851r2150b2891, p8l11t2927r189b3003],
3	response	NN	O	response	nsubjpass	5	SENT_118	[p8l245t2948r567b3003],
4	was	VBD	O	be	auxpass	5	SENT_118	[p8l622t2948r763b2988],
5	observed	VBN	O	observe	_	0	SENT_118	[p8l819t2927r1160b2988],
6	.	.	O	.	_	0	SENT_118	[p8l819t2927r1160b2988],

1	A	DT	O	a	det	3	SENT_119	[p8l1218t2927r1277b2987],
2	partial	JJ	O	partial	amod	3	SENT_119	[p8l1331t2927r1578b3003],
3	response	NN	O	response	nsubjpass	5	SENT_119	[p8l1634t2948r1955b3003],
4	was	VBD	O	be	auxpass	5	SENT_119	[p8l2010t2948r2151b2988],
5	observed	VBN	O	observe	_	0	SENT_119	[p8l12t3024r336b3085],
6	in	IN	O	in	_	0	SENT_119	[p8l369t3026r441b3084],
7	21	CD	NUMBER	21	num	8	SENT_119	[p8l475t3026r558b3084],
8	patients	NNS	O	patient	prep_in	5	SENT_119	[p8l594t3026r894b3100],
9	(	IN	O	(	_	0	SENT_119	[p8l930t3024r1264b3093],
10	44.68	CD	PERCENT	44.68	num	11	SENT_119	[p8l930t3024r1264b3093],
11	%	NN	PERCENT	%	prep_(	5	SENT_119	[p8l930t3024r1264b3093],
12	)	CD	NUMBER	)	dep	11	SENT_119	[p8l930t3024r1264b3093],
13	.	.	O	.	_	0	SENT_119	[p8l930t3024r1264b3093],

1	After	IN	O	after	_	0	SENT_120	[p8l1301t3024r1493b3085],
2	a	DT	O	a	det	5	SENT_120	[p8l1527t3044r1568b3085],
3	median	JJ	O	median	amod	5	SENT_120	[p8l1601t3024r1874b3085],
4	followup	JJ	O	followup	amod	5	SENT_120	[p8l1908t3024r2151b3085, p8l11t3142r103b3198],
5	period	NN	O	period	prep_after	12	SENT_120	[p8l137t3122r367b3198],
6	of	IN	O	of	_	0	SENT_120	[p8l401t3122r475b3182],
7	5.7	CD	DURATION	5.7	num	8	SENT_120	[p8l500t3124r604b3182],
8	months	NNS	NUMBER	month	prep_of	5	SENT_120	[p8l640t3122r934b3195],
9	,	,	O	,	_	0	SENT_120	[p8l640t3122r934b3195],
10	disease	NN	O	disease	nn	11	SENT_120	[p8l972t3122r1236b3182],
11	progression	NN	O	progression	nsubj	12	SENT_120	[p8l1271t3123r1697b3198],
12	occurred	VBD	O	occur	_	0	SENT_120	[p8l1731t3122r2047b3182],
13	in	IN	O	in	_	0	SENT_120	[p8l2080t3123r2152b3181],
14	43	CD	NUMBER	43	num	15	SENT_120	[p8l11t3221r94b3279],
15	patients	NNS	O	patient	prep_in	12	SENT_120	[p8l137t3220r436b3294],
16	(	IN	O	(	_	0	SENT_120	[p8l477t3218r1045b3288],
17	91.49	CD	PERCENT	91.49	num	18	SENT_120	[p8l477t3218r1045b3288],
18	%	NN	PERCENT	%	prep_(	12	SENT_120	[p8l477t3218r1045b3288],
19	)	CD	NUMBER	)	dep	18	SENT_120	[p8l477t3218r1045b3288],
20	.	.	O	.	_	0	SENT_120	[p8l477t3218r1045b3288],

1	—	NN	O	—	_	0	SENT_121	[p8l477t3218r1045b3288],
2	.	.	O	.	_	0	SENT_121	[p8l477t3218r1045b3288],

1	local	JJ	O	local	_	0	SENT_122	[p8l477t3218r1045b3288],
2	in	IN	O	in	_	0	SENT_122	[p8l1084t3220r1156b3278],
3	26	CD	NUMBER	26	prep_in	1	SENT_122	[p8l1196t3221r1280b3279],
4	and	CC	O	and	_	0	SENT_122	[p8l1322t3218r1457b3279],
5	metastatic	JJ	O	metastatic	conj_and	1	SENT_122	[p8l1497t3220r1884b3279],
6	in	IN	O	in	_	0	SENT_122	[p8l1923t3220r1995b3278],
7	the	DT	O	the	det	9	SENT_122	[p8l2034t3218r2151b3279],
8	other	JJ	O	other	amod	9	SENT_122	[p8l12t3315r206b3376],
9	17	CD	NUMBER	17	prep_in	5	SENT_122	[p8l247t3317r345b3376],
10	.	.	O	.	_	0	SENT_122	[p8l247t3317r345b3376],

1	The	DT	O	the	det	3	SENT_123	[p8l385t3315r524b3376],
2	median	JJ	O	median	amod	3	SENT_123	[p8l562t3315r835b3376],
3	time	NN	O	time	nsubj	10	SENT_123	[p8l871t3317r1034b3376],
4	to	TO	O	to	_	0	SENT_123	[p8l1072t3320r1139b3376],
5	progression	NN	O	progression	prep_to	3	SENT_123	[p8l1177t3317r1604b3391],
6	in	IN	O	in	_	0	SENT_123	[p8l1639t3317r1711b3375],
7	responders	NNS	O	responder	prep_in	5	SENT_123	[p8l1747t3315r2150b3391],
8	was	VBD	O	be	cop	10	SENT_123	[p8l10t3434r151b3474],
9	5.1	CD	DURATION	5.1	num	10	SENT_123	[p8l190t3416r294b3474],
10	months	NNS	NUMBER	month	_	0	SENT_123	[p8l333t3414r606b3474],
11	(	JJ	O	(	amod	12	SENT_123	[p8l645t3414r900b3489],
12	range	NN	O	range	attr	10	SENT_123	[p8l645t3414r900b3489],
13	,	,	O	,	_	0	SENT_123	[p8l645t3414r900b3489],
14	1	CD	DURATION	1	num	15	SENT_123	[p8l946t3416r978b3473],
15	month	NN	NUMBER	month	appos	12	SENT_123	[p8l1017t3414r1255b3474],
16	to	TO	O	to	_	0	SENT_123	[p8l1291t3419r1359b3474],
17	34	CD	DURATION	34	num	18	SENT_123	[p8l1397t3416r1481b3474],
18	months	NNS	NUMBER	month	prep_to	15	SENT_123	[p8l1518t3414r1837b3483],
19	)	RB	O	)	advmod	18	SENT_123	[p8l1518t3414r1837b3483],
20	.	.	O	.	_	0	SENT_123	[p8l1518t3414r1837b3483],

1	Overall	JJ	O	overall	amod	2	SENT_124	[p8l1880t3414r2152b3474],
2	survival	NN	O	survival	nsubj	8	SENT_124	[p8l13t3510r312b3571],
3	for	IN	O	for	_	0	SENT_124	[p8l335t3510r435b3571],
4	all	DT	O	all	det	5	SENT_124	[p8l460t3510r549b3571],
5	patients	NNS	O	patient	prep_for	2	SENT_124	[p8l573t3512r872b3586],
6	was	VBD	O	be	cop	8	SENT_124	[p8l896t3531r1036b3571],
7	5.6	CD	DURATION	5.6	num	8	SENT_124	[p8l1063t3513r1168b3571],
8	months	NNS	NUMBER	month	_	0	SENT_124	[p8l1192t3510r1484b3571],
9	.	.	O	.	_	0	SENT_124	[p8l1192t3510r1484b3571],

1	Genotype	NN	O	genotype	nn	2	SENT_125	[p9l12t87r405b167],
2	Frequencies	NNS	O	frequency	_	0	SENT_125	[p9l433t87r959b167],

1	The	DT	O	the	det	3	SENT_126	[p9l190t188r329b248],
2	SNP	NN	O	snp	nn	3	SENT_126	[p9l368t188r532b248],
3	frequencies	NNS	O	frequency	nsubj	16	SENT_126	[p9l568t188r988b264],
4	according	VBG	O	accord	_	0	SENT_126	[p9l1027t188r1380b264],
5	to	TO	O	to	prepc_according_to	3	SENT_126	[p9l1415t193r1482b248],
6	the	DT	O	the	det	7	SENT_126	[p9l1519t188r1635b248],
7	classiﬁcation	NN	O	classiﬁcation	pobj	3	SENT_126	[p9l1674t188r2152b248],
8	between	IN	O	between	_	0	SENT_126	[p9l10t284r316b345],
9	wild-type/non	JJ	O	wild-type/non	amod	10	SENT_126	[p9l418t284r1313b360],
10	—	NN	O	—	prep_between	7	SENT_126	[p9l418t284r1313b360],
11	wild-type	JJ	O	wild-type	amod	10	SENT_126	[p9l418t284r1313b360],
12	were	VBD	O	be	cop	16	SENT_126	[p9l1416t305r1591b345],
13	as	IN	O	as	mark	14	SENT_126	[p9l1697t305r1772b345],
14	follows	VBZ	O	follow	dep	16	SENT_126	[p9l1875t284r2148b345],
15	:	:	O	:	_	0	SENT_126	[p9l1875t284r2148b345],
16	CYP2C8	NN	O	cyp2c8	_	0	SENT_126	[p9l12t382r335b455],
17	,	,	O	,	_	0	SENT_126	[p9l12t382r335b455],
18	23/24	CD	NUMBER	23/24	appos	16	SENT_126	[p9l385t382r601b456],
19	;	:	O	;	_	0	SENT_126	[p9l385t382r601b456],
20	GSTT1	NN	O	gstt1	conj_and	16	SENT_126	[p9l645t382r925b455],
21	,	,	O	,	_	0	SENT_126	[p9l645t382r925b455],
22	45/2	CD	NUMBER	45/2	appos	20	SENT_126	[p9l975t382r1147b456],
23	;	:	O	;	_	0	SENT_126	[p9l975t382r1147b456],
24	GSTP1	NN	O	gstp1	conj_and	16	SENT_126	[p9l1191t382r1470b455],
25	,	,	O	,	_	0	SENT_126	[p9l1191t382r1470b455],
26	36/11	CD	NUMBER	36/11	appos	24	SENT_126	[p9l1520t382r1732b456],
27	;	:	O	;	_	0	SENT_126	[p9l1520t382r1732b456],
28	MDR1-62	NN	O	mdr1-62	conj_and	16	SENT_126	[p9l1770t383r2143b455],
29	,	,	O	,	_	0	SENT_126	[p9l1770t383r2143b455],
30	21/26	CD	NUMBER	21/26	appos	28	SENT_126	[p9l12t480r228b554],
31	;	:	O	;	_	0	SENT_126	[p9l12t480r228b554],
32	MDR1-57	NN	O	mdr1-57	conj_and	16	SENT_126	[p9l253t481r626b552],
33	,	,	O	,	_	0	SENT_126	[p9l253t481r626b552],
34	13/34	CD	NUMBER	13/34	appos	32	SENT_126	[p9l668t480r879b554],
35	;	:	O	;	_	0	SENT_126	[p9l668t480r879b554],
36	and	CC	O	and	_	0	SENT_126	[p9l910t480r1046b540],
37	ERCC1	NN	O	ercc1	conj_and	16	SENT_126	[p9l1067t480r1360b552],
38	,	,	O	,	_	0	SENT_126	[p9l1067t480r1360b552],
39	27/20	CD	NUMBER	27/20	appos	37	SENT_126	[p9l1396t480r1610b540],
40	.	.	O	.	_	0	SENT_126	[p9l1396t480r1610b540],

1	The	DT	O	the	det	3	SENT_127	[p9l1642t480r1781b540],
2	wild-type	JJ	O	wild-type	amod	3	SENT_127	[p9l1808t480r2151b556],
3	population	NN	O	population	nsubj	4	SENT_127	[p9l11t576r405b652],
4	comprised	VBN	O	comprise	_	0	SENT_127	[p9l429t576r803b652],
5	homozygous	JJ	O	homozygous	amod	7	SENT_127	[p9l827t576r1275b652],
6	wild-type	JJ	O	wild-type	amod	7	SENT_127	[p9l1300t576r1643b652],
7	patients	NNS	O	patient	dobj	4	SENT_127	[p9l1668t578r1988b652],
8	,	,	O	,	_	0	SENT_127	[p9l1668t578r1988b652],
9	and	CC	O	and	_	0	SENT_127	[p9l2017t576r2152b637],
10	the	DT	O	the	det	11	SENT_127	[p9l11t673r127b734],
11	non	JJ	O	non	dobj	4	SENT_127	[p9l156t673r681b749],
12	.	.	O	.	_	0	SENT_127	[p9l156t673r681b749],

1	—	NN	O	—	_	0	SENT_128	[p9l156t673r681b749],
2	.	.	O	.	_	0	SENT_128	[p9l156t673r681b749],

1	Wild-type	JJ	O	wild-type	amod	2	SENT_129	[p9l156t673r681b749],
2	population	NN	O	population	nsubj	3	SENT_129	[p9l710t673r1103b749],
3	included	VBD	O	include	_	0	SENT_129	[p9l1130t673r1445b734],
4	patients	NNS	O	patient	dobj	3	SENT_129	[p9l1472t675r1771b749],
5	who	WP	O	who	nsubj	10	SENT_129	[p9l1799t673r1948b734],
6	were	VBD	O	be	cop	8	SENT_129	[p9l1975t693r2151b734],
7	either	DT	O	either	preconj	8	SENT_129	[p9l12t771r231b831],
8	heterozygous	JJ	O	heterozygous	rcmod	4	SENT_129	[p9l255t771r740b846],
9	or	CC	O	or	_	0	SENT_129	[p9l768t791r841b831],
10	homozygous	JJ	O	homozygous	rcmod	4	SENT_129	[p9l865t771r1314b846],
11	for	IN	O	for	_	0	SENT_129	[p9l1340t771r1441b831],
12	SNP	NN	O	snp	prep_for	8	SENT_129	[p9l1468t771r1640b831],
13	.	.	O	.	_	0	SENT_129	[p9l1468t771r1640b831],

1	Complete	JJ	O	complete	amod	3	SENT_130	[p9l1672t771r2017b847],
2	genotype	NN	O	genotype	nn	3	SENT_130	[p9l2045t790r2150b846, p9l11t873r257b943],
3	frequencies	NNS	O	frequency	nsubjpass	27	SENT_130	[p9l366t867r787b943],
4	for	IN	O	for	_	0	SENT_130	[p9l896t867r997b928],
5	each	DT	O	each	det	6	SENT_130	[p9l1105t867r1271b928],
6	polymorphism	NN	O	polymorphism	prep_for	3	SENT_130	[p9l1380t867r1908b943],
7	and	CC	O	and	_	0	SENT_130	[p9l2017t867r2152b928],
8	frequencies	NNS	O	frequency	prep_for	3	SENT_130	[p9l11t964r431b1040],
9	observed	VBN	O	observe	partmod	6	SENT_130	[p9l465t964r789b1025],
10	in	IN	O	in	_	0	SENT_130	[p9l819t966r892b1024],
11	the	DT	O	the	det	13	SENT_130	[p9l923t964r1039b1025],
12	European	JJ	LOCATION	european	amod	13	SENT_130	[p9l1073t965r1433b1040],
13	population	NN	O	population	prep_in	9	SENT_130	[p9l1465t964r1858b1040],
14	according	VBG	O	accord	_	0	SENT_130	[p9l1891t964r2150b1025, p9l11t1064r128b1138],
15	to	TO	O	to	prepc_according_to	9	SENT_130	[p9l155t1068r223b1123],
16	the	DT	O	the	det	18	SENT_130	[p9l253t1063r369b1123],
17	National	NNP	ORGANIZATION	National	nn	18	SENT_130	[p9l400t1063r722b1123],
18	Center	NNP	ORGANIZATION	Center	pobj	9	SENT_130	[p9l753t1063r1003b1123],
19	for	IN	ORGANIZATION	for	_	0	SENT_130	[p9l1031t1063r1132b1123],
20	Biotechnology	NNP	ORGANIZATION	Biotechnology	nn	25	SENT_130	[p9l1162t1063r1680b1138],
21	Information	NNP	ORGANIZATION	Information	nn	25	SENT_130	[p9l1710t1063r2152b1123],
22	(	NNP	O	(	nn	25	SENT_130	[p9l12t1159r274b1228],
23	NCBI	NNP	ORGANIZATION	NCBI	nn	25	SENT_130	[p9l12t1159r274b1228],
24	)	NN	O	)	nn	25	SENT_130	[p9l12t1159r274b1228],
25	database	NN	O	database	prep_for	18	SENT_130	[p9l307t1159r633b1220],
26	are	VBP	O	be	auxpass	27	SENT_130	[p9l666t1180r781b1220],
27	shown	VBN	O	show	_	0	SENT_130	[p9l815t1159r1048b1220],
28	in	IN	O	in	_	0	SENT_130	[p9l1078t1161r1150b1219],
29	Table	NNP	O	Table	nn	30	SENT_130	[p9l1181t1159r1380b1220],
30	III	NNP	O	III	prep_in	27	SENT_130	[p9l1413t1160r1525b1220],
31	.	.	O	.	_	0	SENT_130	[p9l1413t1160r1525b1220],

1	The	DT	O	the	det	2	SENT_131	[p9l1560t1159r1699b1220],
2	frequencies	NNS	O	frequency	nsubj	11	SENT_131	[p9l1730t1159r2151b1235],
3	observed	VBN	O	observe	partmod	2	SENT_131	[p9l12t1256r336b1317],
4	in	IN	O	in	_	0	SENT_131	[p9l366t1258r438b1316],
5	GSTT1	NN	O	gstt1	prep_in	3	SENT_131	[p9l469t1256r755b1330],
6	,	,	O	,	_	0	SENT_131	[p9l469t1256r755b1330],
7	GSTP1	NN	O	gstp1	prep_in	3	SENT_131	[p9l791t1256r1075b1330],
8	,	,	O	,	_	0	SENT_131	[p9l791t1256r1075b1330],
9	and	CC	O	and	_	0	SENT_131	[p9l1111t1256r1246b1317],
10	ERCC1	NN	O	ercc1	prep_in	3	SENT_131	[p9l1272t1256r1544b1317],
11	differed	VBD	O	differ	_	0	SENT_131	[p9l1583t1256r1866b1317],
12	signiﬁcantly	RB	O	signiﬁcantly	advmod	11	SENT_131	[p9l1899t1256r2150b1332, p9l12t1354r239b1429],
13	from	IN	O	from	_	0	SENT_131	[p9l307t1354r479b1414],
14	those	DT	O	those	prep_from	11	SENT_131	[p9l547t1354r741b1414],
15	reported	VBN	O	report	partmod	14	SENT_131	[p9l811t1354r1124b1429],
16	in	IN	O	in	_	0	SENT_131	[p9l1193t1355r1265b1413],
17	the	DT	O	the	det	19	SENT_131	[p9l1334t1354r1450b1414],
18	NCBI	NN	ORGANIZATION	ncbus	nn	19	SENT_131	[p9l1520t1354r1730b1414],
19	database	NN	O	database	prep_in	15	SENT_131	[p9l1802t1354r2147b1414],
20	.	.	O	.	_	0	SENT_131	[p9l1802t1354r2147b1414],

1	However	RB	O	however	advmod	4	SENT_132	[p9l11t1452r351b1524],
2	,	,	O	,	_	0	SENT_132	[p9l11t1452r351b1524],
3	We	PRP	O	we	nsubj	4	SENT_132	[p9l379t1471r479b1511],
4	observed	VBD	O	observe	_	0	SENT_132	[p9l506t1451r829b1511],
5	no	DT	O	no	det	22	SENT_132	[p9l855t1471r940b1511],
6	statistically	RB	O	statistically	advmod	7	SENT_132	[p9l968t1451r1399b1526],
7	signiﬁcant	JJ	O	signiﬁcant	amod	22	SENT_132	[p9l1425t1451r1813b1526],
8	differences	NNS	O	difference	nsubj	14	SENT_132	[p9l1840t1451r2150b1511, p9l12t1568r120b1608],
9	in	IN	O	in	_	0	SENT_132	[p9l167t1549r239b1607],
10	the	DT	O	the	det	13	SENT_132	[p9l286t1547r403b1608],
11	other	JJ	O	other	amod	13	SENT_132	[p9l452t1547r645b1608],
12	three	CD	NUMBER	three	num	13	SENT_132	[p9l690t1547r883b1608],
13	genes	NNS	O	gene	prep_in	8	SENT_132	[p9l931t1567r1137b1623],
14	(	VBP	O	(	ccomp	7	SENT_132	[p9l1186t1547r1541b1621],
15	CYP2C8	NN	O	cyp2c8	dobj	14	SENT_132	[p9l1186t1547r1541b1621],
16	,	,	O	,	_	0	SENT_132	[p9l1186t1547r1541b1621],
17	MDR1-62	NN	O	mdr1-62	dobj	14	SENT_132	[p9l1587t1548r1960b1620],
18	,	,	O	,	_	0	SENT_132	[p9l1587t1548r1960b1620],
19	and	CC	O	and	_	0	SENT_132	[p9l2017t1547r2152b1608],
20	MDR1	NN	O	mdr1	dobj	14	SENT_132	[p9l7t1645r245b1705],
21	-57	CD	NUMBER	-57	num	22	SENT_132	[p9l255t1644r392b1713],
22	)	NN	O	)	dobj	4	SENT_132	[p9l255t1644r392b1713],
23	compared	VBN	O	compare	_	0	SENT_132	[p9l457t1644r813b1720],
24	with	IN	O	with	prepc_compared_with	4	SENT_132	[p9l875t1644r1041b1705],
25	the	DT	O	the	det	26	SENT_132	[p9l1104t1644r1220b1705],
26	frequencies	NNS	O	frequency	pobj	4	SENT_132	[p9l1285t1644r1705b1720],
27	previously	RB	DATE	previously	advmod	28	SENT_132	[p9l1769t1644r2153b1720],
28	published	VBN	O	publish	amod	26	SENT_132	[p9l11t1742r388b1817],
29	.	.	O	.	_	0	SENT_132	[p9l11t1742r388b1817],

1	TABLE	NN	O	table	_	0	SENT_133	[p9l934t1992r1146b2043],
2	II	CD	NUMBER	ii	dep	1	SENT_133	[p9l1177t1992r1223b2043],
3	.	.	O	.	_	0	SENT_133	[p9l1177t1992r1223b2043],

1	Patient	NN	O	patient	nn	2	SENT_134	[p9l715t2081r931b2133],
2	Characteristics	NNS	O	characteristic	_	0	SENT_134	[p9l959t2080r1448b2134],
3	.	.	O	.	_	0	SENT_134	[p9l959t2080r1448b2134],

1	No.	NN	O	no.	_	0	SENT_135	[p9l1882t2221r1971b2267],
2	(	CD	PERCENT	(	num	3	SENT_135	[p9l2000t2220r2089b2279],
3	%	NN	PERCENT	%	dep	1	SENT_135	[p9l2000t2220r2089b2279],
4	)	CD	NUMBER	)	dep	1	SENT_135	[p9l2000t2220r2089b2279],

1	Gender	NN	O	gender	nn	2	SENT_136	[p9l12t2378r247b2432],
2	Male	NN	O	male	dep	20	SENT_136	[p9l1240t2379r1388b2432],
3	4	CD	NUMBER	4	num	4	SENT_136	[p9l1857t2380r1893b2431],
4	(	NN	O	(	dep	2	SENT_136	[p9l1922t2378r2052b2446],
5	8.5	CD	NUMBER	8.5	number	6	SENT_136	[p9l1922t2378r2052b2446],
6	)	CD	NUMBER	)	dep	4	SENT_136	[p9l1922t2378r2052b2446],
7	Female	JJ	O	female	amod	15	SENT_136	[p9l1240t2481r1466b2533],
8	43	CD	NUMBER	43	number	9	SENT_136	[p9l1818t2481r1893b2533],
9	(	CD	NUMBER	(	num	11	SENT_136	[p9l1922t2479r2091b2547],
10	92.5	CD	NUMBER	92.5	number	11	SENT_136	[p9l1922t2479r2091b2547],
11	)	CD	NUMBER	)	npadvmod	12	SENT_136	[p9l1922t2479r2091b2547],
12	Primary	JJ	O	primary	amod	15	SENT_136	[p9l15t2583r254b2650],
13	site	NN	O	site	nn	15	SENT_136	[p9l279t2583r388b2636],
14	Oral	JJ	O	oral	amod	15	SENT_136	[p9l1237t2582r1363b2636],
15	cavity	NN	O	cavity	dep	4	SENT_136	[p9l1393t2583r1576b2650],
16	12	CD	NUMBER	12	number	17	SENT_136	[p9l1823t2584r1892b2635],
17	(	CD	NUMBER	(	num	15	SENT_136	[p9l1922t2582r2091b2649],
18	25.5	CD	NUMBER	25.5	num	19	SENT_136	[p9l1922t2582r2091b2649],
19	)	NN	O	)	dep	20	SENT_136	[p9l1922t2582r2091b2649],
20	Oropharynx	NN	O	oropharynx	dep	30	SENT_136	[p9l1237t2684r1608b2752],
21	12	CD	NUMBER	12	num	20	SENT_136	[p9l1823t2686r1892b2737],
22	(	CD	NUMBER	(	number	23	SENT_136	[p9l1922t2684r2091b2752],
23	25.5	CD	NUMBER	25.5	num	25	SENT_136	[p9l1922t2684r2091b2752],
24	)	NN	O	)	nn	25	SENT_136	[p9l1922t2684r2091b2752],
25	Supraglottis	NN	O	supraglotti	dep	20	SENT_136	[p9l1237t2785r1616b2852],
26	10	CD	NUMBER	10	num	27	SENT_136	[p9l1823t2786r1893b2838],
27	(	CD	NUMBER	(	dep	25	SENT_136	[p9l1922t2784r2073b2852],
28	21.3	CD	NUMBER	21.3	num	30	SENT_136	[p9l1922t2784r2073b2852],
29	)	NN	O	)	nn	30	SENT_136	[p9l2099t2784r2114b2852],
30	Hypopharynx	NN	O	hypopharynx	dep	39	SENT_136	[p9l1240t2888r1660b2955],
31	7	CD	NUMBER	7	dep	30	SENT_136	[p9l1859t2889r1892b2940],
32	(	CD	NUMBER	(	number	33	SENT_136	[p9l1922t2887r2073b2954],
33	14.9	CD	NUMBER	14.9	num	37	SENT_136	[p9l1922t2887r2073b2954],
34	)	NN	O	)	nn	37	SENT_136	[p9l2098t2887r2114b2954],
35	Glottis	NN	O	glottis	nn	37	SENT_136	[p9l1238t2989r1439b3043],
36	6	CD	NUMBER	6	num	37	SENT_136	[p9l1858t2991r1893b3043],
37	(	NN	O	(	dep	31	SENT_136	[p9l1922t2989r2074b3057],
38	12.8	CD	NUMBER	12.8	num	39	SENT_136	[p9l1922t2989r2074b3057],
39	)	NN	O	)	_	0	SENT_136	[p9l2098t2989r2114b3057],

1	Performance	NNP	O	Performance	dep	7	SENT_137	[p9l15t3091r418b3144],
2	status	NN	O	status	nn	3	SENT_137	[p9l445t3095r635b3144],
3	o	NN	O	o	dep	1	SENT_137	[p9l1237t3092r1272b3144],
4	1	CD	NUMBER	1	num	5	SENT_137	[p9l1861t3092r1881b3144],
5	(	NN	O	(	dep	7	SENT_137	[p9l1922t3090r2052b3158],
6	2.1	CD	NUMBER	2.1	num	7	SENT_137	[p9l1922t3090r2052b3158],
7	)	NN	O	)	dep	12	SENT_137	[p9l1922t3090r2052b3158],
8	1	CD	NUMBER	1	number	9	SENT_137	[p9l1241t3195r1260b3245],
9	37	CD	NUMBER	37	dep	7	SENT_137	[p9l1818t3195r1893b3246],
10	(	CD	NUMBER	(	num	11	SENT_137	[p9l1922t3193r2091b3259],
11	78.7	CD	NUMBER	78.7	dep	9	SENT_137	[p9l1922t3193r2091b3259],
12	)	NN	O	)	dep	15	SENT_137	[p9l1922t3193r2091b3259],
13	2	CD	NUMBER	2	num	12	SENT_137	[p9l1236t3295r1270b3346],
14	9	CD	NUMBER	9	num	15	SENT_137	[p9l1858t3295r1892b3347],
15	(	NN	O	(	dep	17	SENT_137	[p9l1922t3293r2091b3361],
16	19.1	CD	NUMBER	19.1	num	17	SENT_137	[p9l1922t3293r2091b3361],
17	)	NN	O	)	_	0	SENT_137	[p9l1922t3293r2091b3361],

1	Stage	NN	O	stage	nn	3	SENT_138	[p9l12t3394r195b3461],
2	IV	CD	NUMBER	iv	num	3	SENT_138	[p9l1240t3395r1297b3447],
3	B	NN	O	b	_	0	SENT_138	[p9l1326t3395r1367b3447],
4	29	CD	NUMBER	29	number	5	SENT_138	[p9l1818t3395r1893b3447],
5	(	CD	NUMBER	(	dep	3	SENT_138	[p9l1922t3393r2151b3461],
6	61.7.2	CD	NUMBER	61.7.2	num	7	SENT_138	[p9l1922t3393r2151b3461],
7	)	NN	O	)	dep	5	SENT_138	[p9l1922t3393r2151b3461],

1	IV	CD	NUMBER	iv	num	2	SENT_139	[p9l1240t3497r1297b3549],
2	C	NN	O	c	_	0	SENT_139	[p9l1323t3496r1370b3550],
3	18	CD	NUMBER	18	number	4	SENT_139	[p9l1823t3498r1893b3550],
4	(	CD	NUMBER	(	dep	2	SENT_139	[p9l1922t3496r2091b3564],
5	38.3	CD	NUMBER	38.3	number	6	SENT_139	[p9l1922t3496r2091b3564],
6	)	CD	NUMBER	)	num	8	SENT_139	[p9l1922t3496r2091b3564],
7	Progression	NN	O	progression	nn	8	SENT_139	[p9l15t3599r385b3666],
8	site	NN	O	site	npadvmod	4	SENT_139	[p9l415t3599r523b3652],
9	before	IN	O	before	_	0	SENT_139	[p9l553t3599r751b3652],
10	paclitaxel	NN	O	paclitaxel	prep_before	4	SENT_139	[p9l781t3599r1076b3666],
11	Local	JJ	O	local	amod	10	SENT_139	[p9l1240t3599r1404b3652],
12	27	CD	NUMBER	27	number	13	SENT_139	[p9l1818t3600r1893b3651],
13	(	CD	NUMBER	(	num	10	SENT_139	[p9l1922t3598r2091b3666],
14	57.4	CD	NUMBER	57.4	num	15	SENT_139	[p9l1922t3598r2091b3666],
15	)	NN	O	)	dep	2	SENT_139	[p9l1922t3598r2091b3666],

1	Metastases	NNS	O	metastase	_	0	SENT_140	[p9l1240t3701r1601b3753],
2	16	CD	NUMBER	16	number	3	SENT_140	[p9l1823t3701r1894b3753],
3	34.0	CD	NUMBER	34.0	dep	1	SENT_140	[p9l1939t3699r2091b3767],
4	)	NN	O	)	dep	3	SENT_140	[p9l1939t3699r2091b3767],

1	Both	DT	O	both	det	3	SENT_141	[p10l1240t25r1382b78],
2	4	CD	NUMBER	4	num	3	SENT_141	[p10l1857t26r1893b77],
3	(	NN	O	(	_	0	SENT_141	[p10l1922t24r2052b92],
4	8.5	CD	NUMBER	8.5	number	5	SENT_141	[p10l1922t24r2052b92],
5	)	CD	NUMBER	)	dep	3	SENT_141	[p10l1922t24r2052b92],
6	Neoadjuvant	NNP	ORGANIZATION	Neoadjuvant	dep	3	SENT_141	[p10l1240t127r1635b193],
7	21	CD	NUMBER	21	num	6	SENT_141	[p10l1818t128r1882b179],
8	(	CD	NUMBER	(	number	9	SENT_141	[p10l1922t126r2091b194],
9	44.7	CD	NUMBER	44.7	num	11	SENT_141	[p10l1922t126r2091b194],
10	)	NN	O	)	nn	11	SENT_141	[p10l1922t126r2091b194],
11	Palliative	NN	O	palliative	dep	6	SENT_141	[p10l1240t229r1515b281],
12	26	CD	NUMBER	26	dep	6	SENT_141	[p10l1818t229r1894b281],
13	(	CD	NUMBER	(	number	14	SENT_141	[p10l1922t227r2091b295],
14	55.3	CD	NUMBER	55.3	num	15	SENT_141	[p10l1922t227r2091b295],
15	)	NN	O	)	dep	12	SENT_141	[p10l1922t227r2091b295],

1	Previous	JJ	O	previous	amod	2	SENT_142	[p10l15t127r283b180],
2	chemotherapy	NN	O	chemotherapy	_	0	SENT_142	[p10l310t127r766b194],

1	Grau	NNP	PERSON	Grau	nn	3	SENT_143	[p10l482t502r650b563],
2	et	NNP	O	et	nn	3	SENT_143	[p10l684t507r748b562],
3	aI.	NNP	O	aI.	_	0	SENT_143	[p10l780t504r876b562],
4	:	:	O	:	_	0	SENT_143	[p10l780t504r876b562],
5	Advanced	NNP	O	Advanced	nn	6	SENT_143	[p10l910t504r1267b562],
6	Head	NNP	O	Head	dep	3	SENT_143	[p10l1305t504r1486b562],
7	and	CC	O	and	_	0	SENT_143	[p10l1521t504r1649b562],
8	Neck	NNP	O	Neck	nn	9	SENT_143	[p10l1687t504r1867b562],
9	Cancer	NNP	O	Cancer	dep	3	SENT_143	[p10l1898t502r2154b563],

1	TABLE	NN	O	table	_	0	SENT_144	[p10l1007t657r1105b681],
2	III	CD	NUMBER	iii	dep	1	SENT_144	[p10l1119t657r1150b681],
3	.	.	O	.	_	0	SENT_144	[p10l1119t657r1150b681],

1	Complete	JJ	O	complete	amod	3	SENT_145	[p10l231t702r374b734],
2	Genotype	NN	O	genotype	nn	3	SENT_145	[p10l387t702r530b734],
3	Frequencies	NNS	O	frequency	nsubj	9	SENT_145	[p10l544t703r723b734],
4	for	IN	O	for	_	0	SENT_145	[p10l735t702r775b728],
5	Each	DT	O	each	det	6	SENT_145	[p10l788t703r859b728],
6	Polymorphism	NN	O	polymorphism	prep_for	3	SENT_145	[p10l874t703r1083b734],
7	and	CC	O	and	_	0	SENT_145	[p10l1097t703r1150b728],
8	Frequencies	NNS	O	frequency	prep_for	3	SENT_145	[p10l1166t703r1345b734],
9	Observed	VBN	O	observe	_	0	SENT_145	[p10l1358t702r1500b728],
10	in	IN	O	in	_	0	SENT_145	[p10l1515t703r1537b727],
11	the	DT	O	the	det	13	SENT_145	[p10l1550t703r1596b728],
12	European	JJ	O	european	amod	13	SENT_145	[p10l1610t703r1748b734],
13	Population	NNP	O	Population	prep_in	9	SENT_145	[p10l1763t703r1927b734],
14	.	.	O	.	_	0	SENT_145	[p10l1763t703r1927b734],

1	SNP	NN	O	snp	nn	3	SENT_146	[p10l8t784r123b828],
2	Genotype	NN	O	genotype	nn	3	SENT_146	[p10l1103t784r1357b839],
3	Aminoacids	NNS	O	aminoacid	_	0	SENT_146	[p10l1711t785r2019b828],
4	CYP2C8	NN	O	cyp2c8	nn	5	SENT_146	[p10l9t902r261b952],
5	C96817168T	NN	O	c96817168t	dep	3	SENT_146	[p10l288t902r670b952],
6	CC	NN	O	cc	nn	7	SENT_146	[p10l1184t902r1276b952],
7	INTRON	NN	O	intron	dep	3	SENT_146	[p10l1713t902r1953b952],

1	CT	NNP	O	CT	nn	2	SENT_147	[p10l1189t1002r1274b1052],
2	Tl	NNP	O	Tl	_	0	SENT_147	[p10l1191t1100r1269b1148],
3	‘	IN	O	‘	dep	2	SENT_147	[p10l1191t1100r1269b1148],

1	GSTT1	NN	O	gstt1	nn	2	SENT_148	[p10l9t1160r202b1210],
2	Ex5-182C	NN	O	ex5-182c	_	0	SENT_148	[p10l242t1160r625b1211],
3	>	JJR	O	>	amod	4	SENT_148	[p10l242t1160r625b1211],
4	T	NN	O	t	dep	2	SENT_148	[p10l242t1160r625b1211],
5	Tl	NN	O	tl	dep	4	SENT_148	[p10l1191t1161r1269b1209],
6	"	''	O	"	punct	5	SENT_148	[p10l1191t1161r1269b1209],
7	3	CD	NUMBER	3	num	9	SENT_148	[p10l1710t1158r1893b1210],
8	’	NN	O	’	nn	9	SENT_148	[p10l1710t1158r1893b1210],
9	UTR	NN	O	utr	dep	2	SENT_148	[p10l1710t1158r1893b1210],

1	TC	NN	O	tc	nn	2	SENT_149	[p10l1186t1262r1271b1312],
2	CC	NN	O	cc	_	0	SENT_149	[p10l1184t1358r1276b1408],

1	GSTP1	NN	O	gstp1	nn	2	SENT_150	[p10l9t1457r207b1507],
2	Ex5-24A	NN	O	ex5-24a	_	0	SENT_150	[p10l247t1457r597b1508],
3	>	JJR	O	>	amod	5	SENT_150	[p10l247t1457r597b1508],
4	G	NN	O	g	nn	5	SENT_150	[p10l247t1457r597b1508],
5	AA	NNS	O	aa	nsubj	6	SENT_150	[p10l1186t1458r1274b1506],
6	|	VBP	O	|	rcmod	2	SENT_150	[p10l1713t1458r1955b1507],
7	|	JJ	O	|	amod	8	SENT_150	[p10l1713t1458r1955b1507],
8	e105	NN	O	e105	dobj	6	SENT_150	[p10l1713t1458r1955b1507],
9	|	CD	NUMBER	|	num	10	SENT_150	[p10l1713t1458r1955b1507],
10	|	NN	O	|	dep	8	SENT_150	[p10l1713t1458r1955b1507],
11	e	SYM	O	e	dep	13	SENT_150	[p10l1713t1458r1955b1507],
12	AG	NNP	O	AG	nn	13	SENT_150	[p10l1182t1556r1273b1606],
13	l	NN	O	l	dep	2	SENT_150	[p10l1713t1557r1973b1606],
14	|	CD	NUMBER	|	num	16	SENT_150	[p10l1713t1557r1973b1606],
15	e105Val	NN	O	e105val	nn	16	SENT_150	[p10l1713t1557r1973b1606],
16	GG	NNS	O	gg	nsubj	61	SENT_150	[p10l1181t1655r1277b1705],
17	Va	NNP	O	Va	nsubj	18	SENT_150	[p10l1708t1656r1993b1705],
18	|	VBD	O	|	rcmod	16	SENT_150	[p10l1708t1656r1993b1705],
19	105Val	JJ	O	105val	amod	25	SENT_150	[p10l1708t1656r1993b1705],
20	MDR-1-62	NN	O	mdr-1-62	nn	25	SENT_150	[p10l12t1756r318b1806],
21	Ex12	NN	O	ex12	nn	25	SENT_150	[p10l349t1756r490b1805],
22	C1236T	NN	O	c1236t	nn	25	SENT_150	[p10l519t1755r752b1806],
23	CC	NN	O	cc	nn	25	SENT_150	[p10l1184t1755r1275b1806],
24	G	NN	O	g	nn	25	SENT_150	[p10l1711t1755r2018b1819],
25	|	NNS	O	|	dep	35	SENT_150	[p10l1711t1755r2018b1819],
26	y412G	NN	O	y412g	nn	29	SENT_150	[p10l1711t1755r2018b1819],
27	|	CD	NUMBER	|	num	29	SENT_150	[p10l1711t1755r2018b1819],
28	y	NN	O	y	nn	29	SENT_150	[p10l1711t1755r2018b1819],
29	CT	NN	O	ct	dep	25	SENT_150	[p10l1189t1856r1274b1907],
30	G	NN	O	g	nn	31	SENT_150	[p10l1711t1856r2018b1920],
31	|	NNS	O	|	dep	35	SENT_150	[p10l1711t1856r2018b1920],
32	y412G	NN	O	y412g	nn	35	SENT_150	[p10l1711t1856r2018b1920],
33	|	CD	NUMBER	|	num	35	SENT_150	[p10l1711t1856r2018b1920],
34	y	NN	O	y	nn	35	SENT_150	[p10l1711t1856r2018b1920],
35	Tl	NN	O	tl	dep	39	SENT_150	[p10l1191t1958r1269b2007],
36	’	CD	NUMBER	’	num	38	SENT_150	[p10l1191t1958r1269b2007],
37	G	NN	O	g	nn	38	SENT_150	[p10l1711t1957r2018b2021],
38	|	NNS	O	|	dep	35	SENT_150	[p10l1711t1957r2018b2021],
39	y412G	NN	O	y412g	dep	48	SENT_150	[p10l1711t1957r2018b2021],
40	|	CD	NUMBER	|	num	39	SENT_150	[p10l1711t1957r2018b2021],
41	y	NN	O	y	nn	48	SENT_150	[p10l1711t1957r2018b2021],
42	MDR-1-57	NN	O	mdr-1-57	nn	48	SENT_150	[p10l12t2058r319b2107],
43	EX26	NN	O	ex26	nn	48	SENT_150	[p10l349t2058r492b2107],
44	C3435T	NN	O	c3435t	nn	48	SENT_150	[p10l519t2057r752b2107],
45	CC	NN	O	cc	nn	48	SENT_150	[p10l1184t2057r1276b2107],
46	|	CD	NUMBER	|	num	48	SENT_150	[p10l1713t2058r1992b2107],
47	|	NN	O	|	nn	48	SENT_150	[p10l1713t2058r1992b2107],
48	e1145	NN	O	e1145	dep	18	SENT_150	[p10l1713t2058r1992b2107],
49	|	CD	NUMBER	|	num	50	SENT_150	[p10l1713t2058r1992b2107],
50	|	NN	O	|	dep	48	SENT_150	[p10l1713t2058r1992b2107],
51	e	SYM	O	e	dep	52	SENT_150	[p10l1713t2058r1992b2107],
52	CT	FW	O	ct	rcmod	50	SENT_150	[p10l1189t2156r1274b2206],
53	l	NN	O	l	tmod	50	SENT_150	[p10l1713t2157r1992b2206],
54	|	CD	NUMBER	|	num	55	SENT_150	[p10l1713t2157r1992b2206],
55	e1145	NN	O	e1145	dobj	18	SENT_150	[p10l1713t2157r1992b2206],
56	|	CD	NUMBER	|	num	57	SENT_150	[p10l1713t2157r1992b2206],
57	|	NN	O	|	dep	55	SENT_150	[p10l1713t2157r1992b2206],
58	e	SYM	O	e	dep	59	SENT_150	[p10l1713t2157r1992b2206],
59	‘	CD	NUMBER	‘	dep	60	SENT_150	[p10l1191t2256r1269b2304],
60	IT	PRP	O	it	dep	55	SENT_150	[p10l1191t2256r1269b2304],
61	l	NN	O	l	rcmod	13	SENT_150	[p10l1713t2256r1992b2305],
62	|	CD	NUMBER	|	num	63	SENT_150	[p10l1713t2256r1992b2305],
63	e1145	NN	O	e1145	dobj	61	SENT_150	[p10l1713t2256r1992b2305],
64	|	CD	NUMBER	|	num	65	SENT_150	[p10l1713t2256r1992b2305],
65	|	NN	O	|	dep	63	SENT_150	[p10l1713t2256r1992b2305],
66	e	SYM	O	e	dep	68	SENT_150	[p10l1713t2256r1992b2305],
67	ERCC1	NN	O	ercc1	nn	68	SENT_150	[p10l11t2355r215b2406],
68	1264A	NN	O	1264a	dep	71	SENT_150	[p10l255t2355r538b2407],
69	>	JJR	O	>	amod	71	SENT_150	[p10l255t2355r538b2407],
70	C	NN	O	c	nn	71	SENT_150	[p10l255t2355r538b2407],
71	AA	NN	O	aa	dep	63	SENT_150	[p10l1186t2356r1274b2405],
72	Lys259Lys	NN	O	lys259ly	nn	76	SENT_150	[p10l1713t2356r2022b2419],
73	AC	NN	O	ac	nn	76	SENT_150	[p10l1183t2456r1273b2507],
74	Lys259Thr	NN	O	lys259thr	nn	76	SENT_150	[p10l1713t2457r2020b2520],
75	CC	NN	O	cc	nn	76	SENT_150	[p10l1184t2556r1276b2606],
76	Thr259Thr	NN	O	thr259thr	dep	71	SENT_150	[p10l1708t2557r2016b2606],

1	No.	NN	O	no.	_	0	SENT_151	[p10l321t2663r406b2708],
2	(	CD	PERCENT	(	num	3	SENT_151	[p10l434t2662r521b2719],
3	%	NN	PERCENT	%	dep	1	SENT_151	[p10l434t2662r521b2719],
4	)	CD	NUMBER	)	num	5	SENT_151	[p10l434t2662r521b2719],
5	EP	NN	O	ep	dep	3	SENT_151	[p10l1078t2663r1169b2707],
6	*	CD	NUMBER	*	num	7	SENT_151	[p10l1078t2663r1169b2707],
7	X2	NN	O	x2	dep	1	SENT_151	[p10l1869t2651r1920b2719],

1	23	CD	PERCENT	23	dep	16	SENT_152	[p10l234t2785r306b2835],
2	(	CD	PERCENT	(	num	4	SENT_152	[p10l334t2784r605b2848],
3	48.94	CD	PERCENT	48.94	num	4	SENT_152	[p10l334t2784r605b2848],
4	%	NN	PERCENT	%	dep	1	SENT_152	[p10l334t2784r605b2848],
5	)	CD	PERCENT	)	number	6	SENT_152	[p10l334t2784r605b2848],
6	43.56	CD	PERCENT	43.56	num	7	SENT_152	[p10l1038t2784r1271b2836],
7	%	NN	PERCENT	%	dep	4	SENT_152	[p10l1038t2784r1271b2836],
8	2.845	CD	NUMBER	2.845	dep	4	SENT_152	[p10l1657t2785r1841b2844],
9	,	,	O	,	_	0	SENT_152	[p10l1657t2785r1841b2844],
10	P	NN	O	p	appos	8	SENT_152	[p10l1870t2785r1915b2835],
11	=	JJ	O	=	amod	10	SENT_152	[p10l1940t2809r1987b2825],
12	.241	CD	NUMBER	.241	tmod	11	SENT_152	[p10l2007t2785r2122b2835],
13	16	CD	NUMBER	16	num	14	SENT_152	[p10l238t2888r307b2938],
14	(	NN	O	(	dep	16	SENT_152	[p10l334t2886r605b2950],
15	34.04	CD	PERCENT	34.04	num	16	SENT_152	[p10l334t2886r605b2950],
16	%	NN	PERCENT	%	dep	21	SENT_152	[p10l334t2886r605b2950],
17	)	CD	PERCENT	)	num	19	SENT_152	[p10l334t2886r605b2950],
18	44.88	CD	PERCENT	44.88	num	19	SENT_152	[p10l1038t2887r1271b2938],
19	%	NN	PERCENT	%	dep	16	SENT_152	[p10l1038t2887r1271b2938],
20	8	CD	PERCENT	8	num	21	SENT_152	[p10l273t2990r306b3040],
21	(	NN	PERCENT	(	dep	23	SENT_152	[p10l334t2988r605b3053],
22	17.02	CD	PERCENT	17.02	num	23	SENT_152	[p10l334t2988r605b3053],
23	%	NN	PERCENT	%	dep	33	SENT_152	[p10l334t2988r605b3053],
24	)	CD	PERCENT	)	number	25	SENT_152	[p10l334t2988r605b3053],
25	11.56	CD	PERCENT	11.56	num	26	SENT_152	[p10l1042t2989r1271b3041],
26	%	NN	PERCENT	%	dep	23	SENT_152	[p10l1042t2989r1271b3041],
27	45	CD	PERCENT	45	number	28	SENT_152	[p10l234t3091r306b3142],
28	(	CD	PERCENT	(	amod	26	SENT_152	[p10l334t3090r605b3154],
29	95.74	CD	PERCENT	95.74	num	30	SENT_152	[p10l334t3090r605b3154],
30	%	NN	PERCENT	%	dep	28	SENT_152	[p10l334t3090r605b3154],
31	)	CD	PERCENT	)	num	33	SENT_152	[p10l334t3090r605b3154],
32	86	CD	PERCENT	86	num	33	SENT_152	[p10l970t3090r1107b3142],
33	%	NN	PERCENT	%	dep	42	SENT_152	[p10l970t3090r1107b3142],
34	9.977	CD	NUMBER	9.977	dep	33	SENT_152	[p10l1658t3091r1841b3150],
35	,	,	O	,	_	0	SENT_152	[p10l1658t3091r1841b3150],
36	P	NN	O	p	appos	34	SENT_152	[p10l1870t3091r1915b3141],
37	=	JJ	O	=	amod	36	SENT_152	[p10l1940t3115r1987b3131],
38	.007	CD	NUMBER	.007	number	39	SENT_152	[p10l2007t3091r2132b3141],
39	1	CD	NUMBER	1	num	40	SENT_152	[p10l276t3194r295b3243],
40	(	NN	O	(	dep	36	SENT_152	[p10l334t3192r567b3256],
41	2.13	CD	PERCENT	2.13	num	42	SENT_152	[p10l334t3192r567b3256],
42	%	NN	PERCENT	%	dep	45	SENT_152	[p10l334t3192r567b3256],
43	)	CD	PERCENT	)	num	45	SENT_152	[p10l334t3192r567b3256],
44	14	CD	PERCENT	14	num	45	SENT_152	[p10l973t3193r1107b3244],
45	%	NN	PERCENT	%	dep	52	SENT_152	[p10l973t3193r1107b3244],
46	1	CD	PERCENT	1	number	47	SENT_152	[p10l276t3296r295b3345],
47	(	CD	PERCENT	(	dep	45	SENT_152	[p10l334t3294r481b3359],
48	2.13	CD	PERCENT	2.13	num	49	SENT_152	[p10l334t3294r481b3359],
49	%	NN	PERCENT	%	dep	47	SENT_152	[p10l512t3294r590b3359],
50	)	CD	PERCENT	)	num	52	SENT_152	[p10l512t3294r590b3359],
51	0.7	CD	PERCENT	0.7	num	52	SENT_152	[p10l1077t3295r1233b3347],
52	%	NN	PERCENT	%	dep	59	SENT_152	[p10l1077t3295r1233b3347],
53	36	CD	PERCENT	36	number	54	SENT_152	[p10l234t3397r307b3447],
54	(	CD	PERCENT	(	dep	52	SENT_152	[p10l334t3396r605b3460],
55	76.59	CD	PERCENT	76.59	num	56	SENT_152	[p10l334t3396r605b3460],
56	%	NN	PERCENT	%	dep	54	SENT_152	[p10l334t3396r605b3460],
57	)	CD	PERCENT	)	num	59	SENT_152	[p10l334t3396r605b3460],
58	47	CD	PERCENT	47	num	59	SENT_152	[p10l969t3396r1107b3448],
59	%	NN	PERCENT	%	dep	63	SENT_152	[p10l969t3396r1107b3448],
60	21.213	CD	NUMBER	21.213	dep	59	SENT_152	[p10l1638t3397r1861b3456],
61	,	,	O	,	_	0	SENT_152	[p10l1638t3397r1861b3456],
62	P	NN	O	p	appos	60	SENT_152	[p10l1889t3397r1933b3447],
63	<	JJR	O	<	dep	71	SENT_152	[p10l1962t3409r2004b3449],
64	.001	CD	NUMBER	.001	number	65	SENT_152	[p10l2025t3397r2141b3448],
65	6	CD	NUMBER	6	num	66	SENT_152	[p10l272t3500r306b3550],
66	(	NN	O	(	dep	63	SENT_152	[p10l334t3498r605b3562],
67	12.77	CD	PERCENT	12.77	num	68	SENT_152	[p10l334t3498r605b3562],
68	%	NN	PERCENT	%	dep	66	SENT_152	[p10l334t3498r605b3562],
69	)	CD	PERCENT	)	num	71	SENT_152	[p10l334t3498r605b3562],
70	40	CD	PERCENT	40	num	71	SENT_152	[p10l969t3499r1107b3550],
71	%	NN	PERCENT	%	dep	78	SENT_152	[p10l969t3499r1107b3550],
72	5	CD	PERCENT	5	number	73	SENT_152	[p10l272t3603r306b3652],
73	(	CD	PERCENT	(	dep	71	SENT_152	[p10l334t3600r605b3665],
74	10.64	CD	PERCENT	10.64	num	75	SENT_152	[p10l334t3600r605b3665],
75	%	NN	PERCENT	%	dep	73	SENT_152	[p10l334t3600r605b3665],
76	)	CD	PERCENT	)	num	78	SENT_152	[p10l334t3600r605b3665],
77	12	CD	PERCENT	12	num	78	SENT_152	[p10l973t3601r1107b3653],
78	%	NN	PERCENT	%	dep	85	SENT_152	[p10l973t3601r1107b3653],
79	21	CD	PERCENT	21	number	80	SENT_152	[p10l234t3703r295b3753],
80	(	CD	PERCENT	(	dep	78	SENT_152	[p10l334t3702r605b3766],
81	44.68	CD	PERCENT	44.68	num	82	SENT_152	[p10l334t3702r605b3766],
82	%	NN	PERCENT	%	dep	80	SENT_152	[p10l334t3702r605b3766],
83	)	CD	PERCENT	)	num	85	SENT_152	[p10l334t3702r605b3766],
84	32	CD	PERCENT	32	num	85	SENT_152	[p10l970t3702r1107b3754],
85	%	NN	PERCENT	%	_	0	SENT_152	[p10l970t3702r1107b3754],
86	3.734	CD	NUMBER	3.734	dep	85	SENT_152	[p10l1657t3703r1841b3762],
87	,	,	O	,	_	0	SENT_152	[p10l1657t3703r1841b3762],
88	P	NN	O	p	appos	86	SENT_152	[p10l1870t3703r1915b3753],
89	=	JJ	O	=	amod	88	SENT_152	[p10l1940t3727r1987b3743],
90	.155	CD	NUMBER	.155	tmod	89	SENT_152	[p10l2007t3703r2132b3753],

1	17	CD	PERCENT	17	dep	11	SENT_153	[p11l238t28r306b77],
2	(	CD	PERCENT	(	num	4	SENT_153	[p11l334t26r605b90],
3	36.17	CD	PERCENT	36.17	num	4	SENT_153	[p11l334t26r605b90],
4	%	NN	PERCENT	%	dep	1	SENT_153	[p11l334t26r605b90],
5	)	CD	PERCENT	)	number	6	SENT_153	[p11l334t26r605b90],
6	41	CD	PERCENT	41	num	7	SENT_153	[p11l969t27r1107b78],
7	%	NN	PERCENT	%	dep	4	SENT_153	[p11l969t27r1107b78],
8	9	CD	PERCENT	9	num	9	SENT_153	[p11l272t130r306b180],
9	(	NN	PERCENT	(	dep	11	SENT_153	[p11l334t128r605b193],
10	19.15	CD	PERCENT	19.15	num	11	SENT_153	[p11l334t128r605b193],
11	%	NN	PERCENT	%	dep	21	SENT_153	[p11l334t128r605b193],
12	)	CD	PERCENT	)	number	13	SENT_153	[p11l334t128r605b193],
13	27	CD	PERCENT	27	num	14	SENT_153	[p11l969t129r1107b181],
14	%	NN	PERCENT	%	dep	11	SENT_153	[p11l969t129r1107b181],
15	13	CD	PERCENT	13	number	16	SENT_153	[p11l238t231r306b281],
16	(	CD	PERCENT	(	amod	14	SENT_153	[p11l334t230r605b294],
17	27.66	CD	PERCENT	27.66	num	18	SENT_153	[p11l334t230r605b294],
18	%	NN	PERCENT	%	dep	16	SENT_153	[p11l334t230r605b294],
19	)	CD	PERCENT	)	num	21	SENT_153	[p11l334t230r605b294],
20	22.6	CD	PERCENT	22.6	num	21	SENT_153	[p11l1038t230r1233b282],
21	%	NN	PERCENT	%	dep	28	SENT_153	[p11l1038t230r1233b282],
22	4.588	CD	NUMBER	4.588	dep	21	SENT_153	[p11l1657t231r1842b290],
23	,	,	O	,	_	0	SENT_153	[p11l1657t231r1842b290],
24	P	NN	O	p	appos	22	SENT_153	[p11l1870t231r1915b281],
25	=	JJ	O	=	amod	24	SENT_153	[p11l1940t255r1987b271],
26	.101	CD	NUMBER	.101	tmod	25	SENT_153	[p11l2007t231r2122b281],
27	22	CD	NUMBER	22	num	28	SENT_153	[p11l234t334r305b383],
28	(	NN	O	(	dep	30	SENT_153	[p11l334t332r508b396],
29	46.81	CD	PERCENT	46.81	num	30	SENT_153	[p11l334t332r508b396],
30	%	NN	PERCENT	%	dep	40	SENT_153	[p11l527t332r605b396],
31	)	CD	PERCENT	)	number	32	SENT_153	[p11l527t332r605b396],
32	61.3	CD	PERCENT	61.3	num	33	SENT_153	[p11l1039t333r1233b384],
33	%	NN	PERCENT	%	dep	30	SENT_153	[p11l1039t333r1233b384],
34	12	CD	PERCENT	12	number	35	SENT_153	[p11l238t436r305b485],
35	(	CD	PERCENT	(	amod	33	SENT_153	[p11l334t434r605b499],
36	25.53	CD	PERCENT	25.53	num	37	SENT_153	[p11l334t434r605b499],
37	%	NN	PERCENT	%	dep	35	SENT_153	[p11l334t434r605b499],
38	)	CD	PERCENT	)	num	40	SENT_153	[p11l334t434r605b499],
39	16.1	CD	PERCENT	16.1	num	40	SENT_153	[p11l1042t435r1233b487],
40	%	NN	PERCENT	%	dep	47	SENT_153	[p11l1042t435r1233b487],
41	27	CD	PERCENT	27	number	42	SENT_153	[p11l234t537r306b587],
42	(	CD	PERCENT	(	dep	40	SENT_153	[p11l334t536r605b600],
43	57.45	CD	PERCENT	57.45	num	44	SENT_153	[p11l334t536r605b600],
44	%	NN	PERCENT	%	dep	42	SENT_153	[p11l334t536r605b600],
45	)	CD	PERCENT	)	num	47	SENT_153	[p11l334t536r605b600],
46	73.3	CD	PERCENT	73.3	num	47	SENT_153	[p11l1039t536r1233b588],
47	%	NN	PERCENT	%	dep	51	SENT_153	[p11l1039t536r1233b588],
48	18.147	CD	NUMBER	18.147	dep	47	SENT_153	[p11l1643t537r1861b596],
49	,	,	O	,	_	0	SENT_153	[p11l1643t537r1861b596],
50	P	NN	O	p	appos	48	SENT_153	[p11l1889t537r1933b587],
51	<	JJR	O	<	dep	60	SENT_153	[p11l1962t549r2004b589],
52	.001	CD	NUMBER	.001	number	53	SENT_153	[p11l2025t537r2141b588],
53	9	CD	NUMBER	9	num	54	SENT_153	[p11l272t640r306b690],
54	(	NN	O	(	dep	51	SENT_153	[p11l334t638r605b702],
55	19.15	CD	PERCENT	19.15	num	56	SENT_153	[p11l334t638r605b702],
56	%	NN	PERCENT	%	dep	54	SENT_153	[p11l334t638r605b702],
57	)	CD	PERCENT	)	number	58	SENT_153	[p11l334t638r605b702],
58	13.3	CD	PERCENT	13.3	num	59	SENT_153	[p11l1042t639r1233b690],
59	%	NN	PERCENT	%	dep	56	SENT_153	[p11l1042t639r1233b690],
60	11	CD	PERCENT	11	_	0	SENT_153	[p11l238t742r295b791],
61	(	CD	PERCENT	(	number	62	SENT_153	[p11l335t740r567b805],
62	23.4	CD	PERCENT	23.4	num	63	SENT_153	[p11l335t740r567b805],
63	%	NN	PERCENT	%	dep	60	SENT_153	[p11l335t740r567b805],
64	)	CD	PERCENT	)	number	65	SENT_153	[p11l335t740r567b805],
65	3.4	CD	PERCENT	3.4	dep	66	SENT_153	[p11l1076t741r1233b793],
66	%	NN	PERCENT	%	dep	63	SENT_153	[p11l1076t741r1233b793],

1	SNP	NN	O	snp	_	0	SENT_154	[p11l114t842r170b865],
2	:	:	O	:	_	0	SENT_154	[p11l183t853r202b860],
3	single	JJ	O	single	amod	5	SENT_154	[p11l214t842r288b870],
4	nucleotide	NN	O	nucleotide	nn	5	SENT_154	[p11l301t842r434b864],
5	polymorphism	NN	O	polymorphism	dep	1	SENT_154	[p11l446t842r636b870],
6	;	:	O	;	_	0	SENT_154	[p11l446t842r636b870],
7	EP	NN	O	ep	dep	5	SENT_154	[p11l650t842r684b864],
8	:	:	O	:	_	0	SENT_154	[p11l696t853r716b860],
9	Genotype	NN	O	genotype	nn	10	SENT_154	[p11l728t842r854b870],
10	frequencies	NNS	O	frequency	dep	1	SENT_154	[p11l865t842r1016b870],
11	of	IN	O	of	_	0	SENT_154	[p11l1027t842r1052b864],
12	the	DT	O	the	det	14	SENT_154	[p11l1062t842r1102b864],
13	National	NNP	ORGANIZATION	National	nn	14	SENT_154	[p11l1114t842r1218b864],
14	Center	NNP	ORGANIZATION	Center	prep_of	10	SENT_154	[p11l1231t842r1317b865],
15	for	IN	ORGANIZATION	for	_	0	SENT_154	[p11l1327t842r1362b864],
16	Biotechnology	NNP	ORGANIZATION	Biotechnology	nn	17	SENT_154	[p11l1373t842r1558b870],
17	Information	NNP	ORGANIZATION	Information	prep_for	14	SENT_154	[p11l1571t842r1715b864],
18	for	IN	O	for	_	0	SENT_154	[p11l1726t842r1761b864],
19	the	DT	O	the	det	21	SENT_154	[p11l1771t842r1812b864],
20	European	JJ	LOCATION	european	amod	21	SENT_154	[p11l1824t842r1946b870],
21	population	NN	O	population	prep_for	17	SENT_154	[p11l1959t842r2101b870],
22	.	.	O	.	_	0	SENT_154	[p11l1959t842r2101b870],

1	SNPs	NNS	O	snp	_	0	SENT_155	[p11l8t1030r238b1094],
2	and	CC	O	and	_	0	SENT_155	[p11l272t1030r441b1093],
3	Response	NN	O	response	conj_and	1	SENT_155	[p11l466t1031r864b1110],
4	to	TO	O	to	dep	1	SENT_155	[p11l898t1037r976b1093],
5	Chemotherapy	NNP	O	Chemotherapy	pobj	4	SENT_155	[p11l1009t1030r1636b1110],

1	A	DT	O	a	det	2	SENT_156	[p11l186t1129r245b1189],
2	response	NN	O	response	nsubjpass	4	SENT_156	[p11l287t1150r607b1205],
3	was	VBD	O	be	auxpass	4	SENT_156	[p11l651t1150r791b1190],
4	achieved	VBN	O	achieve	_	0	SENT_156	[p11l838t1129r1158b1190],
5	in	IN	O	in	_	0	SENT_156	[p11l1201t1131r1272b1189],
6	21	CD	NUMBER	21	prep_in	4	SENT_156	[p11l1317t1132r1399b1189],
7	out	IN	O	out	_	0	SENT_156	[p11l1447t1135r1564b1190],
8	of	IN	O	of	_	0	SENT_156	[p11l1608t1129r1680b1190],
9	47	CD	NUMBER	47	num	10	SENT_156	[p11l1715t1132r1798b1190],
10	patients	NNS	O	patient	prep_out_of	4	SENT_156	[p11l1844t1131r2142b1205],
11	(	IN	O	(	_	0	SENT_156	[p11l11t1226r233b1295],
12	45	CD	PERCENT	45	num	13	SENT_156	[p11l11t1226r233b1295],
13	%	NN	PERCENT	%	prep_(	10	SENT_156	[p11l11t1226r233b1295],
14	)	CD	NUMBER	)	tmod	10	SENT_156	[p11l11t1226r233b1295],
15	.	.	O	.	_	0	SENT_156	[p11l11t1226r233b1295],

1	The	DT	O	the	det	3	SENT_157	[p11l274t1226r412b1287],
2	median	JJ	O	median	amod	3	SENT_157	[p11l449t1226r722b1287],
3	duration	NN	O	duration	nsubj	11	SENT_157	[p11l759t1226r1074b1287],
4	of	IN	O	of	_	0	SENT_157	[p11l1110t1226r1183b1287],
5	the	DT	O	the	det	6	SENT_157	[p11l1209t1226r1325b1287],
6	response	NN	O	response	prep_of	3	SENT_157	[p11l1362t1246r1682b1302],
7	in	IN	O	in	_	0	SENT_157	[p11l1719t1228r1791b1286],
8	responders	NNS	O	responder	prep_in	6	SENT_157	[p11l1826t1226r2142b1302, p11l11t1345r118b1385],
9	was	VBD	O	be	cop	11	SENT_157	[p11l149t1345r288b1385],
10	5.1	CD	DURATION	5.1	num	11	SENT_157	[p11l321t1327r424b1385],
11	months	NNS	NUMBER	month	_	0	SENT_157	[p11l456t1325r748b1385],
12	.	.	O	.	_	0	SENT_157	[p11l456t1325r748b1385],

1	Both	CC	O	both	dep	3	SENT_158	[p11l189t1421r363b1482],
2	wild-type	JJ	O	wild-type	amod	3	SENT_158	[p11l404t1421r745b1497],
3	genotypes	NNS	O	genotype	nsubjpass	9	SENT_158	[p11l789t1427r1154b1497],
4	of	IN	O	of	_	0	SENT_158	[p11l1198t1421r1271b1482],
5	MDR1-62	NN	O	mdr1-62	prep_of	3	SENT_158	[p11l1300t1422r1655b1482],
6	and	CC	O	and	_	0	SENT_158	[p11l1701t1421r1836b1482],
7	MDR157	NN	O	mdr157	prep_of	3	SENT_158	[p11l1874t1422r2139b1482, p11l9t1520r98b1579],
8	were	VBD	O	be	auxpass	9	SENT_158	[p11l124t1538r299b1579],
9	associated	VBN	O	associate	_	0	SENT_158	[p11l332t1518r707b1579],
10	with	IN	O	with	_	0	SENT_158	[p11l735t1518r901b1579],
11	a	DT	O	a	det	14	SENT_158	[p11l932t1538r973b1579],
12	lower	JJR	O	lower	amod	14	SENT_158	[p11l1001t1518r1203b1579],
13	response	NN	O	response	nn	14	SENT_158	[p11l1232t1538r1552b1594],
14	rate	NN	O	rate	prep_with	9	SENT_158	[p11l1582t1523r1748b1579],
15	.	.	O	.	_	0	SENT_158	[p11l1582t1523r1748b1579],

1	When	WRB	O	when	advmod	6	SENT_159	[p11l1781t1518r1997b1579],
2	the	DT	O	the	det	4	SENT_159	[p11l2026t1518r2142b1579],
3	MDR1-62	NN	O	mdr1-62	nn	4	SENT_159	[p11l6t1617r362b1676],
4	genotype	NN	O	genotype	nsubj	6	SENT_159	[p11l417t1621r745b1691],
5	was	VBD	O	be	cop	6	SENT_159	[p11l799t1636r939b1676],
6	wild-type	JJ	O	wild-type	advcl	15	SENT_159	[p11l992t1616r1354b1691],
7	,	,	O	,	_	0	SENT_159	[p11l992t1616r1354b1691],
8	a	DT	O	a	det	10	SENT_159	[p11l1412t1636r1452b1676],
9	response	NN	O	response	nn	10	SENT_159	[p11l1505t1636r1825b1691],
10	rate	NN	O	rate	nsubjpass	15	SENT_159	[p11l1878t1621r2025b1676],
11	of	IN	O	of	_	0	SENT_159	[p11l2080t1616r2153b1676],
12	24	CD	PERCENT	24	num	13	SENT_159	[p11l11t1714r161b1773],
13	%	NN	PERCENT	%	prep_of	10	SENT_159	[p11l11t1714r161b1773],
14	was	VBD	O	be	auxpass	15	SENT_159	[p11l194t1733r334b1773],
15	observed	VBN	O	observe	_	0	SENT_159	[p11l369t1712r710b1786],
16	,	,	O	,	_	0	SENT_159	[p11l369t1712r710b1786],
17	but	CC	O	but	_	0	SENT_159	[p11l745t1712r868b1773],
18	in	IN	O	in	_	0	SENT_159	[p11l900t1714r972b1772],
19	the	DT	O	the	det	20	SENT_159	[p11l1004t1712r1120b1773],
20	case	NN	O	case	prep_in	28	SENT_159	[p11l1155t1733r1306b1773],
21	of	IN	O	of	_	0	SENT_159	[p11l1342t1712r1414b1773],
22	SNPS	NNP	O	SNPS	prep_of	20	SENT_159	[p11l1439t1712r1638b1773],
23	the	DT	O	the	det	25	SENT_159	[p11l1672t1712r1788b1773],
24	response	NN	O	response	nn	25	SENT_159	[p11l1822t1733r2142b1788],
25	rate	NN	O	rate	nsubj	28	SENT_159	[p11l10t1815r157b1870],
26	was	VBD	O	be	cop	28	SENT_159	[p11l199t1830r339b1870],
27	61	CD	PERCENT	61	num	28	SENT_159	[p11l384t1812r552b1870],
28	%	NN	PERCENT	%	conj_but	15	SENT_159	[p11l384t1812r552b1870],
29	.	.	O	.	_	0	SENT_159	[p11l384t1812r552b1870],

1	When	WRB	O	when	advmod	6	SENT_160	[p11l597t1809r812b1870],
2	the	DT	O	the	det	4	SENT_160	[p11l853t1809r969b1870],
3	MDR1-57	NN	O	mdr1-57	nn	4	SENT_160	[p11l1009t1810r1369b1870],
4	genotype	NN	O	genotype	nsubj	6	SENT_160	[p11l1408t1815r1736b1885],
5	was	VBD	O	be	cop	6	SENT_160	[p11l1779t1830r1919b1870],
6	wildtype	JJ	O	wildtype	advcl	13	SENT_160	[p11l1961t1809r2142b1870, p11l10t1911r186b1982],
7	,	,	O	,	_	0	SENT_160	[p11l1961t1809r2142b1870, p11l10t1911r186b1982],
8	the	DT	O	the	det	10	SENT_160	[p11l237t1906r353b1967],
9	response	NN	O	response	nn	10	SENT_160	[p11l402t1926r722b1982],
10	rate	NN	O	rate	nsubj	13	SENT_160	[p11l771t1911r918b1967],
11	was	VBD	O	be	cop	13	SENT_160	[p11l966t1926r1106b1967],
12	similar	JJ	O	similar	amod	13	SENT_160	[p11l1157t1906r1415b1967],
13	(	NN	O	(	_	0	SENT_160	[p11l1464t1906r1687b1980],
14	23	CD	PERCENT	23	number	15	SENT_160	[p11l1464t1906r1687b1980],
15	%	NN	PERCENT	%	amod	13	SENT_160	[p11l1464t1906r1687b1980],
16	)	CD	NUMBER	)	tmod	13	SENT_160	[p11l1464t1906r1687b1980],
17	,	,	O	,	_	0	SENT_160	[p11l1464t1906r1687b1980],
18	but	CC	O	but	_	0	SENT_160	[p11l1737t1906r1861b1967],
19	in	IN	O	in	_	0	SENT_160	[p11l1907t1908r1979b1966],
20	the	DT	O	the	det	21	SENT_160	[p11l2026t1906r2142b1967],
21	case	NN	O	case	prep_in	27	SENT_160	[p11l11t2024r162b2064],
22	of	IN	O	of	_	0	SENT_160	[p11l214t2004r286b2064],
23	SNPs	NNS	O	snp	prep_of	21	SENT_160	[p11l328t2004r526b2064],
24	it	PRP	O	it	nsubj	27	SENT_160	[p11l576t2005r631b2064],
25	was	VBD	O	be	cop	27	SENT_160	[p11l678t2024r817b2064],
26	53	CD	PERCENT	53	num	27	SENT_160	[p11l870t2006r1038b2064],
27	%	NN	PERCENT	%	conj_but	13	SENT_160	[p11l870t2006r1038b2064],
28	.	.	O	.	_	0	SENT_160	[p11l870t2006r1038b2064],

1	The	DT	O	the	det	2	SENT_161	[p11l1091t2004r1230b2064],
2	genotype	NN	O	genotype	nsubjpass	16	SENT_161	[p11l1280t2009r1608b2079],
3	of	IN	O	of	_	0	SENT_161	[p11l1659t2004r1731b2064],
4	the	DT	O	the	det	6	SENT_161	[p11l1771t2004r1887b2064],
5	genes	NNS	O	gene	nn	6	SENT_161	[p11l1937t2023r2142b2079],
6	CYP2C8	NN	O	cyp2c8	prep_of	2	SENT_161	[p11l11t2101r338b2175],
7	,	,	O	,	_	0	SENT_161	[p11l11t2101r338b2175],
8	GSTT1	NN	O	gstt1	appos	6	SENT_161	[p11l380t2101r664b2175],
9	,	,	O	,	_	0	SENT_161	[p11l380t2101r664b2175],
10	GSTP1	NN	O	gstp1	appos	6	SENT_161	[p11l706t2101r984b2174],
11	,	,	O	,	_	0	SENT_161	[p11l706t2101r984b2174],
12	or	CC	O	or	_	0	SENT_161	[p11l1030t2122r1103b2162],
13	ERCC1	NN	O	ercc1	appos	6	SENT_161	[p11l1134t2101r1406b2162],
14	was	VBD	O	be	auxpass	16	SENT_161	[p11l1448t2122r1588b2162],
15	not	RB	O	not	neg	16	SENT_161	[p11l1626t2107r1744b2162],
16	related	VBN	O	relate	_	0	SENT_161	[p11l1780t2101r2039b2162],
17	to	TO	O	to	_	0	SENT_161	[p11l2075t2107r2142b2162],
18	the	DT	O	the	det	20	SENT_161	[p11l10t2198r126b2259],
19	response	NN	O	response	nn	20	SENT_161	[p11l156t2218r476b2274],
20	rate	NN	O	rate	prep_to	16	SENT_161	[p11l508t2203r654b2259],
21	(	CD	NUMBER	(	num	24	SENT_161	[p11l686t2198r910b2267],
22	Table	NNP	O	Table	nn	24	SENT_161	[p11l686t2198r910b2267],
23	IV	CD	NUMBER	iv	num	24	SENT_161	[p11l942t2198r1072b2267],
24	)	NN	O	)	xcomp	16	SENT_161	[p11l942t2198r1072b2267],
25	.	.	O	.	_	0	SENT_161	[p11l942t2198r1072b2267],

1	When	WRB	O	when	advmod	7	SENT_162	[p11l187t2297r402b2357],
2	two	CD	NUMBER	two	nn	5	SENT_162	[p11l448t2302r578b2357],
3	or	CC	O	or	_	0	SENT_162	[p11l626t2317r699b2357],
4	more	JJR	O	more	nn	5	SENT_162	[p11l744t2317r927b2357],
5	genes	NNS	O	gene	nsubjpass	7	SENT_162	[p11l975t2316r1180b2372],
6	were	VBD	O	be	auxpass	7	SENT_162	[p11l1227t2317r1401b2357],
7	analyzed	VBN	O	analyze	advcl	14	SENT_162	[p11l1451t2297r1777b2372],
8	concomitantly	RB	O	concomitantly	advmod	7	SENT_162	[p11l1824t2298r2141b2357, p11l10t2393r241b2469],
9	,	,	O	,	_	0	SENT_162	[p11l1824t2298r2141b2357, p11l10t2393r241b2469],
10	the	DT	O	the	det	12	SENT_162	[p11l284t2393r400b2454],
11	response	NN	O	response	nn	12	SENT_162	[p11l441t2414r761b2469],
12	rate	NN	O	rate	nsubj	14	SENT_162	[p11l802t2399r948b2454],
13	was	VBD	O	be	cop	14	SENT_162	[p11l989t2414r1129b2454],
14	higher	JJR	O	higher	_	0	SENT_162	[p11l1169t2393r1410b2469],
15	in	IN	O	in	_	0	SENT_162	[p11l1449t2395r1520b2453],
16	the	DT	O	the	det	17	SENT_162	[p11l1559t2393r1676b2454],
17	case	NN	O	case	prep_in	14	SENT_162	[p11l1717t2414r1869b2454],
18	of	IN	O	of	_	0	SENT_162	[p11l1910t2393r1983b2454],
19	two	CD	NUMBER	two	num	23	SENT_162	[p11l2013t2399r2142b2454],
20	or	CC	O	or	_	0	SENT_162	[p11l11t2511r84b2551],
21	more	JJR	O	more	num	23	SENT_162	[p11l117t2510r300b2551],
22	accumulated	VBN	O	accumulate	amod	23	SENT_162	[p11l336t2490r803b2551],
23	SNPs	NNS	O	snp	prep_of	17	SENT_162	[p11l839t2490r1038b2551],
24	than	IN	O	than	dep	14	SENT_162	[p11l1072t2490r1243b2551],
25	in	IN	O	in	_	0	SENT_162	[p11l1276t2492r1348b2550],
26	the	DT	O	the	det	27	SENT_162	[p11l1381t2490r1497b2551],
27	case	NN	O	case	prep_in	14	SENT_162	[p11l1533t2510r1685b2551],
28	of	IN	O	of	_	0	SENT_162	[p11l1721t2490r1794b2551],
29	one	CD	NUMBER	one	num	30	SENT_162	[p11l1819t2510r1943b2551],
30	SNP	NN	O	snp	prep_of	27	SENT_162	[p11l1980t2490r2144b2551],
31	or	CC	O	or	_	0	SENT_162	[p11l11t2608r84b2648],
32	wild-type	JJ	O	wild-type	amod	33	SENT_162	[p11l112t2588r453b2663],
33	gene	NN	O	gene	conj_or	27	SENT_162	[p11l484t2607r652b2663],
34	(	CD	PERCENT	(	number	35	SENT_162	[p11l684t2588r861b2657],
35	40	CD	PERCENT	40	num	36	SENT_162	[p11l684t2588r861b2657],
36	%	NN	PERCENT	%	dep	33	SENT_162	[p11l684t2588r861b2657],
37	vs.	CC	O	vs.	_	0	SENT_162	[p11l890t2608r986b2648],
38	5	CD	PERCENT	5	num	39	SENT_162	[p11l1022t2588r1154b2657],
39	%	NN	PERCENT	%	conj_vs.	33	SENT_162	[p11l1022t2588r1154b2657],
40	)	CD	NUMBER	)	number	41	SENT_162	[p11l1022t2588r1154b2657],
41	(	CD	NUMBER	(	num	42	SENT_162	[p11l1185t2588r1263b2656],
42	P	NN	O	p	npadvmod	43	SENT_162	[p11l1185t2588r1263b2656],
43	<	JJR	O	<	amod	39	SENT_162	[p11l1296t2603r1345b2650],
44	.001	CD	NUMBER	.001	num	45	SENT_162	[p11l1373t2588r1566b2657],
45	)	NN	O	)	dep	39	SENT_162	[p11l1373t2588r1566b2657],
46	.	.	O	.	_	0	SENT_162	[p11l1373t2588r1566b2657],

1	Toxicity	NN	O	toxicity	_	0	SENT_163	[p11l12t2824r345b2904],

1	The	DT	O	the	det	2	SENT_164	[p11l188t2925r327b2985],
2	treatment	NN	O	treatment	nsubjpass	5	SENT_164	[p11l370t2930r741b2985],
3	was	VBD	O	be	auxpass	5	SENT_164	[p11l783t2945r923b2985],
4	well	RB	O	well	advmod	5	SENT_164	[p11l967t2925r1117b2985],
5	tolerated	VBN	O	tolerate	_	0	SENT_164	[p11l1159t2925r1490b2985],
6	and	CC	O	and	_	0	SENT_164	[p11l1534t2925r1669b2985],
7	the	DT	O	the	det	8	SENT_164	[p11l1711t2925r1827b2985],
8	toxicity	NN	O	toxicity	nsubj	12	SENT_164	[p11l1872t2926r2144b3001],
9	was	VBD	O	be	cop	12	SENT_164	[p11l9t3042r149b3082],
10	mild	JJ	O	mild	amod	12	SENT_164	[p11l190t3021r354b3082],
11	(	JJ	O	(	amod	12	SENT_164	[p11l394t3021r661b3097],
12	grades	NNS	O	grade	conj_and	5	SENT_164	[p11l394t3021r661b3097],
13	1	CD	NUMBER	1	npadvmod	12	SENT_164	[p11l707t3024r740b3081],
14	or	CC	O	or	_	0	SENT_164	[p11l782t3042r855b3082],
15	2	CD	NUMBER	2	npadvmod	12	SENT_164	[p11l894t3024r932b3081],
16	in	IN	O	in	_	0	SENT_164	[p11l973t3023r1044b3081],
17	general	JJ	O	general	amod	18	SENT_164	[p11l1084t3021r1403b3097],
18	)	NN	O	)	prep_in	12	SENT_164	[p11l1084t3021r1403b3097],
19	.	.	O	.	_	0	SENT_164	[p11l1084t3021r1403b3097],

1	Hematologic	JJ	MISC	hematologic	amod	2	SENT_165	[p11l1447t3021r1905b3097],
2	toxicities	NNS	O	toxicity	nsubj	5	SENT_165	[p11l1944t3023r2141b3082, p11l10t3120r163b3179],
3	observed	VBN	O	observe	partmod	2	SENT_165	[p11l206t3118r528b3179],
4	were	VBD	O	be	cop	5	SENT_165	[p11l567t3139r742b3179],
5	leukopenia	NN	O	leukopenia	dep	18	SENT_165	[p11l783t3118r1187b3194],
6	(	CD	PERCENT	(	number	7	SENT_165	[p11l1228t3119r1518b3192],
7	26.7	CD	PERCENT	26.7	num	8	SENT_165	[p11l1228t3119r1518b3192],
8	%	NN	PERCENT	%	dep	5	SENT_165	[p11l1228t3119r1518b3192],
9	)	CD	NUMBER	)	dep	5	SENT_165	[p11l1228t3119r1518b3192],
10	,	,	O	,	_	0	SENT_165	[p11l1228t3119r1518b3192],
11	anemia	NN	O	anemia	conj_and	5	SENT_165	[p11l1562t3120r1832b3179],
12	(	CD	PERCENT	(	number	13	SENT_165	[p11l1872t3119r2142b3188],
13	43.3	CD	PERCENT	43.3	num	14	SENT_165	[p11l1872t3119r2142b3188],
14	%	NN	PERCENT	%	dep	11	SENT_165	[p11l1872t3119r2142b3188],
15	)	CD	NUMBER	)	dep	11	SENT_165	[p11l1872t3119r2142b3188],
16	and	CC	O	and	_	0	SENT_165	[p11l12t3215r147b3276],
17	thrombophlebitis	NN	O	thrombophlebitis	conj_and	5	SENT_165	[p11l200t3215r829b3291],
18	(	VBP	O	(	_	0	SENT_165	[p11l885t3215r1130b3284],
19	6.7	CD	PERCENT	6.7	num	20	SENT_165	[p11l885t3215r1130b3284],
20	%	NN	PERCENT	%	dobj	18	SENT_165	[p11l885t3215r1130b3284],
21	)	CD	NUMBER	)	nsubj	18	SENT_165	[p11l885t3215r1130b3284],
22	.	.	O	.	_	0	SENT_165	[p11l885t3215r1130b3284],

1	No	DT	O	no	det	3	SENT_166	[p11l1188t3216r1290b3276],
2	platelet	NN	O	platelet	nn	3	SENT_166	[p11l1345t3215r1624b3291],
3	toxicity	NN	O	toxicity	nsubjpass	5	SENT_166	[p11l1677t3217r1949b3291],
4	was	VBD	O	be	auxpass	5	SENT_166	[p11l2002t3236r2142b3276],
5	recorded	VBN	O	record	_	0	SENT_166	[p11l10t3313r344b3373],
6	.	.	O	.	_	0	SENT_166	[p11l10t3313r344b3373],

1	The	DT	O	the	det	3	SENT_167	[p11l398t3313r536b3373],
2	nonhematologic	JJ	O	nonhematologic	amod	3	SENT_167	[p11l588t3313r1167b3389],
3	toxicities	NNS	O	toxicity	nsubj	6	SENT_167	[p11l1216t3314r1545b3373],
4	observed	VBN	O	observe	partmod	3	SENT_167	[p11l1596t3313r1919b3373],
5	were	VBD	O	be	cop	6	SENT_167	[p11l1967t3333r2142b3373],
6	diarrhea	NN	O	diarrhea	_	0	SENT_167	[p11l12t3409r328b3470],
7	(	CD	PERCENT	(	num	9	SENT_167	[p11l363t3410r609b3483],
8	5.0	CD	PERCENT	5.0	num	9	SENT_167	[p11l363t3410r609b3483],
9	%	NN	PERCENT	%	dep	6	SENT_167	[p11l363t3410r609b3483],
10	)	CD	NUMBER	)	dep	6	SENT_167	[p11l363t3410r609b3483],
11	,	,	O	,	_	0	SENT_167	[p11l363t3410r609b3483],
12	nausea	NN	O	nausea	conj_and	6	SENT_167	[p11l647t3430r908b3470],
13	(	CD	PERCENT	(	num	15	SENT_167	[p11l943t3410r1189b3483],
14	5.0	CD	PERCENT	5.0	num	15	SENT_167	[p11l943t3410r1189b3483],
15	%	NN	PERCENT	%	dep	12	SENT_167	[p11l943t3410r1189b3483],
16	)	CD	NUMBER	)	dep	12	SENT_167	[p11l943t3410r1189b3483],
17	,	,	O	,	_	0	SENT_167	[p11l943t3410r1189b3483],
18	fatigue	NN	O	fatigue	conj_and	6	SENT_167	[p11l1226t3409r1481b3485],
19	(	CD	PERCENT	(	number	20	SENT_167	[p11l1518t3410r1808b3483],
20	36.7	CD	PERCENT	36.7	num	21	SENT_167	[p11l1518t3410r1808b3483],
21	%	NN	PERCENT	%	dep	18	SENT_167	[p11l1518t3410r1808b3483],
22	)	CD	NUMBER	)	dep	18	SENT_167	[p11l1518t3410r1808b3483],
23	,	,	O	,	_	0	SENT_167	[p11l1518t3410r1808b3483],
24	alopecia	NN	O	alopecia	conj_and	6	SENT_167	[p11l1848t3409r2144b3485],
25	(	CD	PERCENT	(	number	26	SENT_167	[p11l11t3506r301b3580],
26	18.3	CD	PERCENT	18.3	num	27	SENT_167	[p11l11t3506r301b3580],
27	%	NN	PERCENT	%	dep	24	SENT_167	[p11l11t3506r301b3580],
28	)	CD	NUMBER	)	dep	24	SENT_167	[p11l11t3506r301b3580],
29	,	,	O	,	_	0	SENT_167	[p11l11t3506r301b3580],
30	paresthesia	NN	O	paresthesium	conj_and	6	SENT_167	[p11l352t3506r777b3582],
31	(	CD	PERCENT	(	num	33	SENT_167	[p11l824t3507r1050b3575],
32	5.0	CD	PERCENT	5.0	num	33	SENT_167	[p11l824t3507r1050b3575],
33	%	NN	PERCENT	%	dep	30	SENT_167	[p11l824t3507r1050b3575],
34	)	CD	NUMBER	)	num	35	SENT_167	[p11l824t3507r1050b3575],
35	rash/desquamation	NN	O	rash/desquamation	dep	30	SENT_167	[p11l1097t3506r1803b3582],
36	(	CD	PERCENT	(	number	37	SENT_167	[p11l1850t3506r2140b3580],
37	13.3	CD	PERCENT	13.3	num	38	SENT_167	[p11l1850t3506r2140b3580],
38	%	NN	PERCENT	%	dep	35	SENT_167	[p11l1850t3506r2140b3580],
39	)	CD	NUMBER	)	dep	35	SENT_167	[p11l1850t3506r2140b3580],
40	,	,	O	,	_	0	SENT_167	[p11l1850t3506r2140b3580],
41	and	CC	O	and	_	0	SENT_167	[p11l12t3604r147b3664],
42	stomatitis/pharyngitis	NN	O	stomatitis/pharyngitis	conj_and	6	SENT_167	[p11l194t3604r1009b3680],
43	(	CD	PERCENT	(	number	44	SENT_167	[p11l1057t3604r1346b3673],
44	10.0	CD	PERCENT	10.0	num	45	SENT_167	[p11l1057t3604r1346b3673],
45	%	NN	PERCENT	%	dep	42	SENT_167	[p11l1057t3604r1346b3673],
46	)	CD	NUMBER	)	dep	42	SENT_167	[p11l1057t3604r1346b3673],
47	.	.	O	.	_	0	SENT_167	[p11l1057t3604r1346b3673],

1	There	EX	O	there	expl	2	SENT_168	[p11l1396t3604r1610b3664],
2	were	VBD	O	be	_	0	SENT_168	[p11l1656t3624r1831b3664],
3	no	DT	O	no	det	4	SENT_168	[p11l1877t3624r1962b3664],
4	episodes	NNS	O	episode	nsubj	2	SENT_168	[p11l2010t3605r2142b3680, p11l12t3700r205b3761],
5	of	IN	O	of	_	0	SENT_168	[p11l286t3700r359b3761],
6	ﬂuid	JJ	O	ﬂuid	amod	7	SENT_168	[p11l427t3700r596b3761],
7	retention	NN	O	retention	prep_of	4	SENT_168	[p11l675t3702r1031b3761],
8	.	.	O	.	_	0	SENT_168	[p11l675t3702r1031b3761],

1	No	DT	O	no	det	2	SENT_169	[p11l1114t3701r1215b3761],
2	patients	NNS	O	patient	nsubj	3	SENT_169	[p11l1296t3702r1594b3776],
3	discontinued	VBN	O	discontinue	_	0	SENT_169	[p11l1675t3700r2144b3761],
4	therapy	NN	O	therapy	dobj	3	SENT_169	[p12l10t17r297b93],
5	because	IN	O	because	_	0	SENT_169	[p12l347t17r634b78],
6	of	IN	O	of	prepc_because_of	3	SENT_169	[p12l688t17r760b78],
7	toxicity	NN	O	toxicity	pobj	3	SENT_169	[p12l803t19r1085b93],
8	,	,	O	,	_	0	SENT_169	[p12l803t19r1085b93],
9	and	CC	O	and	_	0	SENT_169	[p12l1142t17r1276b78],
10	there	EX	O	there	expl	11	SENT_169	[p12l1328t17r1520b78],
11	were	VBD	O	be	conj_and	3	SENT_169	[p12l1572t37r1746b78],
12	no	DT	O	no	det	14	SENT_169	[p12l1800t37r1885b78],
13	treatment-related	JJ	O	treatment-related	amod	14	SENT_169	[p12l1937t22r2141b78, p12l10t115r487b175],
14	deaths	NNS	O	death	nsubj	11	SENT_169	[p12l518t115r759b175],
15	during	IN	O	during	_	0	SENT_169	[p12l791t115r1036b191],
16	the	DT	O	the	det	17	SENT_169	[p12l1064t115r1180b175],
17	study	NN	O	study	prep_during	14	SENT_169	[p12l1213t115r1423b191],
18	.	.	O	.	_	0	SENT_169	[p12l1213t115r1423b191],

1	No	DT	O	no	det	3	SENT_170	[p12l188t212r289b272],
2	signiﬁcant	NN	O	signiﬁcant	nn	3	SENT_170	[p12l330t211r717b287],
3	differences	NNS	O	difference	nsubjpass	7	SENT_170	[p12l755t211r1151b272],
4	in	IN	O	in	_	0	SENT_170	[p12l1189t213r1261b271],
5	toxicity	NN	O	toxicity	prep_in	3	SENT_170	[p12l1298t213r1571b287],
6	were	VBD	O	be	auxpass	7	SENT_170	[p12l1607t232r1781b272],
7	observed	VBN	O	observe	_	0	SENT_170	[p12l1821t211r2144b272],
8	between	IN	O	between	_	0	SENT_170	[p12l9t308r314b369],
9	patients	NNS	O	patient	prep_between	7	SENT_170	[p12l354t310r652b384],
10	with	IN	O	with	_	0	SENT_170	[p12l692t308r857b369],
11	SNP	NN	ORGANIZATION	snp	nn	12	SENT_170	[p12l900t308r1063b369],
12	genes	NNS	O	gene	prep_with	9	SENT_170	[p12l1102t327r1307b384],
13	and	CC	O	and	_	0	SENT_170	[p12l1350t308r1484b369],
14	those	DT	O	those	conj_and	9	SENT_170	[p12l1523t308r1716b369],
15	with	IN	O	with	_	0	SENT_170	[p12l1757t308r1922b369],
16	wildtype	JJ	O	wildtype	amod	17	SENT_170	[p12l1961t308r2142b369, p12l10t412r166b482],
17	genes	NNS	O	gene	prep_with	14	SENT_170	[p12l197t426r421b481],
18	.	.	O	.	_	0	SENT_170	[p12l197t426r421b481],

1	Laryngoscope	NN	O	laryngoscope	_	0	SENT_171	[p12l14t639r517b713],
2	119	CD	NUMBER	119	num	1	SENT_171	[p12l552t639r694b697],
3	:	:	O	:	_	0	SENT_171	[p12l552t639r694b697],
4	August	NNP	DATE	August	nn	6	SENT_171	[p12l727t639r976b713],
5	2009	CD	DATE	2009	num	6	SENT_171	[p12l1007t639r1179b697],
6	SNPs	NNS	O	snp	dep	1	SENT_171	[p12l6t732r238b796],
7	and	CC	O	and	_	0	SENT_171	[p12l271t732r441b796],
8	Time	NNP	O	Time	dep	1	SENT_171	[p12l474t732r680b796],
9	to	TO	O	to	_	0	SENT_171	[p12l714t739r793b796],
10	Progression	NNP	O	Progression	prep_to	8	SENT_171	[p12l820t732r1338b812],
11	or	CC	O	or	_	0	SENT_171	[p12l1371t753r1464b796],
12	Survival	NNP	O	Survival	conj_or	10	SENT_171	[p12l1492t732r1868b796],

1	The	DT	O	the	det	3	SENT_172	[p12l187t832r326b893],
2	primary	JJ	O	primary	amod	3	SENT_172	[p12l369t834r668b908],
3	endpoint	NN	O	endpoint	nsubj	8	SENT_172	[p12l710t832r1034b908],
4	of	IN	O	of	_	0	SENT_172	[p12l1075t832r1148b893],
5	the	DT	O	the	det	7	SENT_172	[p12l1179t832r1296b893],
6	present	JJ	DATE	present	amod	7	SENT_172	[p12l1339t838r1616b908],
7	study	NN	O	study	prep_of	3	SENT_172	[p12l1659t832r1861b908],
8	was	VBD	O	be	_	0	SENT_172	[p12l1901t853r2041b893],
9	to	TO	O	to	aux	10	SENT_172	[p12l2083t838r2151b893],
10	determine	VB	O	determine	xcomp	8	SENT_172	[p12l10t929r383b990],
11	the	DT	O	the	det	12	SENT_172	[p12l461t929r578b990],
12	correlation	NN	O	correlation	dobj	10	SENT_172	[p12l657t929r1057b990],
13	between	IN	O	between	_	0	SENT_172	[p12l1133t929r1439b990],
14	SNPS	NNP	O	SNPS	prep_between	12	SENT_172	[p12l1518t929r1718b990],
15	in	IN	O	in	_	0	SENT_172	[p12l1796t931r1868b989],
16	genes	NNS	O	gene	prep_in	10	SENT_172	[p12l1945t948r2151b1005],
17	involved	VBN	O	involve	partmod	16	SENT_172	[p12l8t1027r319b1087],
18	in	IN	O	in	_	0	SENT_172	[p12l358t1028r429b1086],
19	drug	NN	O	drug	nn	20	SENT_172	[p12l471t1027r643b1102],
20	metabolism	NN	O	metabolism	prep_in	17	SENT_172	[p12l681t1027r1127b1101],
21	,	,	O	,	_	0	SENT_172	[p12l681t1027r1127b1101],
22	drug	NN	O	drug	nn	23	SENT_172	[p12l1172t1027r1344b1102],
23	transport	NN	O	transport	prep_in	17	SENT_172	[p12l1382t1032r1749b1103],
24	,	,	O	,	_	0	SENT_172	[p12l1382t1032r1749b1103],
25	and	CC	O	and	_	0	SENT_172	[p12l1794t1027r1930b1087],
26	DNA	NN	O	dna	nn	27	SENT_172	[p12l1969t1027r2154b1087],
27	repair	NN	O	repair	prep_in	17	SENT_172	[p12l8t1125r234b1199],
28	and	CC	O	and	_	0	SENT_172	[p12l264t1123r399b1184],
29	the	DT	O	the	det	30	SENT_172	[p12l429t1123r545b1184],
30	survival	NN	O	survival	prep_in	17	SENT_172	[p12l578t1123r877b1184],
31	of	IN	O	of	_	0	SENT_172	[p12l908t1123r981b1184],
32	stage	NN	O	stage	prep_of	30	SENT_172	[p12l1002t1129r1192b1199],
33	IV	CD	NUMBER	iv	num	32	SENT_172	[p12l1224t1124r1313b1184],
34	head	NN	O	head	advmod	17	SENT_172	[p12l1339t1123r1518b1184],
35	and	CC	O	and	_	0	SENT_172	[p12l1548t1123r1683b1184],
36	neck	NN	O	neck	advmod	17	SENT_172	[p12l1714t1123r1885b1184],
37	cancer	NN	O	cancer	nn	38	SENT_172	[p12l1914t1144r2153b1184],
38	patients	NNS	O	patient	dep	8	SENT_172	[p12l8t1222r308b1296],
39	treated	VBN	O	treat	partmod	38	SENT_172	[p12l372t1220r639b1281],
40	with	IN	O	with	_	0	SENT_172	[p12l702t1220r868b1281],
41	Weekly	NNP	SET	Weekly	nn	42	SENT_172	[p12l931t1220r1189b1296],
42	paclitaxel	NN	O	paclitaxel	prep_with	39	SENT_172	[p12l1252t1220r1627b1296],
43	.	.	O	.	_	0	SENT_172	[p12l1252t1220r1627b1296],

1	The	DT	O	the	det	4	SENT_173	[p12l1696t1220r1835b1281],
2	overall	JJ	O	overall	amod	4	SENT_173	[p12l1901t1220r2152b1281],
3	median	NN	O	median	nn	4	SENT_173	[p12l8t1318r282b1378],
4	survival	NN	O	survival	nsubj	10	SENT_173	[p12l323t1318r622b1378],
5	for	IN	O	for	_	0	SENT_173	[p12l661t1318r762b1378],
6	all	DT	O	all	det	7	SENT_173	[p12l802t1318r892b1378],
7	patients	NNS	O	patient	prep_for	4	SENT_173	[p12l932t1319r1231b1393],
8	was	VBD	O	be	cop	10	SENT_173	[p12l1271t1338r1412b1378],
9	5.6	CD	DURATION	5.6	num	10	SENT_173	[p12l1454t1320r1560b1378],
10	months	NNS	NUMBER	month	_	0	SENT_173	[p12l1600t1318r1893b1378],
11	.	.	O	.	_	0	SENT_173	[p12l1600t1318r1893b1378],

1	When	WRB	O	when	_	0	SENT_174	[p12l1935t1318r2152b1378],

1	TABLE	NN	O	table	nsubj	2	SENT_175	[p12l924t1587r1136b1639],
2	|	VBD	O	|	_	0	SENT_175	[p12l1167t1587r1229b1639],
3	\	CD	NUMBER	\	dep	2	SENT_175	[p12l1167t1587r1229b1639],
4	/	:	O	/	punct	3	SENT_175	[p12l1167t1587r1229b1639],
5	.	.	O	.	_	0	SENT_175	[p12l1167t1587r1229b1639],

1	Response	NN	O	response	nn	2	SENT_176	[p12l327t1676r641b1743],
2	Rates	NNS	O	rate	_	0	SENT_176	[p12l672t1676r849b1729],
3	According	VBG	O	accord	_	0	SENT_176	[p12l874t1676r1196b1743],
4	to	TO	O	to	prepc_according_to	2	SENT_176	[p12l1224t1679r1285b1729],
5	Gene	NNP	PERSON	Gene	nn	6	SENT_176	[p12l1314t1675r1480b1729],
6	Genotype	NNP	PERSON	Genotype	pobj	2	SENT_176	[p12l1509t1675r1832b1743],
7	.	.	O	.	_	0	SENT_176	[p12l1509t1675r1832b1743],

1	Gene	NNP	O	Gene	nn	2	SENT_177	[p12l9t1850r155b1897],
2	Genotype	NNP	O	Genotype	_	0	SENT_177	[p12l439t1850r709b1909],
3	No.	NN	O	no.	dep	2	SENT_177	[p12l838t1851r926b1896],
4	.	.	O	.	_	0	SENT_177	[p12l838t1851r926b1896],

1	Response	NN	O	response	_	0	SENT_178	[p12l1059t1851r1348b1908],
2	,	,	O	,	_	0	SENT_178	[p12l1059t1851r1348b1908],
3	No.	NN	O	no.	appos	1	SENT_178	[p12l1379t1851r1468b1896],
4	(	CD	PERCENT	(	num	5	SENT_178	[p12l1497t1850r1586b1908],
5	%	NN	PERCENT	%	dep	1	SENT_178	[p12l1497t1850r1586b1908],
6	)	CD	NUMBER	)	num	7	SENT_178	[p12l1497t1850r1586b1908],
7	X2	NN	O	x2	dep	5	SENT_178	[p12l1906t1838r1959b1909],

1	CYP2C8	CD	NUMBER	cyp2c8	num	2	SENT_179	[p12l9t1977r278b2031],
2	CC	NN	O	cc	_	0	SENT_179	[p12l525t1977r622b2031],
3	23	CD	PERCENT	23	num	5	SENT_179	[p12l845t1978r920b2031],
4	11	CD	PERCENT	11	num	5	SENT_179	[p12l1134t1978r1193b2030],
5	(	NN	PERCENT	(	dep	2	SENT_179	[p12l1233t1977r1475b2044],
6	47.8	CD	PERCENT	47.8	num	7	SENT_179	[p12l1233t1977r1475b2044],
7	%	NN	PERCENT	%	dep	5	SENT_179	[p12l1233t1977r1475b2044],
8	)	CD	NUMBER	)	number	9	SENT_179	[p12l1233t1977r1475b2044],
9	0.876	CD	NUMBER	0.876	num	7	SENT_179	[p12l1847t1978r2020b2031],

1	CT	NN	O	ct	dep	8	SENT_180	[p12l531t2084r620b2138],
2	16	CD	PERCENT	16	num	1	SENT_180	[p12l849t2086r920b2138],
3	7	CD	PERCENT	7	num	4	SENT_180	[p12l1170t2086r1203b2137],
4	(	NN	PERCENT	(	dep	1	SENT_180	[p12l1233t2084r1475b2151],
5	43.8	CD	PERCENT	43.8	num	6	SENT_180	[p12l1233t2084r1475b2151],
6	%	NN	PERCENT	%	dep	8	SENT_180	[p12l1233t2084r1475b2151],
7	)	CD	NUMBER	)	num	8	SENT_180	[p12l1233t2084r1475b2151],
8	TI	NNP	O	TI	dep	15	SENT_180	[p12l533t2193r615b2245],
9	’	CD	NUMBER	’	num	8	SENT_180	[p12l533t2193r615b2245],
10	8	CD	PERCENT	8	number	11	SENT_180	[p12l885t2193r920b2245],
11	3	CD	PERCENT	3	num	12	SENT_180	[p12l1169t2193r1204b2245],
12	(	NN	PERCENT	(	dep	8	SENT_180	[p12l1233t2192r1475b2259],
13	37.5	CD	PERCENT	37.5	number	14	SENT_180	[p12l1233t2192r1475b2259],
14	%	NN	PERCENT	%	amod	12	SENT_180	[p12l1233t2192r1475b2259],
15	)	CD	NUMBER	)	_	0	SENT_180	[p12l1233t2192r1475b2259],

1	GST	NN	O	gst	dep	9	SENT_181	[p12l9t2298r215b2352],
2	|	NN	O	|	dep	1	SENT_181	[p12l9t2298r215b2352],
3	'	''	O	'	_	0	SENT_181	[p12l9t2298r215b2352],
4	1	CD	NUMBER	1	number	5	SENT_181	[p12l9t2298r215b2352],
5	‘	CD	NUMBER	‘	dep	2	SENT_181	[p12l533t2299r615b2351],
6	IT	PRP	O	it	dep	9	SENT_181	[p12l533t2299r615b2351],
7	45	CD	NUMBER	45	number	8	SENT_181	[p12l845t2299r920b2352],
8	20	CD	NUMBER	20	num	9	SENT_181	[p12l1129t2299r1204b2352],
9	(	NN	O	(	dep	13	SENT_181	[p12l1233t2298r1475b2365],
10	44.4	CD	PERCENT	44.4	num	11	SENT_181	[p12l1233t2298r1475b2365],
11	%	NN	PERCENT	%	dep	9	SENT_181	[p12l1233t2298r1475b2365],
12	)	CD	NUMBER	)	num	13	SENT_181	[p12l1233t2298r1475b2365],
13	0.359	CD	NUMBER	0.359	_	0	SENT_181	[p12l1847t2299r2019b2352],

1	TC	NN	O	tc	dep	8	SENT_182	[p12l528t2405r618b2459],
2	1	CD	PERCENT	1	num	1	SENT_182	[p12l889t2407r909b2458],
3	1	CD	PERCENT	1	num	4	SENT_182	[p12l1173t2407r1192b2458],
4	(	NN	PERCENT	(	dep	1	SENT_182	[p12l1233t2405r1513b2472],
5	100.0	CD	PERCENT	100.0	num	6	SENT_182	[p12l1233t2405r1513b2472],
6	%	NN	PERCENT	%	dep	8	SENT_182	[p12l1233t2405r1513b2472],
7	)	CD	NUMBER	)	num	8	SENT_182	[p12l1233t2405r1513b2472],
8	CC	NN	ORGANIZATION	cc	dep	13	SENT_182	[p12l525t2512r622b2566],
9	1	CD	NUMBER	1	num	12	SENT_182	[p12l889t2513r909b2565],
10	o	NN	O	o	nn	12	SENT_182	[p12l1170t2513r1204b2565],
11	(	NN	O	(	nn	12	SENT_182	[p12l1233t2512r1375b2579],
12	o	NN	O	o	dep	8	SENT_182	[p12l1233t2512r1375b2579],
13	%	NN	O	%	_	0	SENT_182	[p12l1233t2512r1375b2579],
14	)	CD	NUMBER	)	num	13	SENT_182	[p12l1233t2512r1375b2579],

1	GSTP1	NN	O	gstp1	nn	2	SENT_183	[p12l9t2619r220b2673],
2	AA	NN	O	aa	_	0	SENT_183	[p12l527t2620r621b2672],
3	36	CD	PERCENT	36	number	4	SENT_183	[p12l845t2620r920b2673],
4	15	CD	PERCENT	15	num	5	SENT_183	[p12l1134t2620r1204b2673],
5	(	NN	PERCENT	(	dep	2	SENT_183	[p12l1233t2619r1475b2686],
6	41.7	CD	PERCENT	41.7	num	7	SENT_183	[p12l1233t2619r1475b2686],
7	%	NN	PERCENT	%	dep	5	SENT_183	[p12l1233t2619r1475b2686],
8	)	CD	NUMBER	)	number	9	SENT_183	[p12l1233t2619r1475b2686],
9	0.227	CD	NUMBER	0.227	num	7	SENT_183	[p12l1847t2620r2019b2673],

1	AG	NNP	ORGANIZATION	AG	dep	11	SENT_184	[p12l523t2726r620b2780],
2	6	CD	PERCENT	6	number	3	SENT_184	[p12l885t2728r920b2780],
3	2	CD	PERCENT	2	dep	1	SENT_184	[p12l1168t2728r1202b2779],
4	(	CD	PERCENT	(	num	6	SENT_184	[p12l1233t2726r1475b2793],
5	33.3	CD	PERCENT	33.3	num	6	SENT_184	[p12l1233t2726r1475b2793],
6	%	NN	PERCENT	%	dep	3	SENT_184	[p12l1233t2726r1475b2793],
7	)	CD	NUMBER	)	num	8	SENT_184	[p12l1233t2726r1475b2793],
8	GG	NNS	O	gg	dep	11	SENT_184	[p12l522t2833r624b2887],
9	5	CD	NUMBER	5	number	10	SENT_184	[p12l885t2835r920b2886],
10	4	CD	NUMBER	4	num	11	SENT_184	[p12l1168t2834r1204b2886],
11	(	NN	O	(	dep	14	SENT_184	[p12l1233t2833r1475b2900],
12	80.0	CD	PERCENT	80.0	num	13	SENT_184	[p12l1233t2833r1475b2900],
13	%	NN	PERCENT	%	dep	11	SENT_184	[p12l1233t2833r1475b2900],
14	)	CD	NUMBER	)	_	0	SENT_184	[p12l1233t2833r1475b2900],

1	MDR1-62	NN	O	mdr1-62	nn	2	SENT_185	[p12l12t2941r311b2994],
2	CC	NN	O	cc	_	0	SENT_185	[p12l525t2940r622b2994],
3	21	CD	NUMBER	21	num	5	SENT_185	[p12l845t2941r909b2993],
4	5	CD	NUMBER	5	num	5	SENT_185	[p12l1169t2942r1203b2994],
5	(	NN	O	(	dep	2	SENT_185	[p12l1233t2940r1475b3007],
6	23.8	CD	PERCENT	23.8	num	7	SENT_185	[p12l1233t2940r1475b3007],
7	%	NN	PERCENT	%	dep	5	SENT_185	[p12l1233t2940r1475b3007],
8	)	CD	NUMBER	)	number	9	SENT_185	[p12l1233t2940r1475b3007],
9	0.017	CD	NUMBER	0.017	num	7	SENT_185	[p12l1847t2941r2019b2994],

1	CT	NN	O	ct	dep	8	SENT_186	[p12l531t3047r620b3101],
2	17	CD	NUMBER	17	num	1	SENT_186	[p12l849t3049r920b3100],
3	9	CD	NUMBER	9	num	4	SENT_186	[p12l1169t3049r1204b3101],
4	(	NN	O	(	dep	1	SENT_186	[p12l1233t3047r1475b3114],
5	52.9	CD	PERCENT	52.9	num	6	SENT_186	[p12l1233t3047r1475b3114],
6	%	NN	PERCENT	%	dep	8	SENT_186	[p12l1233t3047r1475b3114],
7	)	CD	NUMBER	)	num	8	SENT_186	[p12l1233t3047r1475b3114],
8	TI	NNP	O	TI	dep	15	SENT_186	[p12l533t3140r615b3192],
9	’	CD	NUMBER	’	num	8	SENT_186	[p12l533t3140r615b3192],
10	9	CD	NUMBER	9	number	11	SENT_186	[p12l885t3140r920b3192],
11	7	CD	PERCENT	7	num	12	SENT_186	[p12l1170t3141r1203b3192],
12	(	NN	PERCENT	(	dep	8	SENT_186	[p12l1233t3139r1475b3206],
13	77.8	CD	PERCENT	77.8	num	14	SENT_186	[p12l1233t3139r1475b3206],
14	%	NN	PERCENT	%	dep	12	SENT_186	[p12l1233t3139r1475b3206],
15	)	CD	NUMBER	)	_	0	SENT_186	[p12l1233t3139r1475b3206],

1	MDR1-57	NN	O	mdr1-57	nn	2	SENT_187	[p12l12t3226r312b3279],
2	CC	NN	O	cc	_	0	SENT_187	[p12l525t3225r622b3279],
3	13	CD	PERCENT	13	number	4	SENT_187	[p12l849t3226r920b3279],
4	3	CD	PERCENT	3	num	5	SENT_187	[p12l1169t3226r1204b3279],
5	(	NN	PERCENT	(	dep	2	SENT_187	[p12l1233t3225r1475b3292],
6	23.1	CD	PERCENT	23.1	num	7	SENT_187	[p12l1233t3225r1475b3292],
7	%	NN	PERCENT	%	dep	2	SENT_187	[p12l1233t3225r1475b3292],
8	)	CD	NUMBER	)	number	9	SENT_187	[p12l1233t3225r1475b3292],
9	0.090	CD	NUMBER	0.090	num	10	SENT_187	[p12l1715t3226r1888b3279],
10	(	NN	O	(	dep	7	SENT_187	[p12l1917t3225r2152b3292],
11	0.030	CD	NUMBER	0.030	number	12	SENT_187	[p12l1917t3225r2152b3292],
12	)	CD	NUMBER	)	num	13	SENT_187	[p12l1917t3225r2152b3292],
13	*	NN	O	*	dep	7	SENT_187	[p12l1917t3225r2152b3292],

1	CT	NN	O	ct	dep	8	SENT_188	[p12l531t3332r620b3386],
2	22	CD	PERCENT	22	num	1	SENT_188	[p12l845t3334r918b3385],
3	10	CD	PERCENT	10	num	4	SENT_188	[p12l1134t3334r1204b3386],
4	(	NN	PERCENT	(	dep	1	SENT_188	[p12l1233t3332r1475b3399],
5	45.5	CD	PERCENT	45.5	num	6	SENT_188	[p12l1233t3332r1475b3399],
6	%	NN	PERCENT	%	dep	8	SENT_188	[p12l1233t3332r1475b3399],
7	)	CD	NUMBER	)	num	8	SENT_188	[p12l1233t3332r1475b3399],
8	TI	NNP	O	TI	dep	15	SENT_188	[p12l533t3440r615b3492],
9	’	CD	NUMBER	’	num	8	SENT_188	[p12l533t3440r615b3492],
10	12	CD	NUMBER	12	number	11	SENT_188	[p12l849t3440r918b3492],
11	8	CD	PERCENT	8	num	12	SENT_188	[p12l1169t3440r1204b3492],
12	(	NN	PERCENT	(	dep	8	SENT_188	[p12l1233t3439r1475b3506],
13	66.7	CD	PERCENT	66.7	number	14	SENT_188	[p12l1233t3439r1475b3506],
14	%	NN	PERCENT	%	amod	12	SENT_188	[p12l1233t3439r1475b3506],
15	)	CD	NUMBER	)	_	0	SENT_188	[p12l1233t3439r1475b3506],

1	ERCC1	NN	O	ercc1	nn	2	SENT_189	[p12l12t3546r228b3600],
2	AA	NN	O	aa	_	0	SENT_189	[p12l527t3547r621b3599],
3	27	CD	PERCENT	27	num	5	SENT_189	[p12l845t3547r920b3599],
4	12	CD	PERCENT	12	num	5	SENT_189	[p12l1134t3547r1203b3599],
5	(	NN	PERCENT	(	dep	2	SENT_189	[p12l1233t3546r1475b3613],
6	44.4	CD	PERCENT	44.4	num	7	SENT_189	[p12l1233t3546r1475b3613],
7	%	NN	PERCENT	%	dep	5	SENT_189	[p12l1233t3546r1475b3613],
8	)	CD	NUMBER	)	number	9	SENT_189	[p12l1233t3546r1475b3613],
9	0.691	CD	NUMBER	0.691	num	7	SENT_189	[p12l1847t3547r2008b3600],

1	AC	NN	ORGANIZATION	ac	_	0	SENT_190	[p12l524t3653r620b3707],
2	9	CD	NUMBER	9	number	3	SENT_190	[p12l885t3655r920b3707],
3	5	CD	NUMBER	5	num	4	SENT_190	[p12l1169t3655r1203b3707],
4	(	NN	O	(	dep	1	SENT_190	[p12l1233t3653r1475b3720],
5	55.6	CD	PERCENT	55.6	number	6	SENT_190	[p12l1233t3653r1475b3720],
6	%	NN	PERCENT	%	amod	4	SENT_190	[p12l1233t3653r1475b3720],
7	)	CD	NUMBER	)	dep	1	SENT_190	[p12l1233t3653r1475b3720],

1	cc	NN	O	cc	_	0	SENT_191	[p13l525t27r622b81],
2	11	CD	NUMBER	11	number	3	SENT_191	[p13l849t28r909b80],
3	4	CD	NUMBER	4	num	4	SENT_191	[p13l1168t28r1204b80],
4	(	NN	O	(	dep	1	SENT_191	[p13l1233t27r1475b94],
5	36.4	CD	PERCENT	36.4	number	6	SENT_191	[p13l1233t27r1475b94],
6	%	NN	PERCENT	%	amod	4	SENT_191	[p13l1233t27r1475b94],
7	)	CD	NUMBER	)	dep	1	SENT_191	[p13l1233t27r1475b94],

1	*	NN	O	*	_	0	SENT_192	[p13l187t173r368b219],
2	Linea	NNP	O	Linea	nn	4	SENT_192	[p13l187t173r368b219],
3	|	CD	NUMBER	|	num	4	SENT_192	[p13l187t173r368b219],
4	test	NN	O	test	dep	1	SENT_192	[p13l393t176r510b219],
5	.	.	O	.	_	0	SENT_192	[p13l393t176r510b219],

1	Grau	NNP	PERSON	Grau	nn	3	SENT_193	[p13l480t380r648b441],
2	et	NNP	O	et	nn	3	SENT_193	[p13l682t385r746b440],
3	aI.	NNP	O	aI.	_	0	SENT_193	[p13l778t382r875b440],
4	:	:	O	:	_	0	SENT_193	[p13l778t382r875b440],
5	Advanced	NNP	O	Advanced	nn	6	SENT_193	[p13l908t382r1266b440],
6	Head	NNP	O	Head	dep	3	SENT_193	[p13l1304t382r1485b440],
7	and	CC	O	and	_	0	SENT_193	[p13l1520t382r1648b440],
8	Neck	NNP	O	Neck	nn	9	SENT_193	[p13l1686t382r1867b440],
9	Cancer	NNP	O	Cancer	dep	3	SENT_193	[p13l1897t380r2154b441],
10	1487	CD	DATE	1487	num	9	SENT_193	[p13l1963t500r2150b565],

1	H	NN	O	h	_	0	SENT_194	[p13l1250t1793r1325b1852],
2	least	JJS	O	least	dep	1	SENT_194	[p13l1351t1793r1507b1852],
3	2	CD	NUMBER	2	num	5	SENT_194	[p13l1523t1793r1561b1852],
4	SH	NN	O	sh	nn	5	SENT_194	[p13l1582t1793r1673b1852],
5	P5	NN	O	p5	dep	1	SENT_194	[p13l1683t1793r1764b1852],

1	Fig	NN	O	fig	_	0	SENT_195	[p13l10t2629r117b2695],
2	.	.	O	.	_	0	SENT_195	[p13l10t2629r117b2695],

1	1	LS	NUMBER	1	_	0	SENT_196	[p13l153t2629r201b2680],
2	.	.	O	.	_	0	SENT_196	[p13l153t2629r201b2680],

1	Overall	JJ	O	overall	amod	2	SENT_197	[p13l234t2627r449b2681],
2	survival	NN	O	survival	nsubj	11	SENT_197	[p13l480t2629r713b2680],
3	was	VBD	O	be	cop	5	SENT_197	[p13l743t2642r868b2680],
4	significantly	RB	O	significantly	advmod	5	SENT_197	[p13l896t2628r1267b2694],
5	higher	JJR	O	higher	dep	30	SENT_197	[p13l1296t2629r1489b2695],
6	in	IN	O	in	_	0	SENT_197	[p13l1518t2629r1564b2680],
7	patients	NNS	O	patient	prep_in	5	SENT_197	[p13l1598t2629r1846b2694],
8	with	IN	O	with	_	0	SENT_197	[p13l1873t2629r1999b2680],
9	two	CD	NUMBER	two	prep_with	7	SENT_197	[p13l2028t2631r2143b2680],
10	or	CC	O	or	_	0	SENT_197	[p13l8t2721r70b2759],
11	more	JJR	O	more	conj_or	5	SENT_197	[p13l124t2721r281b2759],
12	accumulated	VBN	O	accumulate	amod	14	SENT_197	[p13l335t2708r740b2759],
13	gene	NN	O	gene	nn	14	SENT_197	[p13l797t2721r951b2774],
14	polymorphisms	NNS	O	polymorphism	nsubj	15	SENT_197	[p13l1007t2708r1489b2773],
15	(	VBP	O	(	conj_or	15	SENT_197	[p13l1543t2706r1594b2773],
16	n	NN	O	n	dobj	15	SENT_197	[p13l1543t2706r1594b2773],
17	=	JJ	O	=	amod	16	SENT_197	[p13l1652t2732r1700b2750],
18	36	CD	NUMBER	36	num	19	SENT_197	[p13l1755t2706r1848b2773],
19	)	NN	O	)	npadvmod	20	SENT_197	[p13l1755t2706r1848b2773],
20	than	IN	O	than	prep	15	SENT_197	[p13l1901t2708r2036b2759],
21	in	IN	O	in	_	0	SENT_197	[p13l2095t2708r2141b2759],
22	patients	NNS	O	patient	prep_in	15	SENT_197	[p13l10t2786r258b2851],
23	wild-type	JJ	O	wild-type	amod	22	SENT_197	[p13l284t2786r575b2852],
24	or	CC	O	or	_	0	SENT_197	[p13l603t2799r665b2838],
25	with	IN	O	with	_	0	SENT_197	[p13l689t2786r816b2837],
26	only	RB	O	only	quantmod	27	SENT_197	[p13l846t2786r974b2852],
27	one	CD	NUMBER	one	num	29	SENT_197	[p13l1000t2799r1115b2838],
28	gene	NN	O	gene	nn	29	SENT_197	[p13l1143t2799r1296b2852],
29	polymorphisms	NNS	O	polymorphism	prep_with	15	SENT_197	[p13l1325t2786r1808b2852],
30	(	VBP	O	(	_	0	SENT_197	[p13l1836t2785r1887b2851],
31	n	NN	O	n	nsubj	32	SENT_197	[p13l1836t2785r1887b2851],
32	=	JJ	O	=	xcomp	30	SENT_197	[p13l1918t2811r1966b2828],
33	11	CD	NUMBER	11	num	34	SENT_197	[p13l1999t2785r2104b2851],
34	)	NN	O	)	nsubj	30	SENT_197	[p13l1999t2785r2104b2851],
35	.	.	O	.	_	0	SENT_197	[p13l1999t2785r2104b2851],

1	We	PRP	O	we	nsubj	2	SENT_198	[p13l6t3033r106b3073],
2	analyzed	VBD	O	analyze	ccomp	24	SENT_198	[p13l152t3013r479b3089],
3	the	DT	O	the	det	4	SENT_198	[p13l521t3013r638b3073],
4	relationship	NN	O	relationship	dobj	2	SENT_198	[p13l682t3013r1126b3089],
5	between	IN	O	between	_	0	SENT_198	[p13l1170t3013r1475b3073],
6	SNPs	NNS	O	snp	prep_between	4	SENT_198	[p13l1522t3013r1720b3073],
7	in	IN	O	in	_	0	SENT_198	[p13l1765t3014r1837b3072],
8	the	DT	O	the	det	10	SENT_198	[p13l1880t3013r1996b3073],
9	six	CD	NUMBER	six	num	10	SENT_198	[p13l2043t3014r2144b3073],
10	genes	NNS	O	gene	prep_in	6	SENT_198	[p13l7t3129r212b3185],
11	individually	RB	O	individually	advmod	2	SENT_198	[p13l245t3109r690b3185],
12	with	IN	O	with	_	0	SENT_198	[p13l721t3109r886b3170],
13	overall	JJ	O	overall	amod	14	SENT_198	[p13l919t3109r1169b3170],
14	survival	NN	O	survival	prep_with	2	SENT_198	[p13l1203t3109r1501b3170],
15	and	CC	O	and	_	0	SENT_198	[p13l1535t3109r1670b3170],
16	time	NN	O	time	conj_and	14	SENT_198	[p13l1701t3111r1865b3170],
17	to	TO	O	to	_	0	SENT_198	[p13l1897t3115r1965b3170],
18	progression	NN	O	progression	prep_to	2	SENT_198	[p13l1998t3130r2141b3185, p13l7t3208r330b3282],
19	,	,	O	,	_	0	SENT_198	[p13l1998t3130r2141b3185, p13l7t3208r330b3282],
20	no	DT	O	no	det	22	SENT_198	[p13l379t3226r464b3267],
21	signiﬁcant	JJ	O	signiﬁcant	amod	22	SENT_198	[p13l513t3206r900b3282],
22	differences	NNS	O	difference	nsubjpass	24	SENT_198	[p13l946t3206r1342b3267],
23	were	VBD	O	be	auxpass	24	SENT_198	[p13l1389t3226r1564b3267],
24	observed	VBN	O	observe	_	0	SENT_198	[p13l1611t3206r1934b3267],
25	with	IN	O	with	_	0	SENT_198	[p13l1978t3206r2143b3267],
26	regard	NN	O	regard	prep_with	24	SENT_198	[p13l7t3304r250b3380],
27	to	TO	O	to	_	0	SENT_198	[p13l283t3309r350b3364],
28	the	DT	O	the	det	30	SENT_198	[p13l383t3304r500b3364],
29	homozygous	JJ	O	homozygous	amod	30	SENT_198	[p13l534t3304r982b3380],
30	wild-type	JJ	O	wild-type	prep_to	24	SENT_198	[p13l1016t3304r1377b3380],
31	.	.	O	.	_	0	SENT_198	[p13l1016t3304r1377b3380],

1	To	TO	O	to	aux	2	SENT_199	[p13l1415t3305r1498b3364],
2	establish	VB	O	establish	purpcl	24	SENT_199	[p13l1533t3304r1862b3364],
3	phenotypes	NNS	O	phenotype	dobj	2	SENT_199	[p13l1895t3304r2142b3380, p13l7t3406r200b3476],
4	of	IN	O	of	_	0	SENT_199	[p13l243t3400r315b3461],
5	genes	NNS	O	gene	prep_of	3	SENT_199	[p13l346t3420r552b3476],
6	in	IN	O	in	_	0	SENT_199	[p13l593t3402r665b3460],
7	combinations	NNS	O	combination	prep_in	2	SENT_199	[p13l706t3400r1193b3461],
8	that	WDT	O	that	nsubj	11	SENT_199	[p13l1235t3400r1388b3461],
9	might	MD	O	might	aux	11	SENT_199	[p13l1428t3400r1645b3476],
10	be	VB	O	be	cop	11	SENT_199	[p13l1684t3400r1766b3461],
11	useful	JJ	O	useful	rcmod	7	SENT_199	[p13l1807t3400r2031b3461],
12	in	IN	O	in	_	0	SENT_199	[p13l2072t3402r2143b3460],
13	selecting	VBG	O	select	prepc_in	11	SENT_199	[p13l9t3497r332b3573],
14	patients	NNS	O	patient	dobj	13	SENT_199	[p13l371t3499r669b3573],
15	who	WP	O	who	nsubj	17	SENT_199	[p13l710t3497r859b3558],
16	would	MD	O	would	aux	17	SENT_199	[p13l899t3497r1120b3558],
17	respond	VB	O	respond	rcmod	14	SENT_199	[p13l1159t3497r1450b3573],
18	best	RB	O	best	advmod	17	SENT_199	[p13l1489t3497r1640b3558],
19	to	TO	O	to	_	0	SENT_199	[p13l1678t3502r1746b3558],
20	paclitaxel	NN	O	paclitaxel	nn	21	SENT_199	[p13l1787t3497r2143b3573],
21	treatment	NN	O	treatment	prep_to	17	SENT_199	[p13l7t3600r397b3669],
22	,	,	O	,	_	0	SENT_199	[p13l7t3600r397b3669],
23	we	PRP	O	we	nsubj	24	SENT_199	[p13l429t3615r528b3655],
24	studied	VBD	O	study	_	0	SENT_199	[p13l560t3595r829b3655],
25	combinations	NNS	O	combination	dobj	24	SENT_199	[p13l860t3595r1347b3655],
26	of	IN	O	of	_	0	SENT_199	[p13l1378t3595r1450b3655],
27	genotypes	NNS	O	genotype	prep_of	25	SENT_199	[p13l1470t3600r1855b3671],
28	.	.	O	.	_	0	SENT_199	[p13l1470t3600r1855b3671],

1	Exploring	VBG	O	explore	partmod	13	SENT_200	[p13l186t3691r550b3767],
2	the	DT	O	the	det	3	SENT_200	[p13l593t3691r709b3752],
3	impact	NN	O	impact	dobj	1	SENT_200	[p13l755t3693r1006b3767],
4	of	IN	O	of	_	0	SENT_200	[p13l1051t3691r1124b3752],
5	increasing	VBG	O	increase	prepc_of	3	SENT_200	[p13l1158t3693r1542b3767],
6	the	DT	O	the	det	7	SENT_200	[p13l1585t3691r1702b3752],
7	number	NN	O	number	dobj	5	SENT_200	[p13l1748t3691r2036b3752],
8	of	IN	O	of	_	0	SENT_200	[p13l2080t3691r2153b3752],
9	variant	JJ	O	variant	amod	10	SENT_200	[p14l6t19r278b78],
10	genotypes	NNS	O	genotype	prep_of	7	SENT_200	[p14l307t22r693b93],
11	,	,	O	,	_	0	SENT_200	[p14l307t22r693b93],
12	we	PRP	O	we	nsubj	13	SENT_200	[p14l726t37r825b78],
13	found	VBD	O	find	_	0	SENT_200	[p14l856t17r1065b78],
14	that	IN	O	that	complm	32	SENT_200	[p14l1094t17r1248b78],
15	if	IN	O	if	mark	17	SENT_200	[p14l1277t17r1335b77],
16	we	PRP	O	we	nsubj	17	SENT_200	[p14l1355t37r1454b78],
17	analyzed	VBD	O	analyze	advcl	32	SENT_200	[p14l1487t17r1814b93],
18	patients	NNS	O	patient	dobj	17	SENT_200	[p14l1844t19r2142b93],
19	with	IN	O	with	_	0	SENT_200	[p14l6t116r172b176],
20	at	IN	O	at	quantmod	22	SENT_200	[p14l203t121r274b176],
21	least	JJS	O	least	mwe	20	SENT_200	[p14l302t116r478b176],
22	two	CD	NUMBER	two	num	23	SENT_200	[p14l505t121r635b176],
23	genes	NNS	O	gene	prep_with	17	SENT_200	[p14l666t135r871b191],
24	with	IN	O	with	_	0	SENT_200	[p14l900t116r1066b176],
25	some	DT	O	some	det	26	SENT_200	[p14l1097t136r1279b176],
26	SNPs	NNS	O	snp	prep_with	17	SENT_200	[p14l1311t116r1531b190],
27	,	,	O	,	_	0	SENT_200	[p14l1311t116r1531b190],
28	overall	JJ	O	overall	amod	29	SENT_200	[p14l1565t116r1814b176],
29	survival	NN	O	survival	nsubj	32	SENT_200	[p14l1846t116r2144b176],
30	was	VBD	O	be	cop	32	SENT_200	[p14l6t233r146b273],
31	signiﬁcantly	RB	O	signiﬁcantly	advmod	32	SENT_200	[p14l202t212r658b288],
32	better	JJR	O	better	ccomp	13	SENT_200	[p14l707t212r928b273],
33	than	IN	O	than	prep	32	SENT_200	[p14l978t212r1150b273],
34	in	IN	O	in	pcomp	33	SENT_200	[p14l1201t214r1273b272],
35	wild-type	JJ	O	wild-type	amod	36	SENT_200	[p14l1324t212r1666b288],
36	patients	NNS	O	patient	pobj	34	SENT_200	[p14l1719t214r2017b288],
37	or	CC	O	or	_	0	SENT_200	[p14l2072t233r2144b273],
38	patients	NNS	O	patient	ccomp	13	SENT_200	[p14l7t311r306b385],
39	with	IN	O	with	_	0	SENT_200	[p14l344t309r510b370],
40	an	DT	O	a	det	41	SENT_200	[p14l550t329r639b370],
41	SNP	NN	ORGANIZATION	snp	prep_with	38	SENT_200	[p14l679t309r843b370],
42	in	IN	O	in	_	0	SENT_200	[p14l880t311r952b369],
43	only	RB	O	only	advmod	47	SENT_200	[p14l991t309r1146b385],
44	one	CD	NUMBER	one	num	46	SENT_200	[p14l1184t329r1308b370],
45	gene	NN	O	gene	nn	46	SENT_200	[p14l1348t328r1516b385],
46	(	NN	O	(	pobj	43	SENT_200	[p14l1557t309r1634b378],
47	P	NN	O	p	prep_in	41	SENT_200	[p14l1557t309r1634b378],
48	=	JJ	O	=	amod	47	SENT_200	[p14l1674t339r1727b358],
49	.039	CD	NUMBER	.039	tmod	48	SENT_200	[p14l1762t309r1936b378],
50	)	CD	NUMBER	)	number	51	SENT_200	[p14l1762t309r1936b378],
51	(	CD	NUMBER	(	num	52	SENT_200	[p14l1976t309r2138b385],
52	Fig	NN	O	fig	dep	32	SENT_200	[p14l1976t309r2138b385],
53	.	.	O	.	_	0	SENT_200	[p14l1976t309r2138b385],

1	1	CD	NUMBER	1	_	0	SENT_201	[p14l13t406r93b475],
2	)	NN	O	)	dep	1	SENT_201	[p14l13t406r93b475],
3	.	.	O	.	_	0	SENT_201	[p14l13t406r93b475],

1	No	DT	O	no	det	4	SENT_202	[p14l135t407r236b467],
2	statistically	RB	O	statistically	advmod	3	SENT_202	[p14l277t406r707b482],
3	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_202	[p14l746t406r1133b482],
4	differences	NNS	O	difference	nsubjpass	6	SENT_202	[p14l1171t406r1568b467],
5	were	VBD	O	be	auxpass	6	SENT_202	[p14l1606t426r1781b467],
6	observed	VBN	O	observe	_	0	SENT_202	[p14l1821t406r2144b467],
7	in	IN	O	in	_	0	SENT_202	[p14l7t505r78b563],
8	time	NN	O	time	prep_in	6	SENT_202	[p14l122t505r285b564],
9	to	TO	O	to	_	0	SENT_202	[p14l330t509r397b564],
10	progression	NN	O	progression	prep_to	6	SENT_202	[p14l443t505r869b580],
11	when	WRB	O	when	advmod	13	SENT_202	[p14l912t504r1111b564],
12	we	PRP	O	we	nsubj	13	SENT_202	[p14l1154t524r1253b564],
13	selected	VBD	O	select	advcl	6	SENT_202	[p14l1301t504r1591b564],
14	patients	NNS	O	patient	dobj	13	SENT_202	[p14l1635t505r1933b580],
15	with	IN	O	with	_	0	SENT_202	[p14l1978t504r2143b564],
16	two	CD	NUMBER	two	num	19	SENT_202	[p14l7t606r137b661],
17	or	CC	O	or	_	0	SENT_202	[p14l168t621r241b661],
18	more	JJR	O	more	num	19	SENT_202	[p14l270t621r452b661],
19	polymorphisms	NNS	O	polymorphism	prep_with	13	SENT_202	[p14l483t600r1045b676],
20	(	CD	NUMBER	(	num	21	SENT_202	[p14l1077t601r1154b669],
21	P	NN	O	p	dep	19	SENT_202	[p14l1077t601r1154b669],
22	:	:	O	:	_	0	SENT_202	[p14l1185t630r1239b649],
23	.522	CD	NUMBER	.522	num	24	SENT_202	[p14l1264t601r1457b670],
24	)	NN	O	)	dep	19	SENT_202	[p14l1264t601r1457b670],
25	.	.	O	.	_	0	SENT_202	[p14l1264t601r1457b670],

1	The	DT	O	the	det	5	SENT_203	[p14l185t697r324b758],
2	Cox	NN	ORGANIZATION	cox	nn	5	SENT_203	[p14l369t697r506b758],
3	univariate	JJ	O	univariate	amod	5	SENT_203	[p14l546t699r930b758],
4	regression	NN	O	regression	nn	5	SENT_203	[p14l973t699r1353b773],
5	analysis	NN	O	analysis	nsubj	8	SENT_203	[p14l1396t697r1695b773],
6	of	IN	O	of	_	0	SENT_203	[p14l1739t697r1811b758],
7	survival	NN	O	survival	prep_of	5	SENT_203	[p14l1846t697r2143b758],
8	showed	VBD	O	show	_	0	SENT_203	[p14l9t796r279b856],
9	statistical	JJ	O	statistical	amod	10	SENT_203	[p14l352t796r712b856],
10	signiﬁcance	NN	O	signiﬁcance	dobj	8	SENT_203	[p14l786t796r1215b871],
11	only	RB	O	only	advmod	10	SENT_203	[p14l1289t796r1444b871],
12	in	IN	O	in	_	0	SENT_203	[p14l1513t797r1585b855],
13	the	DT	O	the	det	16	SENT_203	[p14l1656t796r1772b856],
14	Variable	JJ	O	variable	amod	16	SENT_203	[p14l1843t796r2142b856],
15	“	NN	O	“	nn	16	SENT_203	[p14l7t892r328b953],
16	number	NN	O	number	prep_in	10	SENT_203	[p14l7t892r328b953],
17	of	IN	O	of	_	0	SENT_203	[p14l366t892r438b953],
18	accumulated	VBN	O	accumulate	amod	19	SENT_203	[p14l470t892r937b953],
19	SNPs	NNS	O	snp	prep_of	16	SENT_203	[p14l978t892r1211b953],
20	”	CD	NUMBER	”	number	21	SENT_203	[p14l978t892r1211b953],
21	(	CD	NUMBER	(	num	23	SENT_203	[p14l1252t892r1619b968],
22	wild-type	JJ	O	wild-type	amod	23	SENT_203	[p14l1252t892r1619b968],
23	genes	NNS	O	gene	dep	10	SENT_203	[p14l1659t912r1864b968],
24	or	CC	O	or	_	0	SENT_203	[p14l1906t913r1979b953],
25	one	CD	NUMBER	one	num	26	SENT_203	[p14l2018t913r2142b953],
26	SNP	NN	O	snp	conj_or	23	SENT_203	[p14l9t990r173b1050],
27	vs.	IN	O	vs.	_	0	SENT_203	[p14l201t1010r297b1050],
28	two	CD	NUMBER	two	num	32	SENT_203	[p14l331t995r461b1050],
29	or	CC	O	or	_	0	SENT_203	[p14l493t1010r565b1050],
30	more	JJR	O	more	conj_or	28	SENT_203	[p14l593t1010r776b1050],
31	accumulated	VBN	O	accumulate	amod	32	SENT_203	[p14l809t990r1276b1050],
32	SNPs	NNS	O	snp	prep_vs.	26	SENT_203	[p14l1308t990r1534b1058],
33	)	CD	NUMBER	)	number	34	SENT_203	[p14l1308t990r1534b1058],
34	(	CD	NUMBER	(	dep	10	SENT_203	[p14l1565t990r1790b1058],
35	Table	NNP	O	Table	nn	37	SENT_203	[p14l1565t990r1790b1058],
36	V	NNP	O	V	nn	37	SENT_203	[p14l1818t990r1919b1058],
37	)	NN	O	)	dep	34	SENT_203	[p14l1818t990r1919b1058],
38	.	.	O	.	_	0	SENT_203	[p14l1818t990r1919b1058],

1	In	IN	O	in	dep	105	SENT_204	[p14l187t1088r264b1146],
2	the	DT	O	the	dep	105	SENT_204	[p14l295t1087r411b1147],
3	Cox	NN	O	cox	dep	105	SENT_204	[p14l444t1087r582b1147],
4	multivariate	JJ	O	multivariate	dep	105	SENT_204	[p14l611t1087r1072b1147],
5	regression	NN	O	regression	dep	105	SENT_204	[p14l1104t1088r1484b1162],
6	analysis	NN	O	analysis	dep	105	SENT_204	[p14l1517t1087r1816b1162],
7	comparing	VBG	O	compare	dep	105	SENT_204	[p14l1848t1107r2142b1162, p14l7t1185r123b1259],
8	age	NN	O	age	dep	105	SENT_204	[p14l184t1203r306b1259],
9	59	CD	DURATION	59	dep	105	SENT_204	[p14l369t1186r451b1244],
10	years	NNS	NUMBER	year	dep	105	SENT_204	[p14l512t1204r709b1259],
11	or	CC	O	or	dep	105	SENT_204	[p14l772t1204r845b1244],
12	less	JJR	O	less	dep	105	SENT_204	[p14l904t1183r1039b1244],
13	versus	CC	O	versus	dep	105	SENT_204	[p14l1099t1204r1338b1244],
14	60	CD	DURATION	60	dep	105	SENT_204	[p14l1401t1186r1484b1244],
15	years	NNS	NUMBER	year	dep	105	SENT_204	[p14l1544t1204r1742b1259],
16	or	CC	O	or	dep	105	SENT_204	[p14l1805t1204r1877b1244],
17	more	JJR	O	more	dep	105	SENT_204	[p14l1937t1204r2140b1257],
18	,	,	O	,	_	0	SENT_204	[p14l1937t1204r2140b1257],
19	performance	NN	O	performance	dep	105	SENT_204	[p14l7t1280r467b1356],
20	status	NN	O	status	dep	105	SENT_204	[p14l500t1285r723b1341],
21	1	CD	NUMBER	1	dep	105	SENT_204	[p14l760t1282r792b1340],
22	versus	CC	O	versus	dep	105	SENT_204	[p14l822t1300r1061b1341],
23	2	CD	NUMBER	2	dep	105	SENT_204	[p14l1093t1282r1153b1354],
24	,	,	O	,	_	0	SENT_204	[p14l1093t1282r1153b1354],
25	gender	NN	O	gender	dep	105	SENT_204	[p14l1185t1280r1450b1356],
26	,	,	O	,	_	0	SENT_204	[p14l1185t1280r1450b1356],
27	stage	NN	O	stage	dep	105	SENT_204	[p14l1485t1285r1674b1356],
28	IV	CD	NUMBER	iv	dep	105	SENT_204	[p14l1705t1281r1794b1341],
29	B	NN	O	b	dep	105	SENT_204	[p14l1821t1281r1873b1340],
30	versus	CC	O	versus	dep	105	SENT_204	[p14l1903t1300r2142b1341],
31	stage	NN	O	stage	dep	105	SENT_204	[p14l9t1384r198b1454],
32	IV	CD	NUMBER	iv	dep	105	SENT_204	[p14l232t1380r321b1439],
33	C	NN	O	c	dep	105	SENT_204	[p14l351t1379r423b1452],
34	,	,	O	,	_	0	SENT_204	[p14l351t1379r423b1452],
35	SNP	NN	ORGANIZATION	snp	dep	105	SENT_204	[p14l460t1379r624b1439],
36	in	IN	O	in	dep	105	SENT_204	[p14l654t1380r726b1438],
37	each	DT	O	each	dep	105	SENT_204	[p14l759t1379r924b1439],
38	of	IN	O	of	dep	105	SENT_204	[p14l957t1379r1029b1439],
39	the	DT	O	the	dep	105	SENT_204	[p14l1051t1379r1167b1439],
40	six	CD	NUMBER	six	dep	105	SENT_204	[p14l1202t1380r1303b1439],
41	genes	NNS	O	gene	dep	105	SENT_204	[p14l1333t1398r1559b1454],
42	,	,	O	,	_	0	SENT_204	[p14l1333t1398r1559b1454],
43	and	CC	O	and	dep	105	SENT_204	[p14l1596t1379r1731b1439],
44	number	NN	O	number	dep	105	SENT_204	[p14l1762t1379r2049b1439],
45	of	IN	O	of	dep	105	SENT_204	[p14l2080t1379r2153b1439],
46	accumulated	VBN	O	accumulate	dep	105	SENT_204	[p14l9t1475r476b1536],
47	SNPs	NNS	O	snp	dep	105	SENT_204	[p14l514t1475r713b1536],
48	(	CD	NUMBER	(	dep	105	SENT_204	[p14l753t1475r1120b1551],
49	wild-type	JJ	O	wild-type	dep	105	SENT_204	[p14l753t1475r1120b1551],
50	genes	NNS	O	gene	dep	105	SENT_204	[p14l1158t1495r1363b1551],
51	or	CC	O	or	dep	105	SENT_204	[p14l1402t1496r1475b1536],
52	one	CD	NUMBER	one	dep	105	SENT_204	[p14l1512t1496r1636b1536],
53	SNP	NN	O	snp	dep	105	SENT_204	[p14l1677t1475r1840b1536],
54	vs.	IN	O	vs.	dep	105	SENT_204	[p14l1875t1496r1971b1536],
55	two	CD	NUMBER	two	dep	105	SENT_204	[p14l2013t1481r2142b1536],
56	or	CC	O	or	dep	105	SENT_204	[p14l8t1594r80b1634],
57	more	JJR	O	more	dep	105	SENT_204	[p14l128t1594r310b1634],
58	accumulated	VBN	O	accumulate	dep	105	SENT_204	[p14l361t1574r828b1634],
59	SNPS	NNP	O	SNPS	dep	105	SENT_204	[p14l878t1574r1123b1648],
60	)	CD	NUMBER	)	dep	105	SENT_204	[p14l878t1574r1123b1648],
61	,	,	O	,	_	0	SENT_204	[p14l878t1574r1123b1648],
62	we	PRP	O	we	dep	105	SENT_204	[p14l1174t1594r1273b1634],
63	observed	VBD	O	observe	dep	105	SENT_204	[p14l1323t1574r1646b1634],
64	that	IN	O	that	dep	105	SENT_204	[p14l1693t1574r1846b1634],
65	overall	JJ	O	overall	dep	105	SENT_204	[p14l1893t1574r2143b1634],
66	survival	NN	O	survival	dep	105	SENT_204	[p14l9t1671r307b1731],
67	was	VBD	O	be	dep	105	SENT_204	[p14l354t1691r493b1731],
68	only	RB	O	only	dep	105	SENT_204	[p14l543t1671r697b1746],
69	signiﬁcantly	RB	O	signiﬁcantly	dep	105	SENT_204	[p14l745t1671r1201b1746],
70	better	RBR	O	better	dep	105	SENT_204	[p14l1246t1671r1467b1731],
71	in	IN	O	in	dep	105	SENT_204	[p14l1513t1672r1585b1730],
72	patients	NNS	O	patient	dep	105	SENT_204	[p14l1632t1672r1931b1746],
73	with	IN	O	with	dep	105	SENT_204	[p14l1978t1671r2143b1731],
74	two	CD	NUMBER	two	dep	105	SENT_204	[p14l7t1773r137b1828],
75	or	CC	O	or	dep	105	SENT_204	[p14l185t1788r257b1828],
76	more	JJR	O	more	dep	105	SENT_204	[p14l303t1788r486b1828],
77	SNPs	NNS	O	snp	dep	105	SENT_204	[p14l536t1767r735b1828],
78	accumulated	VBN	O	accumulate	dep	105	SENT_204	[p14l784t1767r1251b1828],
79	than	IN	O	than	dep	105	SENT_204	[p14l1297t1767r1469b1828],
80	in	IN	O	in	dep	105	SENT_204	[p14l1514t1769r1586b1827],
81	patients	NNS	O	patient	dep	105	SENT_204	[p14l1633t1769r1931b1843],
82	with	IN	O	with	dep	105	SENT_204	[p14l1978t1767r2143b1828],
83	wild-type	JJ	O	wild-type	dep	105	SENT_204	[p14l6t1865r348b1941],
84	or	CC	O	or	dep	105	SENT_204	[p14l382t1885r454b1925],
85	one	CD	NUMBER	one	dep	105	SENT_204	[p14l486t1885r610b1925],
86	SNP	NN	O	snp	dep	105	SENT_204	[p14l644t1865r808b1925],
87	genotype	NN	O	genotype	dep	105	SENT_204	[p14l839t1870r1168b1941],
88	(	CD	NUMBER	(	dep	105	SENT_204	[p14l1201t1865r1279b1934],
89	P	NN	O	p	dep	105	SENT_204	[p14l1201t1865r1279b1934],
90	:	:	O	:	_	0	SENT_204	[p14l1311t1894r1365b1914],
91	.048	CD	NUMBER	.048	dep	105	SENT_204	[p14l1392t1867r1560b1939],
92	;	:	O	;	_	0	SENT_204	[p14l1392t1867r1560b1939],
93	hazard	NN	O	hazard	dep	105	SENT_204	[p14l1593t1865r1849b1925],
94	ratio	NN	O	ratio	dep	105	SENT_204	[p14l1880t1866r2052b1925],
95	=	JJ	O	=	dep	105	SENT_204	[p14l2087t1894r2141b1914],
96	2.177	CD	NUMBER	2.177	dep	105	SENT_204	[p14l8t1965r223b2037],
97	;	:	O	;	_	0	SENT_204	[p14l8t1965r223b2037],
98	95	CD	PERCENT	95	dep	105	SENT_204	[p14l257t1965r406b2023],
99	%	NN	PERCENT	%	dep	105	SENT_204	[p14l257t1965r406b2023],
100	conﬁdence	NN	O	conﬁdence	dep	105	SENT_204	[p14l438t1962r821b2023],
101	interval	NN	O	interval	dep	105	SENT_204	[p14l851t1962r1161b2023],
102	:	:	O	:	_	0	SENT_204	[p14l851t1962r1161b2023],
103	1.007-4	CD	NUMBER	1.007-4	dep	105	SENT_204	[p14l1201t1963r1662b2031],
104	.707	CD	NUMBER	.707	dep	105	SENT_204	[p14l1201t1963r1662b2031],
105	)	NN	O	)	_	0	SENT_204	[p14l1201t1963r1662b2031],
106	.	.	O	.	_	0	SENT_204	[p14l1201t1963r1662b2031],

1	DISCUSSION	NN	O	discussion	_	0	SENT_205	[p14l7t2198r600b2262],

1	Paclitaxel	NN	O	paclitaxel	nsubj	6	SENT_206	[p14l186t2299r550b2359],
2	is	VBZ	O	be	cop	6	SENT_206	[p14l591t2300r649b2359],
3	an	DT	O	a	det	6	SENT_206	[p14l694t2319r783b2359],
4	alternative	JJ	O	alternative	amod	6	SENT_206	[p14l826t2299r1229b2359],
5	palliative	JJ	O	palliative	amod	6	SENT_206	[p14l1273t2299r1617b2375],
6	treatment	NN	O	treatment	_	0	SENT_206	[p14l1660t2304r2031b2359],
7	in	IN	O	in	_	0	SENT_206	[p14l2072t2300r2143b2358],
8	patients	NNS	O	patient	prep_in	6	SENT_206	[p14l7t2397r306b2471],
9	with	IN	O	with	_	0	SENT_206	[p14l339t2395r504b2456],
10	advanced	JJ	O	advanced	amod	11	SENT_206	[p14l539t2395r883b2456],
11	head	NN	O	head	prep_with	8	SENT_206	[p14l915t2395r1092b2456],
12	and	CC	O	and	_	0	SENT_206	[p14l1127t2395r1262b2456],
13	neck	NN	O	neck	nn	14	SENT_206	[p14l1294t2395r1465b2456],
14	cancer	NN	O	cancer	conj_and	11	SENT_206	[p14l1497t2416r1735b2456],
15	that	WDT	O	that	nsubj	17	SENT_206	[p14l1767t2395r1920b2456],
16	is	VBZ	O	be	cop	17	SENT_206	[p14l1952t2397r2010b2456],
17	resistant	JJ	O	resistant	rcmod	11	SENT_206	[p14l2044t2416r2142b2456, p14l9t2494r259b2553],
18	to	TO	O	to	_	0	SENT_206	[p14l391t2497r459b2553],
19	platinum	NN	O	platinum	nn	20	SENT_206	[p14l593t2492r931b2568],
20	chemotherapy	NN	O	chemotherapy	prep_to	17	SENT_206	[p14l1066t2492r1597b2568],
21	.	.	O	.	_	0	SENT_206	[p14l1066t2492r1597b2568],

1	A	DT	O	a	det	3	SENT_207	[p14l1733t2492r1793b2552],
2	better	JJR	O	better	amod	3	SENT_207	[p14l1923t2492r2144b2553],
3	understanding	NN	O	understanding	_	0	SENT_207	[p14l7t2590r551b2665],
4	of	IN	O	of	_	0	SENT_207	[p14l583t2590r656b2650],
5	predictive	JJ	O	predictive	amod	6	SENT_207	[p14l679t2590r1042b2666],
6	markers	NNS	O	marker	prep_of	3	SENT_207	[p14l1076t2590r1383b2650],
7	for	IN	O	for	dep	3	SENT_207	[p14l1417t2590r1518b2650],
8	response	NN	O	response	pobj	7	SENT_207	[p14l1549t2610r1870b2666],
9	to	TO	O	to	dep	3	SENT_207	[p14l1904t2595r1971b2650],
10	this	DT	O	this	pobj	9	SENT_207	[p14l2004t2590r2142b2650],

1	Laryngoscope	NN	O	laryngoscope	_	0	SENT_208	[p14l11t2823r514b2897],
2	119	CD	NUMBER	119	num	1	SENT_208	[p14l550t2823r692b2881],
3	:	:	O	:	_	0	SENT_208	[p14l550t2823r692b2881],
4	August	NNP	DATE	August	dep	1	SENT_208	[p14l725t2823r974b2897],
5	2009	CD	DATE	2009	num	4	SENT_208	[p14l1005t2823r1177b2881],
6	1488	CD	DATE	1488	num	7	SENT_208	[p14l13t2941r199b3006],
7	drug	NN	O	drug	nsubj	12	SENT_208	[p14l12t3044r183b3119],
8	and	CC	O	and	_	0	SENT_208	[p14l229t3044r364b3104],
9	its	PRP$	O	its	poss	10	SENT_208	[p14l410t3045r499b3104],
10	toxicity	NN	O	toxicity	nsubj	12	SENT_208	[p14l546t3045r818b3119],
11	will	MD	O	will	aux	12	SENT_208	[p14l863t3044r998b3104],
12	allow	VB	O	allow	rcmod	4	SENT_208	[p14l1046t3044r1239b3104],
13	us	PRP	O	we	nsubj	15	SENT_208	[p14l1285t3064r1367b3104],
14	to	TO	O	to	aux	15	SENT_208	[p14l1414t3049r1481b3104],
15	determine	VB	O	determine	xcomp	12	SENT_208	[p14l1530t3044r1902b3104],
16	those	DT	O	those	det	17	SENT_208	[p14l1949t3044r2142b3104],
17	patients	NNS	O	patient	dobj	15	SENT_208	[p14l10t3142r308b3216],
18	who	WP	O	who	nsubj	21	SENT_208	[p14l339t3140r487b3201],
19	could	MD	O	could	aux	21	SENT_208	[p14l518t3140r711b3201],
20	be	VB	O	be	cop	21	SENT_208	[p14l739t3140r820b3201],
21	candidates	NNS	O	candidate	rcmod	17	SENT_208	[p14l852t3140r1244b3201],
22	for	IN	O	for	_	0	SENT_208	[p14l1274t3140r1374b3201],
23	the	DT	O	the	det	24	SENT_208	[p14l1403t3140r1519b3201],
24	treatment	NN	O	treatment	prep_for	21	SENT_208	[p14l1549t3146r1937b3201],
25	.	.	O	.	_	0	SENT_208	[p14l1549t3146r1937b3201],

1	In	IN	O	in	_	0	SENT_209	[p14l189t3239r267b3297],
2	our	PRP$	O	we	poss	3	SENT_209	[p14l349t3258r471b3298],
3	patients	NNS	O	patient	prep_in	15	SENT_209	[p14l552t3239r870b3314],
4	,	,	O	,	_	0	SENT_209	[p14l552t3239r870b3314],
5	SNP	NN	ORGANIZATION	snp	nn	6	SENT_209	[p14l957t3238r1120b3298],
6	frequencies	NNS	O	frequency	nsubj	15	SENT_209	[p14l1200t3238r1619b3314],
7	in	IN	O	in	_	0	SENT_209	[p14l1701t3239r1773b3297],
8	GSTT1	NN	O	gstt1	nn	10	SENT_209	[p14l1855t3238r2140b3312],
9	,	,	O	,	_	0	SENT_209	[p14l1855t3238r2140b3312],
10	GSTP1	NN	O	gstp1	prep_in	6	SENT_209	[p14l11t3334r289b3407],
11	,	,	O	,	_	0	SENT_209	[p14l11t3334r289b3407],
12	and	CC	O	and	_	0	SENT_209	[p14l338t3334r473b3395],
13	ERCC1	NN	O	ercc1	nn	14	SENT_209	[p14l507t3334r779b3395],
14	genes	NNS	O	gene	prep_in	6	SENT_209	[p14l824t3354r1028b3410],
15	differed	VBD	O	differ	_	0	SENT_209	[p14l1070t3334r1352b3395],
16	from	IN	O	from	_	0	SENT_209	[p14l1390t3334r1561b3395],
17	those	DT	O	those	prep_from	15	SENT_209	[p14l1599t3334r1792b3395],
18	reported	VBN	O	report	partmod	17	SENT_209	[p14l1832t3334r2144b3410],
19	in	IN	O	in	_	0	SENT_209	[p14l10t3433r82b3491],
20	the	DT	O	the	det	22	SENT_209	[p14l113t3431r229b3492],
21	NCBI	NN	ORGANIZATION	ncbus	nn	22	SENT_209	[p14l262t3431r471b3492],
22	database	NN	O	database	prep_in	18	SENT_209	[p14l506t3431r830b3492],
23	for	IN	O	for	_	0	SENT_209	[p14l863t3431r964b3492],
24	the	DT	O	the	det	26	SENT_209	[p14l995t3431r1111b3492],
25	European	JJ	LOCATION	european	amod	26	SENT_209	[p14l1145t3432r1503b3507],
26	population	NN	O	population	prep_for	22	SENT_209	[p14l1536t3431r1945b3507],
27	.	.	O	.	_	0	SENT_209	[p14l1536t3431r1945b3507],

1	This	DT	DATE	this	nsubj	4	SENT_210	[p14l1982t3431r2142b3492],
2	may	MD	DATE	may	aux	4	SENT_210	[p14l10t3549r166b3605],
3	be	VB	O	be	cop	4	SENT_210	[p14l204t3529r286b3589],
4	due	JJ	O	due	_	0	SENT_210	[p14l327t3529r457b3589],
5	to	TO	O	to	_	0	SENT_210	[p14l498t3534r565b3589],
6	the	DT	O	the	det	8	SENT_210	[p14l605t3529r722b3589],
7	small	JJ	O	small	amod	8	SENT_210	[p14l765t3529r961b3589],
8	number	NN	O	number	prep_to	4	SENT_210	[p14l1001t3529r1288b3589],
9	of	IN	O	of	_	0	SENT_210	[p14l1328t3529r1401b3589],
10	patients	NNS	O	patient	prep_of	8	SENT_210	[p14l1431t3530r1729b3605],
11	in	IN	O	in	_	0	SENT_210	[p14l1770t3530r1842b3588],
12	our	PRP$	O	we	poss	13	SENT_210	[p14l1882t3549r2004b3589],
13	series	NN	O	series	prep_in	10	SENT_210	[p14l2045t3549r2142b3589, p14l10t3627r164b3699],
14	,	,	O	,	_	0	SENT_210	[p14l2045t3549r2142b3589, p14l10t3627r164b3699],
15	to	TO	O	to	_	0	SENT_210	[p14l222t3631r289b3686],
16	geographical	JJ	O	geographical	amod	18	SENT_210	[p14l345t3625r814b3701],
17	genotype	NN	O	genotype	nn	18	SENT_210	[p14l870t3631r1198b3701],
18	differences	NNS	O	difference	conj_or	8	SENT_210	[p14l1256t3625r1672b3699],
19	,	,	O	,	_	0	SENT_210	[p14l1256t3625r1672b3699],
20	or	CC	O	or	_	0	SENT_210	[p14l1732t3646r1805b3686],
21	to	TO	O	to	_	0	SENT_210	[p14l1859t3631r1926b3686],
22	both	DT	O	both	det	23	SENT_210	[p14l1981t3625r2143b3686],
23	factors	NNS	O	factor	conj_or	8	SENT_210	[p14l10t3722r275b3783],
24	.	.	O	.	_	0	SENT_210	[p14l10t3722r275b3783],

1	Nevertheless	RB	O	nevertheless	advmod	9	SENT_211	[p14l309t3722r808b3796],
2	,	,	O	,	_	0	SENT_211	[p14l309t3722r808b3796],
3	patients	NNS	O	patient	nsubjpass	9	SENT_211	[p14l842t3724r1140b3798],
4	with	IN	O	with	_	0	SENT_211	[p14l1170t3722r1336b3783],
5	these	DT	O	these	det	6	SENT_211	[p14l1366t3722r1558b3783],
6	SNPs	NNS	O	snp	prep_with	3	SENT_211	[p14l1591t3722r1790b3783],
7	were	VBD	O	be	auxpass	9	SENT_211	[p14l1820t3742r1995b3783],
8	not	RB	O	not	neg	9	SENT_211	[p14l2027t3727r2145b3783],
9	associated	VBN	O	associate	_	0	SENT_211	[p15l12t18r387b78],
10	with	IN	O	with	_	0	SENT_211	[p15l423t18r588b78],
11	differences	NNS	O	difference	prep_with	9	SENT_211	[p15l626t18r1022b78],
12	in	IN	O	in	_	0	SENT_211	[p15l1060t19r1132b77],
13	response	NN	O	response	nn	14	SENT_211	[p15l1168t38r1489b94],
14	rate	NN	O	rate	prep_in	11	SENT_211	[p15l1527t23r1673b78],
15	or	CC	O	or	_	0	SENT_211	[p15l1713t38r1785b78],
16	survival	NN	O	survival	conj_or	14	SENT_211	[p15l1824t18r2138b78],
17	.	.	O	.	_	0	SENT_211	[p15l1824t18r2138b78],

1	Other	JJ	O	other	amod	3	SENT_212	[p15l12t114r226b175],
2	epidemiological	JJ	O	epidemiological	amod	3	SENT_212	[p15l271t114r838b190],
3	studies	NNS	O	study	nsubjpass	11	SENT_212	[p15l885t114r1143b175],
4	with	IN	O	with	_	0	SENT_212	[p15l1188t114r1353b175],
5	a	DT	O	a	det	7	SENT_212	[p15l1399t135r1440b175],
6	larger	JJR	O	larger	amod	7	SENT_212	[p15l1483t114r1705b190],
7	number	NN	O	number	prep_with	3	SENT_212	[p15l1749t114r2036b175],
8	of	IN	O	of	_	0	SENT_212	[p15l2081t114r2153b175],
9	patients	NNS	O	patient	prep_of	7	SENT_212	[p15l11t213r309b287],
10	are	VBP	O	be	auxpass	11	SENT_212	[p15l341t231r455b272],
11	needed	VBN	O	need	_	0	SENT_212	[p15l486t211r744b272],
12	to	TO	O	to	aux	13	SENT_212	[p15l773t216r840b272],
13	examine	VB	O	examine	xcomp	11	SENT_212	[p15l872t213r1179b272],
14	this	DT	O	this	det	15	SENT_212	[p15l1210t211r1347b272],
15	issue	NN	O	issue	dobj	13	SENT_212	[p15l1377t213r1561b272],
16	in	IN	O	in	_	0	SENT_212	[p15l1591t213r1663b271],
17	more	JJR	O	more	amod	18	SENT_212	[p15l1692t231r1875b272],
18	depth	NN	O	depth	prep_in	15	SENT_212	[p15l1907t211r2132b287],
19	.	.	O	.	_	0	SENT_212	[p15l1907t211r2132b287],

1	Only	RB	O	only	advmod	2	SENT_213	[p15l190t309r366b384],
2	patients	NNS	O	patient	nsubj	11	SENT_213	[p15l403t310r701b384],
3	with	IN	O	with	_	0	SENT_213	[p15l738t309r903b369],
4	SNPs	NNS	O	snp	prep_with	2	SENT_213	[p15l943t309r1142b369],
5	in	IN	O	in	_	0	SENT_213	[p15l1180t310r1251b368],
6	MDR1	NN	O	mdr1	prep_in	4	SENT_213	[p15l1285t310r1645b369],
7	—	CD	NUMBER	—	number	8	SENT_213	[p15l1285t310r1645b369],
8	57	CD	NUMBER	57	dep	6	SENT_213	[p15l1285t310r1645b369],
9	or	CC	O	or	_	0	SENT_213	[p15l1681t329r1753b369],
10	MDR1-62	NN	O	mdr1-62	prep_in	4	SENT_213	[p15l1786t310r2142b369],
11	had	VBD	O	have	_	0	SENT_213	[p15l10t405r147b466],
12	a	DT	O	a	det	16	SENT_213	[p15l183t426r223b466],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_213	[p15l259t405r714b481],
14	higher	JJR	O	higher	amod	16	SENT_213	[p15l748t405r989b481],
15	response	NN	O	response	nn	16	SENT_213	[p15l1023t426r1343b481],
16	rate	NN	O	rate	dobj	11	SENT_213	[p15l1379t411r1544b466],
17	.	.	O	.	_	0	SENT_213	[p15l1379t411r1544b466],

1	Similar	JJ	O	similar	amod	2	SENT_214	[p15l1587t405r1858b466],
2	results	NNS	O	result	nsubjpass	4	SENT_214	[p15l1892t405r2142b466],
3	were	VBD	O	be	auxpass	4	SENT_214	[p15l10t522r184b563],
4	obtained	VBN	O	obtain	_	0	SENT_214	[p15l233t502r549b563],
5	in	IN	O	in	_	0	SENT_214	[p15l594t504r666b562],
6	ovarian	JJ	O	ovarian	amod	8	SENT_214	[p15l713t504r991b563],
7	cancer	NN	O	cancer	nn	8	SENT_214	[p15l1038t522r1276b563],
8	patients	NNS	O	patient	prep_in	4	SENT_214	[p15l1322t504r1620b578],
9	treated	VBN	O	treat	partmod	8	SENT_214	[p15l1668t502r1933b563],
10	with	IN	O	with	_	0	SENT_214	[p15l1978t502r2144b563],
11	higher	JJR	O	higher	amod	12	SENT_214	[p15l10t600r250b675],
12	doses	NNS	O	dose	prep_with	9	SENT_214	[p15l323t600r516b660],
13	of	IN	O	of	_	0	SENT_214	[p15l589t600r662b660],
14	paclitaxel	NN	O	paclitaxel	prep_of	12	SENT_214	[p15l724t600r1099b676],
15	,	,	O	,	_	0	SENT_214	[p15l724t600r1099b676],
16	which	WDT	O	which	nsubj	17	SENT_214	[p15l1173t600r1393b660],
17	suggests	VBZ	O	suggest	rcmod	14	SENT_214	[p15l1466t605r1776b675],
18	that	IN	O	that	complm	28	SENT_214	[p15l1848t600r2002b660],
19	in	IN	O	in	_	0	SENT_214	[p15l2072t601r2144b659],
20	patients	NNS	O	patient	prep_in	28	SENT_214	[p15l11t698r308b773],
21	with	IN	O	with	_	0	SENT_214	[p15l383t697r548b757],
22	SNPS	NN	O	snp	prep_with	20	SENT_214	[p15l623t697r822b757],
23	the	DT	O	the	det	24	SENT_214	[p15l896t697r1012b757],
24	P-glycoprotein	NN	MISC	p-glycoprotein	nsubj	28	SENT_214	[p15l1087t697r1618b773],
25	encoded	VBN	O	encode	partmod	24	SENT_214	[p15l1693t697r1986b757],
26	by	IN	O	by	_	0	SENT_214	[p15l2058t697r2144b773],
27	MDR1	NN	O	mdr1	agent	25	SENT_214	[p15l7t795r243b855],
28	has	VBZ	O	have	ccomp	17	SENT_214	[p15l277t794r404b855],
29	a	DT	O	a	det	31	SENT_214	[p15l436t815r476b855],
30	reduced	VBN	O	reduce	amod	31	SENT_214	[p15l505t794r795b855],
31	capacity	NN	O	capacity	dobj	28	SENT_214	[p15l825t796r1128b870],
32	for	IN	O	for	_	0	SENT_214	[p15l1156t794r1257b855],
33	extruding	VBG	O	extrude	prepc_for	31	SENT_214	[p15l1286t794r1646b870],
34	the	DT	O	the	det	36	SENT_214	[p15l1674t794r1790b855],
35	drug	NN	O	drug	nn	36	SENT_214	[p15l1823t780r2047b870],
36	.9	NN	NUMBER	.9	dobj	33	SENT_214	[p15l1823t780r2047b870],

1	Surprisingly	RB	O	surprisingly	advmod	6	SENT_215	[p15l191t891r660b967],
2	,	,	O	,	_	0	SENT_215	[p15l191t891r660b967],
3	toxic	JJ	O	toxic	amod	4	SENT_215	[p15l708t893r880b952],
4	effects	NNS	O	effect	nsubj	6	SENT_215	[p15l926t891r1158b952],
5	were	VBD	O	be	cop	6	SENT_215	[p15l1203t912r1378b952],
6	similar	JJ	O	similar	_	0	SENT_215	[p15l1426t891r1684b952],
7	in	IN	O	in	_	0	SENT_215	[p15l1728t893r1800b951],
8	patients	NNS	O	patient	prep_in	6	SENT_215	[p15l1844t893r2142b967],
9	with	IN	O	with	_	0	SENT_215	[p15l9t989r175b1049],
10	wild-type	JJ	O	wild-type	amod	11	SENT_215	[p15l208t989r549b1065],
11	genotype	NN	O	genotype	prep_with	8	SENT_215	[p15l585t994r913b1065],
12	and	CC	O	and	_	0	SENT_215	[p15l950t989r1085b1049],
13	in	IN	O	in	_	0	SENT_215	[p15l1118t990r1190b1048],
14	those	DT	O	those	conj_and	8	SENT_215	[p15l1224t989r1416b1049],
15	with	IN	O	with	_	0	SENT_215	[p15l1451t989r1616b1049],
16	SNPs	NNS	O	snp	prep_with	14	SENT_215	[p15l1652t989r1870b1049],
17	.	.	O	.	_	0	SENT_215	[p15l1652t989r1870b1049],

1	In	IN	O	in	_	0	SENT_216	[p15l1910t990r1988b1048],
2	our	PRP$	O	we	poss	3	SENT_216	[p15l2022t1009r2144b1049],
3	opinion	NN	O	opinion	prep_in	8	SENT_216	[p15l11t1087r301b1161],
4	,	,	O	,	_	0	SENT_216	[p15l11t1087r301b1161],
5	this	DT	DATE	this	nsubj	8	SENT_216	[p15l347t1085r485b1146],
6	may	MD	DATE	may	aux	8	SENT_216	[p15l530t1106r687b1161],
7	be	VB	O	be	cop	8	SENT_216	[p15l728t1085r809b1146],
8	due	JJ	O	due	_	0	SENT_216	[p15l856t1085r985b1146],
9	to	TO	O	to	_	0	SENT_216	[p15l1029t1091r1097b1146],
10	the	DT	O	the	det	12	SENT_216	[p15l1141t1085r1257b1146],
11	good	JJ	O	good	amod	12	SENT_216	[p15l1302t1085r1468b1161],
12	tolerance	NN	O	tolerance	prep_to	8	SENT_216	[p15l1511t1085r1848b1146],
13	to	TO	O	to	_	0	SENT_216	[p15l1893t1091r1960b1146],
14	this	DT	O	this	prep_to	8	SENT_216	[p15l2004t1085r2142b1146],

1	TABLE	NN	O	table	_	0	SENT_217	[p15l931t1352r1141b1403],
2	V.	NNP	O	V.	dep	1	SENT_217	[p15l1167t1352r1216b1403],

1	Univariate	NNP	O	Univariate	nn	4	SENT_218	[p15l505t1440r816b1492],
2	Cox	NNP	O	Cox	nn	4	SENT_218	[p15l844t1439r969b1492],
3	Regression	NN	O	regression	nn	4	SENT_218	[p15l999t1440r1346b1506],
4	Analysis	NN	O	analysis	_	0	SENT_218	[p15l1372t1440r1648b1505],
5	.	.	O	.	_	0	SENT_218	[p15l1372t1440r1648b1505],

1	Hazard	NN	O	hazard	_	0	SENT_219	[p15l1031t1612r1222b1658],

1	Variable	JJ	O	variable	amod	3	SENT_220	[p15l9t1683r229b1729],
2	Value	NN	O	value	nn	3	SENT_220	[p15l692t1683r841b1729],
3	Ratio	NN	O	ratio	_	0	SENT_220	[p15l1058t1683r1196b1729],
4	95	CD	PERCENT	95	num	5	SENT_220	[p15l1411t1683r1535b1730],
5	%	NN	PERCENT	%	dep	3	SENT_220	[p15l1411t1683r1535b1730],
6	Cl	NN	O	cl	nn	7	SENT_220	[p15l1564t1682r1617b1729],
7	Significance	NN	O	significance	dep	3	SENT_220	[p15l1808t1682r2142b1741],

1	Age	NNP	O	Age	_	0	SENT_221	[p15l8t1810r148b1876],
2	,	,	O	,	_	0	SENT_221	[p15l8t1810r148b1876],
3	y	NN	O	y	appos	1	SENT_221	[p15l178t1824r212b1876],
4	359	CD	NUMBER	359	number	5	SENT_221	[p15l707t1810r832b1871],
5	1	CD	NUMBER	1	dep	3	SENT_221	[p15l1043t1810r1063b1861],
6	.526	CD	NUMBER	.526	num	7	SENT_221	[p15l1346t1810r1688b1862],
7	—	NN	O	—	dep	1	SENT_221	[p15l1346t1810r1688b1862],
8	1.887	CD	NUMBER	1.887	number	9	SENT_221	[p15l1346t1810r1688b1862],
9	.991	CD	NUMBER	.991	dep	7	SENT_221	[p15l1912t1810r2031b1862],

1	PS	NNP	O	PS	_	0	SENT_222	[p15l14t2020r98b2073],
2	1	CD	NUMBER	1	number	3	SENT_222	[p15l801t2021r820b2072],
3	1	CD	NUMBER	1	dep	1	SENT_222	[p15l1043t2021r1063b2072],
4	.563	CD	NUMBER	.563	num	5	SENT_222	[p15l1346t2021r1677b2072],
5	—	NN	O	—	dep	3	SENT_222	[p15l1346t2021r1677b2072],
6	2.671	CD	NUMBER	2.671	num	7	SENT_222	[p15l1346t2021r1677b2072],
7	.608	CD	NUMBER	.608	dep	1	SENT_222	[p15l1900t2021r2029b2072],

1	Gender	NN	O	gender	_	0	SENT_223	[p15l11t2230r245b2283],
2	Female	JJ	O	female	amod	1	SENT_223	[p15l657t2231r882b2283],
3	1	CD	NUMBER	1	number	4	SENT_223	[p15l1043t2232r1063b2282],
4	.333	CD	NUMBER	.333	num	5	SENT_223	[p15l1346t2232r1688b2283],
5	—	NN	O	—	dep	1	SENT_223	[p15l1346t2232r1688b2283],
6	2.696	CD	NUMBER	2.696	num	7	SENT_223	[p15l1346t2232r1688b2283],
7	.921	CD	NUMBER	.921	dep	5	SENT_223	[p15l1900t2232r2018b2283],

1	Male	JJ	O	male	_	0	SENT_224	[p15l695t2336r843b2387],
2	.948	CD	NUMBER	.948	tmod	1	SENT_224	[p15l1083t2336r1213b2387],

1	Stage	NN	O	stage	_	0	SENT_225	[p15l11t2440r193b2507],
2	IV	CD	NUMBER	iv	num	3	SENT_225	[p15l706t2441r762b2492],
3	B	NN	O	b	dep	1	SENT_225	[p15l791t2441r832b2492],
4	1	CD	NUMBER	1	number	5	SENT_225	[p15l1043t2441r1063b2492],
5	.514	CD	NUMBER	.514	num	6	SENT_225	[p15l1346t2441r1688b2493],
6	—	NN	O	—	dep	3	SENT_225	[p15l1346t2441r1688b2493],
7	1.787	CD	NUMBER	1.787	num	8	SENT_225	[p15l1346t2441r1688b2493],
8	.894	CD	NUMBER	.894	dep	1	SENT_225	[p15l1900t2441r2029b2493],

1	IV	CD	NUMBER	iv	num	2	SENT_226	[p15l704t2546r761b2597],
2	C	NN	O	c	_	0	SENT_226	[p15l788t2545r834b2598],
3	.958	CD	NUMBER	.958	dep	2	SENT_226	[p15l1082t2547r1213b2598],

1	Gene	NNP	O	Gene	nn	2	SENT_227	[p15l11t2650r177b2703],
2	CYP2C8	NNP	O	CYP2C8	_	0	SENT_227	[p15l205t2650r472b2703],
3	CC	NN	O	cc	dep	2	SENT_227	[p15l719t2650r817b2703],
4	1	CD	NUMBER	1	dep	2	SENT_227	[p15l1043t2651r1063b2702],

1	CT	NN	O	ct	dep	8	SENT_228	[p15l725t2755r814b2808],
2	1	CD	NUMBER	1	number	3	SENT_228	[p15l1043t2756r1063b2807],
3	.342	CD	NUMBER	.342	dep	1	SENT_228	[p15l1083t2756r1211b2808],
4	.568	CD	NUMBER	.568	dep	3	SENT_228	[p15l1346t2756r1688b2808],
5	—	NN	O	—	dep	8	SENT_228	[p15l1346t2756r1688b2808],
6	3.173	CD	NUMBER	3.173	num	5	SENT_228	[p15l1346t2756r1688b2808],
7	.503	CD	NUMBER	.503	num	8	SENT_228	[p15l1900t2756r2029b2808],
8	‘	CD	NUMBER	‘	dep	14	SENT_228	[p15l727t2861r808b2912],
9	IT	PRP	O	it	dep	8	SENT_228	[p15l727t2861r808b2912],
10	.994	CD	NUMBER	.994	number	11	SENT_228	[p15l1082t2862r1213b2913],
11	.392	CD	NUMBER	.392	num	12	SENT_228	[p15l1346t2862r1688b2913],
12	—	NN	O	—	dep	9	SENT_228	[p15l1346t2862r1688b2913],
13	2.520	CD	NUMBER	2.520	num	14	SENT_228	[p15l1346t2862r1688b2913],
14	.991	CD	NUMBER	.991	_	0	SENT_228	[p15l1900t2862r2018b2913],

1	Gene	NNP	O	Gene	nn	2	SENT_229	[p15l11t2965r177b3018],
2	GST	NN	O	gst	_	0	SENT_229	[p15l205t2965r410b3018],
3	|	NN	O	|	dep	2	SENT_229	[p15l205t2965r410b3018],
4	'	''	O	'	_	0	SENT_229	[p15l205t2965r410b3018],
5	1	CD	NUMBER	1	num	6	SENT_229	[p15l205t2965r410b3018],
6	TI	NNP	O	TI	dep	3	SENT_229	[p15l727t2966r809b3017],
7	"	``	O	"	punct	8	SENT_229	[p15l727t2966r809b3017],
8	1	CD	NUMBER	1	dep	2	SENT_229	[p15l1043t2966r1063b3017],

1	TC	NN	O	tc	_	0	SENT_230	[p15l721t3070r811b3123],
2	.481	CD	NUMBER	.481	dep	1	SENT_230	[p15l1083t3071r1201b3123],
3	.	.	O	.	_	0	SENT_230	[p15l1346t3071r1639b3123],

1	O64	CD	NUMBER	o64	number	2	SENT_231	[p15l1346t3071r1639b3123],
2	—	CD	NUMBER	—	_	0	SENT_231	[p15l1346t3071r1639b3123],
3	3.61	CD	NUMBER	3.61	num	4	SENT_231	[p15l1346t3071r1639b3123],
4	5	CD	NUMBER	5	dep	2	SENT_231	[p15l1653t3072r1687b3123],
5	.477	CD	NUMBER	.477	num	6	SENT_231	[p15l1900t3071r2029b3122],
6	CC	NN	O	cc	dep	2	SENT_231	[p15l719t3175r817b3228],
7	.865	CD	NUMBER	.865	number	8	SENT_231	[p15l1083t3177r1212b3228],
8	.054	CD	NUMBER	.054	num	9	SENT_231	[p15l1346t3177r1728b3228],
9	—	NN	O	—	dep	6	SENT_231	[p15l1346t3177r1728b3228],
10	13.934	CD	NUMBER	13.934	number	11	SENT_231	[p15l1346t3177r1728b3228],
11	.919	CD	NUMBER	.919	num	9	SENT_231	[p15l1900t3177r2029b3228],

1	Gene	NNP	O	Gene	nn	3	SENT_232	[p15l11t3280r177b3333],
2	GSTP1	NNP	O	GSTP1	nn	3	SENT_232	[p15l205t3280r415b3333],
3	AA	NNP	O	AA	_	0	SENT_232	[p15l721t3281r814b3332],
4	1	CD	NUMBER	1	dep	3	SENT_232	[p15l1043t3281r1063b3332],

1	AG	NNP	O	AG	dep	7	SENT_233	[p15l717t3385r814b3438],
2	2.301	CD	NUMBER	2.301	num	1	SENT_233	[p15l1039t3386r1201b3438],
3	.690	CD	NUMBER	.690	dep	1	SENT_233	[p15l1346t3386r1687b3438],
4	—	NN	O	—	dep	7	SENT_233	[p15l1346t3386r1687b3438],
5	7.672	CD	NUMBER	7.672	num	4	SENT_233	[p15l1346t3386r1687b3438],
6	.175	CD	NUMBER	.175	num	7	SENT_233	[p15l1900t3386r2029b3438],
7	GG	NNS	O	gg	dep	12	SENT_233	[p15l716t3490r818b3543],
8	2.525	CD	NUMBER	2.525	number	9	SENT_233	[p15l1039t3492r1212b3543],
9	.617	CD	NUMBER	.617	dep	7	SENT_233	[p15l1346t3492r1727b3543],
10	—	NN	O	—	dep	9	SENT_233	[p15l1346t3492r1727b3543],
11	10.337	CD	NUMBER	10.337	num	12	SENT_233	[p15l1346t3492r1727b3543],
12	.198	CD	NUMBER	.198	_	0	SENT_233	[p15l1900t3492r2029b3543],

1	Gene	NNP	O	Gene	nn	2	SENT_234	[p15l11t3595r177b3648],
2	MDR1	NN	O	mdr1	_	0	SENT_234	[p15l208t3596r390b3647],
3	-62	CD	NUMBER	-62	num	4	SENT_234	[p15l406t3596r506b3647],
4	CC	NN	O	cc	dep	2	SENT_234	[p15l719t3595r817b3648],
5	1	CD	NUMBER	1	dep	2	SENT_234	[p15l1043t3596r1063b3647],

1	CT	NN	O	ct	_	0	SENT_235	[p15l725t3700r814b3753],
2	1	CD	NUMBER	1	dep	1	SENT_235	[p15l1043t3701r1063b3752],
3	.402	CD	NUMBER	.402	num	4	SENT_235	[p15l1083t3701r1211b3753],
4	.590	CD	NUMBER	.590	dep	2	SENT_235	[p15l1346t3701r1687b3753],
5	—	NN	O	—	prep	4	SENT_235	[p15l1346t3701r1687b3753],
6	3.332	CD	NUMBER	3.332	num	7	SENT_235	[p15l1346t3701r1687b3753],
7	.444	CD	NUMBER	.444	dep	5	SENT_235	[p15l1900t3701r2029b3752],
8	"	''	O	"	punct	4	SENT_235	[p16l727t33r808b84],

1	IT	PRP	O	it	_	0	SENT_236	[p16l727t33r808b84],
2	1	CD	NUMBER	1	number	3	SENT_236	[p16l1043t34r1063b84],
3	.348	CD	NUMBER	.348	dep	1	SENT_236	[p16l1082t34r1213b85],
4	.536	CD	NUMBER	.536	num	5	SENT_236	[p16l1346t34r1687b85],
5	—	NN	O	—	dep	3	SENT_236	[p16l1346t34r1687b85],
6	3.392	CD	NUMBER	3.392	num	7	SENT_236	[p16l1346t34r1687b85],
7	.526	CD	NUMBER	.526	dep	1	SENT_236	[p16l1900t34r2030b85],

1	Gene	NNP	O	Gene	nn	2	SENT_237	[p16l11t137r177b190],
2	MDR1	NN	O	mdr1	_	0	SENT_237	[p16l208t138r390b189],
3	-57	CD	NUMBER	-57	num	4	SENT_237	[p16l406t139r507b189],
4	CC	NN	O	cc	dep	2	SENT_237	[p16l719t137r817b190],
5	1	CD	NUMBER	1	dep	2	SENT_237	[p16l1043t138r1063b189],

1	CT	NN	O	ct	_	0	SENT_238	[p16l725t242r814b295],
2	1.710	CD	NUMBER	1.710	num	1	SENT_238	[p16l1043t243r1212b295],
3	.717	CD	NUMBER	.717	num	4	SENT_238	[p16l1346t243r1688b295],
4	—	NN	O	—	dep	1	SENT_238	[p16l1346t243r1688b295],
5	4.078	CD	NUMBER	4.078	number	6	SENT_238	[p16l1346t243r1688b295],
6	.227	CD	NUMBER	.227	dep	4	SENT_238	[p16l1900t243r2029b294],

1	‘	RB	O	‘	dep	2	SENT_239	[p16l727t348r808b399],
2	IT	PRP	O	it	dep	3	SENT_239	[p16l727t348r808b399],
3	1.276	CD	NUMBER	1.276	dep	4	SENT_239	[p16l1043t349r1213b400],
4	.571	CD	NUMBER	.571	dep	6	SENT_239	[p16l1346t349r1465b400],
5	-2.849	CD	NUMBER	-2.849	num	6	SENT_239	[p16l1479t349r1688b400],
6	.552	CD	NUMBER	.552	_	0	SENT_239	[p16l1900t349r2028b400],

1	Gene	NNP	O	Gene	nn	3	SENT_240	[p16l11t452r177b505],
2	ERCC1	NNP	O	ERCC1	nn	3	SENT_240	[p16l208t452r423b505],
3	AA	NNP	O	AA	_	0	SENT_240	[p16l721t453r814b504],
4	1	CD	NUMBER	1	dep	3	SENT_240	[p16l1043t453r1063b504],

1	AC	NN	O	ac	_	0	SENT_241	[p16l719t557r814b610],
2	1.537	CD	NUMBER	1.537	num	1	SENT_241	[p16l1043t558r1212b610],
3	.712	CD	NUMBER	.712	num	4	SENT_241	[p16l1346t558r1688b610],
4	—	NN	O	—	dep	1	SENT_241	[p16l1346t558r1688b610],
5	3.318	CD	NUMBER	3.318	number	6	SENT_241	[p16l1346t558r1688b610],
6	.273	CD	NUMBER	.273	dep	4	SENT_241	[p16l1900t558r2029b610],

1	CC	NN	O	cc	_	0	SENT_242	[p16l719t662r817b715],
2	1.565	CD	NUMBER	1.565	num	1	SENT_242	[p16l1043t664r1212b715],
3	.627	CD	NUMBER	.627	num	4	SENT_242	[p16l1346t664r1688b715],
4	—	NN	O	—	dep	1	SENT_242	[p16l1346t664r1688b715],
5	3.909	CD	NUMBER	3.909	number	6	SENT_242	[p16l1346t664r1688b715],
6	.337	CD	NUMBER	.337	dep	4	SENT_242	[p16l1900t664r2029b715],

1	Number	NNP	O	Number	nn	3	SENT_243	[p16l14t768r264b820],
2	Wild	NNP	O	Wild	nn	3	SENT_243	[p16l585t768r719b820],
3	type	NN	O	type	_	0	SENT_243	[p16l747t771r884b833],
4	1	CD	NUMBER	1	number	5	SENT_243	[p16l1043t768r1063b819],
5	1.007	CD	NUMBER	1.007	num	6	SENT_243	[p16l1307t768r1688b820],
6	—	NN	O	—	dep	3	SENT_243	[p16l1307t768r1688b820],
7	4.707	CD	NUMBER	4.707	number	8	SENT_243	[p16l1307t768r1688b820],
8	.048	CD	NUMBER	.048	num	9	SENT_243	[p16l1900t768r2055b820],
9	*	NN	O	*	dep	6	SENT_243	[p16l1900t768r2055b820],

1	of	IN	O	of	_	0	SENT_244	[p16l84t857r143b909],
2	SNPS	NN	O	snp	nn	5	SENT_244	[p16l169t856r343b909],
3	or	CC	O	or	_	0	SENT_244	[p16l659t871r722b909],
4	1	CD	NUMBER	1	nn	5	SENT_244	[p16l751t858r771b908],
5	SNP	NN	ORGANIZATION	snp	pobj	1	SENT_244	[p16l810t856r949b909],

1	22	CD	NUMBER	22	num	2	SENT_245	[p16l625t963r710b1024],
2	SNPS	NN	O	snp	_	0	SENT_245	[p16l740t962r914b1015],
3	2.177	CD	NUMBER	2.177	dep	2	SENT_245	[p16l1039t963r1212b1014],

1	CI	NN	O	ci	_	0	SENT_246	[p16l189t1106r243b1153],
2	=	JJ	O	=	amod	4	SENT_246	[p16l273t1129r315b1144],
3	confidence	NN	O	confidence	nn	4	SENT_246	[p16l342t1107r647b1153],
4	interval	NN	O	interval	dep	1	SENT_246	[p16l675t1107r884b1161],
5	;	:	O	;	_	0	SENT_246	[p16l675t1107r884b1161],
6	SNP	NN	O	snp	nn	10	SENT_246	[p16l914t1106r1035b1153],
7	=	JJ	O	=	amod	10	SENT_246	[p16l1063t1129r1105b1144],
8	single	JJ	O	single	amod	10	SENT_246	[p16l1132t1107r1290b1165],
9	nucleotide	NN	O	nucleotide	nn	10	SENT_246	[p16l1318t1107r1603b1153],
10	polymorphism	NN	O	polymorphism	dep	1	SENT_246	[p16l1631t1107r2037b1165],
11	;	:	O	;	_	0	SENT_246	[p16l1631t1107r2037b1165],
12	P8	NN	O	p8	dep	10	SENT_246	[p16l2069t1106r2142b1153],

1	=	JJ	O	=	amod	2	SENT_247	[p16l12t1199r53b1215],
2	performance	NN	O	performance	_	0	SENT_247	[p16l81t1177r431b1235],
3	status	NN	O	status	dep	2	SENT_247	[p16l455t1180r636b1223],
4	.	.	O	.	_	0	SENT_247	[p16l455t1180r636b1223],

1	*	SYM	O	*	dep	2	SENT_248	[p16l188t1248r524b1307],
2	Statistica	FW	O	statistica	_	0	SENT_248	[p16l188t1248r524b1307],
3	|	FW	O	|	dep	2	SENT_248	[p16l188t1248r524b1307],
4	|	FW	O	|	nn	5	SENT_248	[p16l188t1248r524b1307],
5	y	FW	O	y	rcmod	3	SENT_248	[p16l188t1248r524b1307],
6	significant	JJ	O	significant	dep	5	SENT_248	[p16l548t1249r841b1307],
7	.	.	O	.	_	0	SENT_248	[p16l548t1249r841b1307],

1	Grau	NNP	PERSON	Grau	nn	3	SENT_249	[p16l480t1466r647b1527],
2	et	NNP	O	et	nn	3	SENT_249	[p16l681t1471r745b1526],
3	aI.	NNP	O	aI.	_	0	SENT_249	[p16l776t1468r872b1526],
4	:	:	O	:	_	0	SENT_249	[p16l776t1468r872b1526],
5	Advanced	NNP	O	Advanced	nn	6	SENT_249	[p16l905t1468r1262b1526],
6	Head	NNP	O	Head	dep	3	SENT_249	[p16l1299t1468r1480b1526],
7	and	CC	O	and	_	0	SENT_249	[p16l1515t1468r1642b1526],
8	Neck	NNP	O	Neck	nn	9	SENT_249	[p16l1680t1468r1859b1526],
9	Cancer	NNP	O	Cancer	dep	3	SENT_249	[p16l1890t1466r2145b1527],
10	lower	JJR	O	lower	amod	11	SENT_249	[p16l9t1564r210b1624],
11	dose	NN	O	dose	dep	6	SENT_249	[p16l248t1564r405b1624],
12	of	IN	O	of	_	0	SENT_249	[p16l445t1564r517b1624],
13	paclitaxel	NN	O	paclitaxel	prep_of	6	SENT_249	[p16l545t1564r920b1639],
14	,	,	O	,	_	0	SENT_249	[p16l545t1564r920b1639],
15	which	WDT	O	which	nsubj	16	SENT_249	[p16l961t1564r1180b1624],
16	caused	VBD	O	cause	rcmod	13	SENT_249	[p16l1218t1564r1466b1624],
17	such	JJ	O	such	amod	19	SENT_249	[p16l1506t1564r1672b1624],
18	low	JJ	O	low	amod	19	SENT_249	[p16l1709t1564r1834b1624],
19	toxicity	NN	O	toxicity	dobj	16	SENT_249	[p16l1871t1565r2143b1639],
20	that	IN	O	that	complm	23	SENT_249	[p16l9t1660r162b1721],
21	it	PRP	O	it	nsubj	23	SENT_249	[p16l203t1662r257b1721],
22	was	VBD	O	be	cop	23	SENT_249	[p16l298t1681r438b1721],
23	impossible	JJ	O	impossible	ccomp	16	SENT_249	[p16l482t1660r867b1736],
24	to	TO	O	to	aux	25	SENT_249	[p16l911t1666r978b1721],
25	establish	VB	O	establish	xcomp	23	SENT_249	[p16l1023t1660r1351b1721],
26	differences	NNS	O	difference	dobj	25	SENT_249	[p16l1395t1660r1791b1721],
27	in	IN	O	in	_	0	SENT_249	[p16l1835t1662r1906b1720],
28	these	DT	O	these	det	29	SENT_249	[p16l1948t1660r2141b1721],
29	patients	NNS	O	patient	prep_in	25	SENT_249	[p16l9t1759r326b1834],
30	.	.	O	.	_	0	SENT_249	[p16l9t1759r326b1834],

1	However	RB	O	however	advmod	16	SENT_250	[p16l374t1759r712b1832],
2	,	,	O	,	_	0	SENT_250	[p16l374t1759r712b1832],
3	in	IN	O	in	_	0	SENT_250	[p16l757t1759r829b1817],
4	one	CD	NUMBER	one	num	5	SENT_250	[p16l871t1778r995b1818],
5	report	NN	O	report	prep_in	16	SENT_250	[p16l1039t1763r1265b1834],
6	with	IN	O	with	_	0	SENT_250	[p16l1306t1758r1471b1818],
7	a	DT	O	a	det	9	SENT_250	[p16l1514t1778r1555b1818],
8	higher	JJR	O	higher	amod	9	SENT_250	[p16l1595t1758r1836b1834],
9	dose	NN	O	dose	prep_with	5	SENT_250	[p16l1879t1758r2036b1818],
10	of	IN	O	of	_	0	SENT_250	[p16l2079t1758r2152b1818],
11	paclitaxel	NN	O	paclitaxel	prep_of	9	SENT_250	[p16l9t1854r384b1930],
12	,	,	O	,	_	0	SENT_250	[p16l9t1854r384b1930],
13	no	DT	O	no	det	14	SENT_250	[p16l427t1875r512b1915],
14	association	NN	O	association	nsubjpass	23	SENT_250	[p16l553t1856r956b1915],
15	was	VBD	O	be	auxpass	16	SENT_250	[p16l995t1875r1134b1915],
16	found	VBN	O	find	_	0	SENT_250	[p16l1174t1854r1383b1915],
17	between	IN	O	between	_	0	SENT_250	[p16l1420t1854r1725b1915],
18	the	DT	O	the	det	21	SENT_250	[p16l1763t1854r1880b1915],
19	different	JJ	O	different	amod	21	SENT_250	[p16l1921t1854r2140b1915, p16l10t1958r127b2013],
20	target	NN	O	target	nn	21	SENT_250	[p16l155t1958r378b2028],
21	genotypes	NNS	O	genotype	prep_between	16	SENT_250	[p16l407t1958r772b2028],
22	and	CC	O	and	_	0	SENT_250	[p16l805t1952r940b2013],
23	increased	VBD	O	increase	conj_and	16	SENT_250	[p16l968t1952r1319b2013],
24	toxicity	NN	O	toxicity	dobj	23	SENT_250	[p16l1347t1938r1699b2028],
25	.19	CD	NUMBER	.19	num	24	SENT_250	[p16l1347t1938r1699b2028],

1	Our	PRP$	O	we	poss	2	SENT_251	[p16l189t2050r332b2110],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_251	[p16l366t2050r663b2126],
3	indicate	VBP	O	indicate	_	0	SENT_251	[p16l698t2050r990b2110],
4	that	IN	O	that	complm	6	SENT_251	[p16l1026t2050r1179b2110],
5	there	EX	O	there	expl	6	SENT_251	[p16l1212t2050r1404b2110],
6	are	VBP	O	be	ccomp	3	SENT_251	[p16l1441t2070r1555b2110],
7	no	DT	O	no	det	10	SENT_251	[p16l1591t2070r1677b2110],
8	statistically	RB	O	statistically	advmod	9	SENT_251	[p16l1714t2050r2143b2126],
9	signiﬁcant	JJ	O	signiﬁcant	amod	10	SENT_251	[p16l11t2146r398b2222],
10	differences	NNS	O	difference	nsubj	6	SENT_251	[p16l441t2146r837b2207],
11	in	IN	O	in	_	0	SENT_251	[p16l880t2148r951b2206],
12	time	NN	O	time	prep_in	10	SENT_251	[p16l993t2148r1156b2207],
13	to	TO	O	to	_	0	SENT_251	[p16l1199t2152r1267b2207],
14	progression	NN	O	progression	nn	17	SENT_251	[p16l1310t2148r1735b2222],
15	or	CC	O	or	_	0	SENT_251	[p16l1778t2167r1850b2207],
16	overall	JJ	O	overall	conj_or	14	SENT_251	[p16l1893t2146r2142b2207],
17	survival	NN	O	survival	prep_to	6	SENT_251	[p16l11t2243r308b2304],
18	between	IN	O	between	_	0	SENT_251	[p16l357t2243r662b2304],
19	wild-type	JJ	O	wild-type	amod	22	SENT_251	[p16l711t2243r1053b2319],
20	and	CC	O	and	_	0	SENT_251	[p16l1105t2243r1240b2304],
21	SNP	NN	ORGANIZATION	snp	conj_and	19	SENT_251	[p16l1292t2243r1455b2304],
22	patients	NNS	O	patient	prep_between	17	SENT_251	[p16l1505t2245r1803b2319],
23	when	WRB	O	when	advmod	28	SENT_251	[p16l1853t2243r2052b2304],
24	a	DT	O	a	det	26	SENT_251	[p16l2103t2263r2144b2304],
25	single	JJ	O	single	amod	26	SENT_251	[p16l11t2341r224b2417],
26	gene	NN	O	gene	nsubjpass	28	SENT_251	[p16l254t2360r423b2417],
27	is	VBZ	O	be	auxpass	28	SENT_251	[p16l452t2342r510b2401],
28	analyzed	VBN	O	analyze	advcl	6	SENT_251	[p16l542t2341r885b2417],
29	.	.	O	.	_	0	SENT_251	[p16l542t2341r885b2417],

1	However	RB	O	however	advmod	10	SENT_252	[p16l919t2342r1257b2415],
2	,	,	O	,	_	0	SENT_252	[p16l919t2342r1257b2415],
3	the	DT	O	the	det	4	SENT_252	[p16l1289t2341r1405b2401],
4	number	NN	O	number	nsubj	10	SENT_252	[p16l1435t2341r1722b2401],
5	of	IN	O	of	_	0	SENT_252	[p16l1751t2341r1824b2401],
6	patients	NNS	O	patient	prep_of	4	SENT_252	[p16l1843t2342r2141b2417],
7	studied	VBN	O	study	partmod	6	SENT_252	[p16l11t2437r280b2498],
8	was	VBD	O	be	cop	10	SENT_252	[p16l337t2458r477b2498],
9	relatively	RB	O	relatively	advmod	10	SENT_252	[p16l536t2437r886b2513],
10	small	JJ	O	small	_	0	SENT_252	[p16l946t2437r1142b2498],
11	and	CC	O	and	_	0	SENT_252	[p16l1202t2437r1337b2498],
12	further	JJ	O	further	amod	13	SENT_252	[p16l1394t2437r1660b2498],
13	evaluations	NNS	O	evaluation	nsubjpass	22	SENT_252	[p16l1719t2437r2141b2498],
14	with	IN	O	with	_	0	SENT_252	[p16l8t2534r174b2595],
15	a	DT	O	a	det	17	SENT_252	[p16l225t2554r265b2595],
16	larger	JJR	O	larger	amod	17	SENT_252	[p16l313t2534r535b2610],
17	number	NN	O	number	prep_with	13	SENT_252	[p16l584t2534r871b2595],
18	of	IN	O	of	_	0	SENT_252	[p16l920t2534r992b2595],
19	cases	NNS	O	case	prep_of	17	SENT_252	[p16l1033t2554r1221b2595],
20	should	MD	O	should	aux	22	SENT_252	[p16l1274t2534r1515b2595],
21	be	VB	O	be	auxpass	22	SENT_252	[p16l1563t2534r1644b2595],
22	carried	VBN	O	carry	conj_and	10	SENT_252	[p16l1695t2534r1954b2595],
23	out	RP	O	out	prt	22	SENT_252	[p16l2004t2539r2137b2595],
24	.	.	O	.	_	0	SENT_252	[p16l2004t2539r2137b2595],

1	Analyzing	VBG	O	analyze	partmod	13	SENT_253	[p16l7t2632r383b2707],
2	patients	NNS	O	patient	dobj	1	SENT_253	[p16l424t2633r722b2707],
3	with	IN	O	with	_	0	SENT_253	[p16l765t2632r930b2692],
4	SNPS	NN	O	snp	prep_with	1	SENT_253	[p16l975t2632r1173b2692],
5	in	IN	O	in	_	0	SENT_253	[p16l1216t2633r1288b2691],
6	at	IN	O	at	quantmod	8	SENT_253	[p16l1332t2637r1403b2692],
7	least	JJS	O	least	mwe	6	SENT_253	[p16l1445t2632r1619b2692],
8	two	CD	NUMBER	two	num	10	SENT_253	[p16l1660t2637r1790b2692],
9	accumulated	VBN	O	accumulate	amod	10	SENT_253	[p16l1835t2652r2140b2692, p16l9t2728r192b2789],
10	genes	NNS	O	gene	prep_in	4	SENT_253	[p16l249t2748r474b2804],
11	,	,	O	,	_	0	SENT_253	[p16l249t2748r474b2804],
12	we	PRP	O	we	nsubj	13	SENT_253	[p16l534t2749r633b2789],
13	found	VBD	O	find	_	0	SENT_253	[p16l690t2728r899b2789],
14	that	IN	O	that	complm	20	SENT_253	[p16l955t2728r1108b2789],
15	the	DT	O	the	det	17	SENT_253	[p16l1164t2728r1280b2789],
16	overall	JJ	O	overall	amod	17	SENT_253	[p16l1339t2728r1588b2789],
17	survival	NN	O	survival	nsubj	20	SENT_253	[p16l1648t2728r1945b2789],
18	was	VBD	O	be	cop	20	SENT_253	[p16l2001t2749r2141b2789],
19	signiﬁcantly	RB	O	signiﬁcantly	advmod	20	SENT_253	[p16l11t2825r466b2901],
20	better	JJR	O	better	ccomp	13	SENT_253	[p16l495t2825r715b2886],
21	than	IN	O	than	prep	20	SENT_253	[p16l745t2825r916b2886],
22	in	IN	O	in	pcomp	21	SENT_253	[p16l946t2827r1017b2885],
23	patients	NNS	O	patient	pobj	22	SENT_253	[p16l1048t2827r1347b2901],
24	with	IN	O	with	_	0	SENT_253	[p16l1377t2825r1543b2886],
25	wild-type	JJ	O	wild-type	amod	26	SENT_253	[p16l1573t2825r1914b2901],
26	genotype	NN	O	genotype	prep_with	23	SENT_253	[p16l1947t2844r2141b2901, p16l9t2928r164b2999],
27	in	IN	O	in	_	0	SENT_253	[p16l204t2924r275b2982],
28	the	DT	O	the	det	30	SENT_253	[p16l313t2923r429b2983],
29	six	CD	NUMBER	six	num	30	SENT_253	[p16l471t2924r572b2983],
30	genes	NNS	O	gene	prep_in	20	SENT_253	[p16l609t2942r815b2998],
31	analyzed	VBN	O	analyze	partmod	30	SENT_253	[p16l856t2923r1199b2998],
32	.	.	O	.	_	0	SENT_253	[p16l856t2923r1199b2998],

1	As	IN	O	as	mark	4	SENT_254	[p16l1240t2923r1332b2983],
2	all	DT	O	all	det	3	SENT_254	[p16l1374t2923r1463b2983],
3	patients	NNS	O	patient	nsubj	4	SENT_254	[p16l1501t2924r1800b2998],
4	received	VBD	O	receive	advcl	12	SENT_254	[p16l1839t2923r2143b2983],
5	the	DT	O	the	det	7	SENT_254	[p16l9t3020r125b3080],
6	same	JJ	O	same	amod	7	SENT_254	[p16l162t3040r347b3080],
7	treatment	NN	O	treatment	dobj	4	SENT_254	[p16l381t3025r752b3080],
8	with	IN	O	with	_	0	SENT_254	[p16l783t3020r949b3080],
9	paclitaxel	NN	O	paclitaxel	prep_with	4	SENT_254	[p16l982t3020r1357b3096],
10	,	,	O	,	_	0	SENT_254	[p16l982t3020r1357b3096],
11	there	EX	O	there	expl	12	SENT_254	[p16l1394t3020r1586b3080],
12	are	VBP	O	be	_	0	SENT_254	[p16l1622t3040r1736b3080],
13	two	CD	NUMBER	two	num	15	SENT_254	[p16l1770t3025r1900b3080],
14	possible	JJ	O	possible	amod	15	SENT_254	[p16l1935t3021r2140b3096, p16l8t3116r114b3177],
15	explanations	NNS	O	explanation	nsubj	12	SENT_254	[p16l158t3116r627b3192],
16	for	IN	O	for	_	0	SENT_254	[p16l670t3116r770b3177],
17	the	DT	O	the	det	18	SENT_254	[p16l811t3116r927b3177],
18	differences	NNS	O	difference	prep_for	15	SENT_254	[p16l972t3116r1368b3177],
19	in	IN	O	in	_	0	SENT_254	[p16l1411t3118r1482b3176],
20	outcome	NN	O	outcome	prep_in	18	SENT_254	[p16l1526t3122r1846b3177],
21	.	.	O	.	_	0	SENT_254	[p16l1526t3122r1846b3177],

1	One	CD	NUMBER	one	nsubj	3	SENT_255	[p16l1895t3116r2040b3177],
2	is	VBZ	O	be	cop	3	SENT_255	[p16l2083t3118r2141b3177],
3	pharmacogenetic	JJ	O	pharmacogenetic	_	0	SENT_255	[p16l9t3213r655b3289],
4	:	:	O	:	_	0	SENT_255	[p16l9t3213r655b3289],
5	the	DT	O	the	det	6	SENT_255	[p16l699t3213r815b3274],
6	patients	NNS	O	patient	nsubj	10	SENT_255	[p16l858t3215r1156b3289],
7	with	IN	O	with	_	0	SENT_255	[p16l1197t3213r1362b3274],
8	SNPS	NN	O	snp	prep_with	6	SENT_255	[p16l1405t3213r1604b3274],
9	probably	RB	O	probably	advmod	10	SENT_255	[p16l1646t3213r1966b3289],
10	had	VBD	O	have	parataxis	3	SENT_255	[p16l2005t3213r2142b3274],
11	less	RBR	O	less	amod	13	SENT_255	[p16l9t3311r143b3371],
12	enzyme	NN	O	enzyme	nn	13	SENT_255	[p16l181t3331r457b3387],
13	activity	NN	O	activity	dobj	10	SENT_255	[p16l496t3312r780b3387],
14	,	,	O	,	_	0	SENT_255	[p16l496t3312r780b3387],
15	thus	RB	O	thus	advmod	10	SENT_255	[p16l819t3311r980b3371],
16	causing	VBG	O	cause	xcomp	10	SENT_255	[p16l1018t3312r1299b3387],
17	a	DT	O	a	det	18	SENT_255	[p16l1335t3331r1375b3371],
18	reduction	NN	O	reduction	dobj	16	SENT_255	[p16l1409t3311r1758b3371],
19	of	IN	O	of	_	0	SENT_255	[p16l1794t3311r1867b3371],
20	the	DT	O	the	det	22	SENT_255	[p16l1892t3311r2008b3371],
21	intracellular	JJ	O	intracellular	amod	22	SENT_255	[p16l2044t3312r2140b3370, p16l9t3407r398b3468],
22	metabolism	NN	O	metabolism	prep_of	18	SENT_255	[p16l434t3407r860b3468],
23	and	CC	O	and	_	0	SENT_255	[p16l899t3407r1033b3468],
24	the	DT	O	the	det	25	SENT_255	[p16l1070t3407r1186b3468],
25	extrusion	NN	O	extrusion	prep_of	18	SENT_255	[p16l1226t3409r1572b3468],
26	out	IN	O	out	_	0	SENT_255	[p16l1610t3413r1727b3468],
27	of	IN	O	of	_	0	SENT_255	[p16l1765t3407r1837b3468],
28	the	DT	O	the	det	29	SENT_255	[p16l1865t3407r1981b3468],
29	cell	NN	O	cell	prep_out_of	16	SENT_255	[p16l2020t3407r2142b3468],
30	of	IN	O	of	_	0	SENT_255	[p16l10t3504r82b3565],
31	paclitaxel	NN	O	paclitaxel	prep_of	29	SENT_255	[p16l104t3504r479b3580],
32	;	:	O	;	_	0	SENT_255	[p16l104t3504r479b3580],
33	as	IN	O	as	_	0	SENT_255	[p16l514t3524r589b3565],
34	a	DT	O	a	det	35	SENT_255	[p16l623t3524r663b3565],
35	result	NN	O	result	prep_as	43	SENT_255	[p16l693t3504r927b3578],
36	,	,	O	,	_	0	SENT_255	[p16l693t3504r927b3578],
37	the	DT	O	the	det	38	SENT_255	[p16l960t3504r1076b3565],
38	activity	NN	O	activity	nsubj	43	SENT_255	[p16l1110t3506r1384b3580],
39	of	IN	O	of	_	0	SENT_255	[p16l1415t3504r1488b3565],
40	the	DT	O	the	det	41	SENT_255	[p16l1508t3504r1624b3565],
41	drug	NN	O	drug	prep_of	38	SENT_255	[p16l1657t3504r1828b3580],
42	is	VBZ	O	be	cop	43	SENT_255	[p16l1857t3506r1915b3565],
43	superior	JJ	O	superior	parataxis	3	SENT_255	[p16l1949t3524r2141b3580, p16l9t3603r155b3662],
44	.	.	O	.	_	0	SENT_255	[p16l1949t3524r2141b3580, p16l9t3603r155b3662],

1	Many	JJ	O	many	amod	4	SENT_256	[p16l258t3603r469b3677],
2	basic	JJ	O	basic	amod	4	SENT_256	[p16l566t3602r750b3662],
3	research	NN	O	research	nn	4	SENT_256	[p16l849t3602r1163b3662],
4	reports	NNS	O	report	nsubj	5	SENT_256	[p16l1262t3607r1523b3677],
5	support	VBP	O	support	_	0	SENT_256	[p16l1626t3607r1905b3678],
6	this	DT	O	this	det	7	SENT_256	[p16l2003t3602r2141b3662],
7	opinion	NN	O	opinion	dobj	5	SENT_256	[p16l10t3685r451b3775],
8	.20	CD	NUMBER	.20	number	9	SENT_256	[p16l10t3685r451b3775],
9	’21	CD	NUMBER	’21	num	7	SENT_256	[p16l10t3685r451b3775],
10	The	DT	O	the	det	12	SENT_256	[p16l488t3699r627b3760],
11	other	JJ	O	other	amod	12	SENT_256	[p16l665t3699r857b3760],
12	explanation	NN	O	explanation	nsubj	13	SENT_256	[p16l892t3699r1325b3775],
13	is	VBZ	O	be	rcmod	7	SENT_256	[p16l1360t3701r1418b3760],
14	that	IN	O	that	complm	20	SENT_256	[p16l1455t3699r1608b3760],
15	patients	NNS	O	patient	nsubj	20	SENT_256	[p16l1643t3701r1941b3775],
16	with	IN	O	with	_	0	SENT_256	[p16l1977t3699r2142b3760],
17	wild-type	JJ	O	wild-type	amod	18	SENT_256	[p17l8t17r350b93],
18	genotype	NN	O	genotype	prep_with	15	SENT_256	[p17l414t22r742b93],
19	may	MD	O	may	aux	20	SENT_256	[p17l807t37r963b93],
20	have	VB	O	have	ccomp	13	SENT_256	[p17l1025t17r1198b78],
21	poorer	JJR	O	poorer	amod	22	SENT_256	[p17l1262t37r1497b93],
22	prognosis	NN	O	prognosis	dobj	20	SENT_256	[p17l1560t19r1908b93],
23	than	IN	O	than	_	0	SENT_256	[p17l1972t17r2143b78],
24	those	DT	O	those	prep_than	20	SENT_256	[p17l9t115r202b175],
25	with	IN	O	with	_	0	SENT_256	[p17l239t115r404b175],
26	SNP	NN	O	snp	nn	27	SENT_256	[p17l442t115r605b175],
27	genotype	NN	O	genotype	prep_with	24	SENT_256	[p17l641t120r970b190],
28	and	CC	O	and	_	0	SENT_256	[p17l1009t115r1143b175],
29	are	VBP	O	be	auxpass	31	SENT_256	[p17l1181t135r1295b175],
30	not	RB	O	not	neg	31	SENT_256	[p17l1333t120r1450b175],
31	inﬂuenced	VBN	O	inﬂuenced	conj_and	20	SENT_256	[p17l1485t115r1869b175],
32	by	IN	O	by	_	0	SENT_256	[p17l1903t115r1990b190],
33	the	DT	O	the	det	34	SENT_256	[p17l2025t115r2141b175],
34	chemotherapy	NN	O	chemotherapy	agent	31	SENT_256	[p17l10t211r540b287],
35	.	.	O	.	_	0	SENT_256	[p17l10t211r540b287],

1	There	EX	O	there	dep	101	SENT_257	[p17l584t211r798b272],
2	are	VBP	O	be	dep	101	SENT_257	[p17l839t232r953b272],
3	some	DT	O	some	dep	101	SENT_257	[p17l995t232r1177b272],
4	studies	NNS	O	study	dep	101	SENT_257	[p17l1218t211r1476b272],
5	that	WDT	O	that	dep	101	SENT_257	[p17l1515t211r1668b272],
6	suggest	VBP	O	suggest	dep	101	SENT_257	[p17l1708t217r1984b287],
7	differences	NNS	O	difference	dep	101	SENT_257	[p17l2023t211r2140b272, p17l9t309r309b370],
8	in	IN	O	in	dep	101	SENT_257	[p17l341t311r413b369],
9	outcome	NN	O	outcome	dep	101	SENT_257	[p17l445t314r746b370],
10	according	VBG	O	accord	dep	101	SENT_257	[p17l781t309r1133b385],
11	to	TO	O	to	dep	101	SENT_257	[p17l1162t314r1229b370],
12	genotype	NN	O	genotype	dep	101	SENT_257	[p17l1262t294r1762b385],
13	.16	CD	NUMBER	.16	dep	101	SENT_257	[p17l1262t294r1762b385],
14	’22	CD	NUMBER	’22	dep	101	SENT_257	[p17l1262t294r1762b385],
15	To	TO	O	to	dep	101	SENT_257	[p17l1794t310r1878b370],
16	clarify	VB	O	clarify	dep	101	SENT_257	[p17l1910t309r2144b385],
17	this	DT	O	this	dep	101	SENT_257	[p17l9t407r146b467],
18	point	NN	O	point	dep	101	SENT_257	[p17l189t408r396b483],
19	,	,	O	,	_	0	SENT_257	[p17l189t408r396b483],
20	a	DT	O	a	dep	101	SENT_257	[p17l442t427r482b467],
21	randomized	VBN	O	randomize	dep	101	SENT_257	[p17l522t407r955b467],
22	clinical	JJ	O	clinical	dep	101	SENT_257	[p17l996t407r1257b467],
23	trial	NN	O	trial	dep	101	SENT_257	[p17l1298t407r1457b467],
24	between	IN	O	between	dep	101	SENT_257	[p17l1496t407r1802b467],
25	patients	NNS	O	patient	dep	101	SENT_257	[p17l1843t408r2141b482],
26	treated	VBN	O	treat	dep	101	SENT_257	[p17l9t503r274b564],
27	with	IN	O	with	dep	101	SENT_257	[p17l322t503r488b564],
28	paclitaxel	NN	O	paclitaxel	dep	101	SENT_257	[p17l537t503r893b579],
29	versus	CC	O	versus	dep	101	SENT_257	[p17l941t524r1180b564],
30	best	JJS	O	best	dep	101	SENT_257	[p17l1229t503r1380b564],
31	supportive	JJ	O	supportive	dep	101	SENT_257	[p17l1431t505r1817b579],
32	care	NN	O	care	dep	101	SENT_257	[p17l1868t524r2019b564],
33	or	CC	O	or	dep	101	SENT_257	[p17l2071t524r2143b564],
34	other	JJ	O	other	dep	101	SENT_257	[p17l10t600r203b661],
35	therapies	NNS	O	therapy	dep	101	SENT_257	[p17l232t600r576b676],
36	should	MD	O	should	dep	101	SENT_257	[p17l610t600r851b661],
37	be	VB	O	be	dep	101	SENT_257	[p17l880t600r961b661],
38	performed	VBN	O	perform	dep	101	SENT_257	[p17l994t600r1391b676],
39	;	:	O	;	_	0	SENT_257	[p17l994t600r1391b676],
40	however	RB	O	however	dep	101	SENT_257	[p17l1424t600r1746b674],
41	,	,	O	,	_	0	SENT_257	[p17l1424t600r1746b674],
42	the	DT	O	the	dep	101	SENT_257	[p17l1779t600r1896b661],
43	ethics	NNS	O	ethic	dep	101	SENT_257	[p17l1929t600r2141b661],
44	of	IN	O	of	dep	101	SENT_257	[p17l10t698r82b758],
45	such	PDT	O	such	dep	101	SENT_257	[p17l120t698r285b758],
46	an	DT	O	a	dep	101	SENT_257	[p17l332t718r420b758],
47	approach	NN	O	approach	dep	101	SENT_257	[p17l466t698r803b773],
48	are	VBP	O	be	dep	101	SENT_257	[p17l850t718r963b758],
49	questionable	JJ	O	questionable	dep	101	SENT_257	[p17l1010t698r1494b773],
50	,	,	O	,	_	0	SENT_257	[p17l1010t698r1494b773],
51	especially	RB	O	especially	dep	101	SENT_257	[p17l1543t698r1901b774],
52	when	WRB	O	when	dep	101	SENT_257	[p17l1944t698r2143b758],
53	agents	NNS	O	agent	dep	101	SENT_257	[p17l11t800r249b870],
54	such	JJ	O	such	dep	101	SENT_257	[p17l299t794r465b855],
55	as	IN	O	as	dep	101	SENT_257	[p17l513t815r588b855],
56	cetuximab	NN	O	cetuximab	dep	101	SENT_257	[p17l637t794r1016b855],
57	have	VBP	O	have	dep	101	SENT_257	[p17l1062t794r1236b855],
58	been	VBN	O	be	dep	101	SENT_257	[p17l1282t794r1454b855],
59	shown	VBN	O	show	dep	101	SENT_257	[p17l1502t794r1735b855],
60	to	TO	O	to	dep	101	SENT_257	[p17l1781t800r1849b855],
61	extend	VB	O	extend	dep	101	SENT_257	[p17l1897t794r2143b855],
62	survival	NN	O	survival	dep	101	SENT_257	[p17l11t892r308b952],
63	in	IN	O	in	dep	101	SENT_257	[p17l342t893r414b951],
64	settings	NNS	O	setting	dep	101	SENT_257	[p17l450t893r737b968],
65	of	IN	O	of	dep	101	SENT_257	[p17l773t892r845b952],
66	advanced	JJ	O	advanced	dep	101	SENT_257	[p17l871t892r1215b952],
67	disease	NN	O	disease	dep	101	SENT_257	[p17l1250t877r1601b952],
68	.23	CD	NUMBER	.23	dep	101	SENT_257	[p17l1250t877r1601b952],
69	In	FW	O	in	dep	101	SENT_257	[p17l1639t893r1716b952],
70	vitro	FW	O	vitro	dep	101	SENT_257	[p17l1749t894r1921b953],
71	studies	NNS	O	study	dep	101	SENT_257	[p17l1958t892r2140b953, p17l9t990r106b1049],
72	support	VBP	O	support	dep	101	SENT_257	[p17l140t994r420b1065],
73	the	DT	O	the	dep	101	SENT_257	[p17l449t989r566b1049],
74	idea	NN	O	idea	dep	101	SENT_257	[p17l597t989r751b1049],
75	that	IN	O	that	dep	101	SENT_257	[p17l780t989r933b1049],
76	several	JJ	O	several	dep	101	SENT_257	[p17l965t989r1225b1049],
77	accumulated	VBN	O	accumulate	dep	101	SENT_257	[p17l1257t989r1724b1049],
78	SNPs	NNS	O	snp	dep	101	SENT_257	[p17l1756t989r1955b1049],
79	may	MD	O	may	dep	101	SENT_257	[p17l1987t1009r2143b1064],
80	have	VB	O	have	dep	101	SENT_257	[p17l8t1085r181b1146],
81	lower	JJR	O	lower	dep	101	SENT_257	[p17l223t1085r425b1146],
82	enzyme	NN	O	enzyme	dep	101	SENT_257	[p17l466t1106r742b1161],
83	activity	NN	O	activity	dep	101	SENT_257	[p17l786t1087r1060b1161],
84	and	CC	O	and	dep	101	SENT_257	[p17l1102t1085r1256b1159],
85	,	,	O	,	_	0	SENT_257	[p17l1102t1085r1256b1159],
86	as	IN	O	as	dep	101	SENT_257	[p17l1301t1106r1376b1146],
87	a	DT	O	a	dep	101	SENT_257	[p17l1420t1106r1460b1146],
88	consequence	NN	O	consequence	dep	101	SENT_257	[p17l1501t1106r1976b1161],
89	,	,	O	,	_	0	SENT_257	[p17l1501t1106r1976b1161],
90	our	PRP$	O	we	dep	101	SENT_257	[p17l2021t1106r2143b1146],
91	clinical	JJ	O	clinical	dep	101	SENT_257	[p17l10t1183r271b1243],
92	results	NNS	O	result	dep	101	SENT_257	[p17l301t1183r551b1243],
93	provide	VBP	O	provide	dep	101	SENT_257	[p17l582t1183r853b1259],
94	in	FW	O	in	dep	101	SENT_257	[p17l883t1184r955b1242],
95	vivo	FW	O	vivo	dep	101	SENT_257	[p17l983t1184r1132b1243],
96	conﬁrmation	NN	O	conﬁrmation	dep	101	SENT_257	[p17l1164t1183r1633b1243],
97	of	IN	O	of	dep	101	SENT_257	[p17l1663t1183r1735b1243],
98	a	DT	O	a	dep	101	SENT_257	[p17l1757t1203r1797b1243],
99	different	JJ	O	different	dep	101	SENT_257	[p17l1827t1183r2144b1243],
100	drug	NN	O	drug	dep	101	SENT_257	[p17l11t1281r182b1356],
101	metabolism	NN	O	metabolism	_	0	SENT_257	[p17l210t1281r652b1341],
102	.	.	O	.	_	0	SENT_257	[p17l210t1281r652b1341],

1	For	IN	O	for	_	0	SENT_258	[p17l187t1378r314b1438],
2	example	NN	O	example	prep_for	10	SENT_258	[p17l348t1377r673b1453],
3	,	,	O	,	_	0	SENT_258	[p17l348t1377r673b1453],
4	glutathione	NN	O	glutathione	nn	6	SENT_258	[p17l710t1377r1133b1453],
5	S-transferase	NN	O	s-transferase	nn	6	SENT_258	[p17l1170t1377r1660b1438],
6	P1	NN	O	p1	nsubj	10	SENT_258	[p17l1696t1378r1787b1437],
7	(	CD	NUMBER	(	num	9	SENT_258	[p17l1825t1377r2141b1447],
8	GSTP1	NN	O	gstp1	nn	9	SENT_258	[p17l1825t1377r2141b1447],
9	)	NN	O	)	dep	6	SENT_258	[p17l1825t1377r2141b1447],
10	belongs	VBZ	O	belong	_	0	SENT_258	[p17l8t1475r283b1551],
11	to	TO	O	to	_	0	SENT_258	[p17l326t1480r393b1535],
12	a	DT	O	a	det	13	SENT_258	[p17l438t1495r478b1535],
13	family	NN	O	family	prep_to	10	SENT_258	[p17l519t1475r753b1551],
14	of	IN	O	of	_	0	SENT_258	[p17l795t1475r867b1535],
15	phase	NN	O	phase	prep_of	13	SENT_258	[p17l900t1475r1112b1551],
16	2	CD	NUMBER	2	num	18	SENT_258	[p17l1155t1477r1194b1535],
17	metabolic	JJ	O	metabolic	amod	18	SENT_258	[p17l1238t1475r1591b1535],
18	enzymes	NNS	O	enzyme	dobj	10	SENT_258	[p17l1634t1495r1947b1551],
19	that	WDT	O	that	nsubj	21	SENT_258	[p17l1990t1475r2144b1535],
20	can	MD	O	can	aux	21	SENT_258	[p17l10t1592r135b1632],
21	detoxify	VB	O	detoxify	rcmod	18	SENT_258	[p17l194t1571r485b1647],
22	several	JJ	O	several	amod	24	SENT_258	[p17l544t1571r803b1632],
23	anticancer	JJ	O	anticancer	amod	24	SENT_258	[p17l863t1573r1249b1632],
24	drugs	NNS	O	drug	dobj	21	SENT_258	[p17l1307t1571r1511b1647],
25	by	IN	O	by	_	0	SENT_258	[p17l1569t1571r1656b1647],
26	conjugating	VBG	O	conjugate	prepc_by	21	SENT_258	[p17l1713t1573r2144b1647],
27	them	PRP	O	they	dobj	26	SENT_258	[p17l9t1668r197b1729],
28	with	IN	O	with	_	0	SENT_258	[p17l242t1668r407b1729],
29	glutathione	NN	O	glutathione	prep_with	26	SENT_258	[p17l452t1668r894b1744],
30	.	.	O	.	_	0	SENT_258	[p17l452t1668r894b1744],

1	GSTP1	NN	O	gstp1	nsubjpass	4	SENT_259	[p17l946t1668r1204b1729],
2	is	VBZ	O	be	auxpass	4	SENT_259	[p17l1254t1670r1312b1729],
3	therefore	RB	O	therefore	advmod	4	SENT_259	[p17l1358t1668r1693b1729],
4	thought	VBN	O	think	_	0	SENT_259	[p17l1739t1668r2030b1744],
5	to	TO	O	to	aux	6	SENT_259	[p17l2074t1674r2141b1729],
6	confer	VB	O	confer	xcomp	4	SENT_259	[p17l10t1766r234b1826],
7	resistance	NN	O	resistance	dobj	6	SENT_259	[p17l272t1767r642b1826],
8	to	TO	O	to	_	0	SENT_259	[p17l681t1771r748b1826],
9	platin-based	JJ	O	platin-based	amod	10	SENT_259	[p17l788t1766r1242b1842],
10	chemotherapy	NN	O	chemotherapy	prep_to	6	SENT_259	[p17l1281t1766r1803b1842],
11	but	CC	O	but	_	0	SENT_259	[p17l1839t1766r1963b1826],
12	also	RB	O	also	_	0	SENT_259	[p17l2001t1766r2141b1826],
13	to	TO	O	to	_	0	SENT_259	[p17l9t1868r76b1923],
14	taxanes	NNS	O	taxane	prep_to	6	SENT_259	[p17l111t1868r414b1923],
15	.	.	O	.	_	0	SENT_259	[p17l111t1868r414b1923],

1	The	DT	O	the	det	2	SENT_260	[p17l454t1862r592b1923],
2	role	NN	O	role	nsubjpass	12	SENT_260	[p17l629t1862r765b1923],
3	of	IN	O	of	_	0	SENT_260	[p17l802t1862r875b1923],
4	GSTP1	NN	O	gstp1	nn	5	SENT_260	[p17l901t1862r1159b1923],
5	genotypes	NNS	O	genotype	prep_of	2	SENT_260	[p17l1200t1868r1565b1938],
6	with	IN	O	with	_	0	SENT_260	[p17l1600t1862r1765b1923],
7	docetaxel	NN	O	docetaxel	prep_with	5	SENT_260	[p17l1802t1862r2142b1923],
8	and	CC	O	and	_	0	SENT_260	[p17l11t1959r145b2020],
9	paclitaxel	NN	O	paclitaxel	conj_and	7	SENT_260	[p17l191t1959r546b2035],
10	has	VBZ	O	have	aux	12	SENT_260	[p17l590t1959r717b2020],
11	been	VBN	O	be	auxpass	12	SENT_260	[p17l762t1959r933b2020],
12	studied	VBN	O	study	_	0	SENT_260	[p17l980t1959r1249b2020],
13	in	IN	O	in	_	0	SENT_260	[p17l1293t1961r1365b2019],
14	breast	NN	O	breast	nn	18	SENT_260	[p17l1408t1959r1638b2020],
15	and	CC	O	and	_	0	SENT_260	[p17l1684t1959r1819b2020],
16	ovarian	JJ	O	ovarian	conj_and	14	SENT_260	[p17l1865t1961r2143b2020],
17	cancer	NN	O	cancer	nn	18	SENT_260	[p17l10t2078r248b2118],
18	patients	NNS	O	patient	prep_in	12	SENT_260	[p17l278t2059r597b2134],
19	,	,	O	,	_	0	SENT_260	[p17l278t2059r597b2134],
20	but	CC	O	but	_	0	SENT_260	[p17l630t2058r753b2118],
21	mainly	RB	O	mainly	advmod	34	SENT_260	[p17l782t2058r1038b2134],
22	in	IN	O	in	_	0	SENT_260	[p17l1068t2059r1139b2117],
23	combined	JJ	O	combined	amod	24	SENT_260	[p17l1171t2058r1519b2118],
24	therapies	NNS	O	therapy	prep_in	34	SENT_260	[p17l1549t2044r2032b2134],
25	.6	CD	NUMBER	.6	num	26	SENT_260	[p17l1549t2044r2032b2134],
26	’19	CD	NUMBER	’19	npadvmod	34	SENT_260	[p17l1549t2044r2032b2134],
27	In	IN	O	in	_	0	SENT_260	[p17l2064t2059r2142b2117],
28	our	PRP$	O	we	poss	29	SENT_260	[p17l10t2175r132b2215],
29	series	NN	O	series	prep_in	34	SENT_260	[p17l165t2156r393b2228],
30	,	,	O	,	_	0	SENT_260	[p17l165t2156r393b2228],
31	the	DT	O	the	det	32	SENT_260	[p17l427t2154r543b2215],
32	patients	NNS	O	patient	nsubjpass	34	SENT_260	[p17l576t2156r874b2230],
33	were	VBD	O	be	auxpass	34	SENT_260	[p17l905t2175r1081b2215],
34	treated	VBN	O	treat	conj_but	12	SENT_260	[p17l1113t2154r1378b2215],
35	with	IN	O	with	_	0	SENT_260	[p17l1408t2154r1573b2215],
36	paclitaxel	NN	O	paclitaxel	prep_with	34	SENT_260	[p17l1605t2154r1961b2230],
37	as	IN	O	as	_	0	SENT_260	[p17l1994t2175r2069b2215],
38	a	DT	O	a	det	40	SENT_260	[p17l2103t2175r2144b2215],
39	single	JJ	O	single	amod	40	SENT_260	[p17l11t2251r224b2327],
40	agent	NN	O	agent	prep_as	34	SENT_260	[p17l319t2256r540b2327],
41	,	,	O	,	_	0	SENT_260	[p17l319t2256r540b2327],
42	making	VBG	O	make	xcomp	34	SENT_260	[p17l635t2251r913b2327],
43	the	DT	O	the	det	45	SENT_260	[p17l1003t2251r1119b2312],
44	negative	JJ	O	negative	amod	45	SENT_260	[p17l1212t2253r1523b2327],
45	results	NNS	O	result	nsubj	47	SENT_260	[p17l1616t2251r1866b2312],
46	more	RBR	O	more	advmod	47	SENT_260	[p17l1958t2271r2141b2312],
47	convincing	JJ	O	convincing	xcomp	42	SENT_260	[p17l10t2351r419b2426],
48	.	.	O	.	_	0	SENT_260	[p17l10t2351r419b2426],

1	Nevertheless	RB	O	nevertheless	advmod	6	SENT_261	[p17l187t2447r686b2521],
2	,	,	O	,	_	0	SENT_261	[p17l187t2447r686b2521],
3	genes	NNS	O	gene	nsubj	6	SENT_261	[p17l746t2466r951b2523],
4	do	VBP	O	do	aux	6	SENT_261	[p17l1010t2447r1090b2507],
5	not	RB	O	not	neg	6	SENT_261	[p17l1148t2452r1266b2507],
6	act	VB	O	act	_	0	SENT_261	[p17l1323t2452r1430b2507],
7	in	IN	O	in	_	0	SENT_261	[p17l1486t2448r1557b2506],
8	isolation	NN	O	isolation	prep_in	6	SENT_261	[p17l1613t2447r1946b2521],
9	,	,	O	,	_	0	SENT_261	[p17l1613t2447r1946b2521],
10	and	CC	O	and	_	0	SENT_261	[p17l2008t2447r2142b2507],
11	drugs	NNS	O	drug	nsubjpass	14	SENT_261	[p17l11t2543r215b2619],
12	are	VBP	O	be	auxpass	14	SENT_261	[p17l253t2564r367b2604],
13	often	RB	O	often	advmod	14	SENT_261	[p17l403t2543r586b2604],
14	involved	VBN	O	involve	conj_and	6	SENT_261	[p17l620t2543r930b2604],
15	in	IN	O	in	_	0	SENT_261	[p17l963t2545r1035b2603],
16	complex	JJ	O	complex	amod	18	SENT_261	[p17l1070t2543r1368b2619],
17	metabolic	JJ	O	metabolic	amod	18	SENT_261	[p17l1401t2543r1754b2604],
18	pathways	NNS	O	pathway	prep_in	14	SENT_261	[p17l1789t2543r2141b2619],
19	in	IN	O	in	_	0	SENT_261	[p17l9t2642r80b2700],
20	the	DT	O	the	det	21	SENT_261	[p17l115t2640r231b2701],
21	cell	NN	O	cell	prep_in	18	SENT_261	[p17l269t2640r391b2701],
22	before	IN	O	before	mark	25	SENT_261	[p17l425t2640r649b2701],
23	they	PRP	O	they	nsubjpass	25	SENT_261	[p17l685t2640r847b2716],
24	are	VBP	O	be	auxpass	25	SENT_261	[p17l883t2661r997b2701],
25	converted	VBN	O	convert	advcl	14	SENT_261	[p17l1034t2640r1392b2701],
26	into	IN	O	into	_	0	SENT_261	[p17l1427t2642r1568b2701],
27	active	JJ	O	active	amod	30	SENT_261	[p17l1606t2642r1820b2701],
28	or	CC	O	or	_	0	SENT_261	[p17l1857t2661r1930b2701],
29	inactive	JJ	O	inactive	conj_or	27	SENT_261	[p17l1964t2642r2141b2701, p17l9t2739r144b2798],
30	forms	NNS	O	form	prep_into	25	SENT_261	[p17l214t2738r440b2798],
31	.	.	O	.	_	0	SENT_261	[p17l214t2738r440b2798],

1	Combination	NN	O	combination	nsubj	22	SENT_262	[p17l516t2738r988b2798],
2	of	IN	O	of	_	0	SENT_262	[p17l1058t2738r1131b2798],
3	SNPs	NNS	O	snp	prep_of	1	SENT_262	[p17l1193t2738r1392b2798],
4	in	IN	O	in	_	0	SENT_262	[p17l1463t2739r1534b2797],
5	several	JJ	O	several	amod	6	SENT_262	[p17l1606t2738r1866b2798],
6	genes	NNS	O	gene	prep_in	3	SENT_262	[p17l1936t2757r2141b2814],
7	involved	VBN	O	involve	partmod	6	SENT_262	[p17l9t2834r318b2895],
8	in	IN	O	in	_	0	SENT_262	[p17l355t2836r427b2894],
9	drug	NN	O	drug	nn	10	SENT_262	[p17l466t2834r637b2910],
10	metabolism	NN	O	metabolism	prep_in	7	SENT_262	[p17l674t2834r1118b2908],
11	,	,	O	,	_	0	SENT_262	[p17l674t2834r1118b2908],
12	intracellular	JJ	O	intracellular	amod	14	SENT_262	[p17l1159t2834r1622b2895],
13	drug	NN	O	drug	nn	14	SENT_262	[p17l1661t2834r1832b2910],
14	concentration	NN	O	concentration	appos	10	SENT_262	[p17l1870t2855r2141b2895, p17l9t2933r281b3005],
15	,	,	O	,	_	0	SENT_262	[p17l1870t2855r2141b2895, p17l9t2933r281b3005],
16	and	CC	O	and	_	0	SENT_262	[p17l362t2931r497b2992],
17	in	IN	O	in	_	0	SENT_262	[p17l572t2933r644b2991],
18	DNA	NN	MISC	dna	nn	20	SENT_262	[p17l720t2931r904b2992],
19	damage	NN	O	damage	nn	20	SENT_262	[p17l979t2931r1261b3007],
20	repair	NN	O	repair	conj_and	10	SENT_262	[p17l1339t2933r1563b3007],
21	may	MD	O	may	aux	22	SENT_262	[p17l1638t2951r1795b3007],
22	play	VB	O	play	conj_and	22	SENT_262	[p17l1871t2931r2026b3007],
23	a	DT	O	a	det	25	SENT_262	[p17l2103t2951r2144b2992],
24	synergistic	JJ	O	synergistic	amod	25	SENT_262	[p17l11t3030r408b3105],
25	effect	NN	O	effect	dobj	22	SENT_262	[p17l439t3029r636b3089],
26	for	IN	O	for	_	0	SENT_262	[p17l664t3029r765b3089],
27	differences	NNS	O	difference	prep_for	25	SENT_262	[p17l796t3029r1192b3089],
28	in	IN	O	in	_	0	SENT_262	[p17l1222t3030r1294b3088],
29	response	NN	O	response	prep_in	27	SENT_262	[p17l1323t3049r1644b3105],
30	to	TO	O	to	_	0	SENT_262	[p17l1674t3034r1742b3089],
31	treatment	NN	O	treatment	prep_to	22	SENT_262	[p17l1773t3034r2144b3089],
32	and	CC	O	and	_	0	SENT_262	[p17l11t3125r146b3186],
33	in	IN	O	in	_	0	SENT_262	[p17l185t3127r257b3185],
34	patient	NN	O	patient	nn	35	SENT_262	[p17l297t3127r561b3201],
35	outcome	NN	O	outcome	prep_in	22	SENT_262	[p17l601t3131r922b3186],
36	.	.	O	.	_	0	SENT_262	[p17l601t3131r922b3186],

1	This	DT	DATE	this	nsubj	3	SENT_263	[p17l967t3125r1128b3186],
2	may	MD	DATE	may	aux	3	SENT_263	[p17l1169t3146r1325b3201],
3	explain	VB	O	explain	_	0	SENT_263	[p17l1366t3125r1653b3201],
4	,	,	O	,	_	0	SENT_263	[p17l1366t3125r1653b3201],
5	in	IN	O	in	_	0	SENT_263	[p17l1697t3127r1768b3185],
6	part	NN	O	part	prep_in	3	SENT_263	[p17l1809t3131r1981b3201],
7	,	,	O	,	_	0	SENT_263	[p17l1809t3131r1981b3201],
8	the	DT	O	the	det	9	SENT_263	[p17l2025t3125r2141b3186],
9	contribution	NN	O	contribution	appos	6	SENT_263	[p17l10t3222r461b3283],
10	of	IN	O	of	_	0	SENT_263	[p17l509t3222r582b3283],
11	ERCC1	NN	O	ercc1	prep_of	9	SENT_263	[p17l616t3222r887b3283],
12	to	TO	O	to	_	0	SENT_263	[p17l940t3227r1007b3283],
13	the	DT	O	the	det	15	SENT_263	[p17l1056t3222r1172b3283],
14	other	JJ	O	other	amod	15	SENT_263	[p17l1221t3222r1414b3283],
15	genes	NNS	O	gene	prep_to	3	SENT_263	[p17l1461t3241r1666b3298],
16	involved	VBN	O	involve	partmod	15	SENT_263	[p17l1714t3222r2024b3283],
17	in	IN	O	in	_	0	SENT_263	[p17l2071t3224r2142b3282],
18	paclitaxel	NN	O	paclitaxel	nn	19	SENT_263	[p17l9t3320r365b3395],
19	metabolism	NN	O	metabolism	prep_in	16	SENT_263	[p17l395t3320r837b3380],
20	.	.	O	.	_	0	SENT_263	[p17l395t3320r837b3380],

1	In	IN	O	in	dep	4	SENT_264	[p17l188t3417r266b3476],
2	conclusion	NN	O	conclusion	pobj	1	SENT_264	[p17l313t3416r714b3490],
3	,	,	O	,	_	0	SENT_264	[p17l313t3416r714b3490],
4	patients	NNS	O	patient	_	0	SENT_264	[p17l764t3418r1062b3492],
5	with	IN	O	with	_	0	SENT_264	[p17l1109t3416r1275b3477],
6	advanced	JJ	O	advanced	amod	9	SENT_264	[p17l1323t3416r1667b3477],
7	or	CC	O	or	_	0	SENT_264	[p17l1714t3437r1786b3477],
8	relapsed	JJ	O	relapsed	amod	9	SENT_264	[p17l1831t3416r2143b3492],
9	head	NN	O	head	prep_with	4	SENT_264	[p17l8t3513r185b3574],
10	and	CC	O	and	_	0	SENT_264	[p17l241t3513r375b3574],
11	neck	NN	O	neck	nn	12	SENT_264	[p17l428t3513r599b3574],
12	cancer	NN	O	cancer	prep_with	4	SENT_264	[p17l652t3533r890b3574],
13	treated	VBN	O	treat	partmod	4	SENT_264	[p17l941t3513r1207b3574],
14	with	IN	O	with	_	0	SENT_264	[p17l1259t3513r1424b3574],
15	weekly	JJ	SET	weekly	amod	16	SENT_264	[p17l1477t3513r1734b3589],
16	paclitaxel	NN	O	paclitaxel	prep_with	13	SENT_264	[p17l1786t3513r2142b3589],
17	with	IN	O	with	_	0	SENT_264	[p17l8t3611r174b3671],
18	two	CD	NUMBER	two	num	21	SENT_264	[p17l205t3616r335b3671],
19	or	CC	O	or	_	0	SENT_264	[p17l369t3631r442b3671],
20	more	JJR	O	more	conj_or	18	SENT_264	[p17l474t3631r656b3671],
21	SNPs	NNS	O	snp	prep_with	13	SENT_264	[p17l692t3611r890b3671],
22	accumulated	VBN	O	accumulate	partmod	21	SENT_264	[p17l926t3611r1392b3671],
23	in	IN	O	in	_	0	SENT_264	[p17l1424t3612r1495b3670],
24	our	PRP$	O	we	poss	26	SENT_264	[p17l1528t3631r1650b3671],
25	target	NN	O	target	nn	26	SENT_264	[p17l1682t3616r1905b3686],
26	genes	NNS	O	gene	prep_in	22	SENT_264	[p17l1936t3630r2141b3686],

1	Laryngoscope	NN	O	laryngoscope	_	0	SENT_265	[p18l13t91r516b165],
2	119	CD	NUMBER	119	num	1	SENT_265	[p18l551t91r693b149],
3	:	:	O	:	_	0	SENT_265	[p18l551t91r693b149],
4	August	NNP	DATE	August	nsubj	6	SENT_265	[p18l726t91r975b165],
5	2009	CD	DATE	2009	num	4	SENT_265	[p18l1006t91r1178b149],
6	had	VBD	O	have	dep	1	SENT_265	[p18l7t186r145b247],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_265	[p18l198t186r654b262],
8	higher	JJR	O	higher	amod	10	SENT_265	[p18l704t186r945b262],
9	overall	JJ	O	overall	amod	10	SENT_265	[p18l998t186r1248b247],
10	survival	NN	O	survival	dobj	6	SENT_265	[p18l1302t186r1617b247],
11	.	.	O	.	_	0	SENT_265	[p18l1302t186r1617b247],

1	Because	IN	O	because	mark	11	SENT_266	[p18l1675t187r1974b247],
2	the	DT	O	the	det	3	SENT_266	[p18l2027t186r2143b247],
3	number	NN	O	number	nsubj	11	SENT_266	[p18l8t283r296b344],
4	of	IN	O	of	_	0	SENT_266	[p18l327t283r400b344],
5	patients	NNS	O	patient	prep_of	3	SENT_266	[p18l421t285r719b359],
6	included	VBN	O	include	partmod	5	SENT_266	[p18l751t283r1065b344],
7	in	IN	O	in	_	0	SENT_266	[p18l1096t285r1168b343],
8	this	DT	O	this	det	9	SENT_266	[p18l1199t283r1337b344],
9	study	NN	O	study	prep_in	6	SENT_266	[p18l1371t283r1573b359],
10	was	VBD	O	be	cop	11	SENT_266	[p18l1602t304r1742b344],
11	small	JJ	O	small	advcl	15	SENT_266	[p18l1777t283r1993b357],
12	,	,	O	,	_	0	SENT_266	[p18l1777t283r1993b357],
13	the	DT	O	the	det	14	SENT_266	[p18l2027t283r2143b344],
14	ﬁndings	NNS	O	ﬁndings	nsubj	15	SENT_266	[p18l8t381r305b457],
15	need	VBP	O	need	_	0	SENT_266	[p18l337t381r509b441],
16	to	TO	O	to	aux	18	SENT_266	[p18l539t386r606b441],
17	be	VB	O	be	auxpass	18	SENT_266	[p18l636t381r717b441],
18	interpreted	VBN	O	interpret	xcomp	15	SENT_266	[p18l749t381r1166b457],
19	With	IN	O	with	_	0	SENT_266	[p18l1195t381r1361b441],
20	caution	NN	O	caution	prep_with	18	SENT_266	[p18l1392t382r1682b455],
21	,	,	O	,	_	0	SENT_266	[p18l1392t382r1682b455],
22	and	CC	O	and	_	0	SENT_266	[p18l1718t381r1853b441],
23	studies	NNS	O	study	nsubjpass	32	SENT_266	[p18l1885t381r2143b441],
24	with	IN	O	with	_	0	SENT_266	[p18l7t477r173b538],
25	a	DT	O	a	det	27	SENT_266	[p18l214t498r254b538],
26	larger	JJR	O	larger	amod	27	SENT_266	[p18l293t477r515b553],
27	number	NN	O	number	prep_with	23	SENT_266	[p18l555t477r842b538],
28	of	IN	O	of	_	0	SENT_266	[p18l882t477r955b538],
29	patients	NNS	O	patient	prep_of	27	SENT_266	[p18l985t479r1283b553],
30	should	MD	O	should	aux	32	SENT_266	[p18l1326t477r1567b538],
31	be	VB	O	be	auxpass	32	SENT_266	[p18l1605t477r1687b538],
32	carried	VBN	O	carry	conj_and	15	SENT_266	[p18l1728t477r1987b538],
33	out	RP	O	out	prt	32	SENT_266	[p18l2028t483r2145b538],
34	to	TO	O	to	aux	35	SENT_266	[p18l8t579r75b635],
35	conﬁrm	VB	O	conﬁrm	xcomp	32	SENT_266	[p18l106t574r387b635],
36	these	DT	O	these	det	37	SENT_266	[p18l416t574r609b635],
37	results	NNS	O	result	dobj	35	SENT_266	[p18l639t574r909b635],
38	.	.	O	.	_	0	SENT_266	[p18l639t574r909b635],

1	BIBLIOGRAPHY	NN	O	bibliography	_	0	SENT_267	[p18l8t796r752b860],

1	1	LS	NUMBER	1	_	0	SENT_268	[p18l52t915r99b966],
2	.	.	O	.	_	0	SENT_268	[p18l52t915r99b966],

1	Marsh	NNP	PERSON	Marsh	nn	3	SENT_269	[p18l142t913r355b966],
2	S.	NNP	PERSON	S.	nn	3	SENT_269	[p18l392t913r448b966],
3	Pharmacogenomics	NNP	PERSON	Pharmacogenomics	_	0	SENT_269	[p18l488t913r1136b980],
4	.	.	O	.	_	0	SENT_269	[p18l488t913r1136b980],

1	Ann	NNP	O	Ann	nn	2	SENT_270	[p18l1169t913r1309b966],
2	Oncol	NNP	O	Oncol	_	0	SENT_270	[p18l1349t913r1535b966],
3	2007	CD	DATE	2007	num	2	SENT_270	[p18l1572t915r1725b966],
4	;	:	O	;	_	0	SENT_270	[p18l1733t913r2028b980],
5	18	CD	NUMBER	18	num	7	SENT_270	[p18l1733t913r2028b980],
6	(	CD	NUMBER	(	num	7	SENT_270	[p18l1733t913r2028b980],
7	suppl	NN	O	suppl	dep	2	SENT_270	[p18l1733t913r2028b980],
8	9	CD	NUMBER	9	num	9	SENT_270	[p18l2065t913r2141b974],
9	)	NN	O	)	dep	2	SENT_270	[p18l2065t913r2141b974],
10	:	:	O	:	_	0	SENT_270	[p18l2065t913r2141b974],

1	ix24	NN	O	ix24	_	0	SENT_271	[p18l221t993r553b1045],
2	—	CD	NUMBER	—	num	3	SENT_271	[p18l221t993r553b1045],
3	ix28	NN	O	ix28	dep	1	SENT_271	[p18l221t993r553b1045],
4	.	.	O	.	_	0	SENT_271	[p18l221t993r553b1045],

1	2	LS	NUMBER	2	_	0	SENT_272	[p18l47t1073r99b1124],
2	.	.	O	.	_	0	SENT_272	[p18l47t1073r99b1124],

1	Marsh	NNP	PERSON	Marsh	nn	2	SENT_273	[p18l142t1071r355b1124],
2	S	NNP	O	S	_	0	SENT_273	[p18l385t1071r442b1136],
3	,	,	O	,	_	0	SENT_273	[p18l385t1071r442b1136],
4	McLeod	NNP	PERSON	McLeod	nn	5	SENT_273	[p18l473t1071r730b1124],
5	HL	NNS	O	hl	appos	2	SENT_273	[p18l758t1071r878b1124],
6	.	.	O	.	_	0	SENT_273	[p18l758t1071r878b1124],

1	Cancer	NN	O	cancer	nn	2	SENT_274	[p18l913t1071r1142b1124],
2	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_274	[p18l1171t1071r1776b1138],
3	.	.	O	.	_	0	SENT_274	[p18l1171t1071r1776b1138],

1	Br	NN	O	br	_	0	SENT_275	[p18l1805t1072r1890b1123],
2	J	NN	O	j	nn	3	SENT_275	[p18l1916t1072r1963b1124],
3	Cancer	NN	O	cancer	dep	1	SENT_275	[p18l1989t1071r2141b1124, p18l221t1169r315b1203],

1	2004	CD	DATE	2004	_	0	SENT_276	[p18l342t1152r783b1215],
2	;	:	O	;	_	0	SENT_276	[p18l342t1152r783b1215],
3	90:8	CD	NUMBER	90:8	number	4	SENT_276	[p18l342t1152r783b1215],
4	—	CD	NUMBER	—	dep	1	SENT_276	[p18l342t1152r783b1215],
5	11	CD	NUMBER	11	dep	4	SENT_276	[p18l342t1152r783b1215],
6	.	.	O	.	_	0	SENT_276	[p18l342t1152r783b1215],

1	3	LS	NUMBER	3	_	0	SENT_277	[p18l48t1231r99b1283],
2	.	.	O	.	_	0	SENT_277	[p18l48t1231r99b1283],

1	Brotherton	NNP	ORGANIZATION	Brotherton	nn	2	SENT_278	[p18l142t1229r504b1283],
2	TW	NNP	ORGANIZATION	TW	_	0	SENT_278	[p18l530t1230r654b1294],
3	,	,	O	,	_	0	SENT_278	[p18l530t1230r654b1294],
4	Ritch	NNP	PERSON	Ritch	nn	5	SENT_278	[p18l684t1229r858b1283],
5	P	NN	PERSON	p	appos	2	SENT_278	[p18l885t1230r938b1294],
6	,	,	O	,	_	0	SENT_278	[p18l885t1230r938b1294],
7	Ervin	NNP	PERSON	Ervin	nn	8	SENT_278	[p18l967t1230r1152b1283],
8	T	NN	PERSON	t	appos	2	SENT_278	[p18l1179t1230r1234b1294],
9	,	,	O	,	_	0	SENT_278	[p18l1179t1230r1234b1294],
10	et	FW	O	et	nn	11	SENT_278	[p18l1266t1234r1326b1283],
11	al.	FW	O	al.	appos	2	SENT_278	[p18l1354t1229r1427b1283],
12	.	.	O	.	_	0	SENT_278	[p18l1354t1229r1427b1283],

1	Phase	NN	O	phase	npadvmod	3	SENT_279	[p18l1458t1229r1653b1283],
2	II	CD	NUMBER	ii	num	1	SENT_279	[p18l1682t1230r1735b1282],
3	multicenter	JJ	O	multicenter	amod	4	SENT_279	[p18l1763t1229r2146b1283],
4	trial	NN	O	trial	nsubj	13	SENT_279	[p18l221t1308r362b1361],
5	of	IN	O	of	_	0	SENT_279	[p18l394t1308r459b1361],
6	paclitaxel	NN	O	paclitaxel	prep_of	4	SENT_279	[p18l482t1308r799b1375],
7	weekly	JJ	SET	weekly	amod	6	SENT_279	[p18l829t1308r1058b1375],
8	one	CD	DURATION	one	num	10	SENT_279	[p18l1089t1326r1199b1361],
9	hour	NN	NUMBER	hour	nn	10	SENT_279	[p18l1231t1308r1384b1361],
10	infusion	NN	O	infusion	advmod	4	SENT_279	[p18l1415t1308r1680b1361],
11	in	IN	O	in	prep	10	SENT_279	[p18l1711t1309r1774b1360],
12	previously	RB	DATE	previously	pcomp	11	SENT_279	[p18l1806t1308r2146b1375],
13	treated	VBN	O	treat	_	0	SENT_279	[p18l221t1387r458b1441],
14	advanced	JJ	O	advanced	amod	16	SENT_279	[p18l504t1386r810b1441],
15	head/neck	NN	O	head/neck	nn	16	SENT_279	[p18l854t1386r1186b1441],
16	cancer	NN	O	cancer	dobj	13	SENT_279	[p18l1231t1405r1452b1441],
17	.	.	O	.	_	0	SENT_279	[p18l1231t1405r1452b1441],

1	Proc	NNP	O	Proc	nn	5	SENT_280	[p18l1498t1387r1644b1441],
2	Am	NNP	O	Am	nn	5	SENT_280	[p18l1684t1386r1800b1441],
3	Soc	NNP	O	Soc	nn	5	SENT_280	[p18l1846t1387r1958b1441],
4	Clin	NNP	O	Clin	nn	5	SENT_280	[p18l2006t1386r2142b1441],
5	Oncol	NNP	O	Oncol	_	0	SENT_280	[p18l223t1467r408b1520],
6	2001:20	CD	NUMBER	2001:20	dep	5	SENT_280	[p18l437t1469r704b1520],
7	.	.	O	.	_	0	SENT_280	[p18l437t1469r704b1520],

1	Abstract	JJ	O	abstract	_	0	SENT_281	[p18l733t1467r1015b1520],
2	921	CD	NUMBER	921	dep	1	SENT_281	[p18l1040t1469r1171b1520],
3	.	.	O	.	_	0	SENT_281	[p18l1040t1469r1171b1520],

1	4	LS	NUMBER	4	_	0	SENT_282	[p18l47t1548r99b1599],
2	.	.	O	.	_	0	SENT_282	[p18l47t1548r99b1599],

1	Nakajima	NNP	PERSON	Nakajima	nn	2	SENT_283	[p18l142t1546r464b1613],
2	M	NNP	O	M	_	0	SENT_283	[p18l504t1547r586b1611],
3	,	,	O	,	_	0	SENT_283	[p18l504t1547r586b1611],
4	Fujiki	NNP	PERSON	Fujiki	nn	5	SENT_283	[p18l630t1546r826b1613],
5	Y	NN	PERSON	y	appos	2	SENT_283	[p18l864t1547r924b1611],
6	,	,	O	,	_	0	SENT_283	[p18l864t1547r924b1611],
7	Kyo	NN	O	kyo	nn	8	SENT_283	[p18l969t1547r1094b1613],
8	S	NN	O	s	appos	2	SENT_283	[p18l1138t1546r1195b1611],
9	,	,	O	,	_	0	SENT_283	[p18l1138t1546r1195b1611],
10	et	FW	O	et	nn	11	SENT_283	[p18l1240t1551r1300b1599],
11	al.	FW	O	al.	appos	2	SENT_283	[p18l1342t1546r1415b1599],
12	.	.	O	.	_	0	SENT_283	[p18l1342t1546r1415b1599],

1	Pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_284	[p18l1460t1546r2046b1599],
2	of	IN	O	of	_	0	SENT_284	[p18l2089t1546r2153b1599],
3	paclitaxel	NN	O	paclitaxel	prep_of	1	SENT_284	[p18l222t1625r539b1692],
4	in	IN	O	in	_	0	SENT_284	[p18l581t1626r646b1677],
5	ovarian	JJ	O	ovarian	amod	7	SENT_284	[p18l690t1626r938b1678],
6	cancer	NN	O	cancer	nn	7	SENT_284	[p18l982t1643r1193b1678],
7	patients	NNS	O	patient	prep_in	1	SENT_284	[p18l1236t1626r1502b1692],
8	and	CC	O	and	_	0	SENT_284	[p18l1547t1625r1667b1678],
9	genetic	JJ	O	genetic	amod	10	SENT_284	[p18l1711t1626r1943b1692],
10	polymorphisms	NNS	O	polymorphism	prep_in	1	SENT_284	[p18l1987t1625r2144b1692, p18l222t1704r583b1771],
11	of	IN	O	of	_	0	SENT_284	[p18l611t1704r676b1757],
12	CYP2C8	NN	O	cyp2c8	prep_of	1	SENT_284	[p18l694t1704r984b1769],
13	,	,	O	,	_	0	SENT_284	[p18l694t1704r984b1769],
14	CYP3A4	NN	O	cyp3a4	conj_and	12	SENT_284	[p18l1015t1703r1290b1757],
15	and	CC	O	and	_	0	SENT_284	[p18l1316t1704r1436b1757],
16	MDR1	NN	O	mdr1	conj_and	12	SENT_284	[p18l1462t1704r1689b1757],
17	.	.	O	.	_	0	SENT_284	[p18l1462t1704r1689b1757],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_285	[p18l1715t1704r2141b1771, p18l221t1784r447b1836],
2	2005	CD	DATE	2005	num	1	SENT_285	[p18l475t1785r1038b1848],
3	;	:	O	;	_	0	SENT_285	[p18l475t1785r1038b1848],
4	45:674	CD	NUMBER	45:674	number	5	SENT_285	[p18l475t1785r1038b1848],
5	-682	CD	NUMBER	-682	dep	1	SENT_285	[p18l475t1785r1038b1848],
6	.	.	O	.	_	0	SENT_285	[p18l475t1785r1038b1848],

1	5	CD	NUMBER	5	_	0	SENT_286	[p18l48t1864r99b1915],
2	.	.	O	.	_	0	SENT_286	[p18l48t1864r99b1915],

1	Medeiros	NNP	PERSON	Medeiros	nn	2	SENT_287	[p18l142t1862r440b1915],
2	R	NNP	PERSON	R	_	0	SENT_287	[p18l468t1863r533b1927],
3	,	,	O	,	_	0	SENT_287	[p18l468t1863r533b1927],
4	Pereira	NNP	PERSON	Pereira	nn	5	SENT_287	[p18l564t1863r806b1915],
5	D	NNP	PERSON	D	appos	2	SENT_287	[p18l833t1863r902b1927],
6	,	,	O	,	_	0	SENT_287	[p18l833t1863r902b1927],
7	Afonso	NNP	PERSON	Afonso	nn	8	SENT_287	[p18l930t1862r1151b1915],
8	N	NNP	PERSON	N	appos	2	SENT_287	[p18l1179t1863r1252b1927],
9	,	,	O	,	_	0	SENT_287	[p18l1179t1863r1252b1927],
10	et	FW	O	et	nn	11	SENT_287	[p18l1283t1867r1343b1915],
11	al.	FW	O	al.	appos	2	SENT_287	[p18l1371t1862r1444b1915],
12	.	.	O	.	_	0	SENT_287	[p18l1371t1862r1444b1915],

1	Platinum/paclitaxel	NN	O	platinum/paclitaxel	nn	2	SENT_288	[p18l1476t1862r2143b1929],
2	—	NN	O	—	_	0	SENT_288	[p18l1476t1862r2143b1929],
3	based	VBN	O	base	partmod	2	SENT_288	[p18l221t1941r407b1994],
4	chemotherapy	NN	O	chemotherapy	dobj	3	SENT_288	[p18l436t1941r900b2008],
5	in	IN	O	in	_	0	SENT_288	[p18l928t1942r992b1993],
6	advanced	JJ	O	advanced	amod	8	SENT_288	[p18l1023t1941r1329b1994],
7	ovarian	JJ	O	ovarian	amod	8	SENT_288	[p18l1358t1942r1606b1994],
8	carcinoma	NN	O	carcinoma	prep_in	4	SENT_288	[p18l1635t1942r1986b1994],
9	:	:	O	:	_	0	SENT_288	[p18l1635t1942r1986b1994],
10	glutathione	NN	O	glutathione	nn	13	SENT_288	[p18l2019t1941r2144b2008, p18l221t2020r493b2073],
11	S-transferase	NN	MISC	s-transferase	nn	13	SENT_288	[p18l533t2020r969b2073],
12	genetic	JJ	O	genetic	amod	13	SENT_288	[p18l1008t2021r1240b2087],
13	polymorphisms	NNS	O	polymorphism	dep	2	SENT_288	[p18l1277t2020r1776b2087],
14	as	IN	O	as	_	0	SENT_288	[p18l1816t2038r1882b2073],
15	predictive	JJ	O	predictive	amod	16	SENT_288	[p18l1921t2020r2144b2087, p18l221t2100r342b2152],
16	biomarkers	NNS	O	biomarker	prep_as	13	SENT_288	[p18l390t2099r760b2152],
17	of	IN	O	of	_	0	SENT_288	[p18l811t2099r875b2152],
18	disease	NN	O	disease	nn	19	SENT_288	[p18l916t2099r1150b2152],
19	outcome	NN	O	outcome	prep_of	16	SENT_288	[p18l1200t2103r1485b2152],
20	.	.	O	.	_	0	SENT_288	[p18l1200t2103r1485b2152],

1	Int	NN	O	int	nn	3	SENT_289	[p18l1533t2100r1632b2152],
2	J	NN	O	j	nn	3	SENT_289	[p18l1677t2100r1725b2152],
3	Clin	NN	O	clin	_	0	SENT_289	[p18l1771t2099r1906b2152],
4	Oncol	NN	O	oncol	dep	3	SENT_289	[p18l1958t2099r2144b2152],
5	2003	CD	DATE	2003	num	4	SENT_289	[p18l223t2180r746b2243],
6	;	:	O	;	_	0	SENT_289	[p18l223t2180r746b2243],
7	8:156	CD	NUMBER	8:156	num	8	SENT_289	[p18l223t2180r746b2243],
8	—	NN	O	—	dep	3	SENT_289	[p18l223t2180r746b2243],
9	161	CD	NUMBER	161	dep	8	SENT_289	[p18l223t2180r746b2243],
10	.	.	O	.	_	0	SENT_289	[p18l223t2180r746b2243],

1	6	CD	NUMBER	6	_	0	SENT_290	[p18l48t2259r99b2310],
2	.	.	O	.	_	0	SENT_290	[p18l48t2259r99b2310],

1	Arai	NNP	PERSON	Arai	nn	2	SENT_291	[p18l139t2257r284b2310],
2	T	NN	O	t	_	0	SENT_291	[p18l328t2258r384b2322],
3	,	,	O	,	_	0	SENT_291	[p18l328t2258r384b2322],
4	Miyoshi	NNP	PERSON	Miyoshi	nn	5	SENT_291	[p18l431t2257r692b2324],
5	Y	NN	PERSON	y	appos	2	SENT_291	[p18l733t2258r793b2322],
6	,	,	O	,	_	0	SENT_291	[p18l733t2258r793b2322],
7	Kim	NNP	PERSON	Kim	nn	8	SENT_291	[p18l841t2258r979b2309],
8	SJ	NNP	O	SJ	appos	2	SENT_291	[p18l1025t2257r1121b2322],
9	,	,	O	,	_	0	SENT_291	[p18l1025t2257r1121b2322],
10	et	FW	O	et	nn	11	SENT_291	[p18l1169t2262r1230b2310],
11	al.	FW	O	al.	appos	2	SENT_291	[p18l1275t2257r1348b2310],
12	.	.	O	.	_	0	SENT_291	[p18l1275t2257r1348b2310],

1	Association	NNP	O	Association	_	0	SENT_292	[p18l1394t2257r1768b2310],
2	of	IN	O	of	_	0	SENT_292	[p18l1813t2257r1877b2310],
3	GSTP1	NN	O	gstp1	nn	4	SENT_292	[p18l1914t2257r2143b2310],
4	expression	NN	O	expression	prep_of	1	SENT_292	[p18l223t2337r568b2403],
5	with	IN	O	with	_	0	SENT_292	[p18l601t2336r748b2389],
6	resistance	NN	O	resistance	prep_with	4	SENT_292	[p18l781t2337r1111b2389],
7	to	TO	O	to	_	0	SENT_292	[p18l1144t2340r1204b2389],
8	docetaxel	NN	O	docetaxel	prep_to	1	SENT_292	[p18l1240t2336r1542b2389],
9	and	CC	O	and	_	0	SENT_292	[p18l1578t2335r1698b2389],
10	paclitaxel	NN	O	paclitaxel	conj_and	8	SENT_292	[p18l1732t2336r2047b2403],
11	in	IN	O	in	_	0	SENT_292	[p18l2081t2337r2145b2388],
12	human	JJ	O	human	amod	14	SENT_292	[p18l221t2415r453b2468],
13	breast	NN	O	breast	nn	14	SENT_292	[p18l514t2415r720b2468],
14	cancers	NNS	O	cancer	prep_in	1	SENT_292	[p18l782t2433r1042b2468],
15	.	.	O	.	_	0	SENT_292	[p18l782t2433r1042b2468],

1	Eur	NNP	O	Eur	nn	4	SENT_293	[p18l1104t2416r1233b2468],
2	J	NNP	O	J	nn	4	SENT_293	[p18l1293t2416r1340b2468],
3	Surg	NNP	O	Surg	nn	4	SENT_293	[p18l1398t2415r1558b2482],
4	Oncol	NNP	O	Oncol	_	0	SENT_293	[p18l1622t2415r1808b2468],
5	2008	CD	DATE	2008	num	4	SENT_293	[p18l1873t2417r2141b2480],
6	;	:	O	;	_	0	SENT_293	[p18l1873t2417r2141b2480],
7	34	CD	NUMBER	34	num	9	SENT_293	[p18l1873t2417r2141b2480],
8	:	:	O	:	_	0	SENT_293	[p18l1873t2417r2141b2480],
9	734-738	CD	NUMBER	734-738	dep	4	SENT_293	[p18l224t2496r510b2547],
10	.	.	O	.	_	0	SENT_293	[p18l224t2496r510b2547],

1	7	CD	NUMBER	7	_	0	SENT_294	[p18l49t2575r99b2626],
2	.	.	O	.	_	0	SENT_294	[p18l49t2575r99b2626],

1	Obata	NNP	ORGANIZATION	Obata	nn	2	SENT_295	[p18l143t2573r341b2627],
2	H	NNP	ORGANIZATION	H	_	0	SENT_295	[p18l372t2574r445b2638],
3	,	,	O	,	_	0	SENT_295	[p18l372t2574r445b2638],
4	Yahata	NNP	PERSON	Yahata	nn	5	SENT_295	[p18l477t2573r710b2627],
5	T	NN	PERSON	t	appos	2	SENT_295	[p18l740t2574r796b2638],
6	,	,	O	,	_	0	SENT_295	[p18l740t2574r796b2638],
7	Ouan	NN	PERSON	ouan	nn	8	SENT_295	[p18l832t2573r1010b2627],
8	J	NN	PERSON	j	appos	2	SENT_295	[p18l1040t2574r1095b2638],
9	,	,	O	,	_	0	SENT_295	[p18l1040t2574r1095b2638],
10	Sekine	NNP	PERSON	Sekine	nn	11	SENT_295	[p18l1131t2573r1350b2627],
11	M	NNP	O	M	conj_and	5	SENT_295	[p18l1381t2574r1463b2638],
12	,	,	O	,	_	0	SENT_295	[p18l1381t2574r1463b2638],
13	Tanaka	NNP	PERSON	Tanaka	nn	15	SENT_295	[p18l1497t2573r1744b2627],
14	K.	NNP	PERSON	K.	nn	15	SENT_295	[p18l1775t2574r1843b2626],
15	Association	NNP	PERSON	Association	conj_and	5	SENT_295	[p18l1876t2573r2144b2627, p18l221t2653r348b2705],
16	between	IN	O	between	_	0	SENT_295	[p18l391t2652r663b2705],
17	single	JJ	O	single	amod	19	SENT_295	[p18l709t2652r898b2719],
18	nucleotide	NN	O	nucleotide	nn	19	SENT_295	[p18l944t2652r1278b2705],
19	polymorphisms	NNS	O	polymorphism	prep_between	15	SENT_295	[p18l1324t2652r1823b2719],
20	of	IN	O	of	_	0	SENT_295	[p18l1868t2652r1933b2705],
21	drugassociated	JJ	O	drugassociated	amod	22	SENT_295	[p18l1970t2651r2143b2719, p18l223t2731r557b2784],
22	genes	NNS	O	gene	prep_of	19	SENT_295	[p18l624t2748r807b2798],
23	and	CC	O	and	_	0	SENT_295	[p18l878t2731r998b2784],
24	response	NN	O	response	appos	2	SENT_295	[p18l1066t2749r1351b2798],
25	to	TO	O	to	_	0	SENT_295	[p18l1419t2735r1479b2784],
26	chemotherapy	NN	O	chemotherapy	prep_to	24	SENT_295	[p18l1550t2731r2014b2798],
27	in	IN	O	in	_	0	SENT_295	[p18l2081t2732r2145b2783],
28	advanced	JJ	O	advanced	amod	30	SENT_295	[p18l223t2810r529b2863],
29	ovarian	JJ	O	ovarian	amod	30	SENT_295	[p18l610t2811r858b2864],
30	cancer	NN	O	cancer	prep_in	26	SENT_295	[p18l939t2828r1159b2863],
31	.	.	O	.	_	0	SENT_295	[p18l939t2828r1159b2863],

1	Anticancer	JJ	O	anticancer	amod	2	SENT_296	[p18l1237t2810r1598b2863],
2	Res	NNP	O	Res	_	0	SENT_296	[p18l1673t2811r1788b2864],
3	2006	CD	DATE	2006	num	5	SENT_296	[p18l1873t2812r2141b2876],
4	;	:	O	;	_	0	SENT_296	[p18l1873t2812r2141b2876],
5	26	CD	NUMBER	26	dep	2	SENT_296	[p18l1873t2812r2141b2876],
6	:	:	O	:	_	0	SENT_296	[p18l1873t2812r2141b2876],
7	2227	CD	DATE	2227	number	8	SENT_296	[p18l223t2890r588b2941],
8	—	CD	DATE	—	dep	2	SENT_296	[p18l223t2890r588b2941],
9	2232	CD	DATE	2232	dep	8	SENT_296	[p18l223t2890r588b2941],
10	.	.	O	.	_	0	SENT_296	[p18l223t2890r588b2941],

1	8	CD	NUMBER	8	_	0	SENT_297	[p18l48t2970r99b3021],
2	.	.	O	.	_	0	SENT_297	[p18l48t2970r99b3021],

1	Darcy	NNP	PERSON	Darcy	nn	2	SENT_298	[p18l142t2968r338b3034],
2	KM	NNP	PERSON	KM	_	0	SENT_298	[p18l370t2968r507b3033],
3	,	,	O	,	_	0	SENT_298	[p18l370t2968r507b3033],
4	Tian	NNP	O	Tian	nn	5	SENT_298	[p18l542t2968r691b3021],
5	CQ	NNP	O	CQ	appos	2	SENT_298	[p18l725t2968r845b3033],
6	,	,	O	,	_	0	SENT_298	[p18l725t2968r845b3033],
7	Reed	NNP	ORGANIZATION	Reed	nn	8	SENT_298	[p18l881t2968r1042b3021],
8	E	NNP	ORGANIZATION	E	appos	2	SENT_298	[p18l1074t2968r1139b3033],
9	,	,	O	,	_	0	SENT_298	[p18l1074t2968r1139b3033],
10	et	FW	O	et	nn	11	SENT_298	[p18l1176t2972r1236b3021],
11	al.	FW	O	al.	appos	2	SENT_298	[p18l1270t2968r1343b3021],
12	.	.	O	.	_	0	SENT_298	[p18l1270t2968r1343b3021],

1	A	DT	O	a	det	5	SENT_299	[p18l1378t2967r1431b3020],
2	gynecologic	JJ	O	gynecologic	amod	5	SENT_299	[p18l1462t2968r1832b3035],
3	oncology	NN	O	oncology	nn	5	SENT_299	[p18l1866t2968r2146b3035],
4	group	NN	O	group	nn	5	SENT_299	[p18l222t3064r408b3114],
5	study	NN	O	study	nsubj	26	SENT_299	[p18l474t3047r654b3114],
6	of	IN	O	of	_	0	SENT_299	[p18l716t3047r781b3100],
7	platinum-DNA	JJ	O	platinum-dna	amod	8	SENT_299	[p18l835t3047r1325b3114],
8	adducts	NNS	O	adduct	prep_of	5	SENT_299	[p18l1387t3047r1638b3100],
9	and	CC	O	and	_	0	SENT_299	[p18l1703t3047r1823b3100],
10	excision	NN	O	excision	nn	15	SENT_299	[p18l1886t3048r2145b3100],
11	repair	NN	O	repair	nn	15	SENT_299	[p18l222t3127r421b3193],
12	cross	NN	O	cross	nn	15	SENT_299	[p18l453t3126r1205b3193],
13	—	CD	NUMBER	—	num	15	SENT_299	[p18l453t3126r1205b3193],
14	complementation	NN	O	complementation	nn	15	SENT_299	[p18l453t3126r1205b3193],
15	group	NN	O	group	prep_of	5	SENT_299	[p18l1236t3143r1424b3193],
16	1	CD	NUMBER	1	num	17	SENT_299	[p18l1461t3128r1490b3178],
17	expression	NN	O	expression	dep	8	SENT_299	[p18l1525t3127r1871b3193],
18	in	IN	O	in	_	0	SENT_299	[p18l1902t3127r1966b3178],
19	optimal	JJ	O	optimal	prep_in	17	SENT_299	[p18l1998t3127r2143b3193, p18l222t3205r361b3270],
20	,	,	O	,	_	0	SENT_299	[p18l1998t3127r2143b3193, p18l222t3205r361b3270],
21	stage	NN	O	stage	npadvmod	23	SENT_299	[p18l394t3210r562b3272],
22	III	CD	NUMBER	iii	num	21	SENT_299	[p18l592t3206r674b3257],
23	epithelial	JJ	O	epithelial	amod	25	SENT_299	[p18l704t3205r1012b3272],
24	ovarian	JJ	O	ovarian	amod	25	SENT_299	[p18l1041t3206r1288b3258],
25	cancer	NN	O	cancer	appos	8	SENT_299	[p18l1317t3223r1529b3258],
26	treated	VBN	O	treat	_	0	SENT_299	[p18l1556t3205r1792b3258],
27	with	IN	O	with	_	0	SENT_299	[p18l1819t3205r1966b3258],
28	platinum-taxane	JJ	O	platinum-taxane	amod	29	SENT_299	[p18l1995t3205r2144b3272, p18l221t3285r638b3337],
29	chemotherapy	NN	O	chemotherapy	prep_with	26	SENT_299	[p18l743t3284r1215b3351],
30	.	.	O	.	_	0	SENT_299	[p18l743t3284r1215b3351],

1	Cancer	NN	O	cancer	_	0	SENT_300	[p18l1324t3284r1552b3337],
2	Res	NNP	O	Res	dep	1	SENT_300	[p18l1650t3285r1766b3337],
3	2007	CD	DATE	2007	num	2	SENT_300	[p18l1873t3286r2025b3337],
4	;	:	O	;	_	0	SENT_300	[p18l2033t3286r2124b3349],
5	67	CD	NUMBER	67	num	7	SENT_300	[p18l2033t3286r2124b3349],
6	:	:	O	:	_	0	SENT_300	[p18l2131t3302r2141b3337],
7	4474-4481	CD	DURATION	4474-4481	dep	1	SENT_300	[p18l222t3365r588b3416],
8	.	.	O	.	_	0	SENT_300	[p18l222t3365r588b3416],

1	9	CD	NUMBER	9	_	0	SENT_301	[p19l48t22r99b73],
2	.	.	O	.	_	0	SENT_301	[p19l48t22r99b73],

1	Crouthamel	NNP	PERSON	Crouthamel	nn	2	SENT_302	[p19l143t20r532b73],
2	MH	NNP	O	MH	_	0	SENT_302	[p19l576t21r717b85],
3	,	,	O	,	_	0	SENT_302	[p19l576t21r717b85],
4	Wu	NNP	PERSON	Wu	nn	5	SENT_302	[p19l762t21r870b73],
5	D	NNP	PERSON	D	appos	2	SENT_302	[p19l914t21r984b85],
6	,	,	O	,	_	0	SENT_302	[p19l914t21r984b85],
7	Yang	NNP	PERSON	Yang	nn	8	SENT_302	[p19l1027t21r1193b87],
8	Z	NNP	O	Z	appos	2	SENT_302	[p19l1235t21r1293b85],
9	,	,	O	,	_	0	SENT_302	[p19l1235t21r1293b85],
10	Ho	NNP	PERSON	Ho	nn	11	SENT_302	[p19l1340t21r1431b73],
11	RJ	NN	PERSON	rj	appos	2	SENT_302	[p19l1475t21r1578b73],
12	.	.	O	.	_	0	SENT_302	[p19l1475t21r1578b73],

1	A	DT	O	a	det	5	SENT_303	[p19l1623t20r1677b72],
2	novel	JJ	O	novel	amod	5	SENT_303	[p19l1718t20r1891b73],
3	MDR1	NN	O	mdr1	nn	5	SENT_303	[p19l1934t21r2143b73],
4	G1199T	NN	O	g1199t	nn	5	SENT_303	[p19l223t99r476b152],
5	variant	NN	O	variant	nsubj	6	SENT_303	[p19l511t100r753b152],
6	alters	VBZ	O	alter	_	0	SENT_303	[p19l791t99r974b152],
7	drug	NN	O	drug	nn	8	SENT_303	[p19l1014t99r1167b166],
8	resistance	NN	O	resistance	dobj	6	SENT_303	[p19l1202t100r1531b152],
9	and	CC	O	and	_	0	SENT_303	[p19l1570t99r1690b152],
10	efﬂux	NN	O	efﬂux	nn	12	SENT_303	[p19l1727t99r1913b152],
11	transport	NN	O	transport	nn	12	SENT_303	[p19l1948t104r2144b152, p19l222t183r356b245],
12	activity	NN	O	activity	dobj	6	SENT_303	[p19l391t179r636b245],
13	of	IN	O	of	_	0	SENT_303	[p19l671t178r736b231],
14	P-glycoprotein	NN	O	p-glycoprotein	prep_of	8	SENT_303	[p19l762t178r1234b245],
15	in	IN	O	in	_	0	SENT_303	[p19l1268t179r1332b230],
16	recombinant	JJ	O	recombinant	amod	18	SENT_303	[p19l1367t178r1779b231],
17	Hek	NN	O	hek	nn	18	SENT_303	[p19l1814t178r1949b231],
18	cells	NNS	O	cell	prep_in	14	SENT_303	[p19l1984t178r2140b231],
19	.	.	O	.	_	0	SENT_303	[p19l1984t178r2140b231],

1	J	NNP	O	J	nn	3	SENT_304	[p19l219t258r267b310],
2	Pharm	NNP	O	Pharm	nn	3	SENT_304	[p19l285t257r512b310],
3	Sci	NNP	O	Sci	_	0	SENT_304	[p19l538t257r637b310],
4	2006	CD	DATE	2006	num	3	SENT_304	[p19l667t259r1213b322],
5	;	:	O	;	_	0	SENT_304	[p19l667t259r1213b322],
6	95:2767	CD	NUMBER	95:2767	number	7	SENT_304	[p19l667t259r1213b322],
7	—	CD	NUMBER	—	num	8	SENT_304	[p19l667t259r1213b322],
8	27	CD	NUMBER	27	dep	3	SENT_304	[p19l667t259r1213b322],
9	7	CD	NUMBER	7	number	10	SENT_304	[p19l1220t259r1252b310],
10	7	CD	NUMBER	7	amod	8	SENT_304	[p19l1259t259r1292b310],
11	.	.	O	.	_	0	SENT_304	[p19l1300t301r1309b310],

1	10	CD	NUMBER	10	_	0	SENT_305	[p19l13t338r99b389],
2	.	.	O	.	_	0	SENT_305	[p19l13t338r99b389],

1	Henningsson	NN	MISC	henningsson	nn	2	SENT_306	[p19l142t337r570b403],
2	A	NN	MISC	a	_	0	SENT_306	[p19l612t336r679b401],
3	,	,	O	,	_	0	SENT_306	[p19l612t336r679b401],
4	Marsh	NNP	PERSON	Marsh	nn	5	SENT_306	[p19l726t336r938b389],
5	S	NNP	O	S	appos	2	SENT_306	[p19l983t336r1040b401],
6	,	,	O	,	_	0	SENT_306	[p19l983t336r1040b401],
7	Loos	NNP	PERSON	Loos	nn	8	SENT_306	[p19l1086t337r1233b389],
8	WJ	NNP	O	WJ	appos	2	SENT_306	[p19l1277t337r1401b401],
9	,	,	O	,	_	0	SENT_306	[p19l1277t337r1401b401],
10	et	FW	O	et	nn	11	SENT_306	[p19l1448t341r1508b389],
11	al.	FW	O	al.	appos	2	SENT_306	[p19l1553t336r1626b389],
12	.	.	O	.	_	0	SENT_306	[p19l1553t336r1626b389],

1	Association	NNP	O	Association	_	0	SENT_307	[p19l1671t336r2045b389],
2	of	IN	O	of	_	0	SENT_307	[p19l2089t336r2153b389],
3	CYP2C8	NNP	O	CYP2C8	prep_of	1	SENT_307	[p19l223t415r515b480],
4	,	,	O	,	_	0	SENT_307	[p19l223t415r515b480],
5	CYP3A4	NN	O	cyp3a4	prep_of	1	SENT_307	[p19l554t415r846b480],
6	,	,	O	,	_	0	SENT_307	[p19l554t415r846b480],
7	CYP3A5	NN	O	cyp3a5	prep_of	1	SENT_307	[p19l884t415r1176b480],
8	,	,	O	,	_	0	SENT_307	[p19l884t415r1176b480],
9	and	CC	O	and	_	0	SENT_307	[p19l1215t415r1335b468],
10	ABCB1	NN	O	abcb1	nn	11	SENT_307	[p19l1367t415r1609b468],
11	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_307	[p19l1646t415r2144b482],
12	with	IN	O	with	_	0	SENT_307	[p19l221t494r368b547],
13	the	DT	O	the	det	14	SENT_307	[p19l398t494r502b547],
14	pharmacokinetics	NNS	O	pharmacokinetic	prep_with	1	SENT_307	[p19l534t494r1113b561],
15	of	IN	O	of	_	0	SENT_307	[p19l1146t494r1211b547],
16	paclitaxel	NN	O	paclitaxel	prep_of	14	SENT_307	[p19l1233t494r1566b561],
17	.	.	O	.	_	0	SENT_307	[p19l1233t494r1566b561],

1	Clin	NNP	O	Clin	nn	3	SENT_308	[p19l1602t494r1738b547],
2	Cancer	NNP	O	Cancer	nn	3	SENT_308	[p19l1772t494r2000b547],
3	Res	NNP	O	Res	_	0	SENT_308	[p19l2027t495r2142b547],
4	2005	CD	DATE	2005	num	3	SENT_308	[p19l223t575r864b638],
5	;	:	O	;	_	0	SENT_308	[p19l223t575r864b638],
6	15:8097	CD	DURATION	15:8097	number	7	SENT_308	[p19l223t575r864b638],
7	-8104	CD	DURATION	-8104	dep	3	SENT_308	[p19l223t575r864b638],
8	.	.	O	.	_	0	SENT_308	[p19l223t575r864b638],

1	11	CD	NUMBER	11	_	0	SENT_309	[p19l13t654r96b705],
2	.	.	O	.	_	0	SENT_309	[p19l13t654r96b705],

1	Dai	NN	PERSON	daus	nn	2	SENT_310	[p19l138t653r253b705],
2	D	NN	PERSON	d	_	0	SENT_310	[p19l296t653r366b717],
3	,	,	O	,	_	0	SENT_310	[p19l296t653r366b717],
4	Zeldin	NNP	PERSON	Zeldin	nn	5	SENT_310	[p19l412t652r618b705],
5	DC	NNP	O	DC	appos	2	SENT_310	[p19l661t652r782b717],
6	,	,	O	,	_	0	SENT_310	[p19l661t652r782b717],
7	Blaisdell	NNP	PERSON	Blaisdell	nn	8	SENT_310	[p19l827t652r1113b705],
8	JA	NNP	O	JA	appos	2	SENT_310	[p19l1155t652r1261b717],
9	,	,	O	,	_	0	SENT_310	[p19l1155t652r1261b717],
10	et	FW	O	et	nn	11	SENT_310	[p19l1308t657r1368b705],
11	al.	FW	O	al.	appos	2	SENT_310	[p19l1412t652r1485b705],
12	.	.	O	.	_	0	SENT_310	[p19l1412t652r1485b705],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_311	[p19l1532t652r2037b719],
2	in	IN	O	in	_	0	SENT_311	[p19l2081t653r2145b704],
3	human	JJ	O	human	amod	6	SENT_311	[p19l221t731r453b784],
4	CYP2C8	NN	O	cyp2c8	nn	6	SENT_311	[p19l496t731r770b784],
5	decrease	NN	O	decrease	nn	6	SENT_311	[p19l814t731r1093b784],
6	metabolism	NN	O	metabolism	prep_in	1	SENT_311	[p19l1135t731r1514b784],
7	of	IN	O	of	_	0	SENT_311	[p19l1556t731r1621b784],
8	the	DT	O	the	det	11	SENT_311	[p19l1654t731r1758b784],
9	anticancer	JJ	O	anticancer	amod	11	SENT_311	[p19l1802t732r2146b784],
10	drug	NN	O	drug	nn	11	SENT_311	[p19l223t810r375b877],
11	paclitaxel	NN	O	paclitaxel	prep_of	1	SENT_311	[p19l417t810r733b877],
12	and	CC	O	and	_	0	SENT_311	[p19l776t810r897b863],
13	arachidonic	JJ	O	arachidonic	amod	14	SENT_311	[p19l940t810r1318b863],
14	acid	NN	O	acid	conj_and	11	SENT_311	[p19l1362t810r1508b863],
15	.	.	O	.	_	0	SENT_311	[p19l1362t810r1508b863],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_312	[p19l1550t810r2143b877],
2	2001	CD	DATE	2001	num	1	SENT_312	[p19l223t891r781b954],
3	;	:	O	;	_	0	SENT_312	[p19l223t891r781b954],
4	11:597	CD	NUMBER	11:597	number	5	SENT_312	[p19l223t891r781b954],
5	-607	CD	NUMBER	-607	dep	1	SENT_312	[p19l223t891r781b954],
6	.	.	O	.	_	0	SENT_312	[p19l223t891r781b954],

1	12	CD	NUMBER	12	_	0	SENT_313	[p19l13t970r99b1021],
2	.	.	O	.	_	0	SENT_313	[p19l13t970r99b1021],

1	Green	NNP	PERSON	Green	nn	2	SENT_314	[p19l143t968r342b1021],
2	H	NNP	PERSON	H	dep	17	SENT_314	[p19l371t969r445b1033],
3	,	,	O	,	_	0	SENT_314	[p19l371t969r445b1033],
4	Soderkvist	NNP	O	Soderkvist	nn	5	SENT_314	[p19l478t968r825b1021],
5	P	NN	O	p	appos	2	SENT_314	[p19l854t969r907b1033],
6	,	,	O	,	_	0	SENT_314	[p19l854t969r907b1033],
7	Rosenberg	NNP	PERSON	Rosenberg	nn	8	SENT_314	[p19l939t968r1281b1035],
8	P	NN	O	p	appos	2	SENT_314	[p19l1309t969r1361b1033],
9	,	,	O	,	_	0	SENT_314	[p19l1309t969r1361b1033],
10	et	FW	O	et	nn	12	SENT_314	[p19l1395t973r1455b1021],
11	al.	FW	O	al.	nn	12	SENT_314	[p19l1485t968r1558b1021],
12	mdr-1	NN	O	mdr-1	appos	2	SENT_314	[p19l1591t968r1784b1021],
13	single	JJ	O	single	amod	15	SENT_314	[p19l1817t968r2007b1035],
14	nucleotide	NN	O	nucleotide	nn	15	SENT_314	[p19l2036t986r2143b1021, p19l223t1046r469b1100],
15	polymorphisms	NNS	O	polymorphism	dep	17	SENT_314	[p19l505t1046r1004b1113],
16	ovarian	JJ	O	ovarian	amod	17	SENT_314	[p19l1041t1048r1288b1100],
17	cancer	NN	O	cancer	dep	22	SENT_314	[p19l1324t1064r1535b1100],
18	tissue	NN	O	tissue	dep	17	SENT_314	[p19l1569t1048r1778b1100],
19	:	:	O	:	_	0	SENT_314	[p19l1569t1048r1778b1100],
20	G267	NN	O	g267	nn	21	SENT_314	[p19l1817t1046r1986b1100],
21	7T/A	NN	O	7t/a	nsubj	22	SENT_314	[p19l1993t1046r2148b1100],
22	correlates	VBZ	O	correlate	_	0	SENT_314	[p19l223t1126r542b1179],
23	with	IN	O	with	_	0	SENT_314	[p19l572t1126r719b1179],
24	response	NN	O	response	prep_with	22	SENT_314	[p19l748t1144r1032b1193],
25	to	TO	O	to	_	0	SENT_314	[p19l1063t1131r1123b1179],
26	paclitaxel	NN	O	paclitaxel	nn	27	SENT_314	[p19l1154t1126r1469b1193],
27	chemotherapy	NN	O	chemotherapy	prep_to	22	SENT_314	[p19l1499t1126r1971b1193],
28	.	.	O	.	_	0	SENT_314	[p19l1499t1126r1971b1193],

1	Clin	NNP	O	Clin	nn	3	SENT_315	[p19l2006t1126r2142b1179],
2	Cancer	NNP	O	Cancer	nn	3	SENT_315	[p19l223t1205r451b1258],
3	Res	NNP	O	Res	_	0	SENT_315	[p19l472t1206r588b1258],
4	2006	CD	DATE	2006	num	3	SENT_315	[p19l617t1207r1180b1270],
5	;	:	O	;	_	0	SENT_315	[p19l617t1207r1180b1270],
6	12:854	CD	NUMBER	12:854	number	7	SENT_315	[p19l617t1207r1180b1270],
7	-859	CD	NUMBER	-859	dep	3	SENT_315	[p19l617t1207r1180b1270],
8	.	.	O	.	_	0	SENT_315	[p19l617t1207r1180b1270],

1	13	CD	NUMBER	13	_	0	SENT_316	[p19l13t1286r99b1337],
2	.	.	O	.	_	0	SENT_316	[p19l13t1286r99b1337],

1	Marsh	NNP	PERSON	Marsh	nn	2	SENT_317	[p19l142t1284r355b1337],
2	S	NNP	O	S	_	0	SENT_317	[p19l390t1284r448b1349],
3	,	,	O	,	_	0	SENT_317	[p19l390t1284r448b1349],
4	King	NNP	O	King	nn	5	SENT_317	[p19l485t1285r644b1351],
5	CR	NN	O	cr	appos	2	SENT_317	[p19l678t1284r793b1349],
6	,	,	O	,	_	0	SENT_317	[p19l678t1284r793b1349],
7	McLeod	NNP	PERSON	McLeod	nn	8	SENT_317	[p19l830t1284r1086b1337],
8	HL	NNS	O	hl	appos	2	SENT_317	[p19l1121t1285r1242b1349],
9	,	,	O	,	_	0	SENT_317	[p19l1121t1285r1242b1349],
10	et	FW	O	et	nn	11	SENT_317	[p19l1279t1289r1340b1337],
11	al.	FW	O	al.	appos	2	SENT_317	[p19l1374t1284r1448b1337],
12	.	.	O	.	_	0	SENT_317	[p19l1374t1284r1448b1337],

1	ABCB1	NN	O	abcb1	nn	2	SENT_318	[p19l1484t1284r1725b1337],
2	2677G	NN	O	2677g	_	0	SENT_318	[p19l1762t1284r2148b1339],
3	>	JJR	O	>	amod	5	SENT_318	[p19l1762t1284r2148b1339],
4	T/A	NN	O	t/a	nn	5	SENT_318	[p19l1762t1284r2148b1339],
5	genotype	NN	O	genotype	dep	2	SENT_318	[p19l222t1367r514b1429],
6	and	CC	O	and	_	0	SENT_318	[p19l542t1362r662b1416],
7	paclitaxel	NN	O	paclitaxel	nn	8	SENT_318	[p19l688t1362r1004b1429],
8	pharmacogenetics	NNS	O	pharmacogenetic	dep	2	SENT_318	[p19l1031t1362r1619b1429],
9	in	IN	O	in	_	0	SENT_318	[p19l1646t1364r1709b1415],
10	ovarian	JJ	O	ovarian	amod	11	SENT_318	[p19l1736t1364r1984b1416],
11	cancer	NN	O	cancer	prep_in	2	SENT_318	[p19l2009t1380r2144b1416, p19l223t1460r329b1495],
12	.	.	O	.	_	0	SENT_318	[p19l2009t1380r2144b1416, p19l223t1460r329b1495],

1	Clin	NNP	O	Clin	nn	3	SENT_319	[p19l361t1442r497b1495],
2	Cancer	NNP	O	Cancer	nn	3	SENT_319	[p19l527t1442r755b1495],
3	Res	NNP	O	Res	_	0	SENT_319	[p19l776t1443r892b1495],
4	2006	CD	DATE	2006	num	3	SENT_319	[p19l921t1444r1563b1507],
5	;	:	O	;	_	0	SENT_319	[p19l921t1444r1563b1507],
6	12:4127	CD	NUMBER	12:4127	number	7	SENT_319	[p19l921t1444r1563b1507],
7	—	CD	NUMBER	—	dep	3	SENT_319	[p19l921t1444r1563b1507],
8	4129	CD	NUMBER	4129	dep	7	SENT_319	[p19l921t1444r1563b1507],
9	.	.	O	.	_	0	SENT_319	[p19l921t1444r1563b1507],

1	14	CD	NUMBER	14	_	0	SENT_320	[p19l13t1523r100b1574],
2	.	.	O	.	_	0	SENT_320	[p19l13t1523r100b1574],

1	Sissung	NNP	O	Sissung	nn	2	SENT_321	[p19l144t1521r399b1588],
2	TM	NNP	O	TM	_	0	SENT_321	[p19l440t1522r570b1586],
3	,	,	O	,	_	0	SENT_321	[p19l440t1522r570b1586],
4	Mross	NNP	PERSON	Mross	nn	5	SENT_321	[p19l616t1522r813b1574],
5	K	NNP	PERSON	K	appos	2	SENT_321	[p19l857t1522r926b1586],
6	,	,	O	,	_	0	SENT_321	[p19l857t1522r926b1586],
7	Steinberg	NNP	PERSON	Steinberg	nn	8	SENT_321	[p19l974t1521r1290b1588],
8	D	NNP	O	D	appos	2	SENT_321	[p19l1332t1522r1402b1586],
9	,	,	O	,	_	0	SENT_321	[p19l1332t1522r1402b1586],
10	et	FW	O	et	nn	11	SENT_321	[p19l1449t1525r1509b1574],
11	al.	FW	O	al.	appos	2	SENT_321	[p19l1553t1521r1626b1574],
12	.	.	O	.	_	0	SENT_321	[p19l1553t1521r1626b1574],

1	Association	NNP	O	Association	_	0	SENT_322	[p19l1671t1521r2045b1574],
2	of	IN	O	of	_	0	SENT_322	[p19l2089t1521r2153b1574],
3	ABCB1	NN	O	abcb1	nn	4	SENT_322	[p19l220t1600r461b1653],
4	genotypes	NNS	O	genotype	prep_of	1	SENT_322	[p19l519t1605r844b1667],
5	with	IN	O	with	_	0	SENT_322	[p19l900t1600r1047b1653],
6	paclitaxel-mediated	JJ	O	paclitaxel-mediated	amod	8	SENT_322	[p19l1103t1600r1749b1667],
7	peripheral	JJ	O	peripheral	amod	8	SENT_322	[p19l1804t1600r2145b1667],
8	neuropathy	NN	O	neuropathy	prep_with	1	SENT_322	[p19l222t1678r601b1745],
9	and	CC	O	and	_	0	SENT_322	[p19l657t1678r777b1732],
10	neutropenia	NN	O	neutropenia	conj_and	8	SENT_322	[p19l834t1680r1246b1745],
11	.	.	O	.	_	0	SENT_322	[p19l834t1680r1246b1745],

1	Eur	NNP	O	Eur	nn	3	SENT_323	[p19l1303t1679r1432b1732],
2	J	NNP	O	J	nn	3	SENT_323	[p19l1485t1679r1533b1732],
3	Cancer	NNP	O	Cancer	_	0	SENT_323	[p19l1588t1678r1815b1732],
4	2006,42	CD	NUMBER	2006,42	num	3	SENT_323	[p19l1873t1680r2141b1744],
5	:	:	O	:	_	0	SENT_323	[p19l1873t1680r2141b1744],
6	2893-2896	CD	DATE	2893-2896	dep	3	SENT_323	[p19l223t1760r588b1811],
7	.	.	O	.	_	0	SENT_323	[p19l223t1760r588b1811],

1	15	CD	NUMBER	15	_	0	SENT_324	[p19l13t1839r100b1890],
2	.	.	O	.	_	0	SENT_324	[p19l13t1839r100b1890],

1	Bellmunt	NNP	PERSON	Bellmunt	nn	2	SENT_325	[p19l142t1837r449b1890],
2	J	NNP	PERSON	J	_	0	SENT_325	[p19l475t1838r513b1890],
3	,	,	O	,	_	0	SENT_325	[p19l518t1881r530b1902],
4	Paz-Ares	NNP	O	Paz-Ares	nn	5	SENT_325	[p19l561t1837r853b1890],
5	L	NNP	O	L	appos	2	SENT_325	[p19l883t1838r944b1902],
6	,	,	O	,	_	0	SENT_325	[p19l883t1838r944b1902],
7	Cuello	NNP	O	Cuello	nn	8	SENT_325	[p19l976t1837r1182b1890],
8	M	NNP	O	M	appos	2	SENT_325	[p19l1210t1838r1292b1902],
9	,	,	O	,	_	0	SENT_325	[p19l1210t1838r1292b1902],
10	et	FW	O	et	nn	11	SENT_325	[p19l1324t1841r1384b1890],
11	al.	FW	O	al.	appos	2	SENT_325	[p19l1413t1837r1486b1890],
12	.	.	O	.	_	0	SENT_325	[p19l1413t1837r1486b1890],

1	Gene	NN	PERSON	gene	nn	2	SENT_326	[p19l1520t1837r1685b1890],
2	expression	NN	O	expression	_	0	SENT_326	[p19l1714t1838r2061b1904],
3	of	IN	O	of	_	0	SENT_326	[p19l2089t1837r2153b1890],
4	ERCC1	NN	O	ercc1	prep_of	2	SENT_326	[p19l222t1916r461b1969],
5	as	IN	O	as	_	0	SENT_326	[p19l490t1934r557b1969],
6	a	DT	O	a	det	9	SENT_326	[p19l586t1934r621b1969],
7	novel	JJ	O	novel	amod	9	SENT_326	[p19l647t1916r820b1969],
8	prognostic	JJ	O	prognostic	amod	9	SENT_326	[p19l846t1917r1183b1983],
9	marker	NN	O	marker	prep_as	4	SENT_326	[p19l1209t1916r1451b1969],
10	in	IN	O	in	_	0	SENT_326	[p19l1475t1917r1539b1968],
11	advanced	JJ	O	advanced	amod	14	SENT_326	[p19l1567t1916r1872b1969],
12	bladder	NN	O	bladder	nn	14	SENT_326	[p19l1897t1916r2145b1969],
13	cancer	NN	O	cancer	nn	14	SENT_326	[p19l223t2012r434b2048],
14	patients	NNS	O	patient	prep_in	9	SENT_326	[p19l479t1996r744b2061],
15	receiving	VBG	O	receive	partmod	2	SENT_326	[p19l790t1996r1089b2061],
16	cisplatin-based	JJ	O	cisplatin-based	amod	17	SENT_326	[p19l1133t1994r1624b2061],
17	chemotherapy	NN	O	chemotherapy	dobj	15	SENT_326	[p19l1669t1994r2141b2061],
18	.	.	O	.	_	0	SENT_326	[p19l1669t1994r2141b2061],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_327	[p19l214t2074r355b2127],
2	Oncol	NNP	PERSON	Oncol	_	0	SENT_327	[p19l385t2074r570b2127],
3	2007	CD	DATE	2007	num	2	SENT_327	[p19l598t2076r1161b2139],
4	;	:	O	;	_	0	SENT_327	[p19l598t2076r1161b2139],
5	18:522	CD	NUMBER	18:522	number	6	SENT_327	[p19l598t2076r1161b2139],
6	-528	CD	NUMBER	-528	dep	2	SENT_327	[p19l598t2076r1161b2139],
7	.	.	O	.	_	0	SENT_327	[p19l598t2076r1161b2139],

1	16	CD	NUMBER	16	_	0	SENT_328	[p19l13t2155r100b2206],
2	.	.	O	.	_	0	SENT_328	[p19l13t2155r100b2206],

1	Bewick	NNP	PERSON	Bewick	nn	2	SENT_329	[p19l142t2153r379b2206],
2	MA	NNP	PERSON	MA	_	0	SENT_329	[p19l419t2153r552b2218],
3	,	,	O	,	_	0	SENT_329	[p19l419t2153r552b2218],
4	Conlon	NNP	PERSON	Conlon	nn	5	SENT_329	[p19l598t2153r827b2206],
5	MS	NN	O	m	appos	2	SENT_329	[p19l867t2153r994b2218],
6	,	,	O	,	_	0	SENT_329	[p19l867t2153r994b2218],
7	Lafrenie	NN	O	lafrenie	nn	8	SENT_329	[p19l1039t2153r1314b2206],
8	RM	NN	O	rm	appos	5	SENT_329	[p19l1357t2154r1488b2206],
9	.	.	O	.	_	0	SENT_329	[p19l1357t2154r1488b2206],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_330	[p19l1534t2153r2039b2220],
2	in	IN	O	in	_	0	SENT_330	[p19l2081t2154r2145b2205],
3	XRCC1	NN	O	xrcc1	prep_in	1	SENT_330	[p19l220t2232r480b2297],
4	,	,	O	,	_	0	SENT_330	[p19l220t2232r480b2297],
5	XRCC3	NN	O	xrcc3	prep_in	1	SENT_330	[p19l523t2232r783b2297],
6	,	,	O	,	_	0	SENT_330	[p19l523t2232r783b2297],
7	and	CC	O	and	_	0	SENT_330	[p19l831t2232r951b2286],
8	CCND1	NN	O	ccnd1	conj_and	3	SENT_330	[p19l995t2232r1244b2286],
9	and	CC	O	and	_	0	SENT_330	[p19l1291t2232r1411b2286],
10	survival	NN	O	survival	conj_and	3	SENT_330	[p19l1456t2232r1720b2286],
11	after	IN	O	after	_	0	SENT_330	[p19l1765t2232r1920b2286],
12	treatment	NN	O	treatment	prep_after	1	SENT_330	[p19l1962t2237r2144b2286, p19l222t2315r390b2364],
13	for	IN	O	for	_	0	SENT_330	[p19l420t2310r510b2364],
14	metastatic	JJ	O	metastatic	amod	16	SENT_330	[p19l541t2312r883b2364],
15	breast	NN	O	breast	nn	16	SENT_330	[p19l914t2310r1120b2364],
16	cancer	NN	O	cancer	prep_for	1	SENT_330	[p19l1152t2328r1372b2364],
17	.	.	O	.	_	0	SENT_330	[p19l1152t2328r1372b2364],

1	J	NNP	O	J	nn	3	SENT_331	[p19l1406t2311r1453b2364],
2	Clin	NNP	O	Clin	nn	3	SENT_331	[p19l1482t2310r1618b2364],
3	Oncol	NNP	O	Oncol	_	0	SENT_331	[p19l1653t2310r1839b2364],
4	2006,24	CD	NUMBER	2006,24	num	3	SENT_331	[p19l1873t2312r2141b2376],
5	:	:	O	:	_	0	SENT_331	[p19l1873t2312r2141b2376],
6	5645-5651	CD	DURATION	5645-5651	dep	3	SENT_331	[p19l223t2392r588b2443],
7	.	.	O	.	_	0	SENT_331	[p19l223t2392r588b2443],

1	17	CD	NUMBER	17	_	0	SENT_332	[p19l13t2471r100b2522],
2	.	.	O	.	_	0	SENT_332	[p19l13t2471r100b2522],

1	Monzo	NNP	O	Monzo	nn	2	SENT_333	[p19l142t2470r355b2522],
2	M	NNP	O	M	_	0	SENT_333	[p19l383t2470r465b2534],
3	,	,	O	,	_	0	SENT_333	[p19l383t2470r465b2534],
4	Brunet	NNP	PERSON	Brunet	nn	5	SENT_333	[p19l497t2470r728b2522],
5	S	NNP	O	S	appos	2	SENT_333	[p19l757t2469r814b2534],
6	,	,	O	,	_	0	SENT_333	[p19l757t2469r814b2534],
7	Urbano-Ispizua	NNP	O	Urbano-Ispizua	nn	8	SENT_333	[p19l844t2469r1356b2536],
8	A	NNP	O	A	appos	2	SENT_333	[p19l1380t2469r1448b2534],
9	,	,	O	,	_	0	SENT_333	[p19l1380t2469r1448b2534],
10	et	FW	O	et	nn	11	SENT_333	[p19l1480t2473r1540b2522],
11	al.	FW	O	al.	appos	2	SENT_333	[p19l1569t2469r1642b2522],
12	.	.	O	.	_	0	SENT_333	[p19l1569t2469r1642b2522],

1	Genomic	JJ	MISC	genomic	amod	2	SENT_334	[p19l1675t2469r1959b2522],
2	polymorphisms	NNS	O	polymorphism	nsubj	3	SENT_334	[p19l1987t2469r2143b2536, p19l222t2548r560b2615],
3	provide	VBP	O	provide	_	0	SENT_334	[p19l605t2548r829b2615],
4	prognostic	JJ	O	prognostic	amod	5	SENT_334	[p19l873t2549r1185b2615],
5	information	NN	O	information	dobj	3	SENT_334	[p19l1228t2548r1586b2601],
6	in	IN	O	in	_	0	SENT_334	[p19l1629t2549r1690b2600],
7	intermediateGrau	NN	O	intermediategrau	prep_in	5	SENT_334	[p19l1733t2548r2143b2601, p19l478t2772r646b2833],

1	et	FW	O	et	nn	2	SENT_335	[p19l680t2777r744b2832],
2	al.	FW	O	al.	_	0	SENT_335	[p19l775t2774r871b2832],
3	:	:	O	:	_	0	SENT_335	[p19l775t2774r871b2832],
4	Advanced	NNP	O	Advanced	nn	5	SENT_335	[p19l905t2774r1262b2832],
5	Head	NNP	O	Head	nsubj	9	SENT_335	[p19l1299t2774r1480b2832],
6	and	CC	O	and	_	0	SENT_335	[p19l1515t2774r1643b2832],
7	Neck	NNP	O	Neck	nn	8	SENT_335	[p19l1680t2774r1860b2832],
8	Cancer	NNP	O	Cancer	conj_and	5	SENT_335	[p19l1891t2772r2146b2833],
9	risk	NN	O	risk	dep	2	SENT_335	[p19l219t3136r348b3190],
10	acute	JJ	O	acute	amod	12	SENT_335	[p19l420t3141r593b3190],
11	myeloblastic	JJ	O	myeloblastic	amod	12	SENT_335	[p19l665t3136r1074b3204],
12	leukaemia	NN	O	leukaemia	dobj	9	SENT_335	[p19l1146t3136r1503b3190],
13	.	.	O	.	_	0	SENT_335	[p19l1146t3136r1503b3190],

1	Blood	NN	O	blood	_	0	SENT_336	[p19l1575t3136r1767b3190],
2	2006	CD	DATE	2006	num	1	SENT_336	[p19l1840t3138r2149b3202],
3	;	:	O	;	_	0	SENT_336	[p19l1840t3138r2149b3202],
4	107	CD	NUMBER	107	num	6	SENT_336	[p19l1840t3138r2149b3202],
5	:	:	O	:	_	0	SENT_336	[p19l1840t3138r2149b3202],
6	4871-4879	CD	DURATION	4871-4879	dep	1	SENT_336	[p19l220t3217r588b3269],
7	.	.	O	.	_	0	SENT_336	[p19l220t3217r588b3269],

1	18	CD	NUMBER	18	_	0	SENT_337	[p20l10t22r97b74],
2	.	.	O	.	_	0	SENT_337	[p20l10t22r97b74],

1	Therase	NN	O	therase	nn	2	SENT_338	[p20l139t20r403b74],
2	P	NN	O	p	_	0	SENT_338	[p20l442t21r496b86],
3	,	,	O	,	_	0	SENT_338	[p20l442t21r496b86],
4	Arbuck	NNP	O	Arbuck	nn	5	SENT_338	[p20l535t20r778b74],
5	SG	NNP	O	SG	appos	2	SENT_338	[p20l816t20r930b86],
6	,	,	O	,	_	0	SENT_338	[p20l816t20r930b86],
7	Eisenhauer	NNP	PERSON	Eisenhauer	nn	8	SENT_338	[p20l971t20r1350b74],
8	AE	NNP	O	AE	appos	2	SENT_338	[p20l1386t20r1506b86],
9	,	,	O	,	_	0	SENT_338	[p20l1386t20r1506b86],
10	et	FW	O	et	nn	11	SENT_338	[p20l1548t25r1608b74],
11	al.	FW	O	al.	appos	2	SENT_338	[p20l1647t20r1721b74],
12	.	.	O	.	_	0	SENT_338	[p20l1647t20r1721b74],

1	New	NNP	O	New	nn	2	SENT_339	[p20l1763t21r1911b74],
2	guidelines	NNS	O	guideline	nsubj	4	SENT_339	[p20l1950t20r2151b88, p20l219t100r373b154],
3	to	TO	O	to	aux	4	SENT_339	[p20l429t105r489b154],
4	evaluate	VB	O	evaluate	_	0	SENT_339	[p20l546t100r824b154],
5	the	DT	O	the	det	6	SENT_339	[p20l879t100r983b154],
6	response	NN	O	response	dobj	4	SENT_339	[p20l1039t118r1325b168],
7	to	TO	O	to	_	0	SENT_339	[p20l1381t105r1441b154],
8	treatment	NN	O	treatment	prep_to	4	SENT_339	[p20l1496t105r1828b154],
9	in	IN	O	in	_	0	SENT_339	[p20l1882t101r1946b153],
10	solid	JJ	O	solid	amod	11	SENT_339	[p20l2002t100r2153b154],
11	tumors	NNS	O	tumor	prep_in	8	SENT_339	[p20l219t185r468b234],
12	.	.	O	.	_	0	SENT_339	[p20l219t185r468b234],

1	J	NNP	O	J	nn	4	SENT_340	[p20l496t181r544b234],
2	Natl	NNP	O	Natl	nn	4	SENT_340	[p20l561t180r711b234],
3	Cancer	NNP	O	Cancer	nn	4	SENT_340	[p20l740t180r969b234],
4	Inst	NNP	O	Inst	_	0	SENT_340	[p20l991t181r1122b234],
5	2000	CD	DATE	2000	num	4	SENT_340	[p20l1150t182r1716b247],
6	;	:	O	;	_	0	SENT_340	[p20l1150t182r1716b247],
7	92:205	CD	NUMBER	92:205	number	8	SENT_340	[p20l1150t182r1716b247],
8	-216	CD	NUMBER	-216	dep	4	SENT_340	[p20l1150t182r1716b247],
9	.	.	O	.	_	0	SENT_340	[p20l1150t182r1716b247],

1	19	CD	NUMBER	19	_	0	SENT_341	[p20l10t261r97b313],
2	.	.	O	.	_	0	SENT_341	[p20l10t261r97b313],

1	Marsh	NNP	PERSON	Marsh	nn	2	SENT_342	[p20l139t259r353b313],
2	S	NNP	O	S	_	0	SENT_342	[p20l390t259r447b325],
3	,	,	O	,	_	0	SENT_342	[p20l390t259r447b325],
4	Paul	NNP	PERSON	Paul	nn	5	SENT_342	[p20l485t259r635b313],
5	J	NNP	PERSON	J	appos	2	SENT_342	[p20l669t260r724b325],
6	,	,	O	,	_	0	SENT_342	[p20l669t260r724b325],
7	King	NNP	O	King	nn	8	SENT_342	[p20l763t260r922b327],
8	CR	NN	O	cr	appos	2	SENT_342	[p20l956t259r1072b325],
9	,	,	O	,	_	0	SENT_342	[p20l956t259r1072b325],
10	Gifford	NNP	PERSON	Gifford	nn	11	SENT_342	[p20l1111t259r1342b314],
11	G	NNP	PERSON	G	appos	2	SENT_342	[p20l1378t259r1447b325],
12	,	,	O	,	_	0	SENT_342	[p20l1378t259r1447b325],
13	McLeod	NNP	PERSON	McLeod	nn	14	SENT_342	[p20l1484t259r1742b313],
14	HL	NNS	O	hl	appos	2	SENT_342	[p20l1777t260r1898b325],
15	,	,	O	,	_	0	SENT_342	[p20l1777t260r1898b325],
16	Brown	NNP	PERSON	Brown	nn	19	SENT_342	[p20l1937t260r2153b314],
17	R.	NNP	PERSON	R.	nn	19	SENT_342	[p20l220t341r284b394],
18	Pharmacogenetic	NNP	PERSON	Pharmacogenetic	nn	19	SENT_342	[p20l327t340r894b408],
19	assessment	NN	O	assessment	appos	2	SENT_342	[p20l934t345r1307b394],
20	of	IN	O	of	_	0	SENT_342	[p20l1345t340r1410b394],
21	toxicity	NN	O	toxicity	prep_of	19	SENT_342	[p20l1439t341r1683b408],
22	and	CC	O	and	_	0	SENT_342	[p20l1723t340r1843b394],
23	outcome	NN	O	outcome	prep_of	19	SENT_342	[p20l1882t345r2152b394],
24	after	IN	O	after	_	0	SENT_342	[p20l221t420r376b474],
25	platinum	NN	O	platinum	prep_after	2	SENT_342	[p20l405t420r706b488],
26	plus	CC	O	plus	_	0	SENT_342	[p20l734t420r870b488],
27	taxane	NN	O	taxane	nn	28	SENT_342	[p20l899t425r1122b474],
28	chemotherapy	NN	O	chemotherapy	conj_plus	2	SENT_342	[p20l1152t420r1618b488],
29	in	IN	O	in	_	0	SENT_342	[p20l1645t421r1709b473],
30	ovarian	JJ	O	ovarian	amod	31	SENT_342	[p20l1739t421r1988b474],
31	cancer	NN	O	cancer	prep_in	28	SENT_342	[p20l2016t438r2151b474, p20l220t518r333b554],
32	:	:	O	:	_	0	SENT_342	[p20l2016t438r2151b474, p20l220t518r333b554],
33	the	DT	O	the	det	36	SENT_342	[p20l380t500r484b554],
34	Scottish	JJ	MISC	scottish	amod	36	SENT_342	[p20l531t500r793b554],
35	Randomised	JJ	MISC	randomised	amod	36	SENT_342	[p20l837t500r1240b554],
36	Trial	NN	MISC	trial	dep	2	SENT_342	[p20l1284t500r1442b554],
37	in	IN	MISC	in	_	0	SENT_342	[p20l1485t501r1549b553],
38	Ovarian	JJ	MISC	ovarian	amod	39	SENT_342	[p20l1594t500r1863b554],
39	Cancer	NN	MISC	cancer	prep_in	36	SENT_342	[p20l1907t500r2148b554],
40	.	.	O	.	_	0	SENT_342	[p20l1907t500r2148b554],

1	J	NNP	O	J	nn	3	SENT_343	[p20l217t580r264b634],
2	Clin	NNP	O	Clin	nn	3	SENT_343	[p20l289t579r425b633],
3	Oncol	NNP	O	Oncol	_	0	SENT_343	[p20l455t579r642b633],
4	2007	CD	DATE	2007	num	3	SENT_343	[p20l670t581r1314b646],
5	;	:	O	;	_	0	SENT_343	[p20l670t581r1314b646],
6	25:4528	CD	NUMBER	25:4528	number	7	SENT_343	[p20l670t581r1314b646],
7	—	CD	NUMBER	—	dep	3	SENT_343	[p20l670t581r1314b646],
8	4535	CD	NUMBER	4535	dep	7	SENT_343	[p20l670t581r1314b646],
9	.	.	O	.	_	0	SENT_343	[p20l670t581r1314b646],

1	20	CD	NUMBER	20	_	0	SENT_344	[p20l6t662r97b714],
2	.	.	O	.	_	0	SENT_344	[p20l6t662r97b714],

1	Soyama	NN	MISC	soyama	nn	2	SENT_345	[p20l141t660r399b728],
2	A	NN	MISC	a	_	0	SENT_345	[p20l426t660r495b726],
3	,	,	O	,	_	0	SENT_345	[p20l426t660r495b726],
4	Saito	NNP	PERSON	Saito	nn	5	SENT_345	[p20l530t660r694b714],
5	Y	NN	PERSON	y	appos	2	SENT_345	[p20l723t661r783b726],
6	,	,	O	,	_	0	SENT_345	[p20l723t661r783b726],
7	Hanioka	FW	ORGANIZATION	hanioka	dep	2	SENT_345	[p20l817t660r1098b714],
8	N	NN	ORGANIZATION	n	dep	2	SENT_345	[p20l1126t661r1199b726],
9	,	,	O	,	_	0	SENT_345	[p20l1126t661r1199b726],
10	et	FW	O	et	nn	11	SENT_345	[p20l1234t665r1294b714],
11	al.	FW	O	al.	appos	8	SENT_345	[p20l1325t660r1398b714],
12	.	.	O	.	_	0	SENT_345	[p20l1325t660r1398b714],

1	Non-synonymous	JJ	O	non-synonymous	amod	4	SENT_346	[p20l1433t661r2001b728],
2	single	JJ	O	single	amod	4	SENT_346	[p20l2034t661r2151b714, p20l220t740r313b808],
3	nucleotide	NN	O	nucleotide	nn	4	SENT_346	[p20l366t740r702b794],
4	alterations	NNS	O	alteration	nsubj	12	SENT_346	[p20l756t740r1109b794],
5	found	VBN	O	find	partmod	4	SENT_346	[p20l1163t740r1349b794],
6	in	IN	O	in	_	0	SENT_346	[p20l1400t741r1464b793],
7	the	DT	O	the	det	10	SENT_346	[p20l1515t740r1619b794],
8	CYP2C8	NN	O	cyp2c8	nn	10	SENT_346	[p20l1673t740r1948b794],
9	gene	NN	O	gene	nn	10	SENT_346	[p20l2001t757r2151b808],
10	result	NN	O	result	prep_in	5	SENT_346	[p20l219t820r412b874],
11	in	IN	O	in	prep	5	SENT_346	[p20l458t821r522b873],
12	reduced	VBN	O	reduce	_	0	SENT_346	[p20l570t820r829b874],
13	in	FW	O	in	nn	14	SENT_346	[p20l875t821r939b873],
14	vitro	FW	O	vitro	advmod	12	SENT_346	[p20l986t821r1140b874],
15	paclitaxel	NN	O	paclitaxel	nn	16	SENT_346	[p20l1188t820r1506b888],
16	methabolism	NN	O	methabolism	dobj	12	SENT_346	[p20l1553t820r1992b874],
17	.	.	O	.	_	0	SENT_346	[p20l1553t820r1992b874],

1	Bio	NNP	O	Bio	nn	3	SENT_347	[p20l2040t821r2150b874],
2	Pharm	NNP	O	Pharm	nn	3	SENT_347	[p20l216t899r443b953],
3	Bull	NNP	O	Bull	_	0	SENT_347	[p20l468t899r610b953],
4	2001	CD	DATE	2001	num	3	SENT_347	[p20l639t901r1283b966],
5	;	:	O	;	_	0	SENT_347	[p20l639t901r1283b966],
6	241:1427	CD	DURATION	241:1427	number	7	SENT_347	[p20l639t901r1283b966],
7	-1430	CD	DURATION	-1430	dep	3	SENT_347	[p20l639t901r1283b966],
8	.	.	O	.	_	0	SENT_347	[p20l639t901r1283b966],

1	Lawngoscope	NN	O	lawngoscope	_	0	SENT_348	[p20l9t1127r515b1201],
2	119	CD	NUMBER	119	num	1	SENT_348	[p20l550t1127r693b1185],
3	:	:	O	:	_	0	SENT_348	[p20l550t1127r693b1185],
4	August	NNP	DATE	August	dep	1	SENT_348	[p20l726t1127r977b1201],
5	2009	CD	DATE	2009	num	4	SENT_348	[p20l1008t1127r1181b1185],

1	21	CD	NUMBER	21	_	0	SENT_349	[p20l6t1491r96b1543],
2	.	.	O	.	_	0	SENT_349	[p20l6t1491r96b1543],

1	Soyama	NN	MISC	soyama	nn	2	SENT_350	[p20l141t1489r398b1557],
2	A	NN	MISC	a	_	0	SENT_350	[p20l431t1489r499b1555],
3	,	,	O	,	_	0	SENT_350	[p20l431t1489r499b1555],
4	Saito	NNP	PERSON	Saito	nn	5	SENT_350	[p20l541t1489r705b1543],
5	Y	NN	PERSON	y	appos	2	SENT_350	[p20l739t1490r799b1555],
6	,	,	O	,	_	0	SENT_350	[p20l739t1490r799b1555],
7	Komamura	NNP	PERSON	Komamura	nn	8	SENT_350	[p20l839t1490r1208b1543],
8	K	NNP	PERSON	K	appos	2	SENT_350	[p20l1244t1490r1314b1555],
9	,	,	O	,	_	0	SENT_350	[p20l1244t1490r1314b1555],
10	et	FW	O	et	nn	11	SENT_350	[p20l1354t1494r1415b1543],
11	al.	FW	O	al.	appos	2	SENT_350	[p20l1452t1489r1525b1543],
12	.	.	O	.	_	0	SENT_350	[p20l1452t1489r1525b1543],

1	Five	CD	NUMBER	five	num	5	SENT_351	[p20l1566t1490r1706b1543],
2	novel	JJ	O	novel	amod	5	SENT_351	[p20l1743t1489r1916b1543],
3	single	JJ	O	single	amod	5	SENT_351	[p20l1955t1489r2145b1557],
4	nucleotide	NN	O	nucleotide	nn	5	SENT_351	[p20l219t1568r554b1622],
5	polymorphisms	NNS	O	polymorphism	_	0	SENT_351	[p20l600t1568r1099b1636],
6	in	IN	O	in	_	0	SENT_351	[p20l1143t1570r1207b1622],
7	the	DT	O	the	det	9	SENT_351	[p20l1250t1568r1353b1622],
8	CYP2C8	NN	O	cyp2c8	nn	9	SENT_351	[p20l1400t1568r1674b1622],
9	gene	NN	O	gene	prep_in	5	SENT_351	[p20l1718t1585r1886b1636],
10	,	,	O	,	_	0	SENT_351	[p20l1718t1585r1886b1636],
11	one	CD	NUMBER	one	nsubj	14	SENT_351	[p20l1934t1586r2045b1622],
12	of	IN	O	of	_	0	SENT_351	[p20l2090t1568r2154b1622],
13	which	WDT	O	which	prep_of	11	SENT_351	[p20l218t1649r414b1703],
14	induces	VBZ	O	induce	rcmod	9	SENT_351	[p20l446t1649r694b1703],
15	a	DT	O	a	det	16	SENT_351	[p20l729t1667r765b1703],
16	frame-shift	NN	O	frame-shift	dobj	14	SENT_351	[p20l796t1649r1177b1703],
17	.	.	O	.	_	0	SENT_351	[p20l796t1649r1177b1703],

1	Drug	NNP	O	Drug	nn	4	SENT_352	[p20l1210t1650r1381b1717],
2	Metal	NNP	O	Metal	nn	4	SENT_352	[p20l1410t1649r1614b1703],
3	)	NNP	O	)	nn	4	SENT_352	[p20l1410t1649r1614b1703],
4	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_352	[p20l1645t1649r2146b1703],
5	2002	CD	DATE	2002	num	4	SENT_352	[p20l220t1731r783b1794],
6	;	:	O	;	_	0	SENT_352	[p20l220t1731r783b1794],
7	17:374	CD	NUMBER	17:374	number	8	SENT_352	[p20l220t1731r783b1794],
8	-377	CD	NUMBER	-377	dep	4	SENT_352	[p20l220t1731r783b1794],
9	.	.	O	.	_	0	SENT_352	[p20l220t1731r783b1794],

1	22	CD	NUMBER	22	_	0	SENT_353	[p20l6t1810r96b1861],
2	.	.	O	.	_	0	SENT_353	[p20l6t1810r96b1861],

1	Lamba	NNP	PERSON	Lamba	nn	2	SENT_354	[p20l140t1808r366b1862],
2	JK	NNP	O	JK	_	0	SENT_354	[p20l411t1809r523b1873],
3	,	,	O	,	_	0	SENT_354	[p20l411t1809r523b1873],
4	Lin	NNP	PERSON	Lin	nn	5	SENT_354	[p20l574t1809r685b1861],
5	YS	NNP	O	YS	appos	2	SENT_354	[p20l730t1808r842b1873],
6	,	,	O	,	_	0	SENT_354	[p20l730t1808r842b1873],
7	Thummel	NNP	O	Thummel	nn	8	SENT_354	[p20l893t1808r1210b1862],
8	K	NNP	O	K	appos	2	SENT_354	[p20l1258t1809r1328b1873],
9	,	,	O	,	_	0	SENT_354	[p20l1258t1809r1328b1873],
10	et	FW	O	et	nn	11	SENT_354	[p20l1380t1813r1440b1862],
11	al.	FW	O	al.	appos	2	SENT_354	[p20l1489t1808r1562b1862],
12	.	.	O	.	_	0	SENT_354	[p20l1489t1808r1562b1862],

1	Common	JJ	O	common	amod	3	SENT_355	[p20l1616t1808r1905b1862],
2	allelic	JJ	O	allelic	amod	3	SENT_355	[p20l1954t1808r2146b1862],
3	variants	NNS	O	variant	_	0	SENT_355	[p20l218t1888r491b1940],
4	of	IN	O	of	_	0	SENT_355	[p20l526t1886r590b1940],
5	cytochrome	NN	O	cytochrome	nn	6	SENT_355	[p20l617t1886r988b1954],
6	P4503A4	NN	O	p4503a4	prep_of	3	SENT_355	[p20l1023t1886r1315b1940],
7	and	CC	O	and	_	0	SENT_355	[p20l1350t1886r1470b1940],
8	their	PRP$	O	they	poss	9	SENT_355	[p20l1503t1886r1663b1940],
9	prevalence	NN	O	prevalence	prep_of	3	SENT_355	[p20l1696t1886r2048b1954],
10	in	IN	O	in	_	0	SENT_355	[p20l2082t1888r2146b1940],
11	different	JJ	O	different	amod	12	SENT_355	[p20l220t1967r502b2021],
12	populations	NNS	O	population	prep_in	3	SENT_355	[p20l577t1967r974b2035],
13	.	.	O	.	_	0	SENT_355	[p20l577t1967r974b2035],

1	Pharmocogenetics	NNS	O	pharmocogenetic	_	0	SENT_356	[p20l1050t1967r1638b2035],
2	2002	CD	DATE	2002	num	1	SENT_356	[p20l1716t1969r2147b2033, p20l224t2049r350b2100],
3	;	:	O	;	_	0	SENT_356	[p20l1716t1969r2147b2033, p20l224t2049r350b2100],
4	12:121132	CD	NUMBER	12:121132	dep	1	SENT_356	[p20l1716t1969r2147b2033, p20l224t2049r350b2100],
5	.	.	O	.	_	0	SENT_356	[p20l1716t1969r2147b2033, p20l224t2049r350b2100],

1	23	CD	NUMBER	23	_	0	SENT_357	[p20l6t2127r96b2179],
2	.	.	O	.	_	0	SENT_357	[p20l6t2127r96b2179],

1	Hitt	NNP	PERSON	Hitt	nn	2	SENT_358	[p20l139t2126r274b2179],
2	R	NNP	PERSON	R	_	0	SENT_358	[p20l303t2126r368b2191],
3	,	,	O	,	_	0	SENT_358	[p20l303t2126r368b2191],
4	Irigoyen	NNP	MISC	Irigoyen	nn	5	SENT_358	[p20l401t2126r674b2193],
5	A	NNP	MISC	A	appos	2	SENT_358	[p20l700t2125r768b2191],
6	,	,	O	,	_	0	SENT_358	[p20l700t2125r768b2191],
7	Nuﬁez	NNP	O	Nuﬁez	nn	8	SENT_358	[p20l800t2126r1011b2179],
8	J	NNP	O	J	appos	2	SENT_358	[p20l1040t2126r1079b2179],
9	,	,	O	,	_	0	SENT_358	[p20l1084t2170r1095b2191],
10	et	FW	O	et	nn	11	SENT_358	[p20l1129t2130r1189b2179],
11	al.	FW	O	al.	appos	2	SENT_358	[p20l1219t2125r1293b2179],
12	.	.	O	.	_	0	SENT_358	[p20l1219t2125r1293b2179],

1	Phase	NN	O	phase	nn	3	SENT_359	[p20l1326t2125r1522b2179],
2	II	CD	NUMBER	ii	num	3	SENT_359	[p20l1553t2126r1606b2179],
3	study	NN	O	study	_	0	SENT_359	[p20l1638t2125r1818b2193],
4	of	IN	O	of	_	0	SENT_359	[p20l1846t2125r1911b2179],
5	combination	NN	O	combination	nn	6	SENT_359	[p20l1933t2125r2144b2180, p20l219t2207r429b2259],
6	cetuximab	NN	O	cetuximab	prep_of	3	SENT_359	[p20l463t2205r800b2260],
7	and	CC	O	and	_	0	SENT_359	[p20l836t2205r957b2259],
8	weekly	JJ	SET	weekly	amod	9	SENT_359	[p20l989t2205r1218b2273],
9	paclitaxel	NN	O	paclitaxel	conj_and	3	SENT_359	[p20l1250t2205r1568b2273],
10	in	IN	O	in	_	0	SENT_359	[p20l1601t2207r1665b2259],
11	patients	NNS	O	patient	prep_in	9	SENT_359	[p20l1699t2207r1965b2273],
12	with	IN	O	with	_	0	SENT_359	[p20l1998t2205r2146b2260],
13	metastatic/recurrent	JJ	O	metastatic/recurrent	amod	16	SENT_359	[p20l219t2286r898b2340],
14	squamous	JJ	O	squamous	amod	16	SENT_359	[p20l951t2304r1276b2354],
15	cell	NN	O	cell	nn	16	SENT_359	[p20l1330t2286r1438b2340],
16	carcinoma	NN	O	carcinoma	prep_with	11	SENT_359	[p20l1492t2287r1829b2340],
17	of	IN	O	of	_	0	SENT_359	[p20l1880t2286r1945b2340],
18	head	NN	O	head	prep_of	16	SENT_359	[p20l1988t2286r2146b2340],
19	and	CC	O	and	_	0	SENT_359	[p20l220t2366r341b2420],
20	neck	NN	O	neck	conj_and	18	SENT_359	[p20l367t2366r535b2420],
21	:	:	O	:	_	0	SENT_359	[p20l367t2366r535b2420],
22	Spanish	JJ	O	spanish	amod	23	SENT_359	[p20l566t2366r829b2434],
23	Head	NNP	O	Head	dep	3	SENT_359	[p20l856t2366r1029b2420],
24	and	CC	O	and	_	0	SENT_359	[p20l1056t2366r1176b2420],
25	Neck	NNP	O	Neck	nn	30	SENT_359	[p20l1202t2366r1369b2420],
26	Cancer	NNP	O	Cancer	nn	30	SENT_359	[p20l1395t2366r1626b2420],
27	Group	NNP	O	Group	nn	30	SENT_359	[p20l1653t2366r1856b2434],
28	(	CD	NUMBER	(	num	30	SENT_359	[p20l1884t2366r2141b2428],
29	TTCC	NN	O	ttcc	nn	30	SENT_359	[p20l1884t2366r2141b2428],
30	)	NN	O	)	dep	3	SENT_359	[p20l1884t2366r2141b2428],
31	.	.	O	.	_	0	SENT_359	[p20l1884t2366r2141b2428],

1	2007	CD	DATE	2007	num	2	SENT_360	[p20l220t2447r373b2499],
2	ASCO	NNP	ORGANIZATION	ASCO	_	0	SENT_360	[p20l409t2445r609b2499],
3	Annual	JJ	SET	annual	dep	2	SENT_360	[p20l646t2445r890b2499],
4	Meeting	VBG	O	meet	partmod	2	SENT_360	[p20l927t2446r1196b2513],
5	Proceedings	NNP	O	Proceedings	nn	10	SENT_360	[p20l1232t2445r1625b2513],
6	Part	NNP	O	Part	nn	10	SENT_360	[p20l1663t2446r1808b2499],
7	I.	NNP	O	I.	nn	10	SENT_360	[p20l1845t2446r1886b2499],
8	J	NNP	O	J	nn	10	SENT_360	[p20l1925t2446r1972b2500],
9	Clin	NNP	O	Clin	nn	10	SENT_360	[p20l2007t2445r2143b2499],
10	Oncol	NNP	O	Oncol	dobj	4	SENT_360	[p20l220t2525r405b2579],
11	2007	CD	DATE	2007	num	10	SENT_360	[p20l433t2525r1111b2593],
12	;	:	O	;	_	0	SENT_360	[p20l433t2525r1111b2593],
13	25	CD	NUMBER	25	number	14	SENT_360	[p20l433t2525r1111b2593],
14	(	CD	NUMBER	(	num	16	SENT_360	[p20l433t2525r1111b2593],
15	suppl	NN	O	suppl	nn	16	SENT_360	[p20l433t2525r1111b2593],
16	)	NN	O	)	dep	10	SENT_360	[p20l433t2525r1111b2593],
17	:	:	O	:	_	0	SENT_360	[p20l433t2525r1111b2593],
18	S302	NN	O	s302	dep	10	SENT_360	[p20l433t2525r1111b2593],
19	.	.	O	.	_	0	SENT_360	[p20l433t2525r1111b2593],

1	Abstract	JJ	O	abstract	_	0	SENT_361	[p20l1140t2525r1422b2580],
2	6012	CD	NUMBER	6012	dep	1	SENT_361	[p20l1448t2527r1618b2579],
3	.	.	O	.	_	0	SENT_361	[p20l1448t2527r1618b2579],

1	Grau	NNP	PERSON	Grau	_	0	SENT_362	[p20l476t2754r644b2815],
2	et	FW	O	et	nn	3	SENT_362	[p20l678t2759r742b2814],
3	al.	FW	O	al.	dep	1	SENT_362	[p20l773t2756r870b2814],
4	:	:	O	:	_	0	SENT_362	[p20l773t2756r870b2814],
5	Advanced	NNP	O	Advanced	nn	6	SENT_362	[p20l903t2756r1261b2814],
6	Head	NNP	O	Head	dep	1	SENT_362	[p20l1299t2756r1480b2814],
7	and	CC	O	and	_	0	SENT_362	[p20l1515t2756r1643b2814],
8	Neck	NNP	O	Neck	nn	9	SENT_362	[p20l1680t2756r1860b2814],
9	Cancer	NNP	O	Cancer	dep	1	SENT_362	[p20l1891t2754r2147b2815],

